Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AC213203.1 ENSG00000268674 P0DMU3 Unmapped 35407-35916 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "brain: 1.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043267, HPA043292, HPA077864" Uncertain Approved "Intermediate filaments" NA NA "Cluster 21: B-cells - Adaptive immune response" "Intermediate filaments" "HPA043267: , HPA043292: , HPA077864: AB_2686862" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.8 0.3 0.1 0.2 0.3 0.2 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS3 "ADAMTS-4, KIAA0366" ENSG00000156140 "ADAM metallopeptidase with thrombospondin type 1 motif 3" O15072 4 72280969-72569221 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 8.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Excitatory neurons: 50.2;Leydig cells: 19.9;Rod photoreceptor cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.2;AN3-CA: 7.8;HEL: 14.1;K-562: 12.3;SH-SY5Y: 7.0;U-2 OS: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021368, HPA021369" Uncertain Approved "Intermediate filaments" "Secreted to extracellular matrix" NA NA "Cluster 77: Retina - Visual perception" "Cluster 1: K-562 - Erythropoiesis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Intermediate filaments" "HPA021368: AB_2670681, HPA021369: AB_2670682" "unprognostic (1.93e-1)" "unprognostic (3.47e-3)" "unprognostic (1.41e-1)" "unprognostic (1.05e-3)" "unprognostic (6.11e-2)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (1.60e-3)" "unprognostic (5.92e-4)" "unprognostic (3.11e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (8.63e-3)" "unprognostic (1.65e-3)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" "unprognostic (1.50e-4)" 2.3 0.8 0.5 1.0 2.5 0.8 3.2 0.0 1.5 0.4 0.1 0.3 0.1 1.9 1.7 0.2 2.9 0.6 0.9 1.5 0.6 0.9 0.2 1.1 0.8 0.0 0.2 2.0 0.3 2.7 0.2 0.7 0.1 0.7 0.3 8.4 0.4 1.1 0.2 0.4 0.2 1.7 0.0 0.7 0.5 1.9 0.1 0.6 1.2 0.3 0.3 1.3 0.4 0.4 0.0 0.0 13.2 7.8 0.1 0.3 0.1 0.7 2.1 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.8 0.0 1.8 0.0 1.8 14.1 0.9 0.0 0.2 0.0 0.0 1.7 0.1 0.6 0.1 3.3 0.0 0.0 12.3 0.0 0.0 0.0 1.3 0.0 2.2 0.0 4.0 0.0 2.6 0.0 4.6 0.0 0.5 7.0 0.0 0.6 0.2 1.4 0.1 0.2 0.1 5.6 8.5 0.0 0.7 0.0 0.0 0.0 1.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.5 0.0 1.5 1.5 0.6 0.0 0.2 0.1 0.0 0.1 0.4 1.8 0.0 3.4 7.5 0.0 0.5 0.9 0.0 0.0 0.9 0.8 3.2 1.2 1.5 1.3 1.8 14.6 0.0 0.0 0.0 0.0 0.0 4.1 2.2 5.1 3.7 0.0 2.5 50.2 0.0 0.3 3.3 0.0 0.7 1.3 1.9 3.9 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.7 1.9 19.9 0.3 0.0 1.0 0.0 1.8 0.0 7.1 1.3 0.0 0.0 4.5 0.0 1.1 0.0 0.3 0.5 12.9 0.0 0.3 1.2 1.2 0.8 0.3 0.0 0.0 0.0 2.8 0.0 0.1 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449090 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;heart muscle: 105.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2" "Region enriched" "Detected in all" 5 "basal ganglia: 388.0" "Region enriched" "Detected in all" 6 "basal ganglia: 155.9" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 18.9 3.3 25.5 4.9 97.7 0.0 10.6 13.9 43.9 9.8 0.0 35.1 5.2 14.7 5.7 18.8 12.7 10.0 105.2 25.8 15.9 12.8 3.3 4.1 2.3 20.5 18.3 13.2 7.5 0.8 14.3 6.1 17.4 19.8 5.6 4.5 4.0 21.5 2.7 2.6 13.0 18.2 10.8 6.5 21.2 8.2 34.4 1.3 1.9 5.8 3.0 23.2 7.8 30.1 0.0 0.6 1.3 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.2 2.3 0.5 0.6 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 15.5 0.0 0.0 0.8 0.0 0.1 0.0 0.3 2.7 5.2 0.5 1.8 1.6 0.0 0.5 0.1 1.7 0.0 0.1 0.0 0.1 1.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 97.7 13.9 43.9 25.8 15.9 20.5 18.3 17.4 10.8 34.4 30.1 0.3 0.0 0.0 8.1 0.1 0.3 0.1 0.2 0.0 21.8 0.4 5.8 75.5 8.6 0.0 7.3 0.0 1.4 0.0 2.6 0.0 15.9 0.9 1.5 7.1 1.8 0.0 0.0 34.0 6.9 4.0 5.2 0.0 4.0 0.0 4.6 3.9 0.1 0.3 0.0 44.0 0.3 0.0 0.0 0.3 3.0 20.5 0.1 0.0 6.5 1.0 1.0 0.0 19.1 89.7 0.4 59.6 73.7 0.0 0.1 0.3 0.8 0.0 2.2 65.7 0.6 21.4 0.8 6.3 0.2 0.9 12.4 0.2 1.0 2.0 0.1 ALS2 ALS2CR6 ENSG00000003393 "Alsin Rho guanine nucleotide exchange factor ALS2" Q96Q42 2 201700267-201782112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 91.8;granulocytes: 46.9;Inhibitory neurons: 66.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "cerebellum: 26.4" "Group enriched" "Detected in many" 5 "basophil: 23.0;eosinophil: 6.8" "Lineage enriched" "Detected in all" 8 "granulocytes: 23.0" "Cell line enhanced" "Detected in all" "HMC-1: 50.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.8" HPA046588 Enhanced Approved "Intermediate filaments,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Intermediate filaments, Cytosol" "HPA046588: AB_2679709" "unprognostic (3.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-3)" "unprognostic (2.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.04e-3)" "unprognostic (9.17e-2)" "unprognostic (4.16e-2)" "unprognostic (1.52e-1)" "unprognostic (2.99e-1)" "unprognostic (2.83e-2)" "unprognostic (1.09e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (2.10e-1)" "unprognostic (1.84e-1)" 7.3 5.5 2.6 2.6 3.1 5.6 6.8 26.4 4.2 6.4 4.5 6.6 3.2 6.6 7.8 4.8 6.4 3.8 13.7 3.4 1.6 8.0 14.5 6.7 2.8 0.9 1.0 6.0 5.7 4.3 10.0 3.5 1.7 6.1 3.4 5.4 5.4 1.6 13.5 7.1 6.6 4.8 0.3 5.3 6.8 5.3 1.4 2.4 6.3 5.9 2.8 6.2 5.7 2.6 6.5 6.7 7.1 5.6 7.0 5.1 7.2 8.6 10.4 14.0 13.2 5.8 8.4 1.2 3.8 11.7 6.1 3.7 4.6 10.6 18.0 3.5 4.8 15.3 6.2 5.2 8.1 16.4 50.4 9.8 4.1 11.5 14.0 5.7 10.0 8.6 9.8 5.7 9.6 7.5 6.7 20.3 9.2 4.6 5.3 5.4 7.7 4.2 9.8 8.8 3.4 7.8 6.4 7.1 9.2 14.3 5.4 7.2 7.9 11.6 7.2 3.5 6.2 7.1 9.2 4.5 8.5 3.4 7.2 23.0 0.9 6.8 1.6 1.7 1.9 1.2 1.3 1.3 1.4 1.0 1.5 1.5 0.9 3.0 1.2 0.8 2.1 0.8 2.6 3.1 26.4 4.2 3.4 1.6 0.9 1.0 1.7 0.3 1.4 2.6 7.6 12.8 16.7 28.7 2.8 5.4 3.8 4.4 3.4 15.1 5.4 4.3 32.3 8.6 4.3 9.2 29.2 5.7 3.7 3.6 0.0 6.9 16.5 14.0 6.8 10.4 4.8 12.0 91.8 3.3 3.2 6.9 9.7 6.8 46.9 10.1 13.2 20.3 5.9 8.4 66.6 6.9 2.0 3.2 3.0 6.5 7.8 4.8 0.0 27.2 3.1 5.9 4.1 36.2 44.0 6.1 3.9 8.2 2.3 4.4 7.8 6.1 17.5 15.4 0.0 9.3 8.4 7.3 5.6 4.6 6.0 6.7 3.9 5.2 4.7 3.7 ANAPC4 APC4 ENSG00000053900 "Anaphase promoting complex subunit 4" Q9UJX5 4 25377263-25418498 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 266.1;Glandular and luminal cells: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032519, HPA038395, HPA038396" Approved Approved "Intermediate filaments" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" "Intermediate filaments" "CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356" "unprognostic (1.36e-1)" "unprognostic (9.15e-2)" "unprognostic (6.06e-3)" "prognostic favorable (5.73e-7)" "unprognostic (1.14e-1)" "prognostic favorable (1.95e-4)" "unprognostic (1.18e-3)" "unprognostic (5.44e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "unprognostic (8.86e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.95e-2)" "prognostic favorable (1.12e-6)" 13.4 15.7 14.1 15.6 15.0 18.5 15.8 14.5 19.1 23.5 15.1 15.6 11.8 26.7 18.1 13.5 35.1 11.8 11.6 14.6 14.1 15.1 13.0 13.8 20.6 14.1 13.9 18.6 15.8 15.5 12.9 15.5 14.1 16.6 16.7 16.6 12.9 21.2 13.8 14.7 15.8 13.9 14.3 19.2 14.1 10.8 14.7 16.1 13.7 8.5 18.3 18.8 14.3 16.7 21.5 12.4 21.4 22.4 22.0 24.4 30.5 25.0 18.5 23.2 22.3 20.0 33.4 34.9 13.1 21.4 29.5 16.9 22.9 21.1 26.5 12.5 17.5 33.9 23.2 18.9 14.8 26.7 26.6 18.9 15.6 20.5 12.4 16.4 20.4 30.4 49.7 10.2 29.8 16.7 34.6 43.5 29.7 18.9 15.2 24.4 35.7 25.7 19.6 23.0 23.8 14.3 18.7 11.0 16.1 21.8 16.4 28.3 20.9 19.7 12.4 15.3 29.1 13.4 25.3 33.3 21.4 37.6 19.0 2.4 7.4 14.9 9.6 8.8 13.1 8.6 8.7 11.4 6.5 6.9 7.7 9.8 3.0 10.3 12.5 4.2 11.6 6.4 14.1 15.0 14.5 19.1 14.6 14.1 14.1 13.9 14.1 14.3 14.7 16.7 11.1 9.6 14.5 26.8 15.2 12.9 16.5 13.1 14.2 12.9 7.6 7.5 14.0 14.3 17.2 7.3 10.4 56.9 17.5 8.9 5.9 10.3 4.3 266.1 20.6 11.1 12.6 10.3 28.8 12.0 14.2 16.3 17.3 79.0 25.3 15.3 15.0 7.1 17.5 21.9 38.4 8.4 10.2 13.7 8.0 3.4 10.2 13.7 17.8 18.7 15.0 12.2 16.5 34.2 49.0 8.9 6.5 15.1 19.5 4.9 9.8 7.0 45.9 13.9 19.7 15.7 16.3 13.4 15.4 13.0 9.2 23.8 19.7 12.7 11.8 7.8 APOBEC3C "APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI" ENSG00000244509 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3C" Q9NRW3 22 39014257-39020352 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB033048, HPA071523" Approved Approved "Intermediate filaments" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Intermediate filaments" "CAB033048: AB_2057401, HPA071523: AB_2686409" "unprognostic (1.79e-3)" "prognostic favorable (1.08e-5)" "unprognostic (4.32e-3)" "unprognostic (3.20e-3)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (5.18e-2)" "unprognostic (2.55e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-3)" "unprognostic (7.40e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (8.91e-10)" "unprognostic (5.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-1)" "unprognostic (3.52e-3)" 12.3 36.2 3.1 31.1 3.2 31.4 12.3 3.1 4.0 23.1 3.5 20.2 14.0 22.6 51.7 22.7 56.0 18.4 24.0 3.0 3.5 6.0 7.0 20.6 57.8 5.0 3.6 38.2 5.1 10.5 3.8 11.6 5.1 25.9 33.1 3.4 22.1 36.1 2.7 19.8 17.4 30.8 4.5 36.5 18.1 29.4 3.9 25.2 15.2 11.3 67.8 27.6 17.3 6.5 39.4 38.1 6.3 73.9 40.2 82.6 32.4 28.3 54.9 41.0 54.5 36.8 43.7 115.5 18.6 56.1 26.2 39.4 6.5 120.2 39.5 44.3 32.0 111.8 1.6 30.6 43.5 73.4 107.1 90.5 68.1 54.0 13.3 20.4 23.0 0.9 69.9 142.3 83.0 0.4 29.6 39.8 9.8 0.5 82.8 51.1 16.9 96.6 27.2 51.4 1.9 4.9 40.9 0.2 21.7 15.9 0.2 26.8 11.9 21.8 37.1 11.9 12.4 38.6 42.7 9.5 66.9 47.1 58.8 86.6 104.4 277.0 309.1 220.6 212.6 241.6 164.7 276.9 106.9 249.1 54.0 196.9 14.1 196.9 247.8 86.9 168.9 173.6 3.1 3.2 3.1 4.0 3.0 3.5 5.0 3.6 5.1 4.5 3.9 6.5 3.3 3.2 16.2 0.0 68.8 25.2 45.4 44.1 24.5 0.2 16.4 8.9 23.0 28.6 18.4 7.3 0.0 4.3 60.2 56.6 0.0 31.6 3.2 11.0 16.4 9.6 26.4 57.2 0.0 1.3 1.4 26.5 5.6 15.6 57.0 78.6 30.0 1.2 61.9 0.0 0.0 17.8 28.5 49.0 37.3 9.3 57.8 34.2 44.4 0.0 65.1 24.4 117.4 0.5 0.0 11.5 16.6 38.0 55.4 18.9 3.2 1.3 13.6 0.8 26.3 11.9 20.1 1.5 1.5 9.7 16.3 1.9 67.7 53.5 18.8 41.9 ARL11 "ARLTS1, FLJ33930" ENSG00000152213 "ADP ribosylation factor like GTPase 11" Q969Q4 13 49628507-49633872 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.9" "Cell type enhanced" "Detected in many" "B-cells: 18.2;Hofbauer cells: 31.3;Kupffer cells: 34.8;Macrophages: 18.2;monocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "neutrophil: 38.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 7.9;HMC-1: 10.7;NB-4: 11.1;THP-1: 14.5;U-698: 6.6;U-937: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040855, HPA040887" Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Intermediate filaments, Cytosol" "HPA040855: AB_10793864, HPA040887: AB_10796229" "unprognostic (1.19e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (2.82e-1)" "unprognostic (7.86e-2)" "unprognostic (1.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.72e-2)" "unprognostic (2.55e-1)" "unprognostic (2.27e-4)" "unprognostic (1.72e-2)" "unprognostic (5.60e-2)" "unprognostic (1.16e-1)" "unprognostic (3.14e-2)" 0.8 0.8 0.5 3.9 0.5 3.5 0.7 0.6 0.7 0.6 0.8 1.0 1.2 0.2 0.2 1.0 0.3 1.1 0.4 0.4 0.6 0.1 0.6 2.2 6.9 1.0 0.7 0.2 0.1 0.3 0.3 1.9 0.8 0.2 1.5 0.1 0.6 0.2 0.3 0.6 1.9 0.7 0.7 4.8 0.6 0.3 1.0 3.7 0.4 0.4 3.9 1.3 0.8 1.2 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.6 0.0 5.2 10.7 0.1 0.1 0.0 0.0 0.0 0.4 5.1 0.3 0.1 0.0 1.3 4.9 11.1 0.1 0.0 0.0 5.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 3.5 14.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.6 0.0 6.3 0.0 21.8 15.3 16.3 0.1 17.9 0.2 7.9 0.3 0.3 8.1 10.1 0.8 0.4 38.0 0.8 13.4 8.6 0.3 4.4 0.5 0.5 0.6 0.7 0.4 0.6 1.0 0.7 0.8 0.7 1.0 1.2 0.9 0.0 1.1 0.0 18.2 0.3 0.3 0.2 1.2 0.7 1.0 0.9 0.6 2.8 0.0 0.0 0.0 4.7 3.4 1.7 0.0 0.0 1.7 0.1 0.1 1.2 1.2 6.9 0.0 0.0 5.1 0.3 0.0 0.1 7.6 0.0 1.8 0.6 31.3 0.0 0.0 3.4 0.0 34.8 3.5 1.3 0.3 18.2 0.0 3.7 19.2 0.3 1.0 0.0 0.1 0.1 10.2 0.0 2.9 0.1 4.2 0.1 2.3 0.5 0.0 0.3 0.2 1.5 0.3 4.1 0.0 1.5 1.2 0.5 3.1 0.4 BAG2 ENSG00000112208 "BAG cochaperone 2" O95816 6 57172326-57189833 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018862, HPA019918" Enhanced Supported "Intermediate filaments,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" Cytosol "Intermediate filaments" "HPA018862: AB_2669957, HPA019918: AB_2670317" "unprognostic (3.93e-1)" "unprognostic (1.62e-1)" "unprognostic (2.60e-1)" "unprognostic (1.33e-1)" "unprognostic (5.63e-2)" "unprognostic (8.32e-3)" "prognostic unfavorable (6.72e-6)" "unprognostic (1.10e-1)" "unprognostic (7.79e-5)" "unprognostic (6.20e-3)" "unprognostic (4.71e-2)" "unprognostic (6.56e-2)" "unprognostic (6.07e-3)" "unprognostic (5.97e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (1.26e-4)" "unprognostic (6.24e-3)" 3.7 4.4 2.5 6.6 2.7 1.5 1.7 2.8 4.0 11.4 3.0 32.6 2.1 25.1 3.9 7.2 9.1 7.3 9.1 2.5 2.7 2.8 4.1 5.0 2.7 2.3 2.7 8.5 1.6 0.4 2.0 7.6 2.4 11.2 4.5 4.9 1.0 15.9 9.2 1.3 6.5 29.0 2.3 1.1 7.8 6.4 2.6 1.3 4.6 6.5 2.1 22.5 5.9 3.0 17.2 9.3 3.9 13.8 9.4 26.9 10.9 27.2 25.8 19.2 18.2 12.1 8.6 5.7 25.3 43.2 15.7 3.1 22.5 2.4 18.3 18.3 16.4 16.7 13.3 27.5 14.5 14.8 3.7 13.1 1.2 15.8 14.6 11.4 15.2 13.0 34.1 7.9 19.1 1.3 10.5 12.4 14.8 0.3 9.6 9.5 10.9 11.4 23.2 2.8 4.9 4.4 12.2 0.9 10.1 17.8 2.1 12.7 20.8 10.9 17.9 23.2 27.4 5.3 5.5 12.5 9.7 5.8 1.0 0.1 0.2 0.5 1.9 0.2 2.2 3.5 1.7 1.9 0.9 3.0 3.4 2.9 0.1 2.1 0.0 0.3 2.0 1.1 2.5 2.7 2.8 4.0 2.5 2.7 2.3 2.7 2.4 2.3 2.6 3.0 2.4 3.2 3.7 4.6 16.7 2.4 4.6 5.0 1.8 6.9 4.1 2.7 40.0 0.0 3.8 3.7 12.5 73.3 8.0 0.6 1.9 11.6 152.3 11.0 35.5 3.1 1.8 12.2 8.1 3.7 18.2 46.2 3.1 4.2 4.5 25.6 2.2 15.8 15.8 10.1 10.0 0.3 14.2 2.6 6.6 35.9 31.1 5.1 7.2 5.6 9.1 8.2 3.1 10.6 10.6 5.4 1.3 38.7 13.0 6.2 0.4 33.9 9.1 16.9 6.6 32.1 31.0 93.5 9.8 1.3 3.8 18.9 12.2 30.6 1.3 2.1 BCAS4 "CNOL, FLJ20495" ENSG00000124243 "Breast carcinoma amplified sequence 4" Q8TDM0 20 50794894-50882676 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 71.6;B-cells: 76.0;granulocytes: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 73.9;naive B-cell: 76.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 96.5;U-698: 88.7" "Low region specificity" "Detected in all" HPA038812 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Intermediate filaments, Cytosol" "HPA038812: AB_10795141" "unprognostic (3.48e-1)" "unprognostic (1.60e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (8.35e-2)" "unprognostic (2.98e-1)" "unprognostic (2.47e-3)" "unprognostic (1.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.33e-1)" "unprognostic (2.35e-2)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" "unprognostic (4.30e-2)" 1.6 1.2 7.6 7.7 8.2 2.2 3.0 4.8 14.9 5.0 7.2 3.7 1.0 4.1 4.1 2.7 2.8 2.0 1.8 15.4 6.0 5.8 0.8 2.1 21.3 4.8 5.6 2.0 2.0 4.8 4.0 2.2 5.3 6.0 0.7 2.3 2.8 4.0 1.0 1.2 7.6 1.8 3.3 9.4 3.5 3.6 6.4 11.7 4.3 0.8 23.1 5.3 2.8 6.8 12.3 21.8 1.7 9.3 3.3 8.7 3.7 15.8 14.2 11.1 7.8 10.4 7.3 96.5 5.8 6.7 22.3 18.2 10.8 22.9 6.3 6.2 9.4 0.4 8.3 8.7 4.7 0.1 0.5 2.8 13.0 8.5 4.2 13.7 0.6 7.5 0.3 0.6 4.0 42.9 3.7 0.3 7.6 1.8 17.6 30.5 2.9 0.9 5.1 11.0 9.5 9.9 24.5 23.2 0.5 8.1 45.9 1.1 0.5 11.8 17.3 12.1 3.9 1.4 7.4 88.7 4.9 0.7 1.1 2.2 0.3 0.2 15.3 0.2 8.7 73.9 9.4 19.0 0.2 76.1 32.2 25.4 1.4 20.0 0.2 18.8 8.9 13.3 7.6 8.2 4.8 14.9 15.4 6.0 4.8 5.6 5.3 3.3 6.4 6.8 1.2 22.4 71.6 6.5 76.0 2.0 27.5 28.9 2.2 6.2 12.6 8.3 17.7 4.3 35.3 9.2 2.1 29.1 16.1 0.3 41.1 11.8 4.0 6.0 6.4 23.7 33.6 5.2 11.5 3.1 4.8 26.6 3.1 7.7 113.5 9.4 2.2 0.4 3.2 8.4 14.3 3.7 44.7 1.3 2.8 1.1 1.5 6.2 5.4 0.0 1.9 10.6 21.6 8.5 0.8 8.9 0.1 3.0 6.1 15.0 0.7 5.2 40.0 6.6 6.6 4.9 35.7 3.2 11.0 1.2 2.4 10.9 35.7 1.5 1.1 25.5 BICDL2 CCDC64B ENSG00000162069 "BICD family like cargo adaptor 2" A1A5D9 16 3027682-3036944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 104.8;pancreas: 127.2" "Cell type enhanced" "Detected in some" "Breast glandular cells: 52.2;Breast myoepithelial cells: 22.1;Ductal cells: 34.3;Endometrial ciliated cells: 28.9;Exocrine glandular cells: 49.8;Glandular and luminal cells: 28.3;Pancreatic endocrine cells: 35.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.0;BEWO: 15.4;CAPAN-2: 14.4;HaCaT: 22.5;MCF7: 22.8;RT4: 10.8;SK-BR-3: 11.0;T-47d: 14.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 2.7" HPA043251 Approved Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 30: Mammary glandular cells - Lactation" "Intermediate filaments, Actin filaments, Cytosol" "HPA043251: AB_10794925" "unprognostic (2.00e-1)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (6.06e-3)" "unprognostic (9.65e-5)" "unprognostic (5.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.75e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-2)" "unprognostic (2.05e-2)" "unprognostic (4.71e-2)" "unprognostic (8.56e-2)" "unprognostic (2.55e-2)" "unprognostic (2.38e-1)" "unprognostic (4.32e-2)" "prognostic favorable (9.04e-4)" 0.4 0.0 0.2 1.9 0.2 0.0 8.6 0.4 0.4 20.7 0.1 25.1 10.4 0.7 2.6 104.8 6.0 3.4 0.0 0.2 0.1 5.8 0.9 5.9 0.0 0.6 0.3 0.1 127.2 4.1 1.5 0.3 0.8 16.8 6.4 0.0 44.4 3.2 0.6 43.8 13.5 0.2 0.2 0.2 21.5 0.1 0.3 0.2 6.1 0.0 3.1 11.4 44.3 0.2 9.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 2.6 14.4 0.0 0.0 0.0 0.0 22.5 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.0 6.4 0.0 0.1 0.0 0.2 0.0 10.8 0.2 0.1 0.0 11.0 0.0 0.3 14.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.4 0.2 0.1 0.6 0.3 0.8 0.2 0.3 0.2 0.3 12.8 18.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 52.2 22.1 0.0 0.0 12.4 16.5 0.0 4.5 1.3 0.0 3.9 34.3 0.0 28.9 2.8 0.5 0.0 0.0 0.0 49.8 6.1 0.6 0.0 28.3 2.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.1 0.0 0.0 0.2 12.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.5 0.6 0.3 0.0 0.0 C11orf95 MGC3032 ENSG00000188070 "Chromosome 11 open reading frame 95" C9JLR9 11 63759892-63768775 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045002 Approved "Intermediate filaments" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 36: Stromal cells - Cell proliferation" "Intermediate filaments" "HPA045002: AB_2679179" "unprognostic (4.23e-3)" "unprognostic (7.24e-3)" "unprognostic (6.47e-2)" "unprognostic (9.01e-3)" "unprognostic (7.54e-2)" "unprognostic (3.89e-1)" "unprognostic (8.94e-2)" "unprognostic (3.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" "unprognostic (8.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.52e-3)" "unprognostic (1.85e-2)" "unprognostic (6.60e-2)" "unprognostic (5.68e-2)" "unprognostic (1.31e-3)" 12.4 7.1 13.6 5.1 13.5 2.0 9.6 8.4 17.6 16.4 3.8 13.7 3.8 20.3 6.8 4.9 13.6 6.9 9.6 16.1 15.3 12.0 9.6 5.8 6.0 9.0 8.9 22.8 8.7 5.3 11.4 11.0 7.1 8.8 3.5 4.2 6.8 10.1 7.7 4.6 7.5 11.3 7.0 6.7 7.3 4.8 15.2 8.2 11.4 5.4 5.5 12.1 11.3 9.3 3.5 4.6 34.7 11.6 17.7 20.3 5.5 13.0 9.3 6.0 4.2 11.4 2.2 11.2 18.6 12.6 4.5 7.9 15.2 5.2 6.8 11.0 10.3 7.5 8.9 5.2 6.2 3.6 6.0 15.2 1.8 9.9 3.2 19.8 13.5 10.0 9.7 5.0 9.7 4.6 13.6 18.5 16.2 2.1 13.4 31.9 6.6 3.5 8.7 4.4 14.6 30.8 6.2 6.6 18.3 14.1 9.3 8.8 21.3 12.2 11.4 15.7 7.6 4.5 6.3 13.5 3.3 9.1 6.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 13.6 13.5 8.4 17.6 16.1 15.3 9.0 8.9 7.1 7.0 15.2 9.3 8.0 0.0 5.3 6.8 2.2 5.1 1.3 2.8 3.4 4.6 6.3 9.5 7.2 11.5 2.3 0.0 0.0 6.4 2.6 1.0 3.9 2.6 0.3 2.8 11.8 9.0 4.9 0.8 3.9 2.2 0.5 11.3 0.5 4.9 1.3 8.6 13.9 7.0 1.7 6.7 3.0 2.7 4.1 1.6 6.3 1.3 18.3 2.0 3.6 3.7 3.8 11.8 0.0 2.5 0.5 2.1 1.2 7.9 0.7 1.5 0.7 3.6 1.5 3.1 13.1 6.8 11.2 0.4 4.2 1.4 3.4 1.5 1.1 2.3 2.5 1.0 C12orf54 MGC35033 ENSG00000177627 "Chromosome 12 open reading frame 54" Q6X4T0 12 48482498-48496524 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 39 "testis: 40.4" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2541.6" "Cancer enhanced" "Detected in some" "cervical cancer: 2.9;head and neck cancer: 2.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBEC3-KT: 2.7" "Not detected" "Not detected" HPA073090 Approved "Intermediate filaments" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" "Intermediate filaments" "HPA073090: " "unprognostic (2.59e-3)" "unprognostic (5.49e-2)" "unprognostic (7.94e-3)" "unprognostic (2.60e-2)" "unprognostic (2.48e-2)" "unprognostic (8.99e-2)" "unprognostic (5.96e-2)" "unprognostic (1.62e-1)" "unprognostic (8.01e-2)" "unprognostic (1.36e-4)" "unprognostic (2.37e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.92e-1)" 0.0 0.4 0.3 0.0 0.4 0.0 0.2 0.2 1.0 0.1 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.5 0.4 0.5 0.0 0.0 0.0 0.1 0.5 0.2 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.3 0.3 0.1 0.0 40.4 0.3 0.0 0.0 0.2 0.6 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 1.0 0.3 0.2 0.5 0.4 0.5 0.3 0.3 0.5 0.0 0.0 2.6 8.1 0.0 5.1 38.6 19.5 1.2 0.2 0.2 0.1 0.7 0.0 4.5 0.0 0.0 0.1 0.0 0.0 1.9 0.1 543.1 0.0 0.0 1.2 0.0 0.0 5.3 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 9.1 0.0 2.0 0.0 1.8 2541.6 10.8 1.4 0.0 2.8 0.0 0.3 0.0 4.5 2.5 0.0 0.0 13.2 0.0 6.4 0.0 1.9 1.9 0.2 6.6 4.3 1.0 11.5 6.5 5.9 2.3 0.0 0.5 0.4 0.0 10.8 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835086-38841438 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 19.5" "Cell type enriched" "Detected in some" 8 "Early spermatids: 263.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "hTCEpi: 5.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Intermediate filaments" Nucleoli "HPA051696: AB_2681576" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.0 5.6 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 263.7 0.2 0.1 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.2 29.4 1.2 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 3.3 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 C19orf25 FLJ36666 ENSG00000119559 "Chromosome 19 open reading frame 25" Q9UFG5 19 1461143-1479219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050270, HPA067491" Approved Approved "Intermediate filaments" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" "HPA050270: AB_2681069, HPA067491: AB_2685849" "unprognostic (5.82e-2)" "unprognostic (3.87e-2)" "unprognostic (6.51e-2)" "prognostic favorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (2.14e-3)" "prognostic unfavorable (3.81e-4)" "unprognostic (1.10e-2)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.35e-2)" "prognostic favorable (9.20e-8)" "unprognostic (3.50e-3)" "unprognostic (8.01e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 14.4 23.5 33.3 8.8 33.2 7.8 15.9 31.1 43.8 17.7 29.3 18.0 15.6 15.8 5.3 20.4 15.7 8.1 21.2 31.6 30.0 31.0 29.5 14.8 15.0 35.3 33.1 15.9 19.9 15.6 27.1 8.6 32.0 22.1 5.2 6.9 17.6 8.1 16.2 17.3 17.7 6.1 32.7 23.4 17.8 22.0 34.0 9.7 23.8 7.4 7.0 17.5 15.6 36.7 25.0 19.2 11.6 18.3 11.0 10.0 23.4 24.4 16.8 25.5 23.5 27.4 12.1 14.2 18.7 13.0 12.1 30.1 17.9 15.0 6.0 44.7 27.1 17.3 12.2 32.3 23.6 27.5 33.5 9.2 33.2 10.7 17.2 18.3 13.2 29.3 46.1 32.7 16.6 13.9 25.6 21.8 36.2 15.2 29.5 41.4 16.0 36.5 17.8 16.7 19.8 26.5 18.0 23.0 28.5 6.0 33.4 31.8 16.3 19.8 22.4 40.6 23.4 46.3 26.7 24.2 20.4 27.4 35.1 50.1 32.1 59.1 41.3 33.0 33.5 36.6 37.9 35.7 23.4 45.6 38.2 30.9 52.0 30.5 27.7 47.6 52.6 38.6 33.3 33.2 31.1 43.8 31.6 30.0 35.3 33.1 32.0 32.7 34.0 36.7 24.2 16.0 8.7 10.4 44.3 19.2 30.5 27.3 18.8 62.7 28.9 29.7 10.3 21.5 19.9 51.5 64.6 41.5 45.2 68.1 49.0 40.1 6.2 14.7 21.0 23.0 50.6 17.2 14.5 46.1 33.3 21.7 31.1 19.3 11.4 30.4 29.3 18.2 35.9 97.6 11.5 33.7 34.6 27.9 24.9 7.3 26.4 26.4 24.9 8.4 56.7 49.2 82.4 14.1 20.6 52.6 52.0 21.8 26.7 33.5 83.2 35.5 15.3 87.8 46.0 20.0 24.1 33.8 33.0 14.8 19.7 52.9 47.3 36.1 38.2 33.6 C19orf54 FLJ41131 ENSG00000188493 "Chromosome 19 open reading frame 54" Q5BKX5 19 40740856-40751553 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059043, HPA059628" Approved Approved "Intermediate filaments,Centriolar satellite" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 20: HeLa - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Intermediate filaments" "Centriolar satellite" "HPA059043: AB_2683886, HPA059628: AB_2684087" "unprognostic (3.18e-3)" "unprognostic (2.09e-2)" "unprognostic (5.19e-2)" "unprognostic (7.21e-2)" "unprognostic (8.44e-2)" "unprognostic (1.22e-1)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-1)" "unprognostic (3.00e-2)" "unprognostic (3.16e-1)" "unprognostic (2.70e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "unprognostic (1.03e-2)" "unprognostic (6.33e-2)" 5.8 10.1 6.2 6.9 7.7 6.0 5.8 7.3 6.6 4.7 6.8 8.1 10.5 5.1 6.4 6.0 4.9 6.2 7.2 6.1 6.0 9.1 15.3 8.8 5.5 8.4 7.3 3.8 8.6 5.7 4.6 4.8 7.7 6.2 7.1 5.3 5.6 4.5 15.3 5.9 10.7 4.0 6.8 9.8 7.5 8.4 7.1 5.5 7.8 10.3 6.0 6.3 5.0 8.7 7.6 16.6 13.9 12.4 7.4 10.0 10.2 5.4 7.0 9.5 8.9 11.3 11.3 16.5 13.6 6.4 4.7 12.0 23.0 9.2 7.8 11.5 20.7 10.3 24.4 14.3 22.5 7.1 8.8 15.2 4.8 9.3 19.9 11.7 5.7 22.1 13.3 22.8 6.7 9.0 10.0 8.2 10.5 17.4 6.0 18.9 14.2 14.3 9.6 14.5 11.3 7.0 19.5 8.1 8.4 15.3 8.4 9.6 4.8 11.7 11.7 6.1 3.7 25.6 18.9 13.0 11.3 15.4 8.3 0.4 4.5 1.3 1.3 3.8 0.5 1.2 1.1 0.7 5.7 0.9 1.1 1.0 1.0 0.8 5.1 3.5 1.9 1.9 6.2 7.7 7.3 6.6 6.1 6.0 8.4 7.3 7.7 6.8 7.1 8.7 2.9 3.2 8.9 6.2 2.9 1.7 3.7 3.3 5.2 1.6 4.2 3.0 8.0 2.8 1.2 5.5 2.1 7.9 2.5 5.5 3.9 3.4 6.7 3.3 3.7 3.5 1.2 4.6 0.4 2.5 6.6 2.3 7.7 3.1 0.0 4.1 1.8 6.4 8.4 0.0 0.7 5.0 4.1 10.7 1.6 2.9 2.5 7.2 0.0 1.0 8.2 2.2 1.0 1.5 3.4 2.0 4.8 1.2 5.4 2.4 12.3 6.7 2.9 3.8 0.0 1.9 2.3 17.8 12.0 4.4 1.7 5.6 2.8 6.1 5.5 2.8 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.7;testis: 15.5" "Cell type enhanced" "Detected in some" "Early spermatids: 117.8;Granulosa cells: 23.1;Late spermatids: 94.7;Muller glia cells: 63.0;Respiratory ciliated cells: 53.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 44 "HEL: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA035316 Uncertain "Intermediate filaments" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.6 0.2 2.7 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.3 0.6 0.0 0.0 1.0 0.0 1.3 0.9 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 15.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.2 0.6 0.3 0.6 1.3 0.9 0.5 1.1 0.3 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.2 0.0 9.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 117.8 3.8 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 23.1 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 94.7 1.8 0.2 0.0 0.0 0.0 63.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 53.8 2.1 0.0 0.0 1.4 8.8 0.9 0.0 0.0 0.1 0.0 4.0 0.0 0.0 C1orf159 FLJ20584 ENSG00000131591 "Chromosome 1 open reading frame 159" Q96HA4 1 1081818-1116361 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.9" "Cell type enhanced" "Detected in many" "Early spermatids: 60.9;Late spermatids: 124.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010019, HPA075399" Approved Approved "Nucleoli rim,Mitotic chromosome,Intermediate filaments" Yes No "Cluster 34: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli rim, Mitotic chromosome" "Intermediate filaments" "HPA010019: AB_1078885, HPA075399: " "unprognostic (2.79e-1)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (9.58e-6)" "unprognostic (1.34e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" "unprognostic (9.29e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (1.77e-6)" "unprognostic (4.10e-2)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "prognostic favorable (1.62e-4)" 4.0 4.8 9.6 1.6 8.0 2.4 3.8 0.9 10.4 5.3 3.2 6.1 1.8 4.2 1.1 8.6 4.8 2.2 4.3 9.4 1.0 7.7 6.7 3.9 1.8 6.3 2.7 4.3 3.7 0.7 5.3 1.4 2.8 6.9 0.6 1.6 4.6 2.3 2.2 5.0 4.1 0.5 0.7 5.5 6.0 22.9 5.4 1.8 4.5 0.3 0.9 5.5 5.9 6.9 15.7 12.0 5.6 10.0 1.5 1.6 13.3 9.0 2.1 7.8 5.1 6.5 14.7 4.3 10.8 2.8 6.4 12.2 2.5 7.1 2.2 8.6 18.2 3.1 19.6 7.0 3.6 5.5 7.3 3.2 2.8 3.3 1.6 2.3 3.8 6.4 18.6 3.1 2.8 11.9 10.2 13.2 4.7 5.9 19.7 12.0 6.7 8.5 4.7 4.7 11.8 16.1 6.8 12.2 7.6 1.6 7.8 6.5 5.2 8.3 8.8 11.9 9.2 5.6 8.3 7.8 6.8 14.9 6.5 8.1 2.6 1.4 2.6 2.6 2.8 2.5 2.5 3.0 1.7 2.2 2.5 2.6 0.5 2.7 1.8 2.2 0.9 2.3 9.6 8.0 0.9 10.4 9.4 1.0 6.3 2.7 2.8 0.7 5.4 6.9 6.3 0.0 7.7 20.2 3.4 7.5 3.6 6.2 4.6 5.9 8.9 6.6 2.3 5.7 7.1 9.2 4.2 5.0 4.9 13.6 1.9 8.2 60.9 8.6 8.2 4.4 4.2 5.2 26.5 7.0 14.0 4.2 20.4 9.0 5.7 9.0 3.3 5.3 3.9 13.5 21.8 7.4 6.1 1.0 4.8 124.1 2.8 3.9 3.6 2.8 6.0 3.2 9.2 10.6 24.5 7.8 3.5 1.5 6.9 5.1 3.4 1.8 10.4 8.2 0.0 3.5 4.8 18.3 6.8 4.2 7.0 4.9 4.6 4.4 9.4 4.9 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 13.7" "Cell type enhanced" "Detected in many" "Early spermatids: 46.4;Endometrial ciliated cells: 44.9;Late spermatids: 27.3;Respiratory ciliated cells: 37.7;Spermatocytes: 36.1;Spermatogonia: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 6.1;U-266/84: 6.4" "Not detected" "Not detected" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" No No "Cluster 35: T-regs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "Intermediate filaments" "HPA051142: AB_2681359" "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.0 1.8 2.2 0.5 2.2 0.3 1.1 2.3 4.0 0.7 3.1 0.8 3.3 0.5 3.5 0.6 3.3 0.2 0.6 2.2 2.5 4.4 0.7 1.0 0.4 2.6 2.7 1.1 2.2 0.3 2.0 0.2 2.6 2.0 0.3 0.8 0.8 0.5 0.5 1.3 0.7 0.3 2.4 0.7 1.6 13.7 2.3 0.5 0.8 0.2 0.6 0.6 0.5 2.8 1.0 2.0 1.8 1.7 0.6 0.0 3.3 0.3 0.0 0.2 0.4 2.7 1.6 0.2 2.9 0.0 2.8 0.2 1.8 0.0 0.6 1.2 4.5 0.8 0.5 0.5 0.0 1.2 0.5 0.3 2.6 0.7 1.0 0.4 0.0 1.9 3.6 0.3 0.7 6.1 1.5 6.1 1.9 1.4 2.3 1.3 0.4 0.9 0.8 0.5 3.8 2.1 0.8 0.5 3.9 2.3 0.2 1.0 0.7 1.4 0.5 1.0 1.4 2.6 6.4 1.4 2.3 0.9 1.6 0.0 0.2 2.4 0.6 0.5 0.2 0.2 0.7 0.6 0.5 0.3 0.3 0.3 0.3 0.7 0.3 0.4 3.1 0.3 2.2 2.2 2.3 4.0 2.2 2.5 2.6 2.7 2.6 2.4 2.3 2.8 0.7 0.0 2.7 3.3 1.2 1.5 2.0 4.2 0.0 1.6 3.2 3.7 1.3 1.5 2.6 3.7 2.1 2.9 0.2 1.6 5.9 4.1 46.4 44.9 0.9 1.9 3.0 0.0 0.9 6.1 2.3 1.1 2.0 2.5 0.0 0.6 1.4 1.9 1.2 1.7 1.0 1.2 0.0 0.3 1.0 27.3 2.1 0.6 3.6 0.0 1.6 3.3 1.0 0.0 3.5 2.8 2.7 0.0 2.5 2.0 1.3 9.6 37.7 0.9 0.0 1.1 2.1 36.1 20.4 0.6 1.4 1.4 0.4 0.4 1.7 1.0 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590021-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: AB_2678218, HPA052175: AB_2681750" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favorable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 18.1 18.9 16.9 12.2 18.2 21.3 18.9 15.9 18.5 23.0 15.0 21.6 12.6 23.3 6.5 16.5 22.2 9.3 17.6 16.3 16.2 19.6 21.5 17.2 17.3 18.8 17.2 19.9 21.7 10.1 17.0 7.2 16.9 22.9 7.1 3.8 16.6 9.8 21.9 21.4 18.6 11.1 16.0 27.2 20.0 17.3 17.3 18.5 19.0 10.2 10.9 20.9 17.1 20.4 21.5 17.6 12.0 28.5 19.3 10.7 15.8 12.6 10.9 17.8 10.9 16.5 8.7 25.2 16.0 9.4 33.7 23.3 16.2 11.5 8.1 9.9 23.3 9.4 11.5 17.6 22.5 22.7 29.0 12.4 17.0 10.7 11.2 9.4 19.6 26.7 25.1 18.6 10.7 36.1 19.9 46.9 24.0 10.6 23.2 40.1 9.5 21.5 11.6 18.5 15.7 29.2 12.2 39.9 17.3 12.5 18.3 33.8 14.2 14.7 48.2 16.3 27.9 22.5 23.8 23.8 9.9 24.9 44.3 0.5 1.5 2.2 2.0 1.5 2.6 1.7 2.4 2.6 1.1 1.6 2.4 2.0 1.4 1.6 1.6 2.9 2.7 0.9 16.9 18.2 15.9 18.5 16.3 16.2 18.8 17.2 16.9 16.0 17.3 20.4 12.9 9.6 8.6 11.1 13.7 15.2 8.8 4.6 13.1 7.1 14.2 14.5 6.0 12.8 6.1 1.8 6.2 11.6 23.6 11.8 0.0 8.9 8.2 9.9 12.6 12.8 12.6 4.2 9.5 10.2 10.6 11.2 10.7 8.9 1.3 16.0 12.5 7.4 13.4 5.0 8.3 12.5 8.2 11.3 10.2 3.5 8.1 12.9 7.2 7.5 8.4 6.7 18.6 9.5 13.2 10.2 9.8 8.6 10.9 10.9 8.5 8.0 5.3 6.5 6.6 12.0 14.5 11.9 13.5 11.7 12.8 9.7 17.5 14.0 11.6 7.6 CARD10 "BIMP1, CARMA3" ENSG00000100065 "Caspase recruitment domain family member 10" Q9BWT7 22 37490362-37519542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 35.5;Ductal cells: 25.4;Endothelial cells: 24.8;Pancreatic endocrine cells: 39.4;Paneth cells: 27.6;Proximal enterocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.5;U-2197: 82.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029359, HPA055612" Approved Approved "Vesicles,Intermediate filaments,Cytosol" No No "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 18: U-2197 - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Vesicles, Intermediate filaments" Cytosol "HPA029359: AB_10601354, HPA055612: AB_2682861" "unprognostic (9.12e-3)" "unprognostic (2.28e-1)" "unprognostic (7.51e-2)" "prognostic favorable (3.47e-4)" "unprognostic (4.54e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (7.73e-6)" "unprognostic (3.66e-2)" "unprognostic (7.70e-2)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "unprognostic (3.68e-2)" "unprognostic (2.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.34e-1)" "unprognostic (4.31e-2)" "unprognostic (9.69e-2)" 10.0 8.4 3.7 5.0 3.3 0.1 10.5 2.9 4.0 6.5 2.8 13.3 34.1 6.0 1.3 8.4 7.5 7.8 10.7 3.1 3.0 14.9 12.4 6.1 2.1 4.7 3.3 3.1 9.2 2.7 2.1 4.7 5.0 5.4 8.8 0.3 19.0 4.2 8.0 9.7 35.9 4.2 3.3 4.1 9.9 15.0 4.2 0.8 6.8 8.2 1.0 6.1 5.8 2.9 31.3 23.1 4.1 3.0 0.1 8.7 19.6 2.8 6.5 12.8 10.0 14.2 21.8 0.0 10.8 5.4 12.4 43.0 4.9 56.5 3.9 0.1 11.8 0.7 15.6 22.1 5.4 0.5 1.9 2.9 11.5 24.5 31.2 10.2 26.1 0.0 3.3 0.0 9.9 11.0 0.1 2.0 7.2 17.0 13.2 0.0 38.9 3.0 19.1 5.4 1.5 2.4 21.0 9.5 2.1 5.0 10.1 1.7 35.0 9.5 26.9 82.8 16.4 0.1 0.0 0.0 30.2 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.3 2.9 4.0 3.1 3.0 4.7 3.3 5.0 3.3 4.2 2.9 22.6 0.0 2.0 0.0 0.2 8.5 6.8 3.4 2.2 1.2 3.9 4.3 3.7 10.0 1.6 3.7 0.0 0.4 0.2 35.5 1.9 25.4 7.8 3.3 0.4 24.8 7.7 0.0 0.1 19.6 1.6 1.9 15.8 6.2 0.0 0.4 17.9 4.8 0.1 0.0 0.6 19.8 4.1 0.0 1.2 8.6 0.0 0.4 5.4 3.7 0.0 0.0 0.0 0.0 0.1 39.4 27.6 0.7 0.2 8.6 35.5 12.4 1.2 0.2 0.0 6.2 1.1 0.4 3.4 2.5 3.8 0.0 0.6 1.0 11.3 9.7 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 15.0;neutrophil: 11.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "T-47d: 27.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavorable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favorable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favorable (2.51e-4)" 3.3 3.9 2.3 2.9 2.4 10.9 7.0 2.6 2.8 2.8 2.7 4.8 4.9 2.7 2.6 4.5 3.6 3.3 2.1 2.1 2.5 3.8 12.9 3.3 2.9 2.7 2.7 3.0 5.1 3.2 4.3 3.9 3.2 6.9 5.6 3.2 6.6 1.9 2.0 3.8 5.4 1.3 2.0 3.5 5.9 1.4 2.5 2.4 2.9 1.1 2.4 3.2 2.9 3.5 3.1 5.0 0.9 14.0 1.6 0.9 17.9 1.8 2.6 1.2 0.7 4.4 15.3 5.5 10.4 2.1 1.1 3.9 10.3 5.3 1.1 19.4 8.1 3.5 7.5 8.6 4.2 3.9 1.9 5.5 2.6 5.7 1.7 2.8 2.0 6.6 10.6 2.3 1.1 12.5 4.9 6.1 0.2 3.9 3.2 7.2 0.0 7.4 6.7 3.5 5.8 3.6 3.7 8.2 2.8 0.2 27.0 3.9 2.3 1.1 2.0 3.4 2.9 10.8 17.8 2.0 3.5 20.5 0.5 6.9 1.0 15.0 1.1 1.0 0.9 1.1 0.9 0.8 1.7 0.8 0.8 0.5 11.4 1.1 2.8 1.3 0.7 0.9 2.3 2.4 2.6 2.8 2.1 2.5 2.7 2.7 3.2 2.0 2.5 3.5 4.7 25.6 20.4 21.9 5.7 1.0 4.0 8.5 7.4 4.7 13.4 10.3 5.9 7.2 16.8 1.8 2.1 34.2 4.4 11.0 5.9 13.7 0.9 31.6 5.6 3.4 1.2 9.2 17.2 12.2 8.5 5.5 28.5 15.1 15.8 9.9 1.8 17.9 6.1 3.3 16.7 14.1 10.2 4.1 2.7 1.9 2.1 8.7 1.8 17.8 7.8 4.5 5.2 16.1 13.4 8.6 17.1 2.2 6.9 5.5 9.6 8.9 60.7 7.4 0.0 5.3 4.7 1.8 3.1 8.5 1.0 12.4 5.2 14.1 7.9 4.8 CCT8 "C21orf112, Cctq, PRED71" ENSG00000156261 "Chaperonin containing TCP1 subunit 8" P50990 21 29055805-29073797 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018520, HPA021051, HPA029426" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" No No 1100000 "Cluster 44: Non-specific - Transcription" "Cluster 3: T-cells - Adaptive immune response" "Cluster 36: HEL - Hemostasis" "Cluster 10: Non-specific - Unknown function" "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.56e-5)" "unprognostic (8.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" "unprognostic (1.02e-2)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (8.26e-2)" "unprognostic (3.50e-2)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" 72.7 125.0 62.5 99.1 67.0 99.5 100.4 70.3 84.0 78.5 78.0 87.9 77.9 74.8 88.2 83.7 80.9 64.3 116.3 66.9 74.7 102.7 92.7 70.1 140.8 64.5 65.3 88.0 95.3 100.0 40.6 107.0 69.0 77.1 102.1 71.3 70.7 72.5 121.1 75.0 78.6 85.5 66.7 88.9 68.8 79.1 68.7 141.2 78.5 145.2 154.3 122.3 50.3 66.1 437.4 243.1 319.4 233.3 220.4 302.3 350.9 340.5 219.1 386.2 317.5 548.6 269.0 858.8 229.1 237.1 466.8 174.4 632.2 391.7 441.1 364.0 348.1 1185.2 289.8 384.3 227.0 609.0 335.6 229.0 244.9 448.6 372.6 278.6 368.1 379.7 935.8 519.0 404.1 270.9 456.6 359.4 572.6 433.6 310.6 411.7 596.5 547.4 409.1 283.2 316.7 231.6 334.1 356.6 364.7 347.5 319.9 526.7 267.4 221.3 613.7 216.7 439.7 329.2 651.8 695.1 256.3 704.5 339.0 79.9 110.1 54.4 56.9 120.9 79.6 79.8 76.3 73.4 133.3 61.8 85.5 82.1 11.5 87.7 132.2 83.5 92.7 127.4 62.5 67.0 70.3 84.0 66.9 74.7 64.5 65.3 69.0 66.7 68.7 66.1 66.9 64.1 61.7 15.0 120.1 143.1 197.6 278.6 70.0 85.6 88.4 76.5 75.7 90.1 150.0 75.4 18.8 268.9 122.1 67.3 144.8 194.1 17.0 106.6 92.8 94.8 97.0 150.2 26.7 138.0 275.8 93.4 52.0 73.7 112.8 135.6 55.3 53.4 170.5 77.4 31.3 106.2 201.4 115.6 122.4 20.5 84.2 109.9 115.6 26.2 226.6 96.1 97.9 13.6 21.4 131.2 92.1 92.9 130.7 185.9 107.4 189.7 147.7 84.6 105.2 88.7 214.7 170.1 176.8 90.2 131.4 285.3 105.1 254.5 161.1 170.6 CDC42BPA "FLJ23347, KIAA0451, MRCK, MRCKA, PK428" ENSG00000143776 "CDC42 binding protein kinase alpha" Q5VT25 1 226989865-227318474 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 320.3;Excitatory neurons: 447.6;Inhibitory neurons: 479.0;Oligodendrocyte precursor cells: 444.3;Oligodendrocytes: 671.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB070414, HPA071252" Approved Approved "Intermediate filaments" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Intermediate filaments" "CAB070414: AB_11156796, HPA071252: AB_2686374" "unprognostic (3.67e-3)" "unprognostic (1.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" "unprognostic (3.04e-1)" "unprognostic (5.90e-2)" "unprognostic (7.89e-2)" "unprognostic (2.27e-1)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (4.88e-2)" "unprognostic (2.87e-2)" "unprognostic (7.73e-3)" "unprognostic (1.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.79e-2)" "unprognostic (1.21e-2)" 15.6 12.5 26.3 5.5 32.4 3.5 12.2 33.5 30.0 15.8 12.2 21.2 14.7 15.0 7.7 10.1 12.6 13.7 16.4 24.9 25.2 17.3 14.7 12.3 2.0 25.7 26.8 14.0 13.1 19.7 14.6 12.7 27.0 15.8 10.3 23.7 7.6 14.9 11.4 6.3 12.9 14.5 19.8 6.6 22.4 24.4 29.7 2.2 8.1 13.6 1.8 23.0 11.3 37.0 22.6 21.1 21.9 10.4 21.5 26.4 7.7 25.4 35.7 17.2 17.9 17.1 50.1 0.1 26.6 42.4 13.0 10.3 16.3 14.2 20.9 0.1 13.2 17.4 25.5 6.7 24.3 14.1 7.5 18.6 17.9 27.8 27.8 21.3 58.0 13.6 45.1 0.1 28.2 6.2 0.4 2.5 18.0 29.3 20.0 0.0 37.0 0.1 27.7 43.1 15.7 22.9 43.0 17.8 24.8 13.4 23.1 0.8 59.0 31.3 16.2 36.1 33.9 0.1 0.1 0.1 41.4 0.0 42.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.3 32.4 33.5 30.0 24.9 25.2 25.7 26.8 27.0 19.8 29.7 37.0 82.6 41.7 35.7 320.3 0.8 11.7 26.0 15.9 12.0 97.7 14.0 12.8 59.9 30.0 38.9 44.1 118.9 5.9 1.8 49.3 13.7 26.0 128.0 18.7 45.1 68.4 26.4 45.6 447.6 41.1 7.3 44.4 92.8 25.7 7.0 21.5 47.8 28.9 3.7 223.8 479.0 30.5 22.4 4.4 9.9 132.3 44.1 6.4 16.0 180.8 5.9 33.4 0.0 444.3 671.8 65.1 74.0 85.4 1.8 30.1 50.7 41.3 24.8 66.9 78.9 64.0 68.4 45.6 57.7 8.0 8.0 1.4 1.3 23.4 34.4 43.1 CHID1 "FLJ42707, MGC3234, SI-CLP" ENSG00000177830 "Chitinase domain containing 1" Q9BWS9 11 867859-915058 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 404.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039374 Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Intracellular and membrane" No No 1500000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Intermediate filaments" "HPA039374: AB_10673609" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (8.96e-2)" "prognostic favorable (6.76e-4)" "unprognostic (4.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.97e-2)" "unprognostic (3.62e-2)" "unprognostic (7.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.21e-2)" "unprognostic (1.74e-3)" "unprognostic (1.15e-1)" "unprognostic (7.53e-2)" "unprognostic (3.29e-2)" "unprognostic (2.89e-2)" 43.9 63.3 43.1 22.7 44.1 46.2 40.2 41.0 51.7 44.5 60.0 34.2 30.9 38.0 89.5 34.8 63.5 41.3 54.4 44.1 47.2 52.5 85.8 30.9 27.2 42.9 42.9 58.0 149.9 46.1 62.8 42.7 42.5 42.3 29.7 25.2 82.2 41.3 37.0 34.9 27.7 35.7 42.6 71.6 47.1 74.1 45.7 20.1 47.3 31.1 20.2 34.3 35.3 47.0 75.6 71.7 53.2 131.6 203.3 107.5 90.1 83.2 97.0 78.8 76.7 78.7 214.6 61.1 75.1 121.7 78.4 145.2 53.1 95.9 57.3 53.7 131.9 44.1 25.9 75.1 92.6 102.9 37.4 104.1 59.2 53.9 77.2 130.3 67.2 76.6 81.2 152.6 55.8 52.9 58.4 134.0 47.2 141.6 107.3 49.0 50.9 111.8 57.5 21.5 101.8 84.5 90.3 124.0 78.4 53.0 50.4 156.8 66.6 89.6 38.9 25.3 68.3 88.9 81.4 36.0 100.2 88.6 71.7 21.1 50.4 19.2 34.7 45.0 37.1 45.7 33.2 36.8 74.0 32.1 34.9 35.3 6.2 43.4 45.6 69.6 32.4 46.0 43.1 44.1 41.0 51.7 44.1 47.2 42.9 42.9 42.5 42.6 45.7 47.0 33.0 41.7 36.7 4.2 28.6 22.8 62.2 78.9 22.2 38.5 69.9 75.7 25.6 51.5 49.0 53.3 18.8 121.3 34.4 25.2 72.4 62.3 120.9 44.0 44.4 31.5 53.3 56.4 7.8 58.3 79.7 69.6 20.9 36.8 29.2 107.6 50.0 91.2 81.1 30.3 7.8 42.8 57.0 66.6 24.7 404.8 62.7 34.0 55.2 1.9 35.2 60.6 20.6 6.0 6.8 38.0 43.2 58.3 123.7 86.5 71.5 85.1 45.7 53.2 52.6 45.9 41.7 208.3 139.9 37.2 23.3 91.5 19.2 85.4 59.9 62.6 CLK3 ENSG00000179335 "CDC like kinase 3" P49761 15 74598500-74645414 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046817 Approved Supported "Nucleoplasm,Intermediate filaments" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Intermediate filaments" "HPA046817: AB_10964124" "unprognostic (4.10e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (2.05e-6)" "unprognostic (1.91e-3)" "unprognostic (7.91e-2)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (8.14e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "unprognostic (9.73e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-2)" 35.9 28.7 30.3 26.5 31.8 112.4 34.6 36.4 35.9 36.7 32.8 36.6 28.9 32.3 25.9 38.6 31.3 32.7 28.3 30.2 31.2 30.0 29.4 34.0 37.7 32.8 31.6 38.4 33.9 35.3 32.3 31.6 32.5 31.9 21.8 33.1 36.1 29.7 50.7 41.7 33.7 26.2 29.5 41.7 35.1 44.4 32.2 55.8 32.3 52.1 30.3 37.8 33.8 35.4 56.7 35.1 45.5 25.6 57.2 43.4 35.8 37.7 59.2 52.7 64.3 47.9 36.4 51.2 27.2 33.9 73.5 39.0 85.4 36.3 34.3 73.2 46.9 63.0 52.0 33.6 90.7 17.2 46.6 54.8 71.0 69.4 57.4 64.0 58.6 51.0 31.3 36.2 31.1 39.9 50.9 57.3 29.1 55.7 24.6 40.7 21.8 33.7 41.1 40.3 25.5 29.9 30.2 33.0 34.3 34.7 31.4 33.8 27.3 31.0 23.7 19.7 50.2 59.0 51.8 42.2 27.2 82.4 40.1 74.2 65.5 90.0 68.9 74.1 68.2 71.0 73.6 71.9 61.3 78.8 74.4 70.9 115.9 90.7 97.7 69.5 87.7 85.9 30.3 31.8 36.4 35.9 30.2 31.2 32.8 31.6 32.5 29.5 32.2 35.4 29.8 6.4 38.4 14.0 34.1 44.9 44.9 41.6 26.2 35.5 22.8 15.9 18.6 28.6 35.1 12.9 56.3 27.7 41.8 46.7 31.3 34.2 83.6 25.8 19.9 28.6 29.3 31.5 6.6 24.2 46.2 24.5 37.8 41.5 21.5 27.4 21.4 13.4 27.5 28.6 7.9 34.7 42.7 23.3 34.4 19.8 27.7 28.4 28.4 6.5 29.5 18.0 29.9 7.1 9.6 30.8 52.0 20.3 26.6 38.9 35.5 18.6 23.4 42.6 13.1 20.4 35.8 45.4 21.4 21.0 41.9 58.6 40.1 20.4 28.1 63.5 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7;choroid plexus: 34.4;thyroid gland: 25.4" "Cell type enhanced" "Detected in many" "Early spermatids: 116.6;Late spermatids: 401.9;Muller glia cells: 95.8;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 68.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 143.4;Hep G2: 59.6;SK-MEL-30: 51.1;WM-115: 57.8" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: AB_2683679" "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 1.6 1.5 17.5 0.7 35.7 0.0 2.8 22.4 21.6 3.3 34.4 12.1 0.7 1.2 0.2 1.3 1.7 0.1 6.3 13.0 16.5 2.9 0.6 0.4 0.2 37.4 31.0 1.7 7.6 0.1 14.0 0.5 24.2 3.2 0.1 1.6 23.6 1.2 0.5 1.9 3.1 0.1 20.5 0.3 2.7 20.7 31.6 0.1 25.4 0.0 0.0 2.8 3.8 39.7 0.2 0.3 0.3 0.2 0.0 0.8 143.4 0.1 0.0 0.1 0.0 1.6 0.2 0.0 13.1 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.9 0.0 8.2 59.6 0.3 0.0 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.3 0.0 0.0 1.0 0.7 6.4 8.2 0.0 2.5 0.0 1.8 0.0 0.1 0.0 1.5 0.2 0.1 51.1 4.6 0.2 5.4 0.0 0.0 0.7 0.1 1.0 0.2 0.1 0.0 0.2 0.0 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 35.7 22.4 21.6 13.0 16.5 37.4 31.0 24.2 20.5 31.6 39.7 1.6 3.2 0.0 1.0 26.1 3.2 2.2 1.2 1.8 0.9 2.1 2.5 1.6 0.0 0.2 5.5 10.4 5.1 0.4 0.7 1.9 3.6 116.6 2.7 0.4 3.7 4.2 1.3 2.5 0.0 46.4 15.3 6.1 0.7 0.0 0.6 2.5 6.8 2.2 0.0 2.0 3.3 0.0 2.2 0.9 401.9 4.1 1.7 3.6 0.0 0.5 95.8 0.0 84.9 68.9 0.1 7.3 1.5 44.0 1.2 2.3 23.7 2.5 3.7 0.0 0.8 1.0 2.9 7.8 0.9 7.0 4.0 1.4 3.7 2.0 1.0 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "liver: 9388.5" "Group enriched" "Detected in some" 16 "Ductal cells: 1087.7;Hepatocytes: 4142.7" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;HDLM-2: 6.3;U-2 OS: 4.5;U-266/84: 11.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" NA NA 2920000000 5200000000 "Cluster 62: Liver - Hemostasis" "Cluster 16: U-266 - Nucleosome" "Cluster 15: Hepatocytes - Hemostasis" "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 3.4 0.7 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.3 0.0 3.1 0.0 0.5 0.4 111.7 0.7 0.0 0.0 0.7 9388.5 0.5 0.1 0.0 0.0 0.4 118.5 0.0 0.3 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.3 0.6 0.5 0.0 0.0 6.1 0.4 0.4 0.0 0.0 0.3 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.2 0.0 0.0 0.0 6.3 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.8 0.0 11.7 1.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 118.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1087.7 1.4 0.0 0.1 6.3 0.0 163.2 0.0 63.2 0.0 0.0 0.0 0.2 0.0 0.0 89.6 4142.7 0.1 0.0 0.0 0.0 0.0 98.8 0.3 0.7 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 CRTAP "CASP, LEPREL3, P3H5" ENSG00000170275 "Cartilage associated protein" O75718 3 33114014-33147773 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Disease variant, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 377.6" "Group enriched" "Detected in all" 5 "dendritic cells: 306.9;monocytes: 377.6" "Cell line enhanced" "Detected in all" "ASC diff: 795.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043598, HPA044150" Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Secreted to blood" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Intermediate filaments, Actin filaments, Cytosol" "HPA043598: AB_10960991, HPA044150: AB_10959594" "unprognostic (5.29e-2)" "unprognostic (2.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.85e-3)" "unprognostic (7.36e-2)" "unprognostic (4.73e-3)" "unprognostic (4.28e-2)" "unprognostic (1.87e-1)" "unprognostic (9.97e-2)" "unprognostic (4.62e-2)" "unprognostic (3.70e-1)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-1)" "unprognostic (9.93e-2)" "unprognostic (1.28e-3)" 157.2 106.5 65.2 38.7 69.2 43.2 123.9 51.9 54.8 211.2 52.9 145.1 35.0 170.1 57.1 58.7 138.3 80.5 83.9 49.6 64.9 67.9 44.6 92.3 37.3 65.2 62.4 131.4 36.0 45.7 22.8 69.9 63.9 90.7 51.6 19.3 54.0 106.5 54.4 84.1 65.6 115.0 67.5 48.2 78.9 25.0 65.3 23.7 77.2 68.9 38.1 142.7 135.8 69.5 64.1 123.3 37.8 119.2 795.0 516.6 219.0 136.1 294.0 160.6 151.9 42.1 35.1 44.4 147.6 259.3 129.9 80.2 68.0 103.9 115.5 110.1 106.0 69.2 87.6 43.7 237.4 45.4 54.8 415.3 208.5 145.0 183.2 311.7 172.0 27.0 60.3 82.1 164.6 54.7 16.5 46.3 45.5 67.5 165.7 59.4 111.0 86.1 127.8 42.0 7.9 61.0 92.0 79.8 201.1 87.3 85.9 109.3 113.0 209.1 89.1 115.4 145.9 59.0 214.3 6.7 164.3 89.7 117.1 13.4 377.6 28.5 35.8 147.7 52.5 39.9 51.4 40.2 306.9 39.2 29.2 27.8 30.5 42.1 46.0 82.5 74.0 200.5 65.2 69.2 51.9 54.8 49.6 64.9 65.2 62.4 63.9 67.5 65.3 69.5 74.0 9.6 42.8 15.3 29.0 60.4 41.1 39.5 150.8 17.9 32.7 43.7 34.7 25.8 22.0 38.6 8.4 49.0 37.1 14.8 11.7 25.0 1.2 17.4 135.7 72.7 6.0 46.0 10.0 32.0 81.6 142.3 29.0 31.2 48.1 58.4 122.4 53.2 107.0 35.3 14.5 26.0 10.2 181.1 91.1 6.3 142.9 108.6 80.0 10.3 134.1 15.9 22.6 17.1 11.6 18.4 16.3 144.8 58.1 24.5 24.4 52.7 6.8 10.1 111.7 78.4 120.9 1.6 15.9 95.1 46.7 28.0 26.5 89.9 36.1 30.0 CTNS "CTNS-LSB, PQLC4, SLC66A4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636459-3663103 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Protein transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 35.5;Late spermatids: 29.3;Theca cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 34.3;granulocytes: 27.9;monocytes: 10.4" "Cell line enhanced" "Detected in all" "HDLM-2: 144.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 4: Macrophages - Innate immune response" "Vesicles, Intermediate filaments" "HPA046947: AB_2679872" "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favorable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favorable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 10.3 19.5 9.5 10.0 17.0 10.2 9.6 13.5 12.1 20.3 12.1 8.3 12.2 11.3 6.4 8.7 10.3 13.1 10.5 10.8 10.3 15.2 15.9 11.6 10.0 16.5 16.8 12.1 27.0 13.6 9.6 12.9 18.0 10.8 7.2 6.8 12.0 11.6 15.3 19.2 11.0 8.6 10.9 12.1 15.0 24.8 13.2 8.8 9.2 7.4 9.5 9.1 9.4 28.0 17.6 37.0 22.6 18.2 34.5 16.9 13.0 19.6 28.8 21.1 26.0 21.0 16.0 10.2 17.8 11.6 55.9 40.1 19.8 12.1 12.6 144.3 33.7 10.8 32.2 19.3 46.5 8.0 81.3 23.8 14.2 20.2 15.4 28.1 22.2 18.7 12.6 15.9 16.6 15.1 7.8 7.9 9.8 12.2 16.8 16.4 9.3 23.0 15.3 16.2 3.9 17.2 19.2 24.4 20.3 19.0 17.1 7.7 24.2 17.2 11.6 40.3 13.3 12.4 20.0 4.2 28.1 7.8 11.8 27.9 10.4 21.8 3.0 6.9 4.9 5.8 4.0 5.7 9.7 4.9 4.5 5.5 3.1 5.2 7.1 34.3 4.3 7.3 9.5 17.0 13.5 12.1 10.8 10.3 16.5 16.8 18.0 10.9 13.2 28.0 4.4 3.2 2.2 6.5 4.8 1.7 3.5 2.5 4.0 1.6 6.3 5.0 5.2 5.7 2.7 12.9 10.4 6.1 5.2 3.6 0.0 6.7 35.5 5.7 4.4 5.3 2.4 4.0 3.4 6.4 7.1 6.0 7.7 4.3 8.2 6.7 9.3 7.6 25.2 5.0 3.4 2.5 4.1 7.2 5.9 29.3 9.6 12.1 5.4 3.7 10.0 6.5 3.1 5.5 11.1 6.4 3.3 12.8 4.5 6.5 3.2 9.5 7.0 3.9 6.6 3.7 3.5 19.7 8.7 2.9 2.4 8.5 3.3 30.9 1.8 3.2 DDX60 FLJ20035 ENSG00000137628 "DExD/H-box helicase 60" Q8IY21 4 168216291-168318883 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 40.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 57.6;Gastric mucus-secreting cells: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 27.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA046952 Approved Supported "Intermediate filaments,Cytosol" No No "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 4: Stomach - Digestion" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Intermediate filaments" "HPA046952: AB_10963572" "unprognostic (4.05e-2)" "unprognostic (2.87e-1)" "unprognostic (7.22e-3)" "unprognostic (7.71e-2)" "unprognostic (2.30e-1)" "unprognostic (2.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.15e-2)" "unprognostic (3.06e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (3.35e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (2.48e-1)" "unprognostic (3.02e-1)" "unprognostic (3.20e-2)" "unprognostic (2.44e-1)" 8.2 6.0 2.3 9.8 2.6 5.6 7.2 2.0 2.4 9.6 2.6 17.4 13.3 7.7 4.8 3.5 7.1 9.7 5.9 1.9 2.4 6.7 9.4 11.4 9.8 4.8 2.3 11.0 4.0 6.4 4.0 11.5 2.9 6.0 15.7 3.3 21.3 5.8 2.4 6.5 12.3 6.1 5.1 17.4 40.8 3.4 3.2 15.4 6.3 3.5 6.8 6.8 5.6 3.1 8.3 1.1 4.2 1.4 2.9 10.4 5.3 2.3 14.9 27.4 26.1 0.0 20.2 0.0 1.4 3.1 12.6 6.6 0.5 4.1 8.7 6.1 0.3 12.9 7.3 0.0 9.9 3.8 3.3 7.2 1.7 6.7 1.2 7.1 10.1 4.8 0.0 2.0 3.4 0.3 6.2 2.5 0.4 0.4 2.1 5.1 1.5 0.0 5.3 4.6 0.8 0.7 5.4 1.3 18.8 0.3 1.0 5.1 8.9 2.1 1.5 0.9 2.0 1.6 0.3 0.0 6.6 6.1 6.1 1.6 1.2 1.2 4.2 2.5 4.8 1.4 3.2 4.1 1.1 1.4 3.3 3.7 0.6 3.7 3.0 0.0 3.0 1.8 2.3 2.6 2.0 2.4 1.9 2.4 4.8 2.3 2.9 5.1 3.2 3.1 32.4 35.3 6.5 14.0 12.2 4.2 4.8 6.2 5.7 0.8 3.9 3.2 8.6 11.5 11.5 12.9 0.0 7.6 13.4 57.6 5.9 8.2 3.3 11.8 10.5 22.8 3.0 8.4 0.7 6.8 10.4 11.6 90.2 10.2 27.3 16.2 14.3 4.0 6.2 0.0 1.3 22.4 2.0 4.1 2.8 2.2 8.1 13.5 3.6 25.3 9.3 7.4 17.5 27.6 1.3 12.0 14.9 9.4 3.1 4.1 11.0 4.2 15.3 2.9 6.6 10.0 9.0 1.1 1.0 2.2 2.7 2.9 17.2 18.4 6.0 3.7 DES "CMD1I, CSM1, CSM2" ENSG00000175084 Desmin P17661 2 219418377-219426734 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 2531.9" "Cancer enhanced" "Detected in all" "prostate cancer: 562.1;stomach cancer: 400.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "midbrain: 29.5" "CAB000034, HPA018803" Enhanced Supported "Intermediate filaments" NA NA 1600000 "Cluster 7: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "CAB000034: , HPA018803: AB_1847616" "unprognostic (1.75e-1)" "unprognostic (1.95e-3)" "unprognostic (3.43e-2)" "unprognostic (8.76e-2)" "unprognostic (7.75e-3)" "unprognostic (6.61e-3)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (4.67e-1)" "unprognostic (3.84e-2)" "unprognostic (2.57e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (3.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (9.25e-3)" 235.3 57.1 2.1 436.2 4.9 1.1 51.2 2.1 9.6 504.3 5.0 8627.2 291.3 3015.2 86.0 1481.2 1085.0 452.1 13020.7 2.4 2.5 37.6 15.5 173.9 7.2 3.4 2.5 171.8 14.6 0.5 8.4 52.7 2.4 2218.8 245.6 0.0 255.3 2253.1 16532.0 152.4 1343.5 2557.5 2.1 25.2 1965.6 16.1 2.6 3.2 66.2 5753.8 1.2 4761.8 669.4 2.4 0.0 0.0 0.1 0.0 0.0 2.2 5.3 0.2 0.0 0.1 0.1 0.5 0.0 0.0 9.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 17.0 0.1 1.3 70.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 145.3 0.0 0.0 39.5 0.5 0.0 0.0 0.0 333.1 2.1 0.0 0.0 0.2 1.2 0.0 0.0 0.0 9.2 0.0 5.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.1 4.9 2.1 9.6 2.4 2.5 3.4 2.5 2.4 2.1 2.6 2.4 0.4 0.0 0.0 0.0 0.0 4.1 2.7 0.0 0.0 0.0 0.1 0.0 2531.9 1.5 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 90.6 0.5 6.7 22.7 0.0 0.0 0.1 0.0 5.2 104.6 0.0 0.1 0.0 0.0 1.8 0.0 5.6 0.0 0.0 0.9 0.0 0.0 10.7 71.6 28.9 2.8 12.4 0.0 0.6 0.0 0.0 0.5 0.0 0.5 0.0 50.4 0.0 8.7 0.0 0.1 0.0 0.0 46.0 497.8 210.5 5.0 5.1 0.1 9.8 8.5 2.4 0.0 0.2 2.9 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 136.3;Late spermatids: 352.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 25: Spermatids - Spermatogenesis" "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 6.1 9.2 6.6 5.2 6.9 4.8 6.5 6.4 8.8 8.1 6.9 7.1 2.2 7.7 10.3 5.4 6.6 4.2 5.3 7.1 7.2 6.8 5.3 4.9 6.2 5.8 6.5 7.8 7.0 9.7 10.0 5.8 6.0 6.2 5.5 8.5 5.6 6.3 9.1 7.1 5.2 7.3 6.0 5.9 5.7 23.4 6.6 6.7 7.2 5.5 6.3 7.4 6.2 6.5 23.4 19.3 21.0 15.8 13.5 16.6 16.2 15.5 15.9 15.2 14.7 15.7 7.2 7.1 15.6 16.9 17.1 11.8 23.6 18.2 24.9 28.0 18.4 13.3 11.5 21.3 12.2 14.5 7.3 16.0 10.8 20.0 12.5 10.8 20.7 5.2 17.8 9.5 16.7 17.7 14.7 12.9 25.1 10.1 11.4 7.0 27.7 13.9 14.2 8.6 16.8 24.8 15.8 16.4 17.4 14.7 11.7 8.0 15.4 15.1 16.5 10.9 17.7 9.3 12.2 2.8 11.4 10.1 10.2 1.6 6.3 1.2 2.8 4.5 3.6 3.8 2.3 2.1 3.2 4.6 2.9 1.7 0.4 2.3 5.6 1.2 2.5 2.9 6.6 6.9 6.4 8.8 7.1 7.2 5.8 6.5 6.0 6.0 6.6 6.5 6.2 3.2 10.9 24.2 8.8 2.7 2.7 5.9 6.2 24.7 5.2 7.6 6.2 10.0 10.9 23.9 56.3 7.2 4.7 2.5 0.0 7.7 136.3 18.0 13.4 6.3 11.9 8.2 36.7 7.6 6.7 9.3 7.1 6.2 10.8 19.4 9.7 6.2 7.0 18.5 38.0 5.7 4.1 11.7 3.8 352.8 15.8 8.5 1.8 25.3 23.9 9.5 8.2 33.2 20.9 8.5 3.1 13.9 8.1 2.0 2.1 6.0 27.3 27.7 0.0 8.8 6.0 19.3 9.8 5.3 2.6 2.9 7.9 14.7 5.0 2.2 DISC1 ENSG00000162946 "DISC1 scaffold protein" Q9NRI5 1 231626790-232041272 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Developmental protein" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 21.7" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 113.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "THP-1: 11.4;TIME: 8.7;WM-115: 8.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA048911 Supported "Intermediate filaments,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 43: THP-1 - Innate immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Intermediate filaments, Cytosol" "HPA048911: AB_2732549" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.58e-1)" "unprognostic (2.98e-1)" "unprognostic (2.57e-2)" "unprognostic (3.36e-2)" "unprognostic (6.69e-3)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.71e-1)" "unprognostic (8.89e-2)" "unprognostic (9.53e-2)" "unprognostic (1.31e-4)" "unprognostic (1.74e-2)" "unprognostic (2.02e-1)" "unprognostic (5.94e-2)" "unprognostic (1.94e-1)" 2.4 1.4 5.3 3.1 5.4 2.6 1.9 3.9 5.6 2.1 2.6 1.5 1.1 1.5 0.5 1.3 1.1 2.6 9.0 4.2 4.9 1.1 1.4 1.7 2.4 6.9 5.8 4.4 0.8 1.1 1.0 7.3 6.9 1.2 1.2 21.7 2.0 0.9 1.4 1.2 1.3 1.4 5.6 2.9 1.0 0.9 7.3 3.1 1.8 1.1 1.7 1.6 1.3 7.7 0.0 0.4 4.0 0.1 0.1 0.3 2.8 1.6 3.6 4.1 3.5 1.4 0.8 0.1 4.8 1.3 1.0 0.0 0.3 0.1 3.7 2.6 1.7 2.2 0.3 4.0 0.5 3.7 5.1 2.2 0.7 1.4 1.2 2.8 3.8 2.7 0.0 1.4 4.6 0.4 1.1 5.6 2.0 0.0 1.5 2.7 1.1 0.4 0.1 0.0 0.7 2.2 1.4 0.0 2.4 1.0 0.0 11.4 8.7 2.1 2.3 1.0 0.9 0.9 0.7 0.0 1.7 5.6 8.8 0.1 0.8 0.0 0.2 0.8 0.1 0.0 0.4 0.0 1.0 0.1 0.4 0.1 0.7 0.2 0.4 0.6 0.1 0.2 5.3 5.4 3.9 5.6 4.2 4.9 6.9 5.8 6.9 5.6 7.3 7.7 6.7 0.0 1.1 0.0 2.1 0.9 0.5 0.7 3.4 23.3 2.0 1.8 7.2 0.0 1.2 3.7 8.4 8.0 2.0 0.5 0.0 0.6 16.6 3.4 2.1 6.7 0.0 2.1 0.0 1.1 0.8 3.0 0.0 4.5 7.0 8.0 10.0 0.0 11.3 0.0 0.0 0.1 0.0 13.0 12.6 23.2 0.9 13.7 3.6 0.0 5.6 2.4 2.1 0.0 0.0 2.0 0.3 1.5 2.1 0.7 0.0 0.2 2.5 113.1 0.0 4.6 2.7 1.4 1.6 0.5 1.1 2.5 5.8 8.1 0.7 0.6 DMRTC1 ENSG00000269502 "DMRT like family C1" Q5HYR2 X 72872025-72943814 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.5;pituitary gland: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (1.83e-1)" 0.0 0.5 1.5 0.1 1.3 0.0 0.0 0.0 2.5 0.3 0.0 0.1 0.0 0.4 0.0 0.1 0.7 0.2 0.0 1.0 1.8 0.1 0.0 0.1 0.3 0.4 0.2 0.5 0.2 0.2 1.8 0.0 0.5 0.1 0.2 0.8 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.6 1.3 0.2 0.7 0.0 0.3 0.1 0.1 2.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 2.5 1.0 1.8 0.4 0.2 0.5 0.0 1.3 2.4 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 DMRTC1B ENSG00000184911 "DMRT like family C1B" Q5HYR2 X 72777009-72848802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 22.5;pituitary gland: 25.3" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.3;Microglial cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (2.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-1)" "unprognostic (6.52e-2)" 0.2 3.2 17.5 0.8 17.9 0.0 0.6 11.6 22.5 1.1 10.7 1.0 0.4 1.6 6.7 0.2 2.3 0.4 0.2 18.7 19.7 1.4 0.0 0.8 1.0 13.7 14.3 8.2 3.8 1.5 25.3 0.0 13.7 2.7 0.5 9.7 0.8 1.2 0.0 0.3 1.0 0.4 11.9 1.0 1.0 8.9 20.5 1.2 3.3 0.0 1.5 0.3 0.8 16.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 17.5 17.9 11.6 22.5 18.7 19.7 13.7 14.3 13.7 11.9 20.5 16.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;fallopian tube: 5.1;testis: 4.3" "Cell type enhanced" "Detected in some" "Early spermatids: 42.7;Endometrial ciliated cells: 31.0;Late spermatids: 17.1;Respiratory ciliated cells: 77.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062493 Approved "Nuclear membrane,Intermediate filaments" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.4 0.1 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.4 0.5 0.0 0.0 1.2 0.0 2.2 2.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 4.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.4 0.5 2.2 2.1 1.4 1.5 0.5 0.5 0.0 0.0 1.1 0.7 0.0 0.3 0.7 2.0 0.0 0.0 0.1 0.1 1.7 0.0 6.3 0.0 0.0 0.3 0.0 2.0 0.0 0.0 42.7 31.0 0.2 0.3 0.0 0.0 2.9 0.0 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 3.6 1.3 0.0 0.0 0.0 17.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 2.5 1.7 0.0 0.8 0.0 0.0 0.5 1.3 0.0 77.8 0.0 0.0 0.2 1.0 0.9 8.8 0.5 0.6 0.0 0.1 0.0 1.9 0.3 DNAJA2 "CPR3, DNAJ, DNJ3, HIRIP4" ENSG00000069345 "DnaJ heat shock protein family (Hsp40) member A2" O60884 16 46955362-46973674 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049789, HPA060538" Approved Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA 67000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Cytosol" "Intermediate filaments" "HPA049789: AB_2680883, HPA060538: AB_2684315" "unprognostic (7.68e-3)" "unprognostic (1.05e-2)" "unprognostic (4.77e-2)" "unprognostic (3.67e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (2.81e-4)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "prognostic favorable (1.19e-9)" "unprognostic (9.22e-2)" "unprognostic (2.28e-1)" "unprognostic (9.22e-2)" "unprognostic (4.69e-2)" 20.7 25.2 30.5 14.2 32.6 23.9 19.7 33.9 40.5 17.9 32.2 21.3 20.0 22.0 28.6 21.5 17.4 16.4 36.0 32.3 31.9 28.0 36.0 16.6 19.7 29.8 30.2 22.0 17.0 29.2 16.4 19.9 30.5 21.8 19.0 29.5 17.1 20.6 37.1 21.1 20.5 17.0 31.0 22.7 19.2 24.9 31.2 20.3 22.2 38.7 21.4 21.6 18.2 30.5 23.1 26.9 26.6 22.8 35.7 34.1 40.3 29.4 35.4 43.4 20.5 23.7 23.6 37.1 23.2 31.9 18.6 35.0 43.0 30.2 49.8 8.8 36.0 27.2 12.8 50.7 42.7 41.7 36.3 36.5 34.6 25.2 23.7 37.9 30.4 14.7 31.7 12.0 37.0 25.4 30.1 57.5 40.6 21.1 39.6 34.3 48.7 44.1 52.7 24.1 36.1 23.1 34.9 52.1 33.4 26.1 20.3 32.2 31.6 25.4 16.0 18.5 25.1 29.3 21.7 49.0 26.9 35.5 21.8 13.1 10.3 13.5 9.8 12.7 12.9 11.3 13.2 11.2 9.4 8.4 12.9 13.1 10.7 12.8 11.3 6.7 17.2 9.7 30.5 32.6 33.9 40.5 32.3 31.9 29.8 30.2 30.5 31.0 31.2 30.5 64.3 51.3 35.9 11.8 78.4 126.9 75.1 56.4 101.3 38.8 37.5 28.4 100.3 40.0 48.2 40.5 18.8 85.2 76.1 67.6 90.1 73.4 93.3 86.9 76.8 52.2 52.0 49.4 16.6 62.2 72.5 66.2 54.0 72.1 53.9 52.7 31.1 54.9 56.5 37.0 15.3 55.6 52.9 42.5 86.4 56.8 50.1 65.1 72.9 12.2 72.3 60.5 45.3 10.1 11.0 71.2 64.2 59.0 70.7 61.6 83.3 111.4 67.6 43.7 52.6 63.4 99.4 177.7 106.0 111.1 120.5 172.4 89.6 131.4 62.6 87.3 DOLPP1 LSFR2 ENSG00000167130 "Dolichyldiphosphatase 1" Q86YN1 9 129081111-129090438 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 29.1;Proximal enterocytes: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019179 Approved Approved "Vesicles,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" Vesicles "Intermediate filaments" "HPA019179: AB_1847827" "unprognostic (1.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.89e-1)" "unprognostic (6.12e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-2)" "unprognostic (3.18e-1)" "unprognostic (3.10e-2)" "unprognostic (6.96e-2)" "unprognostic (7.12e-2)" "unprognostic (1.65e-1)" "unprognostic (4.37e-3)" "unprognostic (7.59e-3)" "unprognostic (2.38e-2)" "unprognostic (1.35e-1)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" 5.6 11.4 12.2 6.3 13.4 8.1 5.8 13.0 13.8 6.6 8.7 15.5 26.2 5.3 6.0 19.2 5.5 5.8 4.6 12.1 12.5 6.0 22.4 5.0 6.6 13.3 13.4 5.2 10.4 8.7 6.2 7.6 14.3 8.5 12.5 3.8 9.9 4.7 4.9 10.5 22.6 5.3 13.1 7.8 10.8 8.1 13.5 10.1 5.4 4.8 6.6 6.0 8.3 15.2 8.7 33.6 31.4 29.6 10.3 9.1 36.2 20.9 12.2 39.3 22.0 42.9 28.4 16.7 18.2 13.0 30.2 61.8 32.6 17.8 16.6 19.9 20.6 22.0 22.3 34.5 18.8 23.0 26.4 9.5 24.4 25.5 20.3 8.9 17.5 30.7 37.3 16.2 11.4 44.7 26.5 24.8 27.4 64.7 28.2 30.8 25.3 31.2 14.2 14.1 35.9 24.2 27.1 24.1 9.4 18.4 44.8 15.0 14.5 33.5 16.4 33.4 29.0 20.3 41.6 25.3 15.3 4.6 22.8 7.9 8.2 12.6 10.2 10.5 25.2 11.4 12.6 12.6 10.5 7.7 12.5 11.9 1.7 11.2 11.0 15.8 13.6 8.9 12.2 13.4 13.0 13.8 12.1 12.5 13.3 13.4 14.3 13.1 13.5 15.2 3.1 6.4 6.3 4.2 3.9 2.3 3.0 6.9 1.2 3.7 7.3 5.2 2.1 10.0 6.3 1.8 6.2 18.8 2.8 29.1 1.9 7.1 0.5 3.9 5.0 3.4 3.6 13.0 3.1 9.6 14.2 3.9 10.2 5.4 5.7 3.8 5.3 18.3 7.5 3.3 4.4 10.1 6.1 2.9 1.9 0.5 2.1 2.7 5.4 1.0 4.2 8.6 6.2 3.5 6.4 6.6 16.2 4.1 6.7 3.8 42.0 4.1 3.2 3.7 0.0 3.1 4.0 6.3 9.7 11.0 4.0 16.4 4.4 8.1 13.5 4.1 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9" "Cell type enhanced" "Detected in many" "Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 64: Astrocytes - Nervous system maintenance" "Cell Junctions, Intermediate filaments" Nucleoplasm "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favorable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 11.6 6.6 252.7 5.4 248.2 0.8 9.6 243.3 260.1 5.4 120.6 22.4 3.9 8.1 20.5 22.9 11.7 9.4 150.0 250.1 423.0 2.3 2.2 6.6 2.3 461.9 326.9 7.0 18.1 2.4 10.8 4.1 360.4 23.6 7.6 19.8 11.3 25.3 166.9 2.7 8.4 19.4 308.1 4.8 6.8 6.1 269.2 0.5 12.3 209.9 2.0 32.0 5.2 331.0 0.7 0.5 17.3 0.0 9.5 25.1 2.6 3.2 14.8 0.6 1.7 3.8 0.2 0.1 8.9 1.9 15.3 1.1 2.1 7.5 1.8 0.0 10.7 0.1 0.9 5.7 7.1 0.2 0.2 19.2 1.8 11.9 4.5 14.2 6.7 0.1 2.4 1.9 3.8 37.7 0.1 0.2 42.0 0.6 8.1 0.1 7.7 24.1 0.9 0.3 51.9 6.9 0.0 1.7 4.9 23.8 21.8 6.3 0.5 16.7 9.9 0.3 5.2 1.3 2.0 1.0 52.5 0.0 8.4 1.0 0.7 0.0 0.8 0.0 1.1 0.8 1.5 1.1 3.5 0.7 1.6 1.3 0.3 0.8 0.0 0.1 4.3 1.0 252.7 248.2 243.3 260.1 250.1 423.0 461.9 326.9 360.4 308.1 269.2 331.0 5.1 0.0 1.1 1756.1 0.1 1.5 0.1 0.8 0.0 18.3 22.2 12.3 134.3 27.1 1.4 0.0 6.2 0.1 0.4 0.0 5.9 12.6 3.1 7.0 2.6 6.4 0.0 0.0 506.0 25.1 0.1 5.7 0.0 0.4 0.0 2.3 0.0 0.2 9.0 1.7 650.9 0.1 4.1 4.0 21.5 3.7 5.9 8.0 5.4 105.9 0.9 34.0 0.0 491.6 367.4 8.0 0.0 0.4 0.0 1.8 0.1 2.0 7.1 3.8 13.1 22.7 17.3 0.9 4.8 0.2 1.0 0.0 0.2 0.3 0.2 0.2 DVL3 KIAA0208 ENSG00000161202 "Dishevelled segment polarity protein 3" Q92997 3 184155377-184173614 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046486, HPA058265" Approved Approved "Intermediate filaments,Midbody ring,Centrosome" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" "Midbody ring, Centrosome" "Intermediate filaments" "CAB046486: AB_10610845, HPA058265: AB_2683658" "unprognostic (2.20e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.88e-2)" "unprognostic (1.64e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (8.61e-2)" "unprognostic (5.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.77e-5)" "prognostic unfavorable (1.53e-8)" "unprognostic (1.87e-1)" "unprognostic (4.10e-1)" "unprognostic (8.41e-2)" "unprognostic (3.95e-1)" 35.2 28.1 16.4 18.7 17.4 18.6 29.8 17.4 18.9 39.0 15.9 46.0 17.2 44.7 16.1 30.3 34.5 22.6 35.0 16.4 17.1 25.7 20.0 31.7 13.9 18.1 17.3 42.0 25.6 17.9 24.4 38.3 17.6 29.1 16.1 22.8 25.6 25.8 34.9 33.8 27.1 31.7 16.6 25.6 27.9 15.1 17.0 12.4 30.0 22.3 15.9 36.6 31.6 18.3 47.9 13.6 36.4 41.4 37.5 37.8 95.0 28.4 28.9 32.7 27.6 43.6 18.3 33.6 73.3 37.0 32.4 40.8 29.6 22.2 23.4 54.0 32.2 38.1 21.3 28.2 56.6 21.2 27.8 38.4 39.9 23.4 27.3 55.9 24.6 21.6 38.9 44.2 35.5 46.5 28.3 25.2 32.8 34.6 22.1 49.9 42.7 30.0 31.7 36.2 36.3 51.0 34.9 39.8 67.4 35.8 98.7 26.8 25.0 29.5 28.5 31.0 43.8 48.3 38.8 37.0 30.0 22.4 23.6 0.1 0.6 1.3 0.6 1.0 0.8 0.7 0.4 0.7 0.6 0.5 0.5 0.3 0.9 0.4 0.3 0.8 0.2 0.4 16.4 17.4 17.4 18.9 16.4 17.1 18.1 17.3 17.6 16.6 17.0 18.3 15.9 25.6 14.1 16.6 10.8 18.7 15.7 12.9 15.9 20.1 23.5 16.5 26.9 12.8 17.2 22.0 27.1 34.4 14.6 40.8 23.5 13.3 12.8 23.2 30.9 15.9 34.3 6.9 11.4 16.6 21.6 22.6 32.6 27.7 17.1 29.7 19.2 20.5 20.3 62.2 11.8 22.3 12.2 16.2 14.4 47.5 33.5 17.4 12.4 14.0 10.8 19.7 14.4 9.0 11.5 20.7 18.9 37.2 13.9 20.8 25.2 18.3 13.4 18.5 19.7 23.6 27.1 10.6 12.4 20.4 21.7 52.1 10.3 21.9 21.5 25.7 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 48.6;Distal tubular cells: 50.9;Ductal cells: 28.7;Extravillous trophoblasts: 36.9;Hofbauer cells: 34.0;Proximal tubular cells: 41.6;Syncytiotrophoblasts: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803" "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 8.5 15.2 24.8 13.8 25.6 18.2 9.8 24.3 27.3 9.3 20.5 13.6 12.2 9.9 19.4 19.7 13.2 7.7 11.9 26.0 26.2 17.9 16.5 9.3 19.2 22.2 23.2 6.9 10.5 15.8 27.8 9.1 23.9 9.5 11.8 15.9 11.2 7.8 14.0 13.9 10.6 10.6 22.9 14.6 10.8 11.6 25.1 22.2 22.4 15.2 18.0 10.8 11.1 23.6 25.4 48.2 25.9 28.2 15.7 21.1 56.2 26.8 27.8 32.0 24.2 32.5 32.6 45.3 46.8 28.3 30.1 25.9 20.9 39.3 17.3 35.5 37.5 40.7 28.4 76.2 29.9 40.2 49.9 19.5 35.1 32.2 43.6 17.6 41.9 79.0 45.2 30.9 29.7 48.5 37.6 57.9 29.4 61.5 38.1 43.6 26.6 61.6 39.6 35.7 54.5 62.6 18.5 31.7 30.1 13.8 29.0 36.9 29.9 25.3 13.1 21.2 36.9 34.9 88.0 37.8 30.0 40.8 24.1 22.2 15.2 12.8 19.7 17.9 19.6 16.8 16.1 20.6 27.4 20.6 17.6 18.8 6.5 22.2 16.7 30.3 22.2 18.6 24.8 25.6 24.3 27.3 26.0 26.2 22.2 23.2 23.9 22.9 25.1 23.6 5.6 3.2 9.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 8.5 7.0 0.0 0.0 6.2 20.2 0.0 48.6 7.0 0.0 50.9 28.7 0.0 14.9 7.5 7.0 0.0 0.0 0.0 16.0 36.9 5.0 0.0 11.5 3.8 13.7 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 16.5 0.0 0.0 0.0 0.0 20.7 0.0 0.0 2.3 0.0 0.0 41.6 4.4 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 26.7 5.7 24.5 0.0 0.0 EPPK1 EPIPL1 ENSG00000261150 "Epiplakin 1" P58107 8 143857324-143878467 "Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 16.1" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 137.1;Suprabasal keratinocytes: 274.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.3;EFO-21: 13.3;HaCaT: 13.8;HeLa: 26.8;MCF7: 20.2;SK-BR-3: 9.3" "Not detected" "Not detected" "HPA066808, HPA067357, HPA069333" Approved Enhanced "Intermediate filaments" NA NA 1200000 "Cluster 61: Skin - Cornification" "Cluster 20: HeLa - Mitochondria" "Cluster 28: Keratinocytes - Keratinization" "Intermediate filaments" "HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123" "unprognostic (1.42e-1)" "unprognostic (9.30e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (5.52e-5)" "unprognostic (2.85e-2)" "unprognostic (5.86e-3)" "unprognostic (4.90e-2)" "unprognostic (8.73e-2)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.35e-1)" "unprognostic (1.97e-3)" "unprognostic (5.94e-3)" "unprognostic (4.35e-1)" "unprognostic (3.68e-3)" "unprognostic (5.08e-3)" 0.2 0.0 0.4 0.3 0.4 0.1 0.9 3.9 0.5 0.5 1.3 3.3 2.1 2.4 0.3 1.7 2.0 0.2 0.1 0.8 0.6 1.2 0.3 0.9 0.1 2.5 2.7 0.0 0.7 0.2 0.2 0.2 1.7 1.4 0.6 0.0 2.2 1.4 0.2 16.1 2.7 0.9 1.6 1.2 2.1 1.8 0.7 0.1 0.2 0.0 0.2 1.8 0.9 0.4 7.9 0.1 0.1 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 7.4 0.5 0.0 13.3 0.0 0.0 13.8 1.4 0.1 0.0 0.0 3.4 0.0 26.8 4.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 20.2 0.0 0.0 1.4 1.8 0.0 0.0 0.1 0.0 0.0 4.9 2.3 0.0 2.2 9.3 0.0 1.2 7.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 3.9 0.5 0.8 0.6 2.5 2.7 1.7 1.6 0.7 0.4 0.7 19.2 9.2 1.0 1.1 137.1 20.3 8.2 8.0 0.6 32.7 25.0 27.9 11.5 4.4 14.7 0.0 2.5 0.0 48.1 0.0 11.3 0.5 12.6 0.5 3.2 6.0 0.0 0.3 14.7 0.3 2.4 12.2 10.1 0.0 0.6 0.7 4.4 0.3 0.0 0.0 14.5 12.2 0.0 8.2 0.3 0.0 0.4 16.0 0.0 0.0 0.6 0.0 0.0 0.1 31.9 21.7 0.0 0.2 8.6 28.2 7.0 24.2 0.2 0.0 0.0 5.2 1.5 1.0 10.6 274.3 6.2 1.2 0.1 28.4 31.5 EVPL EVPK ENSG00000167880 Envoplakin Q92817 17 76004502-76027306 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 281.2;skin 1: 147.4;vagina: 101.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 26.7;Squamous epithelial cells: 94.1;Suprabasal keratinocytes: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 59.8;MCF7: 40.4;RT4: 87.8;SK-BR-3: 43.2;T-47d: 54.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002220, HPA053969" Enhanced Supported "Intermediate filaments,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" Cytosol "CAB002220: AB_563701, HPA053969: AB_2682326" "unprognostic (2.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (4.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-2)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-1)" "unprognostic (7.40e-3)" "unprognostic (2.64e-1)" "unprognostic (2.40e-2)" "unprognostic (2.31e-1)" "unprognostic (3.47e-1)" "unprognostic (7.93e-2)" "unprognostic (3.09e-2)" 1.3 0.3 0.6 1.0 0.6 2.5 2.6 1.1 1.0 47.5 0.8 8.9 11.0 1.5 1.7 281.2 2.1 1.7 0.2 0.6 0.3 17.0 0.3 9.4 0.6 2.8 1.3 0.3 4.0 3.4 1.5 0.3 2.8 8.0 1.5 0.6 42.3 1.8 1.4 147.4 9.1 1.0 0.5 0.3 5.2 0.8 0.6 0.4 10.7 0.1 7.9 12.7 101.9 1.5 28.1 23.4 0.0 0.3 0.2 0.0 9.6 0.2 0.0 0.0 0.0 2.6 16.7 0.0 0.1 0.0 0.0 59.8 0.1 7.8 0.1 0.1 0.2 0.7 19.4 17.4 0.0 0.2 4.2 0.2 12.3 0.2 0.0 0.0 0.0 3.7 0.1 1.1 0.0 40.4 1.0 3.6 0.1 11.9 10.5 11.5 0.1 0.4 16.7 87.8 1.1 0.0 11.4 43.2 0.0 0.2 54.1 0.8 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.6 0.6 1.1 1.0 0.6 0.3 2.8 1.3 2.8 0.5 0.6 1.5 0.2 19.2 19.5 0.0 0.0 11.7 4.7 10.5 26.7 0.3 5.1 2.9 3.7 4.3 16.5 5.5 0.0 0.2 0.2 10.8 1.9 4.4 0.0 4.3 0.6 0.3 20.4 1.3 0.3 0.5 0.2 0.5 12.8 8.9 12.6 0.2 0.0 0.0 0.0 0.0 0.1 5.7 2.0 0.6 2.1 0.1 0.9 0.2 1.8 0.0 0.1 0.0 0.0 0.0 0.1 8.4 7.4 1.9 1.2 4.6 19.3 3.4 13.1 0.1 0.0 0.7 0.7 0.1 1.2 94.1 25.9 0.0 0.4 0.4 15.5 12.9 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favorable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.0 6.9 16.0 5.0 17.2 2.5 9.7 16.7 18.8 13.6 15.0 9.5 6.8 9.6 12.1 10.4 13.1 8.1 8.7 15.8 15.7 10.4 5.9 8.6 4.2 17.3 16.4 11.0 18.1 16.0 10.0 7.5 17.4 10.2 9.2 13.0 15.4 10.5 11.0 6.6 6.5 10.1 17.1 5.8 9.7 19.9 16.2 7.2 11.5 9.7 4.5 8.4 7.4 18.9 29.6 13.6 10.3 15.3 6.2 7.4 13.0 14.4 12.1 13.1 17.3 11.6 20.3 0.0 10.4 15.1 8.0 16.4 11.5 14.5 14.7 7.4 13.7 8.6 5.2 6.8 24.2 6.4 7.9 15.1 23.5 13.4 8.7 8.1 18.9 7.4 5.5 11.0 12.7 14.8 3.6 9.6 11.2 15.8 13.5 0.0 9.9 10.4 19.5 10.8 20.0 17.8 10.8 22.2 10.6 11.0 29.8 5.5 15.0 12.2 8.5 9.9 7.5 8.3 12.0 0.1 0.1 6.9 9.3 12.2 2.5 2.2 2.2 1.4 4.2 2.9 2.3 2.3 5.4 1.5 2.8 4.1 0.3 2.9 1.4 4.2 1.8 2.3 16.0 17.2 16.7 18.8 15.8 15.7 17.3 16.4 17.4 17.1 16.2 18.9 7.2 12.8 10.9 15.7 4.3 3.2 4.9 6.2 14.2 9.9 9.9 7.2 12.1 7.2 9.0 0.0 8.4 8.5 2.5 4.7 5.9 10.7 3.2 7.7 8.4 6.0 6.1 7.8 27.4 8.8 4.4 6.5 8.2 11.1 1.3 9.6 10.8 5.4 6.8 10.1 22.6 8.4 8.2 6.3 2.2 2.3 6.2 3.3 3.6 11.2 6.8 7.5 2.1 21.6 19.1 8.8 6.2 12.0 5.6 5.6 3.6 4.8 11.0 9.3 0.0 7.2 7.4 36.1 8.1 12.6 4.3 2.9 2.6 6.1 7.9 4.3 FAIM2 "KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2" ENSG00000135472 "Fas apoptotic inhibitory molecule 2" Q9BWQ8 12 49866896-49904217 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 359.4;parathyroid gland: 98.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 141.9;Early spermatids: 202.2;Excitatory neurons: 77.6;Horizontal cells: 232.2;Inhibitory neurons: 105.1" "Cancer enriched" "Detected in many" 8 "glioma: 21.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "HHSteC: 12.2;OE19: 16.7;SH-SY5Y: 6.7;U-87 MG: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018790, HPA048800" Enhanced Uncertain "Intermediate filaments" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Intermediate filaments" "HPA018790: AB_1852822, HPA048800: AB_2680526" "unprognostic (1.74e-1)" "unprognostic (5.98e-4)" "unprognostic (2.22e-1)" "unprognostic (9.75e-3)" "unprognostic (3.36e-2)" "unprognostic (2.61e-4)" "unprognostic (2.62e-1)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (1.75e-2)" "unprognostic (5.66e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-6)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.47e-1)" "unprognostic (6.78e-4)" 4.7 41.6 180.7 4.9 189.0 0.0 1.8 107.7 359.4 6.7 0.0 8.5 2.2 9.9 8.0 4.2 14.2 10.2 41.9 205.6 161.0 2.1 0.4 2.2 3.7 223.0 129.4 3.9 2.4 98.1 42.0 0.2 206.5 14.2 3.5 72.3 2.6 9.0 1.2 0.9 6.3 12.2 106.8 1.9 4.2 30.5 175.3 1.9 1.8 1.2 2.8 9.5 10.5 223.0 0.0 0.5 0.5 0.7 2.7 1.7 0.1 0.7 3.6 0.7 0.4 0.4 0.0 0.0 0.1 5.1 0.2 0.3 1.5 0.0 0.4 0.0 0.0 2.9 0.0 0.0 12.2 0.1 0.1 1.1 0.2 2.7 0.0 0.0 0.0 0.3 1.6 0.4 0.7 0.0 0.1 0.0 0.1 16.7 0.0 0.0 0.2 0.0 0.0 0.0 4.4 6.7 0.0 0.2 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.1 0.1 0.4 0.0 0.0 38.5 0.0 0.4 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.1 180.7 189.0 107.7 359.4 205.6 161.0 223.0 129.4 206.5 106.8 175.3 223.0 0.2 0.0 0.0 31.0 0.0 0.3 0.3 0.7 0.6 141.9 2.3 2.3 1.1 0.0 0.4 0.0 2.1 0.0 0.3 0.1 0.0 0.1 202.2 0.1 0.5 0.7 0.0 0.0 77.6 0.2 0.1 16.7 1.1 0.0 26.1 0.0 0.0 0.0 0.4 232.2 105.1 2.2 12.2 0.0 0.4 52.0 5.0 0.5 0.0 13.1 0.0 35.6 0.0 45.2 55.5 0.1 0.0 5.3 0.3 0.5 0.0 0.4 0.0 20.2 0.0 0.9 0.7 4.8 5.8 0.5 0.3 0.1 0.5 0.4 0.7 0.3 FAM118A "bK268H5.C22.4, C22orf8, FLJ20635" ENSG00000100376 "Family with sequence similarity 118 member A" Q9NWS6 22 45308968-45341955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 104.0;Early spermatids: 125.0;Syncytiotrophoblasts: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003902 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 21: OE19 - Mitochondria" "Cluster 63: NK-cells & T-cells - Immune response" "Intermediate filaments" Cytosol "HPA003902: AB_1848368" "unprognostic (6.22e-3)" "unprognostic (1.19e-2)" "unprognostic (9.92e-2)" "unprognostic (1.56e-3)" "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (3.72e-2)" "unprognostic (7.61e-3)" "unprognostic (9.42e-2)" "unprognostic (6.11e-2)" "unprognostic (5.02e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.87e-6)" "unprognostic (9.76e-2)" "unprognostic (1.28e-1)" "unprognostic (4.50e-1)" "unprognostic (1.16e-3)" 14.1 11.8 14.9 23.7 16.9 21.5 23.3 22.0 17.1 21.9 25.5 23.3 19.9 17.7 66.5 18.6 12.2 24.4 24.5 17.2 15.6 22.9 17.1 19.3 49.1 14.4 15.3 21.7 14.3 38.3 37.6 18.3 14.4 41.7 12.4 9.5 18.4 9.3 30.5 39.7 24.8 10.3 11.4 25.9 21.3 22.7 17.9 13.6 23.7 6.5 27.6 29.7 22.8 15.8 10.9 7.8 11.0 11.9 9.3 8.9 24.0 8.1 13.4 11.5 11.2 25.6 10.1 48.6 6.5 7.5 6.5 40.7 14.3 10.3 11.5 10.6 31.9 26.3 13.2 18.7 12.8 24.8 7.2 9.5 12.3 17.6 10.8 8.0 7.1 14.6 39.5 52.6 5.9 26.1 14.7 51.3 8.2 49.8 10.4 19.0 7.1 17.4 6.6 28.9 21.8 25.6 8.9 19.0 23.9 18.0 8.2 14.4 9.2 8.8 28.8 10.8 10.8 29.0 5.5 24.7 11.9 17.1 16.0 7.1 7.1 2.2 5.8 6.2 4.7 4.3 7.3 7.2 8.8 6.5 11.5 8.6 5.8 5.6 5.0 13.5 10.9 4.4 14.9 16.9 22.0 17.1 17.2 15.6 14.4 15.3 14.4 11.4 17.9 15.8 12.5 9.6 17.0 23.8 21.2 22.6 36.9 18.8 10.8 18.3 10.9 6.6 11.3 8.6 16.6 7.3 18.8 104.0 83.1 21.4 0.0 7.0 125.0 6.7 15.5 20.7 32.9 14.5 23.1 6.2 8.5 19.2 10.2 7.4 1.3 8.8 23.9 14.5 12.9 6.7 18.3 20.5 12.2 13.0 29.9 75.6 35.8 19.8 1.8 62.8 69.5 16.4 39.1 22.6 21.5 4.8 17.7 23.7 25.8 22.6 13.4 3.9 14.6 22.3 0.0 33.6 14.7 72.5 38.8 8.8 9.9 120.9 55.2 7.3 17.5 35.4 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.3;kidney: 14.9" "Cell type enhanced" "Detected in some" "Collecting duct cells: 9.2;Distal tubular cells: 19.6;Horizontal cells: 38.7;Muller glia cells: 31.8" "Cancer enhanced" "Detected in many" "renal cancer: 4.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 7.8;HEK 293: 5.3;PC-3: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: AB_2673711" "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favorable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.3 6.9 10.3 0.0 13.8 0.0 0.2 40.3 12.3 1.1 3.3 0.3 0.0 0.5 0.2 1.5 0.5 0.3 5.6 8.5 15.3 14.9 0.5 0.0 0.0 15.9 14.4 0.4 3.5 3.3 9.4 0.0 18.4 0.2 0.0 3.1 1.9 0.3 0.1 2.7 0.9 0.1 13.5 0.1 1.0 0.7 13.5 0.1 1.2 0.2 0.3 0.2 0.9 20.8 3.3 7.8 0.2 0.4 0.0 0.0 0.0 0.7 0.6 0.8 1.9 0.2 1.7 0.0 0.3 0.4 1.9 0.9 1.0 0.2 0.2 0.0 5.3 0.0 1.6 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.6 2.6 0.5 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.3 1.6 6.0 0.0 0.0 3.5 0.6 0.0 1.1 2.3 0.2 0.9 0.2 0.0 0.2 0.0 1.2 0.1 2.7 0.0 0.0 1.3 0.1 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 13.8 40.3 12.3 8.5 15.3 15.9 14.4 18.4 13.5 13.5 20.8 0.1 0.0 0.0 4.9 0.0 0.3 0.4 0.3 0.0 6.5 0.6 1.0 2.1 1.5 0.3 9.2 4.2 0.1 0.0 0.0 19.6 2.6 1.3 0.3 0.1 0.3 3.5 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.0 0.3 0.7 0.4 0.0 38.7 8.9 0.0 6.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.6 31.8 0.0 0.0 7.1 0.3 0.0 0.0 0.4 0.5 0.0 0.8 0.2 2.4 0.0 2.3 0.4 0.7 3.5 0.2 1.1 0.0 0.1 0.0 0.1 0.5 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617448-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 76.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 105.8;Intestinal goblet cells: 60.9;Late spermatids: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.5;granulocytes: 2.9;T-cells: 8.9" "Cell line enhanced" "Detected in many" "CACO-2: 74.3;MCF7: 91.8;OE19: 76.3;RPMI-8226: 109.6;RT4: 221.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" No No "Cluster 4: T-regs - Cell cycle regulation" "Cluster 25: Pancreas - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Intermediate filaments" "HPA015306: AB_2669182" "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favorable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 5.6 5.6 13.8 5.9 13.2 1.1 27.2 9.7 14.6 16.9 9.1 10.7 6.3 8.2 7.2 8.4 24.0 6.1 10.5 13.9 14.5 5.3 6.9 21.0 8.5 14.0 16.0 16.2 76.6 2.9 26.5 6.7 14.6 32.2 15.2 6.4 52.5 16.2 16.2 8.4 8.5 4.9 7.8 4.0 35.0 17.9 14.9 8.0 37.2 15.9 7.4 26.3 6.6 19.5 0.3 12.2 8.0 2.4 0.0 0.2 1.0 4.6 21.8 0.2 0.0 74.3 8.6 1.2 20.6 0.6 5.8 0.4 13.9 0.5 0.0 0.5 6.5 0.7 1.4 1.0 1.3 1.1 3.2 1.0 0.3 0.2 0.2 0.5 10.5 6.8 1.2 54.7 12.2 91.8 2.7 0.1 39.2 76.3 0.0 8.9 22.5 109.6 5.4 221.3 4.9 3.9 6.4 42.7 14.3 22.7 33.8 7.9 0.0 0.0 1.6 0.3 10.3 1.7 17.2 2.6 0.2 0.8 5.3 0.9 0.6 0.8 0.1 0.7 0.2 0.3 1.8 0.0 0.5 0.3 2.0 2.6 2.9 0.7 0.0 3.5 8.9 0.6 13.8 13.2 9.7 14.6 13.9 14.5 14.0 16.0 14.6 7.8 14.9 19.5 8.5 105.8 22.2 13.7 1.7 2.3 14.7 1.7 5.7 7.0 26.3 11.3 5.2 5.7 12.6 7.3 8.4 1.4 2.3 3.7 7.9 5.5 22.6 17.8 4.2 10.3 42.1 0.8 24.0 14.6 21.2 4.9 19.4 23.4 18.4 1.3 22.1 7.0 5.4 11.8 24.4 60.9 24.4 3.8 4.8 57.8 5.9 4.9 12.4 22.5 0.4 3.9 0.0 17.1 44.8 19.1 1.6 1.9 6.6 24.2 3.0 1.5 14.5 3.7 0.0 7.7 3.7 1.0 5.0 3.9 3.0 0.7 3.4 1.8 5.5 24.3 GFAP FLJ45472 ENSG00000131095 "Glial fibrillary acidic protein" P14136 17 44903159-44916937 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 13076.3" "Cell type enriched" "Detected in some" 7 "Astrocytes: 381.9" "Cancer enriched" "Detected in some" 368 "glioma: 2468.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 6.2" "Group enriched" "Detected in many" 5 "granulocytes: 6.2;NK-cells: 1.7" "Cell line enhanced" "Detected in many" "U-87 MG: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000039, HPA056030, HPA063513" Enhanced Supported Supported "Intermediate filaments" No No 170000000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 70: Brain - Nervous system development" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 64: Astrocytes - Nervous system maintenance" "Intermediate filaments" "CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027" "unprognostic (1.79e-2)" "unprognostic (2.74e-1)" "unprognostic (9.83e-2)" "unprognostic (2.12e-5)" "unprognostic (4.08e-1)" "unprognostic (5.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (6.57e-3)" "unprognostic (7.35e-2)" "unprognostic (5.86e-2)" "unprognostic (1.24e-1)" "unprognostic (7.63e-2)" "unprognostic (2.75e-5)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" 1.9 1.8 5096.2 2.2 5407.4 14.1 3.5 5902.8 4887.4 1.9 2342.2 1.4 0.4 0.9 1.5 3.7 2.2 1.6 8.2 5059.3 9869.7 2.1 1.7 1.3 1.9 13076.3 9001.4 2.1 1.5 1.6 33.9 0.7 9204.1 1.3 1.0 117.7 1.9 1.0 2.1 2.6 0.7 0.9 10040.2 1.5 1.5 1.4 8068.5 0.4 1.7 0.3 1.1 1.4 0.9 10496.9 1.0 0.7 1.2 2.3 0.0 0.4 0.2 1.0 1.2 1.5 1.2 1.3 1.5 2.2 1.9 0.5 0.9 2.7 1.4 0.4 1.8 3.0 1.1 1.4 2.1 0.9 0.0 0.2 2.2 0.1 0.8 1.0 0.0 1.7 0.0 2.3 0.7 5.3 0.8 1.3 1.9 2.6 1.6 0.1 3.3 0.7 0.7 1.2 0.7 0.6 1.6 1.8 0.1 1.7 0.2 1.0 1.2 1.2 0.7 1.2 0.9 1.1 2.0 0.7 1.6 1.6 6.1 2.0 2.7 1.5 0.8 0.3 0.3 0.6 0.2 0.2 0.2 0.4 0.1 0.5 0.3 0.4 6.2 1.7 0.5 0.5 0.2 0.2 5096.2 5407.4 5902.8 4887.4 5059.3 9869.7 13076.3 9001.4 9204.1 10040.2 8068.5 10496.9 0.0 0.0 0.0 381.9 0.1 0.0 0.1 0.0 0.0 0.8 1.3 0.6 5.2 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.8 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.7 0.0 53.5 0.0 10.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.4 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 HOXA13 "HOX1, HOX1J" ENSG00000106031 "Homeobox A13" P31271 7 27193503-27200091 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 23.1;placenta: 17.1;prostate: 22.3;seminal vesicle: 23.3" "Cell type enriched" "Detected in some" 4 "Distal enterocytes: 41.3" "Cancer enhanced" "Detected in many" "prostate cancer: 10.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046098, HPA069061" Supported "Nucleoplasm,Mitotic chromosome,Intermediate filaments" Yes NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Mitotic chromosome, Intermediate filaments" "HPA046098: AB_2679536, HPA069061: " "unprognostic (7.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (8.04e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-2)" "unprognostic (9.22e-3)" "unprognostic (7.30e-3)" "unprognostic (8.39e-3)" "unprognostic (1.54e-1)" "unprognostic (1.42e-11)" "unprognostic (2.58e-3)" "unprognostic (1.38e-1)" "unprognostic (1.72e-1)" "unprognostic (1.36e-2)" 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.1 0.0 9.9 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 22.3 11.9 0.0 0.0 23.3 2.1 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.1 14.1 0.0 2.2 1.6 0.0 2.5 0.2 0.0 0.1 13.2 14.4 5.1 3.3 2.8 0.2 0.0 1.6 6.2 0.7 0.0 26.9 0.0 4.3 0.0 37.3 1.9 6.9 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 8.7 0.0 11.8 18.4 2.7 0.6 0.0 0.1 42.1 0.7 0.0 3.3 0.0 0.3 2.0 0.0 18.2 0.0 0.5 4.5 0.3 0.1 0.0 0.0 0.0 0.0 20.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 41.3 0.0 0.0 0.6 0.1 4.0 1.1 8.4 0.0 0.0 0.0 0.1 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.1 2.8 0.5 0.0 0.0 0.1 0.1 0.1 0.0 10.3 3.1 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122141-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 45.4;Rod photoreceptor cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Supported "Vesicles,Intermediate filaments,Mitochondria" No No "Cluster 34: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "Vesicles, Intermediate filaments" "HPA045745: AB_2679440" "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favorable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 7.5 15.4 14.3 7.1 14.6 4.4 11.9 10.9 13.0 10.6 10.7 7.4 6.2 13.2 10.5 7.8 12.6 7.1 15.7 14.0 18.3 10.8 5.1 9.1 9.0 15.0 14.8 22.0 4.9 15.1 11.9 9.1 18.6 9.8 6.9 34.3 7.3 11.1 20.7 8.0 5.7 10.8 9.5 8.0 6.4 13.2 17.0 14.1 26.8 30.5 9.2 7.3 7.1 10.2 11.1 12.6 57.4 19.8 20.7 14.5 14.6 13.8 13.1 17.0 8.9 14.5 18.8 22.7 24.7 12.4 18.8 7.6 31.1 12.1 26.9 4.9 18.9 10.9 7.9 32.5 21.0 17.1 19.2 11.0 20.0 24.1 15.4 21.9 20.9 30.6 23.0 28.2 34.3 27.3 37.8 17.4 29.5 6.4 13.3 36.7 20.4 8.4 16.6 12.0 27.1 20.2 35.0 5.6 39.0 28.5 34.4 10.2 17.5 19.2 22.9 13.9 11.3 44.1 38.1 36.9 22.8 12.3 18.2 21.2 5.0 11.1 3.8 3.4 5.0 5.0 4.1 4.6 2.8 7.5 5.3 5.6 5.5 4.3 6.3 0.0 5.4 4.4 14.3 14.6 10.9 13.0 14.0 18.3 15.0 14.8 18.6 9.5 17.0 10.2 8.9 12.8 16.4 7.8 8.2 4.8 4.6 6.4 8.6 20.2 10.2 8.3 16.7 1.5 8.6 3.7 14.6 6.9 4.4 3.7 5.9 7.9 38.5 11.4 10.5 7.7 9.5 5.7 12.4 6.7 6.6 7.7 3.6 11.0 1.3 38.6 9.3 4.1 12.2 45.4 15.8 3.7 4.1 6.9 3.5 12.2 5.9 10.4 5.4 11.2 6.1 28.4 5.2 15.6 13.0 6.8 2.5 10.1 10.1 5.2 3.9 8.0 13.7 44.2 0.0 8.0 7.8 35.8 30.1 8.8 7.0 8.8 6.6 12.7 4.5 4.8 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006740-43014456 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 122.4;Paneth cells: 116.7;Proximal enterocytes: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 204.5;BJ hTERT+ SV40 Large T+ RasG12V: 299.2;GAMG: 108.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Supported "Nucleoplasm,Intermediate filaments,Cytosol" "Secreted to blood" NA NA 120000 "Cluster 7: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA045946: AB_2679509, HPA075580: " "prognostic favorable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 27.5 41.3 15.4 27.2 16.4 24.9 24.2 15.6 18.2 18.4 16.2 27.4 24.6 17.4 11.7 10.2 20.8 20.1 20.9 14.9 16.7 29.7 30.6 25.6 26.4 20.2 16.6 23.8 13.6 10.5 14.2 15.0 17.3 27.8 20.4 1.5 29.4 15.2 6.3 11.3 30.2 21.3 20.3 39.9 22.7 5.0 17.0 23.4 20.8 9.3 19.0 21.1 15.4 17.0 12.7 28.8 0.2 1.5 24.2 29.1 6.1 8.2 84.6 204.5 299.2 10.7 46.2 3.9 16.1 24.7 108.0 7.0 1.6 12.9 16.3 33.5 6.1 9.3 10.5 39.5 59.6 10.5 19.3 40.3 4.9 29.0 3.6 18.6 18.8 8.0 5.4 61.2 8.2 12.5 22.7 8.5 0.1 11.6 13.0 18.4 0.1 23.7 25.7 10.9 5.4 0.2 16.4 6.3 88.2 0.6 26.5 20.3 9.3 15.1 0.3 4.8 13.3 54.1 21.8 1.1 27.1 8.2 14.8 60.7 102.7 61.6 44.3 127.8 40.4 37.8 34.0 41.7 62.0 40.0 26.8 33.6 62.1 56.9 122.0 67.0 51.8 80.5 15.4 16.4 15.6 18.2 14.9 16.7 20.2 16.6 17.3 20.3 17.0 17.0 65.2 16.0 9.7 2.6 28.6 10.5 29.6 31.8 12.5 0.8 16.5 11.3 5.5 11.5 22.7 18.4 2.1 22.7 36.7 83.1 41.1 47.8 9.4 12.3 27.4 32.1 31.7 12.8 0.7 64.0 32.5 32.8 26.5 16.2 7.6 122.4 37.1 31.3 84.8 1.7 0.6 39.4 12.2 36.8 19.2 39.5 28.9 47.8 24.9 5.6 75.5 10.4 64.9 1.0 1.0 41.8 116.7 23.7 54.0 19.1 128.0 93.7 18.0 0.8 6.6 13.2 36.3 0.5 0.4 5.1 9.2 10.4 32.3 25.0 34.6 29.6 INA "NEF5, NF-66" ENSG00000148798 "Internexin neuronal intermediate filament protein alpha" Q16352 10 103277138-103290346 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 160.7;pituitary gland: 41.4;retina: 97.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 62.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.4;Excitatory neurons: 28.7;Horizontal cells: 45.4;Inhibitory neurons: 39.8;Late spermatids: 26.5;Rod photoreceptor cells: 48.2;Spermatocytes: 20.3" "Group enriched" "Detected in many" 4 "glioma: 4.7;testis cancer: 18.2;urothelial cancer: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 53.0;SCLC-21H: 103.3;SH-SY5Y: 58.7;SiHa: 71.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002059, HPA007572, HPA008057" Enhanced Supported Approved "Intermediate filaments,Cytosol" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Intermediate filaments" Cytosol "CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833" "unprognostic (1.77e-1)" "unprognostic (2.50e-2)" "unprognostic (9.54e-2)" "unprognostic (5.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.45e-3)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "unprognostic (8.09e-3)" "unprognostic (3.07e-2)" "unprognostic (1.78e-3)" "unprognostic (1.66e-1)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" 0.2 12.1 34.2 1.2 35.5 0.0 0.0 63.3 160.7 0.0 0.0 3.3 0.6 0.0 0.0 0.6 0.0 0.1 0.0 31.8 109.5 0.0 0.0 0.2 0.1 107.9 37.5 0.0 2.0 0.4 41.4 0.1 98.1 0.2 1.2 97.3 0.1 0.0 0.0 0.8 1.1 0.8 25.3 0.0 1.1 2.7 72.8 1.7 0.1 0.0 0.2 1.1 0.5 51.9 0.0 25.4 11.8 0.0 0.1 0.0 19.3 13.3 3.3 3.1 0.3 0.0 0.0 0.0 5.4 0.9 1.5 1.9 11.0 0.0 0.7 24.6 4.9 0.0 6.8 0.1 0.2 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 13.6 0.0 53.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 103.3 58.7 71.6 0.1 0.0 2.7 0.0 0.7 0.1 0.0 0.1 0.0 0.0 3.4 3.1 0.0 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 35.5 63.3 160.7 31.8 109.5 107.9 37.5 98.1 25.3 72.8 51.9 0.1 0.0 0.0 6.2 0.0 0.3 0.1 0.0 0.0 62.4 0.0 0.4 0.5 0.0 0.0 0.0 22.9 0.2 0.0 0.1 0.0 0.1 41.4 0.4 0.2 0.9 7.8 0.0 28.7 0.0 0.2 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.5 45.4 39.8 0.0 0.0 0.0 0.0 26.5 0.3 0.1 0.0 2.8 0.0 8.7 0.0 1.0 5.4 0.4 0.0 0.4 0.0 0.5 0.0 0.0 0.0 48.2 0.0 0.0 0.6 20.3 4.1 1.0 0.4 0.1 0.1 0.1 0.0 0.6 IQUB FLJ35834 ENSG00000164675 "IQ motif and ubiquitin domain containing" Q8NA54 7 123452193-123535077 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 33.4" "Group enriched" "Detected in many" 7 "Early spermatids: 283.9;Endometrial ciliated cells: 82.6;Late spermatids: 157.5;Respiratory ciliated cells: 88.2;Spermatocytes: 116.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049626 Approved "Nucleoplasm,Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "Nucleoplasm, Intermediate filaments, Cytosol" "HPA049626: AB_2732554" "unprognostic (8.71e-2)" "unprognostic (1.25e-2)" "unprognostic (1.98e-1)" "unprognostic (6.42e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (6.23e-2)" "unprognostic (7.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "unprognostic (3.76e-1)" "unprognostic (5.44e-6)" "unprognostic (2.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.14e-1)" "unprognostic (7.30e-2)" 0.1 0.6 0.2 0.0 0.4 0.0 0.5 1.7 0.9 0.8 3.9 0.1 0.0 0.7 1.1 0.0 5.0 0.8 0.1 0.2 0.5 3.0 0.0 0.8 0.0 1.8 2.0 0.2 0.3 1.7 1.0 0.1 1.3 0.5 0.0 1.1 0.2 0.6 0.1 0.1 0.0 0.2 1.0 0.0 0.1 33.4 0.6 0.0 3.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.4 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.3 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.7 0.9 0.2 0.5 1.8 2.0 1.3 1.0 0.6 0.4 1.1 6.4 0.5 19.6 0.0 0.5 0.7 3.8 0.0 2.5 1.9 1.8 1.8 0.0 11.4 18.4 4.2 0.4 0.1 0.1 1.9 1.1 283.9 82.6 3.2 0.9 1.8 0.0 12.0 0.4 0.3 1.1 0.0 1.7 1.3 0.3 0.7 0.0 0.1 3.3 8.6 0.2 8.2 0.0 0.3 157.5 2.5 0.4 0.0 4.7 0.3 1.8 0.0 5.0 2.6 0.2 0.0 3.0 0.0 0.5 0.0 5.7 88.2 9.0 6.6 0.7 2.7 116.2 6.0 0.2 0.1 0.7 0.3 2.9 0.0 0.3 ITFG1 "CDA08, LNKN-1, TIP" ENSG00000129636 "Integrin alpha FG-GAP repeat containing 1" Q8TB96 16 47154387-47464149 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 285.9;Oligodendrocytes: 263.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015590, HPA019728" Approved Approved "Intermediate filaments,Aggresome" "Intracellular and membrane" NA NA 28000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Intermediate filaments" Aggresome "HPA015590: AB_1846347, HPA019728: AB_1846348" "unprognostic (6.53e-3)" "unprognostic (9.26e-3)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-3)" "unprognostic (3.70e-2)" "unprognostic (9.32e-2)" "unprognostic (2.47e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "prognostic favorable (1.95e-8)" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (4.62e-3)" 25.3 42.2 18.5 16.4 23.8 12.5 25.2 17.1 22.0 28.8 26.0 35.1 30.5 27.8 31.2 19.1 26.3 28.8 44.7 23.7 22.9 47.8 45.4 27.4 13.5 13.6 14.0 28.0 27.3 56.0 15.7 40.7 15.9 29.4 33.1 33.3 21.8 28.9 23.8 12.9 26.7 29.1 16.6 19.3 28.3 36.7 18.5 17.2 43.2 24.6 16.7 24.4 13.8 19.5 22.2 24.8 44.0 31.1 84.1 65.0 54.1 50.7 72.9 45.6 24.3 14.2 51.8 25.9 70.4 63.5 30.9 31.9 21.6 33.0 44.9 11.8 17.0 14.0 22.0 33.2 39.4 32.7 59.6 48.3 55.6 23.3 30.1 96.3 44.4 24.2 40.3 33.5 58.3 21.1 20.2 16.3 14.5 27.4 24.5 31.0 43.4 66.5 60.2 15.9 21.9 30.8 46.0 53.6 24.0 43.7 23.7 29.9 43.0 48.9 23.7 26.3 20.7 47.6 66.7 48.4 48.9 20.6 39.2 17.9 33.9 33.4 16.0 33.0 15.2 16.6 19.0 17.7 25.8 17.2 20.7 17.4 21.2 23.8 33.1 17.5 26.1 29.2 18.5 23.8 17.1 22.0 23.7 22.9 13.6 14.0 15.9 16.6 18.5 19.5 38.9 51.3 28.1 165.9 37.2 38.4 43.4 81.3 27.9 50.8 32.6 23.2 56.8 50.1 62.2 82.8 47.9 100.6 32.3 79.3 9.8 60.5 129.0 33.0 28.7 37.8 61.9 27.8 250.7 52.4 86.4 48.5 41.8 35.0 8.2 54.5 39.3 68.7 50.9 40.4 285.9 43.2 73.2 53.8 30.0 32.0 35.1 41.9 28.4 146.1 45.4 39.4 38.1 214.6 263.5 45.3 37.0 61.3 60.1 35.3 65.2 49.6 54.5 47.4 78.9 30.1 49.8 93.7 98.3 25.5 30.3 114.0 29.9 66.0 38.1 37.4 KATNAL2 "DKFZP667C165, MGC33211" ENSG00000167216 "Katanin catalytic subunit A1 like 2" Q8IYT4 18 46917492-47102243 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 84.2;Early spermatids: 91.8;Inhibitory neurons: 41.8;Late spermatids: 71.4;Oligodendrocytes: 38.7;Spermatocytes: 58.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 21.5;Daudi: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040712, HPA042029" Approved Approved "Nucleoplasm,Intermediate filaments" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Intermediate filaments" "HPA040712: AB_2677092, HPA042029: AB_2677807" "unprognostic (3.40e-1)" "unprognostic (7.75e-2)" "unprognostic (9.00e-3)" "unprognostic (9.28e-2)" "unprognostic (1.74e-2)" "unprognostic (6.55e-3)" "unprognostic (6.97e-2)" "unprognostic (1.28e-2)" "unprognostic (3.90e-2)" "unprognostic (5.36e-2)" "unprognostic (9.52e-6)" "unprognostic (1.28e-1)" "prognostic favorable (1.24e-7)" "unprognostic (1.64e-1)" "unprognostic (7.14e-4)" "unprognostic (1.06e-3)" "unprognostic (1.61e-1)" 5.3 3.4 9.6 1.8 11.1 2.7 4.0 14.4 14.7 3.4 23.1 2.6 1.4 2.3 5.5 2.6 7.1 4.4 4.4 9.1 9.2 10.4 6.9 3.3 3.2 10.6 11.5 3.3 2.9 18.0 8.0 1.7 11.2 4.3 2.5 10.8 4.4 2.7 6.1 7.4 2.2 1.8 8.6 3.7 2.2 15.5 10.3 1.9 17.5 2.9 2.1 2.3 3.1 12.9 2.7 5.7 3.5 21.5 7.1 7.9 1.6 2.4 2.1 1.9 2.5 0.2 7.5 28.2 2.2 4.2 2.6 0.9 6.9 0.7 1.6 2.6 3.7 1.3 2.0 0.4 2.8 1.7 2.4 16.5 2.6 3.5 0.9 4.9 0.7 12.8 1.0 2.3 11.5 2.7 1.9 3.7 7.6 4.0 3.9 7.8 1.5 0.1 6.4 0.4 7.6 8.8 2.7 0.5 1.0 11.9 15.5 16.7 1.5 7.1 0.7 2.7 1.7 1.8 1.5 19.7 3.7 18.0 13.4 0.1 0.1 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.0 0.6 0.3 0.3 0.2 0.1 0.2 0.1 0.0 0.0 9.6 11.1 14.4 14.7 9.1 9.2 10.6 11.5 11.2 8.6 10.3 12.9 3.7 0.0 1.1 84.2 1.0 1.5 3.0 2.9 8.0 9.9 1.6 1.3 2.9 1.5 5.2 3.7 6.2 0.0 0.2 2.5 13.7 0.9 91.8 22.6 6.2 2.5 0.0 1.7 28.2 0.2 0.0 3.1 3.6 1.6 0.0 3.9 2.2 4.2 3.6 11.8 41.8 0.7 2.0 1.9 0.9 71.4 1.5 1.5 3.6 18.7 0.9 2.6 0.0 26.7 38.7 0.2 0.3 2.2 0.4 1.0 0.2 12.1 35.2 2.3 0.0 7.5 1.9 58.7 4.6 2.8 1.1 0.1 0.6 2.6 2.3 1.9 KBTBD11 "KIAA0711, KLHDC7C" ENSG00000176595 "Kelch repeat and BTB domain containing 11" O94819 8 1973677-2006936 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5;Proximal enterocytes: 58.0;Proximal tubular cells: 32.2" "Cancer enhanced" "Detected in many" "renal cancer: 14.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.3;HEK 293: 2.0;MOLT-4: 1.4;REH: 1.8;SCLC-21H: 2.0;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051159 Uncertain Approved "Intermediate filaments" NA NA "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 45: Enterocytes - Digestion" "Intermediate filaments" "HPA051159: AB_2681367" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (1.20e-3)" "unprognostic (2.70e-2)" "unprognostic (2.03e-1)" "unprognostic (6.84e-2)" "unprognostic (2.76e-4)" "unprognostic (2.50e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.75e-2)" "unprognostic (9.53e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-2)" 3.0 6.6 3.6 0.2 5.0 0.0 2.8 2.3 10.8 1.5 0.0 7.0 0.1 0.9 0.0 1.2 2.6 0.0 2.6 7.6 0.7 9.2 7.8 2.7 0.0 6.2 1.9 1.3 3.6 0.1 3.7 0.0 3.4 2.8 0.0 0.0 1.2 0.1 1.1 1.6 9.8 0.0 3.3 7.5 2.0 1.2 2.9 0.0 3.9 0.0 0.0 1.9 1.1 9.3 0.5 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.6 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 5.0 2.3 10.8 7.6 0.7 6.2 1.9 3.4 3.3 2.9 9.3 6.1 0.0 8.1 17.6 0.6 1.0 0.4 0.0 0.0 24.3 1.0 0.6 5.2 8.6 0.1 12.9 35.5 0.0 0.6 25.6 25.4 2.0 0.8 0.6 0.4 7.9 6.0 3.6 29.2 3.8 0.2 2.0 1.1 0.7 0.0 1.3 4.2 18.2 3.6 20.2 12.6 13.0 0.0 13.5 1.9 0.3 5.0 8.0 1.8 9.4 15.7 9.6 2.1 9.5 16.3 11.9 10.7 10.5 1.5 3.1 58.0 32.2 1.7 31.3 0.0 15.1 1.3 0.3 3.7 0.0 0.9 0.3 1.0 0.1 19.7 1.4 KCTD9 "BTBD27, FLJ20038" ENSG00000104756 "Potassium channel tetramerization domain containing 9" Q7L273 8 25427847-25458476 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042468, HPA047902" Supported "Nucleoplasm,Intermediate filaments,Cytosol" No No "Cluster 4: T-regs - Cell cycle regulation" "Cluster 8: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "Intermediate filaments, Cytosol" "HPA042468: , HPA047902: AB_2680205" "unprognostic (4.18e-2)" "unprognostic (3.90e-2)" "prognostic favorable (7.88e-4)" "unprognostic (7.04e-2)" "unprognostic (7.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.20e-2)" "unprognostic (6.01e-2)" "unprognostic (4.33e-1)" "unprognostic (2.43e-2)" "unprognostic (4.49e-3)" "unprognostic (2.30e-1)" "unprognostic (1.48e-1)" "unprognostic (6.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.31e-2)" "unprognostic (4.97e-3)" 18.4 8.2 4.9 11.5 5.8 21.5 22.3 7.9 6.5 15.4 8.6 21.1 19.6 11.3 13.0 23.8 14.6 13.3 38.3 5.5 5.9 12.8 10.8 13.4 12.2 9.1 7.7 14.2 11.2 11.0 9.8 12.0 10.0 17.4 22.6 12.9 17.5 15.6 29.5 19.0 17.7 14.5 7.8 9.4 12.8 12.9 6.9 14.7 13.7 36.7 14.4 15.6 18.7 6.9 46.4 32.4 34.5 11.9 44.0 58.0 28.2 68.6 61.4 44.1 44.5 23.4 33.2 30.1 28.6 69.0 62.3 30.3 30.6 32.3 52.9 15.4 18.2 35.3 30.2 21.7 53.2 12.3 25.1 44.8 38.5 40.2 33.2 26.9 37.8 29.6 37.8 23.0 50.7 12.4 48.2 21.6 16.8 35.8 17.0 18.6 39.8 11.2 45.0 26.1 8.8 11.4 52.7 23.1 35.8 30.8 17.8 14.2 42.2 48.5 28.2 94.1 37.6 6.6 12.9 39.1 33.9 21.8 35.8 0.7 0.5 1.2 1.0 0.7 1.0 0.6 1.0 1.0 0.3 0.3 0.6 0.9 0.5 0.2 0.9 1.0 1.1 0.4 4.9 5.8 7.9 6.5 5.5 5.9 9.1 7.7 10.0 7.8 6.9 6.9 19.5 32.1 18.5 18.6 8.9 74.4 36.4 26.0 31.9 13.7 20.4 12.7 61.1 5.7 24.2 27.6 25.0 9.4 23.3 53.8 13.7 17.6 6.5 12.8 12.7 16.8 10.2 20.2 14.3 27.2 17.6 32.5 8.2 17.9 20.3 10.9 12.5 9.0 9.3 3.3 12.9 16.0 18.3 9.3 18.5 5.2 30.7 12.9 30.2 36.5 8.5 8.1 18.6 17.1 13.6 36.6 21.6 55.7 17.1 52.6 25.8 10.4 17.4 19.6 6.6 21.6 26.2 35.6 26.4 41.6 54.7 11.2 19.8 14.4 17.7 46.0 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981389 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Excitatory neurons: 92.2;Inhibitory neurons: 54.6;Oligodendrocyte precursor cells: 69.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "PC-3: 20.6;SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" NA NA 14000 "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favorable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 0.6 1.7 2.7 0.3 3.0 0.3 1.5 0.0 4.4 1.4 0.0 0.8 0.7 1.7 1.8 0.5 2.2 1.0 1.2 4.3 0.8 3.9 0.4 1.8 0.2 1.6 2.5 1.2 6.3 2.4 1.8 1.3 0.0 1.5 0.7 5.7 2.4 5.5 0.5 0.8 0.7 1.3 1.4 0.3 1.3 1.2 2.5 2.4 0.7 0.8 0.2 1.1 0.6 2.4 4.9 9.2 9.1 14.9 0.1 0.0 4.2 5.2 4.6 2.6 3.4 8.4 2.6 0.0 2.9 8.2 8.6 1.0 5.7 1.4 3.6 2.5 3.8 2.6 11.5 2.2 1.3 3.8 3.2 1.2 2.8 0.9 1.4 3.5 4.8 3.4 1.7 0.1 3.6 4.5 2.9 4.7 7.8 4.1 20.6 6.8 4.5 0.0 1.7 3.3 11.8 21.5 2.6 5.2 2.2 5.1 3.7 2.4 3.3 2.9 2.8 0.1 5.1 0.9 0.0 0.1 4.0 1.4 7.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 3.0 0.0 4.4 4.3 0.8 1.6 2.5 0.0 1.4 2.5 2.4 2.0 0.0 2.2 11.8 0.1 0.5 2.1 1.6 0.6 18.5 6.3 4.6 2.5 0.0 2.9 7.3 56.3 2.5 0.2 0.3 0.0 2.3 0.5 8.5 8.1 4.8 10.8 1.3 92.2 3.2 2.2 3.0 3.6 8.0 16.5 13.8 2.2 0.8 0.5 3.3 54.6 2.5 6.1 0.8 1.2 0.2 1.5 0.5 1.8 26.2 0.0 7.2 0.0 69.9 2.2 5.0 1.4 2.6 1.0 3.1 0.5 8.1 12.2 29.2 6.6 2.2 2.9 0.3 7.2 0.1 0.9 1.5 1.1 2.4 2.9 1.6 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.3;retina: 33.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 178.7;Horizontal cells: 185.1;Inhibitory neurons: 157.0;Spermatocytes: 147.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "basophil: 68.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 68.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 2.6 8.0 14.3 3.8 15.2 1.6 5.0 9.7 26.3 4.4 0.0 3.4 2.5 4.7 5.0 3.3 7.0 4.0 4.6 16.5 16.7 5.8 1.4 4.5 3.9 12.6 13.1 5.1 2.7 11.8 11.3 3.2 17.6 5.1 2.6 33.9 2.8 4.8 2.5 4.0 2.0 4.5 1.3 2.8 3.7 21.5 8.2 6.0 5.4 3.1 3.7 3.8 3.0 13.8 10.6 12.6 11.4 20.8 7.7 7.8 9.4 8.9 7.0 8.2 10.9 13.0 8.0 29.7 11.6 10.4 24.8 7.2 9.6 17.6 17.2 8.6 10.2 4.3 6.9 4.7 7.9 5.3 11.4 5.8 8.6 12.1 14.0 11.4 10.4 18.8 4.8 15.3 10.1 7.9 34.5 4.2 5.5 3.8 4.8 8.8 9.2 3.2 8.4 9.4 36.2 11.9 12.0 4.3 14.4 18.6 12.8 1.6 10.9 10.1 15.9 7.3 10.6 11.5 19.6 16.4 12.9 4.4 11.1 68.2 0.6 1.9 6.3 1.5 6.9 6.7 6.5 6.1 1.3 4.0 6.4 7.0 0.6 4.8 2.0 1.2 5.4 2.0 14.3 15.2 9.7 26.3 16.5 16.7 12.6 13.1 17.6 1.3 8.2 13.8 10.9 54.5 38.0 65.3 12.0 13.6 15.6 25.5 12.5 76.5 13.7 18.7 29.9 11.5 31.7 38.6 125.1 14.6 18.4 0.8 29.4 20.5 86.2 69.7 20.4 11.3 19.8 3.4 178.7 12.9 11.5 16.8 5.6 23.7 13.9 24.6 13.2 2.4 6.2 185.1 157.0 3.8 54.9 3.5 7.7 25.0 16.4 4.8 42.7 21.5 5.4 47.0 5.2 122.6 100.7 12.4 4.6 24.5 14.4 7.6 1.1 10.8 121.0 99.6 13.1 23.8 40.5 147.1 102.6 9.0 15.9 9.9 23.6 27.7 2.1 6.0 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926598-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 75.5;retina: 19.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 53.5;Horizontal cells: 42.1;Inhibitory neurons: 45.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favorable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.1 6.8 28.4 2.3 40.2 1.5 2.9 6.9 75.5 4.0 0.0 5.4 1.3 3.6 1.7 2.2 2.7 3.6 2.9 46.1 18.6 1.6 0.7 2.0 1.2 37.5 10.9 6.8 1.4 3.7 11.7 2.1 32.7 2.9 1.7 19.6 2.2 3.8 1.8 2.5 2.5 4.2 0.0 1.6 2.3 2.3 13.8 2.6 3.0 2.5 1.1 2.7 3.7 37.8 25.7 38.1 19.9 15.4 11.4 13.1 15.9 13.1 6.4 7.7 8.7 6.8 3.8 0.0 10.6 11.9 24.1 2.7 15.2 7.8 5.2 4.5 7.3 9.3 2.6 14.0 6.7 2.3 7.7 9.6 2.3 24.2 4.8 29.6 25.8 7.3 3.3 3.2 8.3 1.8 6.7 3.2 20.5 0.7 11.1 10.4 9.9 1.7 17.7 6.2 24.2 54.4 5.2 2.2 27.3 16.4 0.8 3.1 20.6 13.4 13.7 6.1 12.9 0.8 4.6 3.1 30.4 12.5 11.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.5 0.2 0.0 0.0 0.4 0.3 28.4 40.2 6.9 75.5 46.1 18.6 37.5 10.9 32.7 0.0 13.8 37.8 1.9 0.0 0.0 9.4 0.2 0.5 1.6 1.5 1.2 16.7 2.0 2.4 3.5 2.8 1.1 0.0 6.2 0.6 2.1 0.1 0.0 8.4 3.4 1.0 2.1 5.6 3.0 0.0 53.5 1.4 4.2 2.6 0.5 1.4 7.0 8.8 7.9 0.1 3.5 42.1 45.9 0.3 2.0 4.6 1.1 4.8 1.8 2.6 3.6 12.2 2.0 7.0 0.0 27.6 13.7 10.1 0.0 4.5 1.5 1.0 0.0 1.2 1.3 9.6 6.6 2.8 3.1 0.3 1.6 1.0 0.3 1.2 1.7 5.1 0.2 1.0 KRT13 "CK13, K13, MGC161462, MGC3781" ENSG00000171401 "Keratin 13" P13646 17 41500981-41505705 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40925.1;vagina: 13409.3" "Cell type enriched" "Detected in many" 4 "Squamous epithelial cells: 16844.0" "Group enriched" "Detected in many" 5 "cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 93 "A-431: 2462.5;HaCaT: 1626.2" "CAB000133, HPA030877, HPA069771" Enhanced Enhanced "Intermediate filaments" NA NA 680000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141" "unprognostic (1.45e-1)" "unprognostic (6.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" "unprognostic (9.30e-5)" "unprognostic (7.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (5.81e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.45e-6)" "unprognostic (1.80e-1)" "unprognostic (2.76e-1)" "unprognostic (3.04e-2)" "unprognostic (4.33e-1)" 7.7 7.5 0.0 0.0 0.1 6.8 5.1 0.0 0.0 6884.6 0.0 5.6 0.1 10.2 0.0 40925.1 7.0 8.8 9.2 0.0 0.1 5.6 12.8 6.0 0.3 0.0 0.0 9.9 17.2 0.0 26.9 0.0 0.0 115.2 0.0 0.0 6881.1 3.8 9.8 20.5 8.5 14.2 0.0 7.7 31.3 6.9 0.0 13.6 6.1 0.0 1855.2 924.7 13409.3 0.0 2462.5 0.6 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.6 0.8 7.1 0.6 0.0 0.0 1626.2 0.0 0.4 0.0 1.4 0.0 4.5 21.8 0.0 0.0 1.7 1.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 5.4 1.2 0.0 1.3 0.1 0.1 0.1 14.8 0.3 0.2 1.2 0.3 0.0 10.7 0.0 0.0 1.9 2.0 7.7 0.0 2.3 6.4 5.1 0.0 0.4 0.0 6.6 0.3 6.3 5.8 1.9 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.0 1.1 0.0 0.9 2.8 545.6 17.1 146.8 0.0 2.3 4.6 0.6 1.5 94.5 0.0 0.0 0.1 0.2 0.6 0.0 0.0 1.2 2.7 0.2 11.4 1.2 5.5 0.0 0.0 0.5 12.6 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 8.2 0.0 0.0 3.2 55.9 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.7 286.6 27.1 227.9 0.1 0.1 3.3 0.0 0.0 0.0 16.9 0.2 0.6 16844.0 1.6 0.4 8.8 0.0 0.4 3645.4 KRT14 "EBS3, EBS4" ENSG00000186847 "Keratin 14" P02533 17 41582279-41586895 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 6940.5" "Group enriched" "Detected in many" 9 "Basal keratinocytes: 35588.3;Suprabasal keratinocytes: 11677.1" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 5910.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 4065.2;HBEC3-KT: 2003.9;hTCEpi: 2448.6;hTERT-HME1: 794.2;U-2197: 696.0" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "spinal cord: 36.3" "CAB000134, HPA000452, HPA000539, HPA023040" Enhanced Enhanced "Intermediate filaments" NA NA 1600000000 "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 28: Keratinocytes - Keratinization" "Intermediate filaments" "CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201" "prognostic favorable (2.66e-4)" "unprognostic (1.64e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (2.03e-2)" "unprognostic (2.74e-1)" "unprognostic (1.35e-1)" "unprognostic (1.00e-2)" "unprognostic (5.74e-3)" "unprognostic (1.49e-8)" "unprognostic (8.91e-2)" "unprognostic (2.00e-1)" "unprognostic (8.80e-3)" "unprognostic (1.22e-2)" 15.8 1.2 0.0 0.0 0.0 2.7 332.7 0.0 0.0 412.0 0.0 1.7 0.0 0.9 0.0 1304.2 1.7 0.0 3.5 0.0 0.0 0.8 2.5 1.7 0.0 0.0 0.0 1.3 2.9 0.0 4.3 2.2 0.1 29.1 0.0 0.0 702.1 3.8 15.9 6940.5 2.1 0.1 0.0 0.9 1.7 1.5 0.0 186.7 2.3 0.0 262.3 0.7 846.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.7 0.0 4065.2 0.0 2003.9 0.2 0.0 0.0 0.1 1.6 0.0 0.1 0.2 2.5 0.1 2448.6 3.0 794.2 0.0 0.1 0.0 0.5 3.6 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.6 0.2 0.6 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.0 0.4 0.0 0.3 9.1 1.7 696.0 0.0 0.9 0.0 0.0 3.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.5 35588.3 1072.7 181.5 2407.4 0.0 103.5 740.9 0.3 0.0 6.0 0.0 0.0 17.9 3.2 7.3 0.0 0.1 0.0 0.1 0.0 129.0 0.0 0.0 0.0 0.0 127.0 116.5 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 3.4 0.0 0.0 1833.4 0.0 0.0 9.3 1990.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.5 0.0 9.9 702.0 96.8 0.0 2.3 0.0 0.0 0.0 96.3 0.0 0.1 83.2 11677.1 2.5 62.1 0.1 2.3 100.0 KRT15 "CK15, K15, K1CO" ENSG00000171346 "Keratin 15" P19012 17 41513745-41522529 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 419.1;esophagus: 1156.7;skin 1: 1319.5;vagina: 423.3" "Group enriched" "Detected in many" 4 "Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9" "Cancer enhanced" "Detected in many" "cervical cancer: 178.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "HaCaT: 1156.8;hTCEpi: 1001.5" "Region enhanced" "Detected in single" "white matter: 1.9" "Not detected" "Not detected" "HPA023910, HPA024554" Enhanced Supported "Nucleoplasm,Intermediate filaments" No No 480000000 "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" Nucleoplasm "HPA023910: AB_1852205, HPA024554: AB_1852207" "prognostic favorable (4.50e-4)" "unprognostic (9.14e-2)" "unprognostic (3.28e-2)" "unprognostic (1.19e-3)" "unprognostic (3.57e-2)" "unprognostic (8.84e-2)" "unprognostic (6.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.13e-1)" "unprognostic (8.65e-3)" "unprognostic (9.91e-3)" "unprognostic (2.09e-1)" "unprognostic (2.24e-11)" "unprognostic (6.91e-3)" "unprognostic (2.62e-1)" "unprognostic (1.33e-5)" "unprognostic (5.35e-2)" 4.7 0.3 0.1 0.2 0.0 0.7 419.1 0.0 0.1 148.2 0.2 1.1 1.5 0.3 2.2 1156.7 32.4 2.8 0.7 0.1 0.0 0.3 0.6 4.3 0.0 0.1 0.1 0.4 1.4 0.0 1.2 0.3 0.1 182.8 1.6 0.0 140.0 4.1 0.7 1319.5 2.3 0.1 0.0 0.3 1.6 8.0 0.1 93.7 0.5 0.0 77.6 9.5 423.3 0.1 56.4 7.4 0.0 0.0 0.0 0.0 0.7 5.3 1.3 0.3 0.2 5.9 20.2 0.0 1.8 0.6 14.0 1156.8 0.0 41.8 0.2 0.6 0.0 0.0 7.7 1.9 0.0 0.1 4.7 0.0 1001.5 2.2 6.9 2.7 3.4 0.0 0.3 0.5 0.2 3.5 0.1 0.5 0.0 3.9 6.2 0.0 0.0 104.9 3.3 5.9 2.6 0.1 1.1 15.0 1.2 0.3 20.3 0.0 18.6 0.3 2.8 0.3 2.2 0.1 0.1 0.0 8.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 6.1 12.8 10.3 0.0 2.7 1309.8 2789.9 1190.9 8290.4 0.6 577.7 670.3 0.8 5.7 287.5 1.8 0.0 0.7 16.9 18.3 1.9 8.5 117.6 4.1 0.7 22.9 4.8 0.0 0.1 7.5 7.7 21.7 4.6 8.2 2.5 0.0 0.0 0.0 0.4 0.0 0.1 10.3 189.2 0.0 61.7 44.4 1.5 17.2 320.2 0.0 0.0 0.2 0.0 0.0 0.1 14.1 10.5 0.4 88.7 872.9 8.6 0.1 57.7 0.6 0.0 0.4 32.1 0.6 0.8 4637.9 193.6 1.2 21.6 0.1 7.2 906.0 KRT16 NEPPK ENSG00000186832 "Keratin 16" P08779 17 41609778-41615899 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 307.2;esophagus: 1025.8;skin 1: 360.7;vagina: 489.4" "Group enriched" "Detected in many" 6 "Basal keratinocytes: 906.1;Basal prostatic cells: 596.6;Suprabasal keratinocytes: 1348.4;Urothelial cells: 506.9" "Group enriched" "Detected in many" 7 "cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9" "Group enriched" "Detected in some" 4 "cerebellum: 3.9;hippocampal formation: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTCEpi: 816.8" "Not detected" "Not detected" "CAB000136, HPA000539" Approved Approved "Intermediate filaments" NA NA 1700000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 28: Keratinocytes - Keratinization" "Intermediate filaments" "CAB000136: , HPA000539: " "unprognostic (3.95e-3)" "unprognostic (6.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-2)" "unprognostic (1.00e-2)" "unprognostic (7.14e-3)" "unprognostic (1.03e-3)" "unprognostic (2.05e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (8.23e-2)" "unprognostic (6.53e-8)" "unprognostic (3.81e-1)" "unprognostic (1.83e-1)" "unprognostic (7.40e-2)" "unprognostic (3.61e-2)" 7.1 1.4 0.2 0.1 0.3 0.3 17.4 3.9 0.6 307.2 0.0 0.2 0.0 1.0 0.0 1025.8 0.7 2.4 0.5 1.0 0.0 0.8 0.4 0.2 0.1 0.0 0.0 0.3 0.7 0.0 1.4 0.1 0.1 6.3 0.0 0.0 180.6 37.7 0.5 360.7 0.2 0.1 0.0 0.2 0.6 2.6 0.0 16.9 0.3 0.0 112.1 5.5 489.4 0.4 20.0 1.7 0.0 0.0 0.2 0.0 0.2 1.5 0.4 0.5 0.2 0.3 4.9 0.1 2.9 0.1 0.2 24.8 0.0 5.6 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 816.8 0.3 17.6 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.0 0.3 0.0 127.1 0.7 0.0 0.2 98.1 0.8 6.2 0.0 0.0 57.1 1.5 0.0 0.9 0.0 0.0 0.2 0.0 1.6 4.5 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 3.9 0.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 906.1 596.6 70.1 16.5 0.0 37.8 27.1 0.1 0.0 94.6 1.8 0.0 0.1 0.6 0.0 0.0 1.0 0.0 2.6 0.6 9.2 0.0 0.0 0.0 5.8 3.2 11.5 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 94.1 0.0 0.3 1.1 64.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 0.0 0.0 127.3 0.0 0.0 17.1 0.0 0.0 0.0 9.3 0.0 0.3 88.1 1348.4 0.1 3.4 0.0 0.0 506.9 KRT17 PCHC1 ENSG00000128422 "Keratin 17" Q04695 17 41619442-41624842 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 382.1;skin 1: 949.4;urinary bladder: 632.2" "Group enriched" "Detected in many" 5 "Basal prostatic cells: 13196.1;Prostatic glandular cells: 5931.6;Urothelial cells: 8499.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 3317.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "hTCEpi: 20287.9;SiHa: 8539.7" "Not detected" "Not detected" "CAB000029, HPA000452, HPA000453, HPA000539, HPA045062" Enhanced Enhanced "Intermediate filaments" Yes No 610000000 "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Intermediate filaments" "CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204" "prognostic favorable (4.44e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (3.65e-3)" "unprognostic (4.46e-2)" "unprognostic (4.34e-1)" "unprognostic (4.36e-3)" "unprognostic (1.32e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.86e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (2.20e-1)" "unprognostic (3.89e-1)" 5.1 0.4 4.9 0.8 5.3 2.8 382.1 3.5 5.8 102.2 3.5 2.0 0.8 4.3 14.1 320.4 6.9 1.9 2.7 6.3 3.3 3.1 0.6 9.8 0.3 3.5 3.4 0.9 2.6 0.5 6.6 7.0 3.5 132.4 0.3 0.3 263.2 116.1 0.9 949.4 0.6 1.0 3.4 0.4 2.3 4.5 3.3 142.7 1.6 0.0 97.8 632.2 212.3 4.7 212.5 0.2 0.0 0.0 0.8 0.9 48.8 1.9 0.4 2.8 2.7 16.8 1.9 1.0 14.7 0.2 0.4 2101.7 0.1 2129.1 1.9 0.3 1.6 2.0 910.8 2.0 0.5 1.9 2.2 0.4 20287.9 1.3 1539.9 0.0 1.0 0.0 1.0 1.5 0.4 0.7 0.7 0.3 0.4 237.2 0.0 0.7 3.1 1.7 0.8 770.5 0.3 0.2 8539.7 3.8 0.9 4.8 0.3 1.4 0.8 0.0 401.5 0.2 1.0 0.9 0.4 3.1 1.4 77.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 5.3 3.5 5.8 6.3 3.3 3.5 3.4 3.5 3.4 3.3 4.7 5.6 22.4 7.2 0.3 0.5 139.6 13196.1 338.0 327.8 0.2 158.4 792.8 0.1 0.0 415.8 36.8 0.0 21.5 3.8 0.9 0.0 567.7 0.4 116.9 13.5 54.5 1.8 0.0 3.2 202.1 148.5 87.9 0.0 134.1 3.8 0.0 0.0 0.0 3.8 20.2 0.5 0.6 36.7 0.0 14.1 1.6 2.1 37.5 10.6 3.7 6.7 0.0 0.0 0.5 1.4 1754.5 2.5 212.5 0.0 5931.6 0.1 0.4 100.1 0.0 0.0 0.9 101.0 0.3 0.4 48.2 124.3 5.7 60.8 3.1 0.8 8499.3 KRT19 "CK19, K19, K1CS, MGC15366" ENSG00000171345 "Keratin 19" P08727 17 41523617-41528308 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 889.0;salivary gland: 810.7;urinary bladder: 781.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 7444.0;Club cells: 5055.9;Ductal cells: 4717.9;Extravillous trophoblasts: 6919.3;Pancreatic endocrine cells: 7374.9;Proximal enterocytes: 8623.3;Urothelial cells: 5959.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 1945.3;HBEC3-KT: 2945.0;MCF7: 2220.9;RT4: 3146.7;SK-BR-3: 5446.1;T-47d: 3674.2" "Not detected" "Not detected" "CAB000031, HPA002465" Enhanced Supported "Intermediate filaments" NA NA 300000000 "Cluster 40: NK-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Intermediate filaments" "CAB000031: AB_2234418, HPA002465: AB_1079179" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.86e-2)" "unprognostic (1.59e-2)" "unprognostic (2.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (3.14e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (6.82e-5)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (3.52e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.35e-2)" 89.3 18.7 2.0 61.7 2.4 0.3 403.3 7.9 2.5 250.0 1.6 525.7 348.3 57.9 72.0 889.0 176.1 298.6 13.5 1.5 1.7 141.8 7.7 204.1 0.4 1.6 2.9 74.4 48.8 14.3 15.6 175.1 2.2 208.3 359.2 0.1 810.7 194.2 1.3 141.9 776.1 46.5 1.4 1.2 631.5 3.4 1.8 127.8 28.3 1.6 98.3 781.4 317.0 1.8 2.6 343.4 0.0 6.3 0.7 1.8 1169.3 412.1 0.5 12.8 2.9 992.6 1945.3 0.4 393.3 199.0 1.5 1044.6 0.1 2945.0 2.5 0.8 10.4 0.2 213.4 692.3 30.3 0.0 82.0 0.7 524.9 9.0 0.4 0.2 26.2 0.0 148.4 2.5 0.1 2220.9 5.9 3.0 18.5 1323.5 492.7 2.9 0.1 5.8 1335.4 3146.7 40.0 1.7 3.3 5446.1 0.1 266.5 3674.2 0.3 1.7 3.6 6.1 7.7 0.7 1.1 0.8 2.0 1.5 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 2.4 7.9 2.5 1.5 1.7 1.6 2.9 2.2 1.4 1.8 1.8 10.5 673.1 185.5 0.0 17.8 5.2 4317.3 7444.0 1715.8 0.0 1393.0 867.5 2.9 662.0 5055.9 892.0 0.0 1160.8 20.5 3599.6 1.9 4717.9 0.1 737.2 102.8 41.9 362.5 0.0 0.1 2589.9 6919.3 171.8 1571.4 1010.7 94.6 1.0 1.1 0.7 179.0 0.0 0.1 1382.4 2720.0 2.6 2.5 2.6 37.9 25.5 190.3 1.0 30.0 0.8 0.0 0.0 0.0 7374.9 3399.6 88.8 19.9 2228.8 8623.3 26.7 1954.3 0.0 0.0 0.0 240.0 1.1 1.6 1302.6 1.1 2127.5 36.1 4.8 1619.0 5959.8 KRT2 "KRT2A, KRTE" ENSG00000172867 "Keratin 2" P35908 12 52644558-52652211 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 57 "skin 1: 4660.3" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 265.4" "Cancer enriched" "Detected in some" 5 "melanoma: 23.4" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "HEL: 2.0" "Group enriched" "Detected in some" 6 "amygdala: 1.7;hippocampal formation: 2.7" "Not detected" "Not detected" "HPA006299, CAB037321" Enhanced Approved "Golgi apparatus,Intermediate filaments,Cytosol" NA NA 9700000000 "Cluster 32: T-cells - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 3: HMC-1 - Innate immune response" "Cluster 28: Keratinocytes - Keratinization" "Intermediate filaments, Cytosol" "Golgi apparatus" "CAB037321: , HPA006299: AB_1079180" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (8.47e-3)" "unprognostic (1.69e-2)" "unprognostic (1.84e-1)" "unprognostic (3.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.76e-2)" "unprognostic (3.56e-7)" "unprognostic (6.43e-2)" "unprognostic (5.98e-3)" "unprognostic (6.69e-2)" "unprognostic (3.46e-1)" 3.0 0.5 0.0 0.1 0.0 1.0 81.9 0.0 0.0 0.8 0.0 0.9 1.6 0.4 0.3 1.1 0.1 0.0 1.7 0.0 0.0 0.5 1.2 1.0 0.5 0.0 0.0 0.5 1.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 1.6 0.0 47.8 4660.3 0.8 0.0 0.0 0.5 0.7 1.0 0.0 6.8 0.8 0.0 6.1 0.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.5 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 9.5 0.0 0.0 0.1 8.8 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 265.4 0.1 1.0 0.0 0.6 0.1 KRT23 "CK23, DKFZP434G032, HAIK1, K23, MGC26158" ENSG00000108244 "Keratin 23" Q9C075 17 40922700-40937646 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "salivary gland: 147.7;skin 1: 172.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 1328.6;Cytotrophoblasts: 679.8;Prostatic glandular cells: 2203.0;Syncytiotrophoblasts: 3890.8;Urothelial cells: 1590.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 61.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "HBEC3-KT: 9.6;Hep G2: 11.0;SuSa: 7.1;T-47d: 16.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012050, HPA016959, CAB017091" Approved Approved "Intermediate filaments,Cytosol" NA NA 590000 "Cluster 52: Eosinophils - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 6: T47d - Mammary gland" "Cluster 22: Epithelial cell types - Mixed function" "Intermediate filaments" Cytosol "CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228" "unprognostic (1.62e-1)" "unprognostic (5.29e-2)" "unprognostic (4.35e-2)" "unprognostic (6.18e-3)" "unprognostic (1.45e-2)" "unprognostic (2.83e-1)" "unprognostic (5.22e-2)" "unprognostic (6.84e-3)" "unprognostic (2.74e-1)" "unprognostic (2.15e-2)" "unprognostic (8.96e-2)" "unprognostic (1.56e-1)" "unprognostic (8.22e-2)" "unprognostic (6.78e-2)" "unprognostic (1.40e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.26e-4)" 0.4 0.0 0.0 0.3 0.0 1.1 15.7 0.0 0.0 6.8 0.0 0.1 0.2 1.1 2.1 6.5 3.0 1.5 0.2 0.0 0.0 0.6 1.0 1.4 0.0 0.0 0.0 0.1 3.6 0.1 2.8 15.6 0.0 20.7 0.0 0.6 147.7 0.4 0.3 172.3 0.2 0.0 0.0 3.0 0.2 21.7 0.0 0.4 0.1 0.4 2.5 4.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.2 0.0 9.6 0.0 0.0 0.0 0.0 0.1 11.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 7.1 16.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.3 0.3 4.6 1328.6 242.1 0.6 0.0 78.0 27.9 0.4 12.8 390.5 3.7 0.0 679.8 1.1 0.1 1.9 462.9 66.2 49.8 7.8 15.1 7.1 0.0 0.5 0.8 109.3 15.0 0.0 66.4 0.0 0.0 0.0 0.0 63.8 0.0 0.3 0.7 57.0 0.0 0.7 10.6 0.6 3.0 5.4 0.0 5.4 15.8 0.0 0.5 0.3 17.7 1.1 0.7 0.0 2203.0 0.0 0.4 275.0 0.2 0.0 0.0 48.4 62.1 0.7 7.9 8.1 3890.8 7.6 0.1 0.9 1590.3 KRT24 "FLJ20261, MGC138169, MGC138173" ENSG00000167916 "Keratin 24" Q2M2I5 17 40697991-40703752 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 178.0;lymphoid tissue: 76.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 6.0;Fibroblasts: 4.6;Leydig cells: 3.1;Syncytiotrophoblasts: 4.0" "Group enriched" "Detected in some" 4 "cervical cancer: 9.6;head and neck cancer: 15.0;urothelial cancer: 6.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "SK-BR-3: 7.0" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Low region specificity" "Detected in some" HPA022978 Uncertain Approved "Intermediate filaments,Cytosol" No NA 300000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Intermediate filaments, Cytosol" "HPA022978: AB_1852230" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (3.75e-1)" "unprognostic (2.74e-1)" "unprognostic (2.95e-1)" "unprognostic (3.37e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.3 0.0 8.0 0.0 0.1 16.7 178.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 5.8 0.2 2.2 1.6 0.0 0.0 0.3 0.5 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 76.3 2.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 4.0 0.0 0.0 0.0 0.0 KRT35 "Ha-5, KRTHA5" ENSG00000197079 "Keratin 35" Q92764 17 41476689-41481140 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "skin 1: 59.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025750, HPA078713" Enhanced Approved "Intermediate filaments" NA NA 220000000 "Cluster 61: Skin - Cornification" "Intermediate filaments" "HPA025750: , HPA078713: " 2.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 59.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 KRT4 "CK4, CYK4, K4" ENSG00000170477 "Keratin 4" P19013 12 52806549-52814116 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "esophagus: 19735.6" "Cell type enriched" "Detected in some" 18 "Squamous epithelial cells: 5828.7" "Group enriched" "Detected in many" 5 "cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "HaCaT: 734.9;SK-BR-3: 361.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002154, HPA034881" Enhanced Supported "Intermediate filaments" NA NA 600000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "CAB002154: AB_563803, HPA034881: AB_2674370" "unprognostic (4.04e-1)" "unprognostic (3.22e-3)" "unprognostic (5.16e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "unprognostic (2.64e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.85e-3)" "unprognostic (2.84e-2)" "unprognostic (2.58e-11)" "unprognostic (1.64e-1)" "unprognostic (6.97e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (6.26e-4)" 1.5 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 513.5 0.0 1.1 0.0 1.2 0.0 19735.6 9.5 3.1 7.2 0.0 0.0 0.9 2.6 17.3 0.0 0.0 0.0 1.8 2.8 0.0 8.9 0.0 0.0 4.3 0.0 0.0 2124.1 0.0 2.6 3.9 1.7 0.9 0.0 1.5 8.6 0.8 0.0 2.0 1.0 0.1 1418.0 4.4 1040.2 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.8 0.0 0.1 0.0 734.9 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.5 1.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 1.4 0.0 0.2 0.0 15.5 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 1.0 361.6 0.0 0.0 2.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 1.0 0.9 0.5 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 3.3 0.0 0.0 0.0 6.5 36.9 23.3 0.0 0.5 2.9 0.5 0.0 308.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.6 0.2 2.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.5 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.9 6.9 0.0 0.1 53.7 0.0 0.0 0.0 5.3 0.0 0.1 5828.7 0.0 0.0 2.0 0.0 0.0 54.4 KRT5 "EBS2, KRT5A" ENSG00000186081 "Keratin 5" P13647 12 52514575-52520530 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 5865.0;skin 1: 5885.4;vagina: 2150.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2" "Group enriched" "Detected in many" 4 "cervical cancer: 1863.2;head and neck cancer: 3340.4" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 326 "plasmacytoid DC: 32.6" "Lineage enriched" "Detected in single" 326 "dendritic cells: 32.6" "Group enriched" "Detected in some" 7 "HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8" "Region enriched" "Detected in many" 8 "spinal cord: 36.4" "CAB000027, CAB000129, HPA059479" Enhanced Approved "Intermediate filaments" NA NA 3600000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034" "prognostic favorable (1.27e-4)" "unprognostic (9.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (1.84e-1)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "unprognostic (2.82e-1)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.73e-1)" "unprognostic (6.01e-7)" "unprognostic (3.46e-2)" "unprognostic (5.56e-2)" "unprognostic (7.96e-2)" "unprognostic (2.81e-3)" 10.0 1.7 0.2 1.8 0.8 4.6 252.5 0.7 0.5 826.2 58.9 1.9 0.0 2.0 97.2 5865.0 12.5 2.0 3.8 1.7 0.0 1.3 3.5 6.4 3.0 0.1 0.0 2.2 4.7 0.1 8.2 2.0 0.1 125.8 0.0 0.0 880.3 100.0 9.9 5885.4 1.8 0.6 0.1 1.7 5.0 2.1 0.6 527.1 3.0 0.3 648.6 93.2 2150.9 0.4 50.6 0.0 0.0 0.0 2.3 0.2 0.8 0.0 0.0 0.0 0.0 1.0 0.3 2.4 0.5 0.2 0.0 3368.0 0.2 5990.5 0.2 0.0 0.0 0.2 0.1 0.0 0.6 1.4 2.8 0.3 13326.8 0.6 1049.7 0.0 0.8 0.0 1.8 4.0 0.3 0.0 0.2 0.4 0.2 0.0 0.0 0.2 1.0 1.2 0.8 0.9 0.0 0.1 1.2 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.5 0.2 10.1 1.0 0.9 4.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.1 0.2 0.8 0.7 0.5 1.7 0.0 0.1 0.0 0.1 0.1 0.6 0.4 1.7 0.0 1.1 0.0 0.4 5870.1 1037.6 627.1 1571.3 0.0 43.6 226.2 0.5 0.0 180.7 0.0 0.0 0.0 39.8 0.0 0.0 0.5 0.8 31.3 1.2 26.4 0.0 0.0 0.5 0.0 0.0 29.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 273.6 0.1 0.6 7.3 286.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 22.2 789.7 0.0 0.1 34.8 0.0 0.0 0.2 33.4 0.0 0.0 4370.9 2020.2 0.0 17.8 0.0 0.1 459.8 KRT6A "CK6C, CK6D, K6C, K6D, KRT6C, KRT6D" ENSG00000205420 "Keratin 6A" P02538 12 52487176-52493257 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Allergen, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix: 2523.3;esophagus: 7338.5;vagina: 4945.4" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 674.0;Club cells: 200.5;Squamous epithelial cells: 876.0;Suprabasal keratinocytes: 151.4;Urothelial cells: 306.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 3892.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "hTCEpi: 9761.7" "HPA045697, HPA061168" Supported Enhanced "Intermediate filaments" NA NA 4500000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "HPA045697: AB_2679422, HPA061168: AB_2684440" "unprognostic (8.10e-3)" "unprognostic (2.11e-1)" "unprognostic (2.78e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.45e-4)" "unprognostic (2.43e-1)" "unprognostic (3.73e-2)" "unprognostic (1.31e-3)" "unprognostic (1.29e-1)" "unprognostic (2.89e-9)" "unprognostic (8.80e-2)" "unprognostic (7.20e-2)" "unprognostic (1.72e-1)" "unprognostic (2.13e-2)" 3.1 1.5 0.0 1.9 0.0 0.1 6.9 0.0 0.0 2523.3 0.0 1.2 0.0 1.3 0.0 7338.5 9.1 0.9 1.8 0.0 0.0 1.1 2.6 3.4 0.0 0.0 0.0 2.3 3.3 0.0 3.1 8.8 0.0 5.0 0.0 0.0 1025.5 0.0 1.9 480.0 1.3 0.4 0.0 1.4 4.9 1.0 0.0 33.6 1.5 0.0 628.6 19.7 4945.4 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.9 0.0 0.0 1143.8 0.0 2414.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.5 0.6 0.3 9761.7 0.2 306.7 0.0 0.3 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 14.0 0.3 0.1 0.5 0.0 0.3 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.2 0.2 0.4 0.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.5 79.0 674.0 12.0 0.0 0.6 1.7 0.0 0.0 200.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 2.6 0.2 0.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 5.5 0.0 0.0 0.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 100.4 0.0 0.0 24.5 0.0 0.0 0.0 11.8 0.0 0.0 876.0 151.4 0.0 1.7 0.0 0.1 306.8 KRT6B KRTL1 ENSG00000185479 "Keratin 6B" P04259 12 52446651-52452146 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 228.2;esophagus: 934.5;skin 1: 285.1;vagina: 229.6" "Cell type enriched" "Detected in some" 4 "Squamous epithelial cells: 217.5" "Group enriched" "Detected in many" 5 "head and neck cancer: 1424.3;melanoma: 472.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 148.7" "CAB000130, HPA045697, HPA061168" Supported Approved "Intermediate filaments" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440" "prognostic favorable (9.44e-4)" "unprognostic (3.27e-2)" "unprognostic (1.93e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-2)" "unprognostic (2.07e-3)" "unprognostic (2.27e-1)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (5.77e-2)" "unprognostic (9.63e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (9.52e-4)" 0.9 0.2 0.0 2.0 0.0 0.1 16.2 0.0 0.0 228.2 0.0 0.5 0.0 0.1 0.0 934.5 0.2 0.2 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.3 0.0 0.0 0.2 0.0 0.0 168.6 0.0 0.3 285.1 0.2 0.0 0.0 0.1 0.7 0.2 0.0 2.1 0.1 0.0 74.3 0.2 229.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 27.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.7 1.1 0.0 0.1 13.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 20.6 1.8 40.4 0.0 0.0 28.7 16.8 0.1 0.0 16.3 0.0 0.0 0.0 0.9 0.3 0.0 46.2 1.8 0.0 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.0 1.7 1.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 5.6 0.0 0.0 2.8 0.0 0.0 0.0 1.4 0.0 0.2 217.5 32.7 0.0 0.3 0.0 0.6 5.9 KRT6C KRT6E ENSG00000170465 "Keratin 6C" P48668 12 52468516-52473805 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 211.7;esophagus: 799.4;vagina: 333.5" "Cell type enriched" "Detected in some" 60 "Squamous epithelial cells: 234.3" "Group enriched" "Detected in many" 5 "head and neck cancer: 564.7;melanoma: 242.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 94.1" "HPA045697, HPA061168" Supported Approved "Intermediate filaments" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "HPA045697: AB_2679422, HPA061168: AB_2684440" "unprognostic (3.18e-2)" "unprognostic (6.26e-3)" "unprognostic (6.63e-2)" "unprognostic (1.54e-3)" "unprognostic (6.97e-2)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (3.25e-2)" "unprognostic (2.24e-1)" "unprognostic (2.84e-1)" "unprognostic (4.50e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 211.7 0.0 0.1 0.0 0.1 0.0 799.4 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 144.3 0.0 0.1 24.7 0.1 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 0.0 9.5 0.1 333.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 94.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.2 1.3 2.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 234.3 2.4 0.0 0.0 0.0 0.2 3.9 KRT7 "CK7, K2C7, K7, SCL" ENSG00000135480 "Keratin 7" P08729 12 52232520-52252186 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 905.8;thyroid gland: 593.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1756.7;Ductal cells: 2931.3;Exocrine glandular cells: 2143.5;Extravillous trophoblasts: 4196.1;Pancreatic endocrine cells: 6163.7;Prostatic glandular cells: 2386.6;Urothelial cells: 1900.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 560.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 4 "intermediate monocyte: 1.1" "Lineage enriched" "Detected in single" 4 "monocytes: 1.1" "Cell line enhanced" "Detected in many" "A549: 2418.2;BEWO: 2737.9;HBEC3-KT: 6225.3;hTERT-HME1: 2433.8;RT4: 7463.2;SiHa: 5833.6;SK-BR-3: 3363.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000028, HPA007272, HPA007315, CAB079970" Enhanced Approved "Intermediate filaments,Cytosol" NA NA 1300000000 "Cluster 7: Monocytes - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 15: RT4 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Intermediate filaments" Cytosol "CAB000028: AB_2134589, CAB079970: , HPA007272: AB_1079181, HPA007315: " "unprognostic (2.71e-3)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (1.27e-1)" "unprognostic (5.44e-3)" "unprognostic (2.74e-1)" "prognostic unfavorable (9.42e-5)" "prognostic unfavorable (7.78e-5)" "unprognostic (4.54e-2)" "prognostic favorable (2.77e-9)" "unprognostic (2.82e-1)" "unprognostic (1.43e-2)" "unprognostic (3.28e-1)" "unprognostic (3.98e-3)" 27.1 0.7 0.0 1.4 0.0 0.3 272.9 0.0 0.2 48.4 0.0 1.6 0.4 12.9 15.2 91.7 75.9 82.4 5.6 0.0 0.0 147.5 14.2 325.2 1.7 0.2 0.0 2.4 57.4 5.6 12.0 265.1 0.2 58.1 0.7 0.3 905.8 213.2 1.7 78.3 1.3 0.4 0.1 0.8 17.8 0.8 0.1 3.3 593.0 2.0 6.7 389.8 20.1 0.4 4.9 2418.2 0.6 1.7 2.8 0.0 2737.9 509.6 0.6 261.3 23.6 7.6 1683.1 0.3 1.4 176.3 0.8 1871.6 0.2 6225.3 13.3 3.0 0.0 2.2 1179.8 8.0 57.4 1.5 1.5 1.3 380.7 1.3 2433.8 1.0 267.4 0.0 0.7 2.2 0.1 13.7 1.8 3.7 7.6 1.1 2.6 2.0 4.8 38.6 1520.5 7463.2 3.5 2.4 5833.6 3363.4 0.0 27.5 130.3 0.0 2028.2 1.9 3.7 2.4 1.1 1.8 0.4 2.0 2.0 1.6 1.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.4 8.1 653.9 109.4 0.0 2.5 3.6 1172.6 173.6 8.0 0.0 451.3 426.3 0.8 724.9 684.8 360.5 0.0 1756.7 8.9 2.2 135.0 2931.3 16.1 106.2 20.4 30.6 6.6 0.0 0.1 2143.5 4196.1 29.9 14.3 253.2 3.8 0.1 4.2 2.9 189.9 0.0 0.0 3.5 954.2 3.4 4.6 140.0 3.7 11.0 131.6 0.0 35.6 0.0 0.0 0.0 0.0 6163.7 0.3 0.4 1.4 2386.6 0.2 8.5 249.2 0.0 0.0 7.6 72.1 0.6 1.3 35.3 2.3 1442.5 9.2 0.0 4.4 1900.8 KRT74 "K6IRS4, KRT5C, KRT6IRS4" ENSG00000170484 "Keratin 74" Q7RTS7 12 52565782-52573843 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "epididymis: 5.6;skin 1: 16.3" "Cell type enriched" "Detected in some" 5 "Late spermatids: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040655, HPA048596" Enhanced Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA 130000000 "Cluster 61: Skin - Cornification" "Cluster 31: Spermatids - Spermatogenesis" "Intermediate filaments" "Nucleoli, Cytosol" "HPA040655: , HPA048596: AB_2680457" "unprognostic (6.75e-3)" "unprognostic (3.93e-1)" "unprognostic (1.60e-1)" "unprognostic (2.49e-2)" "unprognostic (9.46e-2)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.02e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 KRT8 "CARD2, CK8, CYK8, K2C8, K8, KO" ENSG00000170421 "Keratin 8" P05787 12 52897187-52949954 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1335.5;stomach 1: 800.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 4302.8;Ductal cells: 6037.3;Exocrine glandular cells: 5457.6;Extravillous trophoblasts: 5323.4;Pancreatic endocrine cells: 5278.1;Paneth cells: 4937.3;Proximal enterocytes: 6802.6;Syncytiotrophoblasts: 5268.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 6130.6;BEWO: 3998.7;CACO-2: 7686.4;CAPAN-2: 4774.8;MCF7: 10521.8;SK-BR-3: 5126.4;T-47d: 4325.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 10 "spinal cord: 44.0" "CAB000131, CAB001696, HPA049866" Enhanced Supported "Intermediate filaments" NA NA 1700000000 "Cluster 15: NK-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Intermediate filaments" "CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923" "unprognostic (5.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "unprognostic (2.76e-2)" "unprognostic (4.86e-3)" "unprognostic (3.10e-2)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (8.99e-2)" "unprognostic (2.08e-2)" "unprognostic (2.83e-2)" "unprognostic (3.18e-1)" "unprognostic (3.68e-1)" "unprognostic (1.19e-2)" 135.0 43.6 2.2 158.6 1.3 1.0 113.8 2.0 1.6 183.4 21.3 1079.2 1112.0 34.7 66.4 48.2 134.3 217.5 147.8 1.9 1.9 240.2 463.9 172.5 7.9 8.3 4.5 10.3 654.1 59.9 278.7 368.7 8.8 151.6 564.2 0.4 318.0 73.6 1.5 49.3 1335.5 50.6 0.4 16.3 800.1 7.6 4.9 47.6 237.5 0.3 13.8 209.0 36.7 1.7 2787.7 6130.6 0.2 7.8 0.7 3.2 3998.7 11.1 47.9 6.1 6.3 7686.4 4774.8 1.1 1130.2 14.7 6.9 947.1 17.6 752.6 5.9 4.6 130.8 4.3 1184.4 2234.2 212.8 1.2 2.4 9.5 12.6 14.8 50.8 419.9 17.0 1.0 484.7 1.7 0.1 10521.8 6.5 10.6 418.5 2740.6 132.8 3.8 2.2 15.2 1198.1 1354.5 129.9 5.0 1063.2 5126.4 7.8 1263.8 4325.7 10.5 18.8 5.7 443.4 9.3 10.0 1.6 7.0 7.6 3.3 1.7 13.4 1.3 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.4 0.5 0.1 1.7 0.1 0.2 2.2 1.3 2.0 1.6 1.9 1.9 8.3 4.5 8.8 0.4 4.9 1.7 7.7 400.6 176.5 0.3 26.9 6.0 1948.0 684.7 303.3 2.3 521.6 342.8 30.2 1069.5 734.8 491.1 0.0 2208.2 8.5 4302.8 297.4 6037.3 13.9 419.2 41.0 42.3 942.5 8.6 0.5 5457.6 5323.4 94.7 1740.1 557.1 76.3 88.0 24.3 310.9 252.2 1.7 0.5 2876.3 1625.5 9.9 7.2 69.9 8.1 22.2 131.6 0.0 55.0 3.4 1.0 1.0 0.3 5278.1 4937.3 1.9 6.6 994.7 6802.6 569.1 594.8 4.3 0.0 2.2 167.4 2.0 11.4 258.9 1.7 5268.8 33.4 13.4 2337.3 1542.5 KRT80 KB20 ENSG00000167767 "Keratin 80" Q6KB66 12 52168996-52192014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 219.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 25.9;Ductal cells: 63.0;Endometrial ciliated cells: 33.0;Glandular and luminal cells: 33.5;Pancreatic endocrine cells: 48.4;Suprabasal keratinocytes: 37.4;Syncytiotrophoblasts: 58.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 202.5;MCF7: 287.3;SK-BR-3: 127.7;U-2 OS: 174.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA077836, HPA077918" Enhanced "Intermediate filaments" No No 230000000 "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" "Intermediate filaments" "HPA077836: AB_2686857, HPA077918: AB_2686871" "prognostic unfavorable (1.05e-4)" "unprognostic (5.45e-3)" "unprognostic (5.35e-2)" "unprognostic (9.19e-3)" "unprognostic (2.85e-4)" "unprognostic (6.68e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-3)" "unprognostic (5.60e-2)" "unprognostic (4.06e-2)" "unprognostic (7.06e-3)" "unprognostic (1.02e-1)" "unprognostic (8.79e-3)" "unprognostic (8.85e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.98e-2)" 0.4 5.3 0.0 0.3 0.0 0.1 8.7 0.3 0.6 18.5 0.0 0.1 0.5 1.2 0.9 51.0 3.4 2.7 0.3 0.1 0.0 2.7 0.7 3.4 0.0 0.0 0.0 0.2 11.6 7.0 0.4 7.3 0.0 1.5 0.1 0.5 24.8 3.4 1.3 219.1 0.3 0.1 0.0 0.1 0.5 0.3 0.0 0.8 0.8 0.0 41.1 9.9 36.5 0.0 202.5 66.7 0.0 0.0 0.0 0.0 54.2 2.9 1.8 15.3 4.6 4.5 85.9 0.0 94.4 2.3 99.4 98.5 0.0 1.3 5.3 0.4 0.0 0.0 99.4 2.4 10.1 0.1 0.1 1.1 11.9 3.5 23.0 70.2 23.2 0.0 0.0 0.1 5.4 287.3 0.2 0.1 0.4 58.5 10.1 0.2 79.4 3.0 87.1 35.7 24.5 1.3 50.1 127.7 1.2 5.6 24.1 1.0 13.5 0.3 174.4 0.2 71.6 0.1 0.3 0.5 18.0 7.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.2 3.9 4.4 0.0 0.0 14.7 4.6 0.4 10.0 9.4 11.0 0.0 25.9 0.1 0.3 0.0 63.0 0.9 33.0 3.7 0.5 0.0 0.0 0.1 20.4 3.4 0.4 0.0 33.5 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.1 12.2 0.0 1.6 0.5 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 4.8 0.1 1.8 21.7 0.0 0.0 0.4 2.2 0.1 0.0 2.9 37.4 58.3 0.3 0.3 0.3 8.5 MAFIP "FLJ00219, FLJ35473, FLJ39633, MIP, pp5644, TEKT4P4" ENSG00000274847 "MAFF interacting protein (pseudogene)" Unmapped 53594-115055 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 4.0;Endometrial ciliated cells: 3.9;Endometrial stromal cells: 3.8;Glandular and luminal cells: 5.2;Proximal tubular cells: 3.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA053929 Uncertain "Intermediate filaments" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "Intermediate filaments" "HPA053929: AB_2682314" 3.8 5.5 6.3 1.5 6.6 0.9 1.1 6.9 8.2 1.6 6.4 1.2 1.6 1.5 0.8 2.7 1.9 2.3 2.0 6.6 6.7 2.0 1.8 1.9 3.7 7.2 6.5 3.6 2.7 1.5 1.4 7.1 2.3 0.5 1.4 4.1 1.4 1.8 0.7 2.3 2.1 6.9 3.2 0.8 1.2 6.6 0.4 1.5 1.8 1.3 1.9 7.2 0.0 2.9 0.0 0.9 0.0 0.0 2.0 3.9 1.7 1.1 1.6 6.5 7.5 0.0 6.4 5.1 3.0 0.9 2.3 3.7 0.5 0.0 2.5 1.7 3.0 6.0 0.1 0.0 5.7 0.6 5.7 2.0 0.0 4.7 3.8 0.0 7.6 1.8 2.4 7.8 6.0 0.7 0.0 3.5 1.1 0.0 3.6 1.3 4.1 0.5 1.9 4.2 0.0 2.3 3.6 0.7 5.7 0.1 8.6 2.1 3.4 0.9 2.7 5.6 2.1 0.0 8.7 0.0 1.2 2.1 1.5 1.2 1.3 2.1 0.9 2.1 1.2 1.1 2.5 2.3 1.6 1.6 0.1 1.9 0.9 5.0 2.0 1.4 6.3 6.6 6.9 8.2 6.6 6.7 7.2 6.5 7.1 6.9 6.6 7.2 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.4 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.7 0.0 3.9 3.8 1.2 0.0 0.0 0.0 1.1 0.7 1.1 0.0 5.2 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.0 0.0 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 150.1;Intestinal goblet cells: 68.2;Paneth cells: 102.9;Proximal enterocytes: 199.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 21.7;BEWO: 30.9;CACO-2: 23.6;CAPAN-2: 22.5;HaCaT: 21.4;MCF7: 40.8;RT4: 18.8;SK-BR-3: 18.5;T-47d: 26.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" No NA "Cluster 17: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 45: Enterocytes - Digestion" Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favorable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.2 0.3 0.5 3.1 0.6 0.6 6.2 1.8 0.9 4.0 6.5 23.6 31.1 1.8 7.3 4.2 4.2 4.8 0.3 1.1 0.5 12.9 5.3 2.4 0.5 0.4 0.5 0.5 17.1 12.5 1.0 5.7 0.5 6.0 18.7 2.1 11.6 2.5 0.8 3.3 33.1 0.6 0.1 0.4 2.8 0.9 0.5 0.9 3.9 0.0 1.7 3.8 2.5 0.9 21.7 0.7 0.5 0.9 0.0 0.1 30.9 0.0 0.0 0.0 0.0 23.6 22.5 0.2 2.3 0.0 0.1 21.4 1.9 10.3 0.1 0.0 12.1 0.0 0.4 6.2 0.0 0.1 0.2 0.9 12.5 0.1 0.2 0.1 0.0 0.1 0.3 0.1 0.0 40.8 0.2 0.3 3.5 13.4 0.2 0.0 0.1 8.8 0.3 18.8 3.7 0.2 0.4 18.5 0.0 2.4 26.3 0.3 0.0 0.0 0.4 0.4 0.2 0.2 0.3 0.1 0.2 0.2 0.2 1.8 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.2 1.2 0.4 0.1 0.3 0.2 0.1 0.5 0.6 1.8 0.9 1.1 0.5 0.4 0.5 0.5 0.1 0.5 0.9 0.3 9.6 8.4 0.3 0.8 7.9 28.7 9.6 22.8 7.0 25.4 10.7 0.6 40.0 17.9 9.2 0.0 36.5 1.5 150.1 1.9 29.8 4.4 14.2 1.5 1.0 61.5 0.0 0.6 33.7 2.5 1.5 6.1 19.4 0.0 3.8 0.4 9.1 3.1 0.0 0.6 68.2 14.2 1.0 1.0 3.3 0.3 1.2 0.0 0.0 0.8 1.0 0.0 0.0 0.6 26.3 102.9 0.7 0.0 38.4 199.3 27.6 17.4 19.6 0.0 4.1 1.6 9.6 5.0 19.6 3.7 4.8 1.4 0.0 61.3 44.3 MDN1 "KIAA0301, Rea1" ENSG00000112159 "Midasin AAA ATPase 1" Q9NU22 6 89642498-89819794 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.5;Inhibitory neurons: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 24.7;NTERA-2: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029666, HPA029667, HPA029668, HPA029669" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoli, Cytosol" "Nucleoplasm, Intermediate filaments" "HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429" "unprognostic (2.00e-1)" "unprognostic (4.46e-2)" "unprognostic (7.62e-2)" "unprognostic (2.26e-2)" "unprognostic (6.14e-3)" "unprognostic (3.46e-1)" "unprognostic (6.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.51e-1)" "unprognostic (1.75e-1)" "unprognostic (1.77e-2)" "unprognostic (9.07e-2)" "unprognostic (2.54e-3)" "unprognostic (6.28e-3)" "unprognostic (9.22e-2)" "unprognostic (2.02e-1)" "unprognostic (6.09e-2)" 4.2 4.6 3.4 1.9 3.6 4.2 4.3 4.4 3.3 4.5 1.7 4.4 1.2 5.6 2.1 4.9 5.0 1.2 4.9 3.1 3.3 4.4 9.1 3.9 2.6 3.3 3.1 7.6 5.9 3.0 4.6 1.2 3.7 3.6 1.8 3.0 3.9 1.5 8.3 7.1 5.0 1.7 2.2 4.5 4.6 6.5 3.3 2.8 6.0 3.4 2.5 4.2 4.3 5.7 4.2 4.1 4.1 3.8 6.6 6.3 4.1 2.8 2.1 3.1 3.8 9.4 1.5 12.5 3.1 2.9 3.3 3.6 10.7 3.8 5.5 4.9 7.1 13.5 5.6 6.1 2.5 17.7 3.2 3.9 3.1 8.3 7.6 1.9 5.6 5.6 24.7 2.9 3.1 5.0 2.8 6.6 22.7 3.4 3.5 5.5 7.8 3.1 2.7 5.8 7.5 3.3 3.9 2.3 2.5 5.4 1.6 7.7 7.2 2.1 3.8 2.8 6.5 3.3 3.9 5.9 2.8 9.8 3.7 3.2 0.3 0.6 0.7 0.2 0.6 1.0 1.0 0.8 0.2 1.3 1.3 1.0 0.0 1.1 0.3 3.0 0.4 0.1 3.4 3.6 4.4 3.3 3.1 3.3 3.3 3.1 3.7 2.2 3.3 5.7 13.2 28.9 19.1 55.2 19.2 29.3 8.2 6.0 30.7 24.4 14.0 11.0 39.2 11.5 16.9 14.7 25.0 5.5 25.2 6.6 0.0 6.3 7.5 20.1 21.9 15.0 7.7 58.5 82.5 8.1 7.2 13.3 19.4 25.2 6.3 26.4 6.4 48.5 6.6 18.5 79.5 7.7 6.1 6.3 9.5 4.3 7.2 8.6 12.4 33.7 6.6 8.0 9.2 35.7 74.8 6.9 3.7 8.6 26.0 18.1 4.7 2.5 12.9 18.7 0.0 33.1 12.7 37.5 50.1 26.1 30.1 3.4 19.4 17.4 10.3 8.5 MIEF1 "FLJ20232, L0R8F8, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 266.3;Late spermatids: 377.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favorable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 9.6 8.1 10.9 7.9 10.4 12.8 8.4 10.9 10.4 6.3 8.5 9.5 12.0 7.6 6.8 9.3 7.1 5.5 8.8 10.2 9.9 13.1 16.3 7.4 11.2 10.4 11.5 7.7 9.5 10.9 5.1 8.6 11.1 6.9 9.3 8.3 9.8 8.1 8.4 7.9 10.4 6.8 10.8 9.2 8.2 17.1 11.4 9.5 8.4 9.3 11.7 7.3 6.3 10.3 16.0 15.9 16.5 26.6 15.5 17.0 19.5 15.0 17.4 16.7 15.0 25.9 8.1 44.4 12.2 15.7 10.9 20.0 37.6 20.4 20.1 18.8 36.3 18.1 22.4 26.2 30.1 63.7 23.1 22.3 24.3 14.7 30.7 16.1 17.9 14.5 32.5 23.4 16.7 11.0 20.5 17.8 15.4 32.5 17.2 27.7 23.4 44.6 19.0 18.8 15.3 12.7 16.6 27.6 42.8 17.3 12.3 22.7 17.8 15.7 22.1 14.0 18.6 42.2 47.5 43.9 18.1 28.0 24.7 0.4 5.6 4.7 5.2 6.2 6.4 4.8 5.0 5.1 6.0 4.7 5.4 5.1 0.4 6.8 6.2 3.3 4.7 6.3 10.9 10.4 10.9 10.4 10.2 9.9 10.4 11.5 11.1 10.8 11.4 10.3 10.9 12.8 18.7 7.5 13.6 19.5 16.0 11.4 10.8 19.0 13.6 12.1 19.3 20.0 8.6 16.5 25.0 19.6 17.0 22.0 25.4 13.1 266.3 5.2 14.3 13.1 9.7 14.7 7.4 13.8 19.8 10.4 8.2 8.9 9.5 14.2 16.8 49.8 15.8 6.7 8.3 11.5 24.4 20.7 20.5 377.2 15.5 12.2 16.0 9.4 19.0 18.7 7.2 2.0 8.9 17.6 7.6 13.9 29.1 23.4 21.9 27.8 8.9 15.2 0.0 14.1 10.2 20.4 28.0 16.2 23.0 13.0 10.8 14.7 20.7 19.1 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836560-22849041 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" No No 1400000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: AB_2681484" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 151.5 31.7 5.6 59.9 5.0 1.6 101.5 5.7 7.5 181.3 61.8 77.2 39.5 167.3 19.0 92.1 82.1 148.2 41.3 6.6 7.2 35.9 13.2 91.8 24.8 11.9 8.4 90.2 36.0 65.3 14.2 118.9 9.2 59.9 36.6 9.6 78.1 45.5 18.8 127.5 69.4 106.0 7.3 30.8 57.7 11.7 13.2 13.0 50.0 16.1 30.8 103.9 111.1 10.6 90.6 1.2 26.3 2.0 923.8 651.6 455.9 270.1 606.4 93.3 158.5 21.3 337.4 0.9 146.4 301.9 24.6 216.3 0.3 262.2 99.7 1.1 0.6 37.2 1.7 5.0 794.2 0.4 1.3 887.0 148.7 334.7 288.3 925.5 492.9 0.6 0.8 2.1 185.1 0.7 0.4 79.4 14.7 17.7 52.4 2.1 96.0 0.2 61.4 148.1 0.3 0.6 187.3 0.3 574.2 104.4 1.0 79.5 436.8 724.9 53.7 198.2 329.6 0.8 1.6 1.1 410.9 0.6 396.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 5.0 5.7 7.5 6.6 7.2 11.9 8.4 9.2 7.3 13.2 10.6 13.9 12.8 3.0 2.0 3.4 34.0 23.4 105.4 39.3 0.0 14.1 17.5 4.7 50.1 42.2 7.3 0.0 105.6 0.3 19.9 11.7 63.0 0.4 16.1 81.6 35.2 7.8 0.0 0.0 28.7 244.0 84.0 25.5 14.8 3.8 9.3 32.9 2.7 89.5 0.0 0.0 24.5 34.6 20.2 32.7 2.4 72.1 38.0 37.4 4.7 21.5 14.3 0.0 0.5 0.1 144.7 33.0 54.9 0.3 21.8 19.9 11.7 46.8 0.8 39.5 11.1 73.9 0.8 0.8 33.7 34.2 122.7 2.5 15.6 18.6 37.9 MOB3A "MOB-LAK, MOB1C, MOBKL2A, moblak" ENSG00000172081 "MOB kinase activator 3A" Q96BX8 19 2071036-2096673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 74.4;Langerhans cells: 91.3;monocytes: 81.1;NK-cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (2.05e-2)" "unprognostic (3.58e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.33e-6)" "unprognostic (3.40e-2)" "unprognostic (3.53e-3)" "unprognostic (3.12e-3)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (2.16e-2)" "unprognostic (7.74e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (5.90e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" 24.8 15.3 19.8 49.7 19.3 53.7 20.9 19.5 45.6 25.4 21.9 36.0 12.9 32.3 9.4 22.4 27.4 17.5 14.8 19.7 19.4 15.8 9.7 25.1 73.3 26.8 21.3 20.4 13.6 8.7 12.2 15.8 22.8 25.9 15.0 6.7 17.1 20.1 14.0 21.1 31.7 28.6 20.2 60.4 20.4 8.8 24.8 34.9 16.0 14.4 65.7 27.1 22.9 21.2 45.6 18.4 21.5 20.6 49.7 54.7 16.7 28.1 17.7 18.7 14.9 7.4 16.1 116.4 10.1 48.8 15.2 18.9 12.0 62.2 15.0 41.2 6.2 25.3 12.3 10.1 49.2 40.0 125.7 32.4 40.4 51.5 21.7 21.6 35.5 22.1 13.4 113.4 27.6 18.1 20.9 40.6 6.6 5.5 13.1 12.6 6.4 91.2 23.5 11.3 13.7 18.3 14.3 14.9 15.9 15.9 16.0 64.3 60.8 22.6 12.4 42.5 16.9 22.1 86.8 90.4 61.0 26.7 27.7 80.8 87.0 100.7 62.3 83.8 52.9 43.6 45.8 51.9 58.7 39.1 34.1 44.1 274.5 54.2 96.3 33.4 60.3 85.6 19.8 19.3 19.5 45.6 19.7 19.4 26.8 21.3 22.8 20.2 24.8 21.2 8.6 3.2 4.5 8.8 50.6 15.0 10.9 11.7 8.6 3.7 9.4 7.4 3.7 4.3 9.7 11.0 20.9 11.1 50.8 18.9 3.9 10.8 1.6 6.1 12.7 11.7 14.9 11.8 6.5 9.5 53.5 12.0 8.2 9.6 27.9 8.1 18.5 4.7 33.3 1.7 5.8 12.2 14.2 74.4 91.3 4.8 18.3 50.1 16.0 6.5 81.1 6.9 77.2 4.0 6.0 10.1 12.6 17.0 38.0 11.9 16.0 9.0 10.1 6.6 6.6 10.5 11.2 9.4 6.6 7.2 15.9 27.5 37.3 7.7 9.5 10.8 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 431.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.5;myeloid DC: 2.7;naive B-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.0;HAP1: 16.7;K-562: 49.9;SK-BR-3: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 45: Intestine - Brush border" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favorable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.99e-2)" 5.7 1.7 10.0 3.9 23.8 0.7 6.2 19.3 14.4 7.1 11.7 12.1 17.5 9.6 5.1 3.6 7.9 4.9 1.4 8.5 13.5 7.4 1.4 6.7 4.0 23.7 19.4 26.0 3.6 0.5 1.1 4.6 22.8 2.2 13.1 7.4 3.4 2.9 5.9 6.3 15.6 6.3 19.2 8.1 5.6 3.2 19.2 3.6 5.4 5.3 5.6 3.6 4.7 30.4 3.4 2.5 7.6 0.0 1.9 0.1 16.0 0.0 0.1 0.1 0.1 1.9 0.0 0.1 3.2 0.0 0.0 10.9 16.7 13.2 0.0 7.7 2.6 4.9 9.8 0.1 0.0 0.0 1.0 3.4 13.7 0.0 2.5 0.0 0.0 0.0 49.9 0.1 0.0 0.0 0.0 0.0 9.8 6.3 0.9 3.3 0.7 0.1 4.6 6.4 0.1 2.4 2.7 19.8 4.7 9.9 1.3 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.5 0.0 0.5 0.0 0.0 0.8 0.0 2.5 0.0 0.0 2.7 2.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 10.0 23.8 19.3 14.4 8.5 13.5 23.7 19.4 22.8 19.2 19.2 30.4 6.9 3.2 4.1 13.7 22.1 22.7 7.7 7.6 40.9 2.1 6.7 12.6 1.5 27.1 4.3 11.0 0.0 22.1 0.4 83.3 9.8 16.4 1.0 6.5 20.1 8.7 2.4 1.7 81.7 21.0 56.0 20.8 21.4 9.2 1.3 1.9 4.6 3.1 5.4 1.7 88.9 26.9 12.2 13.2 30.6 3.1 15.8 20.4 16.0 76.8 10.8 65.3 2.1 79.4 431.9 10.6 26.1 16.1 1.2 6.5 50.3 10.5 2.7 1.3 0.0 4.5 19.2 2.2 5.0 8.4 9.5 11.8 1.6 7.7 36.8 6.9 MOB3C "MOB1E, MOBKL2C" ENSG00000142961 "MOB kinase activator 3C" Q70IA8 1 46607715-46616884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (1.76e-3)" "prognostic favorable (3.16e-5)" "unprognostic (1.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (6.26e-3)" "unprognostic (1.56e-1)" "unprognostic (1.76e-1)" "unprognostic (9.97e-2)" "unprognostic (3.85e-2)" "unprognostic (1.20e-1)" "unprognostic (4.81e-2)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (2.35e-2)" "unprognostic (4.61e-3)" 21.2 11.3 11.9 9.4 12.9 5.8 14.2 16.4 11.8 13.3 10.7 15.4 10.3 9.9 10.8 17.5 13.2 11.1 16.6 10.6 15.9 14.3 10.2 16.9 10.1 13.8 12.7 15.6 38.2 11.2 14.1 13.8 13.6 16.6 10.4 1.8 14.2 13.2 24.6 7.8 13.7 11.1 12.7 19.3 14.6 5.7 12.6 9.2 13.1 49.4 10.5 20.8 14.8 11.5 10.6 4.5 2.0 6.1 19.7 15.2 0.9 5.8 14.7 10.3 10.0 1.6 7.3 0.9 6.2 9.9 14.9 14.7 2.2 7.5 5.4 15.7 0.3 24.6 6.1 1.5 10.2 2.1 8.9 12.5 11.3 9.8 2.7 13.7 6.8 2.5 3.8 6.0 4.3 4.4 1.0 3.3 0.7 6.5 12.7 2.8 6.7 4.6 5.7 18.7 0.8 2.5 9.0 6.3 7.4 2.4 3.8 8.2 5.1 5.1 3.6 8.7 5.2 5.6 1.3 0.7 7.7 3.6 4.3 3.0 11.5 22.9 15.8 12.7 27.6 9.3 15.4 15.9 7.9 11.2 13.4 13.6 8.1 22.9 8.4 9.8 11.1 16.8 11.9 12.9 16.4 11.8 10.6 15.9 13.8 12.7 13.6 12.7 12.6 11.5 12.0 6.4 6.9 3.6 4.9 11.1 10.2 5.6 12.5 2.9 6.3 4.8 4.9 5.7 4.6 7.3 0.0 1.9 5.1 7.0 5.9 3.2 7.7 2.0 4.3 7.7 8.4 7.8 0.5 6.3 0.9 9.1 3.1 2.3 5.7 7.7 8.2 3.3 13.1 5.0 0.8 8.9 2.0 8.4 14.9 0.9 6.2 23.9 3.6 5.6 5.9 1.8 4.1 3.5 1.3 3.9 2.7 6.8 5.4 14.5 6.8 4.0 5.4 0.8 6.6 13.7 8.1 0.2 0.4 8.0 6.5 1.4 8.1 6.9 5.7 18.5 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 70.1;Late spermatids: 99.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 8: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 11.2 10.6 5.1 9.5 11.2 5.7 6.3 10.1 10.9 7.2 3.4 8.3 8.9 11.7 12.3 9.3 9.6 11.8 14.4 6.5 9.0 18.7 19.4 13.1 11.1 10.9 10.4 11.4 11.9 12.8 6.7 10.8 10.6 9.0 10.1 19.2 10.5 7.1 28.9 9.1 10.2 12.0 8.2 6.7 6.7 7.1 9.3 7.5 9.0 32.9 10.6 14.4 5.5 20.0 19.3 18.1 10.2 20.0 34.0 13.6 25.1 31.1 18.5 16.5 15.4 27.8 15.1 32.6 27.9 24.6 27.4 11.8 17.0 14.2 27.9 22.9 15.8 14.6 62.0 15.3 21.9 23.4 6.8 18.3 11.4 24.6 18.4 20.4 10.4 8.0 21.9 24.2 9.8 4.2 14.2 11.7 7.3 29.4 19.0 12.4 9.5 14.1 16.2 16.0 14.0 2.5 51.6 33.7 28.6 18.1 10.7 17.5 14.6 31.9 19.7 24.1 22.7 34.7 13.5 27.3 23.1 50.5 19.1 5.3 4.0 3.0 4.1 5.5 7.0 3.3 6.5 5.7 3.6 3.3 4.1 3.6 0.1 3.1 4.4 2.3 9.1 3.3 5.1 11.2 10.1 10.9 6.5 9.0 10.9 10.4 10.6 8.2 9.3 20.0 7.7 16.0 70.1 10.1 11.1 16.3 9.4 4.6 12.0 0.0 9.7 5.1 12.9 5.7 9.0 9.2 0.0 9.9 11.4 11.0 21.5 10.2 50.1 10.0 10.7 8.0 9.6 12.4 25.4 5.5 8.9 11.8 9.2 6.7 10.2 6.5 8.6 19.3 7.7 0.0 20.8 9.1 0.0 11.1 9.4 99.2 10.5 9.7 1.8 15.0 8.1 0.0 7.2 20.1 50.9 7.2 6.0 11.7 26.5 14.3 8.7 28.9 10.1 0.0 6.6 10.7 10.1 17.4 13.1 10.5 20.6 11.2 13.8 11.8 9.4 8.7 NDOR1 "bA350O14.9, CIAE1, NR1" ENSG00000188566 "NADPH dependent diflavin oxidoreductase 1" Q9UHB4 9 137205685-137217009 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 13.4;Oligodendrocytes: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024504 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Cytosol "Nucleoplasm, Intermediate filaments" "HPA024504: AB_1854338" "unprognostic (1.67e-1)" "unprognostic (1.44e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (5.89e-3)" "unprognostic (5.99e-2)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (2.61e-3)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (4.69e-3)" "unprognostic (2.05e-1)" "unprognostic (4.30e-2)" "unprognostic (6.74e-3)" 6.5 8.2 8.7 9.8 9.6 17.2 6.9 7.9 12.5 8.1 5.4 8.4 9.6 7.8 2.0 8.3 7.9 4.6 6.6 8.3 7.1 9.0 7.1 8.6 11.5 10.7 9.0 7.0 8.9 4.0 8.2 4.0 10.2 9.6 2.9 3.9 8.6 5.2 4.0 9.5 10.6 3.7 7.9 14.2 8.7 10.5 9.9 8.9 10.1 1.5 5.4 7.8 7.2 12.9 14.2 21.2 13.8 21.8 5.7 5.6 42.7 20.4 9.1 19.1 13.0 21.6 16.3 19.9 15.6 7.7 15.3 52.1 10.0 14.3 3.8 25.9 16.3 17.6 59.7 11.6 9.6 19.9 36.2 7.8 9.7 21.6 7.9 5.3 8.9 25.9 29.2 20.6 7.0 25.8 21.0 35.8 22.5 12.9 26.0 38.0 16.5 28.2 6.0 12.4 17.6 17.5 16.8 17.0 10.6 6.1 27.2 22.8 12.0 35.3 22.9 41.7 23.2 12.5 26.8 20.7 15.4 18.1 20.7 1.1 2.1 3.1 1.3 2.2 1.1 0.5 1.2 1.2 1.7 1.0 0.6 0.6 2.9 0.7 1.7 1.1 1.8 1.5 8.7 9.6 7.9 12.5 8.3 7.1 10.7 9.0 10.2 7.9 9.9 12.9 1.4 0.0 2.6 13.4 3.9 0.5 0.7 1.0 5.2 0.4 1.5 1.3 1.6 1.5 1.6 3.7 0.0 4.5 1.4 3.3 1.9 1.1 0.8 1.3 1.9 1.8 2.4 1.3 8.6 1.1 3.5 1.6 5.1 2.1 1.3 2.0 1.1 0.8 2.5 0.0 7.5 1.9 2.0 3.2 1.3 1.1 0.6 2.7 1.8 6.5 5.4 0.1 5.2 3.5 10.5 1.6 1.5 0.4 6.9 0.7 2.6 1.2 0.3 0.9 0.0 0.9 1.4 1.9 1.2 3.2 0.3 3.7 3.8 1.6 2.2 0.8 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24956721 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 675.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 32.7;Distal tubular cells: 103.7;Enteroendocrine cells: 33.3;Excitatory neurons: 64.6;Horizontal cells: 30.3;Rod photoreceptor cells: 110.0" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2" "Lineage enriched" "Detected in single" 113 "T-cells: 11.2" "Group enriched" "Detected in some" 4 "HEK 293: 456.2;PC-3: 145.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nucleoplasm,Intermediate filaments,Midbody" Yes NA 200000 "Cluster 32: T-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Intermediate filaments" Midbody "HPA014850: AB_1854397, HPA015021: AB_2669135" "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.1 18.0 35.4 1.3 36.7 0.0 0.0 103.6 675.9 2.0 0.0 2.5 0.6 0.1 0.3 5.4 1.3 0.1 0.1 50.9 75.6 5.0 0.0 0.0 0.1 425.7 41.1 0.2 0.2 0.1 4.0 0.0 231.3 1.8 1.5 89.5 0.0 15.6 0.0 0.9 1.9 1.1 33.9 0.2 0.8 1.7 216.1 12.7 0.7 0.1 0.3 0.0 1.4 184.0 0.0 0.6 68.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.6 0.0 0.0 456.2 0.0 0.0 0.0 21.6 0.0 1.0 8.3 2.0 0.1 1.4 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 18.8 0.0 145.4 0.0 0.0 0.0 31.7 4.2 30.9 31.6 11.2 0.0 1.9 2.2 0.0 0.0 0.0 2.2 31.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.2 1.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.2 1.5 35.4 36.7 103.6 675.9 50.9 75.6 425.7 41.1 231.3 33.9 216.1 184.0 0.1 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.6 32.7 0.0 0.0 3.2 0.0 0.0 0.0 8.4 0.0 0.1 0.1 103.7 0.1 0.4 0.1 0.3 3.7 33.3 0.0 64.6 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 30.3 29.1 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 27.2 0.1 27.8 0.0 14.6 18.4 0.0 0.1 9.4 0.0 0.0 0.0 0.2 0.0 110.0 0.0 0.1 0.2 0.0 13.2 1.5 0.0 0.0 1.6 1.4 0.0 0.0 NEFM "NEF3, NF-M, NFM" ENSG00000104722 "Neurofilament medium" P07197 8 24913758-24919098 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 689.9" "Cell type enhanced" "Detected in many" "Early spermatids: 92.6;Excitatory neurons: 46.6;Late spermatids: 114.6;Rod photoreceptor cells: 69.1;Spermatocytes: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 25 "HEK 293: 3890.8" "CAB010900, CAB012976, HPA022845, HPA023138" Enhanced Enhanced "Intermediate filaments" Yes NA 220000 "Cluster 70: Brain - Nervous system development" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Intermediate filaments" "CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398" "unprognostic (1.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (9.38e-2)" "unprognostic (5.17e-2)" "unprognostic (6.32e-3)" "unprognostic (6.10e-3)" "unprognostic (2.57e-1)" "unprognostic (8.55e-3)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (4.76e-2)" "unprognostic (2.61e-2)" 0.3 19.5 61.1 0.9 27.9 0.0 0.1 150.0 689.9 9.6 0.0 2.8 0.1 4.0 0.0 4.0 5.3 0.2 0.2 57.7 54.0 1.9 0.1 0.2 0.1 610.3 89.1 1.7 2.0 0.0 17.9 0.2 487.1 1.5 0.7 90.8 0.3 27.6 1.7 0.6 1.3 2.5 86.8 0.1 0.9 18.9 430.5 1.7 0.1 0.7 0.5 0.4 6.5 203.6 0.0 0.0 154.3 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3890.8 0.0 0.0 0.0 79.4 0.0 0.1 2.4 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.2 5.9 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 3.7 32.6 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.1 27.9 150.0 689.9 57.7 54.0 610.3 89.1 487.1 86.8 430.5 203.6 3.1 0.0 0.0 12.4 0.0 1.3 0.2 0.1 9.1 30.9 1.1 21.2 2.4 0.0 0.6 0.0 6.2 0.0 3.2 0.1 0.0 0.1 92.6 0.7 19.5 2.9 3.5 0.0 46.6 0.2 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 20.2 17.5 0.0 0.0 0.0 0.7 114.6 0.9 0.7 1.8 13.1 0.0 22.8 0.0 9.5 13.6 0.0 0.0 4.5 0.4 0.3 0.0 0.4 0.0 69.1 0.0 3.3 5.7 43.8 1.0 14.0 0.3 0.0 4.1 0.0 0.1 0.4 NES FLJ21841 ENSG00000132688 Nestin P48681 1 156668763-156677407 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 161.6" "Group enriched" "Detected in many" 4 "Adipocytes: 102.2;Cardiomyocytes: 279.9;Endothelial cells: 105.5;Sertoli cells: 105.2;Smooth muscle cells: 70.5" "Cancer enhanced" "Detected in all" "glioma: 147.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 627.3;HUVEC TERT2: 321.5;LHCN-M2: 512.6;RH-30: 518.3;SuSa: 340.7;WM-115: 247.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005889, HPA006286, HPA007007, HPA026111, CAB058692" Enhanced Enhanced "Intermediate filaments" No No 100000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" "Intermediate filaments" "CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382" "unprognostic (7.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (1.36e-1)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (4.40e-2)" "unprognostic (7.56e-2)" "unprognostic (9.84e-2)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.02e-7)" "unprognostic (2.87e-1)" "unprognostic (2.48e-1)" "unprognostic (6.67e-2)" "unprognostic (8.11e-3)" 40.0 8.5 24.4 13.8 24.8 0.0 28.2 27.2 22.7 27.1 16.5 16.8 5.3 41.1 12.9 8.2 30.3 11.3 161.6 21.1 26.5 35.2 4.8 42.1 4.8 32.8 27.1 10.1 5.6 10.4 12.8 16.7 25.8 21.2 6.6 8.2 9.7 36.1 55.7 8.6 12.5 30.3 30.0 49.1 10.8 6.2 26.4 2.7 19.9 47.3 2.3 24.2 19.0 30.9 0.2 2.5 627.3 134.7 1.3 33.4 0.6 154.7 120.7 2.3 3.4 102.5 1.9 0.6 35.8 14.9 0.1 2.8 63.9 0.0 1.8 0.0 1.1 0.9 9.7 47.3 5.5 0.3 37.1 28.5 0.0 5.7 0.0 5.3 321.5 0.1 4.9 0.2 512.6 4.3 0.0 0.3 102.3 6.0 88.1 0.7 518.3 0.4 0.6 0.0 1.6 100.4 3.6 4.5 124.9 340.7 1.3 0.9 235.1 0.8 34.5 4.1 8.8 0.2 24.0 0.2 13.4 0.1 247.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 24.8 27.2 22.7 21.1 26.5 32.8 27.1 25.8 30.0 26.4 30.9 102.2 0.0 4.4 0.0 0.7 2.4 0.4 0.2 0.6 0.5 9.4 32.9 279.9 0.0 0.6 18.4 0.0 0.2 1.0 0.6 0.0 2.1 0.4 2.1 31.9 105.5 0.0 0.0 0.3 0.0 1.9 29.4 0.5 2.7 0.0 0.2 26.7 0.1 1.8 0.0 0.6 0.2 0.0 0.8 3.1 0.1 8.1 1.7 1.8 12.2 1.0 17.4 0.0 3.0 2.2 0.3 0.1 4.1 0.1 0.5 0.0 0.1 0.0 1.5 105.2 10.9 70.5 0.5 5.0 1.2 2.4 0.1 1.1 1.4 0.3 0.5 NOL9 "FLJ23323, Grc3, NET6" ENSG00000162408 "Nucleolar protein 9" Q5SY16 1 6521347-6554513 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Kinase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036347 Supported "Nucleoli,Intermediate filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 2: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoli "Intermediate filaments" "HPA036347: AB_2675076" "unprognostic (3.03e-1)" "unprognostic (4.93e-2)" "unprognostic (4.99e-2)" "unprognostic (3.14e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (2.48e-1)" "unprognostic (1.31e-1)" "unprognostic (8.90e-2)" "unprognostic (1.44e-3)" "unprognostic (2.32e-1)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (3.40e-1)" "unprognostic (3.54e-2)" "unprognostic (4.65e-2)" 3.8 4.6 4.5 3.5 5.0 7.5 3.7 4.9 5.6 4.7 1.9 5.0 2.4 5.0 3.6 4.7 4.3 2.3 4.5 6.2 4.2 4.4 5.3 3.2 5.2 3.3 3.8 4.8 6.0 3.4 4.0 3.0 3.8 4.1 3.1 4.3 3.6 3.1 7.0 6.0 4.8 3.9 2.7 8.8 4.5 3.7 4.6 3.8 3.4 4.5 5.1 4.5 3.8 4.0 6.4 9.1 5.0 15.2 6.6 4.0 5.4 6.3 4.1 6.4 6.8 12.6 8.6 17.9 7.3 7.1 5.5 8.3 10.2 8.6 10.9 7.3 5.5 12.2 14.7 9.9 6.6 10.4 6.4 5.8 2.6 13.6 11.8 3.7 7.6 7.8 14.3 7.3 6.6 11.2 10.2 9.2 6.9 5.0 8.7 12.7 11.7 8.3 5.1 5.8 9.7 4.4 9.7 12.1 8.1 5.1 7.9 4.8 10.0 10.1 8.1 7.2 10.6 6.1 6.2 31.9 9.4 11.4 4.9 3.5 1.9 1.6 3.1 1.9 3.2 2.9 4.5 2.9 1.3 3.7 4.6 3.8 1.2 1.7 3.2 3.5 3.2 1.2 4.5 5.0 4.9 5.6 6.2 4.2 3.3 3.8 3.8 2.7 4.6 4.0 15.0 19.2 19.5 9.4 16.2 15.4 6.9 6.9 10.8 17.1 9.8 13.2 15.0 11.5 7.4 7.3 14.6 14.8 17.3 6.7 15.6 8.9 6.0 13.7 19.7 15.2 6.7 11.6 18.9 8.6 12.6 15.3 11.7 15.6 5.1 18.3 14.3 13.2 9.1 10.1 18.5 10.9 4.1 13.8 7.3 17.0 9.6 8.6 1.8 10.3 13.4 8.1 12.3 13.0 20.1 9.0 6.2 12.8 17.9 7.3 7.6 10.7 9.0 18.2 0.0 22.6 12.7 11.7 21.5 16.0 14.8 12.7 17.3 19.1 13.2 7.3 NRAP ENSG00000197893 "Nebulin related anchoring protein" Q86VF7 10 113588714-113664070 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 2363.9;tongue: 1144.8" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 534.1" "Group enriched" "Detected in some" 7 "head and neck cancer: 8.2;prostate cancer: 3.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037953, HPA037954, HPA075074" Enhanced Approved "Vesicles,Intermediate filaments,Cytosol" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "Vesicles, Cytosol" "HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: " "unprognostic (1.13e-1)" "unprognostic (2.95e-1)" "unprognostic (3.61e-2)" "unprognostic (2.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.97e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-3)" "unprognostic (3.72e-2)" "unprognostic (4.20e-2)" "unprognostic (6.40e-2)" "unprognostic (2.88e-1)" "unprognostic (5.39e-4)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (3.16e-1)" 0.3 0.1 0.1 0.0 0.5 0.0 0.4 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 24.8 0.0 0.2 428.6 0.2 0.0 0.1 0.5 0.4 0.1 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 20.4 1.0 0.0 22.1 0.0 2363.9 0.8 0.1 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.4 1144.8 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 534.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.4 0.1 0.0 3.7 0.0 0.0 0.3 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.3 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 57.3 3.3 1.0 2.3 0.0 0.1 0.0 0.2 0.0 0.5 0.0 OTUD3 "DUBA4, KIAA0459" ENSG00000169914 "OTU deubiquitinase 3" Q5T2D3 1 19882395-19912945 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028543, HPA028544" Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Nucleoplasm, Intermediate filaments" "HPA028543: AB_10599302, HPA028544: AB_10602277" "unprognostic (6.45e-3)" "unprognostic (9.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" "unprognostic (3.16e-3)" "unprognostic (1.70e-3)" "unprognostic (3.15e-3)" "unprognostic (4.99e-2)" "unprognostic (1.09e-1)" "unprognostic (8.81e-2)" "unprognostic (4.68e-2)" "unprognostic (1.08e-1)" "unprognostic (9.83e-2)" "unprognostic (1.94e-1)" "unprognostic (7.28e-2)" "unprognostic (2.21e-2)" 3.3 5.7 4.8 3.3 5.0 6.4 4.7 5.2 5.9 6.2 2.2 6.4 5.0 7.7 6.0 3.8 5.6 3.3 3.4 4.9 3.2 4.6 3.1 4.9 3.6 2.8 3.1 6.7 4.6 4.1 5.5 2.4 2.8 5.9 3.8 9.3 3.9 4.1 4.9 6.4 5.8 5.6 2.2 4.8 4.8 10.7 3.6 3.7 3.9 4.3 3.0 4.5 4.9 5.2 5.8 2.2 9.5 11.4 4.0 3.5 9.3 6.1 3.5 3.0 3.0 10.2 5.4 9.2 4.8 13.5 2.2 5.6 8.9 3.5 5.9 6.0 11.9 8.8 13.4 7.2 2.2 6.5 7.8 2.9 3.4 4.8 6.2 6.4 4.1 9.2 6.3 3.8 5.3 3.2 5.0 6.5 4.5 4.6 5.6 11.5 24.2 3.4 5.1 6.3 8.4 5.9 4.4 3.5 4.6 9.2 5.2 4.8 5.0 7.3 9.3 8.2 5.3 4.4 4.0 5.6 5.1 8.6 3.4 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.3 0.2 0.0 0.2 0.3 0.3 0.1 0.1 0.0 0.1 0.2 0.0 4.8 5.0 5.2 5.9 4.9 3.2 2.8 3.1 2.8 2.2 3.6 5.2 5.0 16.0 7.5 11.4 5.6 14.1 5.9 2.4 4.6 14.9 10.2 9.1 4.7 4.3 2.0 9.2 16.7 2.7 6.5 4.7 0.0 5.1 16.0 11.7 7.8 5.1 12.0 6.1 32.6 4.5 5.4 7.0 5.1 8.3 1.3 16.4 7.9 2.2 1.9 26.9 28.5 7.0 4.1 2.6 8.9 16.4 5.6 5.2 5.4 6.5 4.1 8.9 5.2 21.1 16.6 5.0 6.7 6.0 8.6 9.8 4.7 4.2 9.7 15.5 6.6 7.8 6.1 23.5 21.4 5.7 8.8 2.5 7.0 4.7 7.0 4.8 PAFAH1B3 ENSG00000079462 "Platelet activating factor acetylhydrolase 1b catalytic subunit 3" Q15102 19 42297033-42303546 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035639 Uncertain Approved "Intermediate filaments" NA NA 290000 "Cluster 26: Non-specific - Mitochondria" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Intermediate filaments" "HPA035639: AB_10670163" "unprognostic (3.19e-1)" "unprognostic (5.38e-3)" "unprognostic (1.13e-1)" "unprognostic (5.99e-2)" "unprognostic (1.83e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" "unprognostic (6.36e-2)" "unprognostic (2.37e-1)" "unprognostic (7.67e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.68e-1)" "unprognostic (3.21e-2)" "unprognostic (4.56e-2)" "unprognostic (6.80e-3)" 8.3 23.5 34.7 12.4 35.4 27.9 13.7 36.5 44.1 18.9 31.3 16.8 12.4 13.8 12.9 28.1 14.8 10.8 4.6 35.1 39.9 21.8 7.9 9.2 17.0 32.2 33.1 18.3 18.1 13.8 21.2 5.9 34.4 15.2 12.1 13.0 17.0 6.3 13.5 13.6 14.7 7.5 32.0 16.0 15.9 23.7 42.9 37.6 9.3 5.2 18.3 14.1 16.6 32.5 111.9 200.2 127.5 135.8 2.6 6.7 38.1 27.9 39.2 91.9 94.4 67.7 94.7 70.0 34.8 35.0 63.7 37.1 58.9 75.2 38.3 105.7 77.0 85.8 52.7 91.8 19.3 54.4 90.3 19.9 33.9 56.5 26.3 50.7 41.3 152.5 58.5 81.9 67.9 162.5 124.2 42.4 70.3 138.3 0.2 90.0 47.9 62.0 76.4 117.7 144.8 109.9 44.6 89.4 47.0 40.4 111.4 62.1 22.3 74.8 98.5 6.7 77.3 38.0 84.9 60.6 41.3 87.4 65.8 23.2 27.5 15.7 23.4 22.3 31.2 38.3 32.8 26.7 51.1 48.2 43.3 30.6 3.4 18.2 12.0 27.8 58.1 21.0 34.7 35.4 36.5 44.1 35.1 39.9 32.2 33.1 34.4 32.0 42.9 32.5 18.8 16.0 11.2 3.6 26.1 28.2 45.7 82.7 46.1 26.5 67.9 83.2 2.3 30.0 41.6 33.1 14.6 38.6 13.2 39.1 80.3 112.9 16.7 30.4 12.4 24.4 58.9 53.0 3.0 55.3 44.9 21.7 38.7 33.1 27.9 71.4 17.9 10.3 62.7 11.8 5.4 54.0 87.5 28.2 33.5 27.0 13.7 21.8 46.2 1.0 18.2 33.7 11.3 3.0 3.6 81.5 36.1 9.1 37.3 31.0 30.9 63.7 35.0 19.8 0.0 3.6 52.6 5.6 188.8 59.0 17.8 13.5 24.6 46.2 74.3 58.9 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121818-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 9.7;Endometrial stromal cells: 8.2;Fibroblasts: 9.5;Horizontal cells: 8.4;Peritubular cells: 6.4;Skeletal myocytes: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 8.7;SH-SY5Y: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 3.2 2.1 2.7 0.7 3.0 0.0 3.4 3.3 3.7 3.6 0.3 2.0 0.6 5.4 3.8 1.5 4.0 2.4 2.3 3.2 4.2 1.5 0.3 2.1 0.4 5.0 3.7 4.2 8.5 1.4 2.7 0.1 5.7 2.4 0.9 1.6 2.1 1.9 1.6 1.3 0.9 3.3 5.0 0.7 1.3 0.5 2.7 0.4 1.5 2.1 0.2 2.1 2.1 6.7 0.0 0.0 0.3 1.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.7 5.8 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.7 3.0 3.3 3.7 3.2 4.2 5.0 3.7 5.7 5.0 2.7 6.7 9.7 0.0 0.5 0.0 0.0 1.1 0.4 0.2 0.6 4.9 2.6 3.8 1.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 8.2 4.3 0.0 0.0 0.0 1.7 0.0 9.5 0.0 0.3 0.0 0.1 3.6 0.0 0.1 8.4 0.0 0.0 2.0 0.0 1.1 0.0 1.5 0.1 1.8 0.0 0.0 2.0 0.0 0.0 0.0 0.6 0.0 6.4 0.0 0.7 0.0 0.0 2.5 0.6 0.0 8.7 4.0 1.4 0.5 0.0 2.0 0.0 0.0 0.5 0.0 0.4 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144420 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 228.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 224.1;Plasma cells: 318.8;Squamous epithelial cells: 208.0;Suprabasal keratinocytes: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 76.9" "Group enriched" "Detected in all" 4 "granulocytes: 76.9;monocytes: 23.2" "Cell line enhanced" "Detected in many" "CACO-2: 58.8;U-698: 146.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 27.6 7.9 10.2 28.1 14.4 228.5 25.7 11.9 13.5 17.9 9.2 18.6 17.6 17.3 8.6 42.9 12.7 26.1 11.8 13.8 11.2 10.6 13.5 31.0 24.7 12.2 11.2 5.5 9.3 37.9 15.8 15.6 12.2 8.9 20.1 5.1 18.9 7.7 7.1 29.7 23.2 13.9 12.6 21.8 18.1 10.7 10.9 28.3 9.7 10.0 29.0 22.4 23.7 15.6 3.6 2.8 36.5 24.6 4.2 3.2 8.3 4.8 5.4 4.3 6.8 58.8 4.1 48.3 11.3 1.7 1.6 5.8 11.1 10.5 8.6 12.2 8.9 4.4 1.7 9.5 12.4 4.8 8.3 4.2 8.1 6.4 21.6 4.5 24.3 18.2 2.7 11.7 3.7 0.3 10.6 6.9 23.8 11.1 1.7 13.2 12.6 28.1 17.7 10.8 16.7 23.3 3.6 5.5 12.9 11.3 3.0 3.3 17.5 4.0 5.7 4.0 7.1 27.0 2.8 146.7 2.1 4.3 10.9 15.0 15.6 15.0 0.9 14.1 1.7 8.5 4.8 1.9 5.4 6.6 5.6 2.5 76.9 3.0 23.2 0.5 11.6 6.6 10.2 14.4 11.9 13.5 13.8 11.2 12.2 11.2 12.2 12.6 10.9 15.6 94.5 28.9 49.2 4.6 84.4 224.1 74.6 48.2 105.9 1.7 60.9 50.3 5.7 15.7 52.0 5.5 0.0 1.7 16.9 57.9 1.9 5.3 10.6 34.6 26.4 52.1 25.7 3.4 23.4 26.7 8.6 24.5 75.4 58.7 15.2 6.3 37.5 7.5 22.8 3.3 19.1 23.4 30.5 67.6 103.7 11.2 1.5 107.0 112.1 119.9 30.6 5.5 3.1 82.9 67.9 20.9 45.9 1.9 318.8 44.7 32.7 9.6 43.6 2.0 0.0 10.1 51.9 8.4 9.6 208.0 217.5 4.0 49.4 3.2 32.4 145.8 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301524 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 114.3;Microglial cells: 100.2;Oligodendrocyte precursor cells: 150.8;Oligodendrocytes: 77.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 33.3;JURKAT: 43.8;MOLT-4: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favorable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 11.6 3.0 8.1 4.3 7.8 18.6 7.7 27.9 5.9 6.7 5.4 7.0 11.0 6.7 2.5 4.4 6.3 10.0 2.9 5.6 6.6 9.2 2.8 6.7 4.0 8.8 10.9 15.0 28.6 1.9 2.7 3.1 9.3 4.7 3.9 15.1 7.7 3.5 2.4 5.9 9.2 3.3 8.0 6.8 14.4 10.0 10.4 19.1 4.1 3.8 2.0 10.6 5.7 9.2 0.1 3.1 8.8 0.0 4.8 7.2 0.2 1.2 4.2 0.9 0.1 0.2 0.7 0.2 4.2 2.5 0.0 0.9 6.9 0.0 0.4 2.3 2.4 7.9 13.0 0.0 4.1 1.1 33.3 4.5 0.4 0.0 0.0 4.8 1.6 43.8 6.0 0.1 0.9 0.0 39.5 0.4 14.5 0.1 1.2 19.2 0.5 1.8 3.6 15.4 17.5 0.0 0.8 0.1 10.2 5.5 0.0 6.3 0.5 2.6 4.4 0.8 4.4 0.7 0.1 1.0 4.6 5.4 2.6 0.9 1.9 2.4 0.3 1.0 0.5 0.1 0.3 0.2 1.3 0.4 0.2 0.1 5.6 0.3 0.8 0.3 0.0 0.7 8.1 7.8 27.9 5.9 5.6 6.6 8.8 10.9 9.3 8.0 10.4 9.2 13.9 0.0 10.0 114.3 7.7 14.3 10.4 1.7 9.6 30.7 7.1 7.7 2.7 8.6 6.7 12.9 29.2 0.1 11.8 15.0 3.9 5.9 3.7 23.7 14.5 18.0 7.2 5.5 13.5 14.1 0.1 13.5 34.1 21.2 5.7 5.7 17.5 1.0 1.2 21.9 22.1 7.9 2.0 19.7 14.0 5.7 17.1 20.3 17.8 100.2 22.9 9.7 10.3 150.8 77.5 9.1 6.0 18.0 5.6 7.8 12.4 10.1 8.8 19.7 13.1 5.4 22.0 2.0 24.0 4.7 18.3 0.1 6.2 5.6 3.1 12.6 PFDN5 "MM-1, PFD5" ENSG00000123349 "Prefoldin subunit 5" Q99471 12 53295291-53299452 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 3559.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA008587 Approved Supported "Intermediate filaments,Cytosol" NA NA 110000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 32: Non-specific - Translation" "Intermediate filaments, Cytosol" "HPA008587: AB_1079597" "unprognostic (3.56e-3)" "unprognostic (2.31e-2)" "unprognostic (2.87e-2)" "unprognostic (4.02e-3)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "unprognostic (3.44e-2)" "unprognostic (1.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.12e-1)" "prognostic favorable (5.45e-4)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.54e-6)" "unprognostic (5.34e-2)" "unprognostic (9.48e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-3)" 719.5 656.4 903.9 307.4 919.3 863.9 819.2 894.2 1279.0 907.5 890.8 684.3 238.6 555.3 867.4 520.1 654.0 366.1 633.1 880.3 907.3 677.4 505.6 539.2 610.5 907.4 899.1 1007.6 724.5 606.1 688.1 399.6 910.7 671.6 371.8 371.8 557.5 394.2 723.2 684.8 514.0 357.2 935.9 712.7 591.9 388.0 927.2 547.7 634.5 615.5 625.9 614.7 651.4 928.1 333.3 492.3 472.8 426.6 889.1 1220.7 347.2 814.5 1081.9 730.8 489.3 456.0 496.9 449.2 479.3 871.1 285.7 299.0 416.7 575.0 702.6 425.4 575.7 410.6 639.1 634.6 574.3 676.8 425.6 1174.9 823.4 522.7 398.6 1269.3 658.4 539.4 485.7 589.1 735.3 1150.9 478.1 993.0 447.7 359.1 757.4 381.1 514.6 530.8 842.9 477.8 396.5 454.1 525.6 450.1 612.1 481.8 588.1 843.6 585.6 408.2 319.1 198.7 372.6 444.5 500.8 670.7 450.3 528.5 386.0 1641.6 2761.6 989.6 1636.2 2095.6 2283.3 3705.2 2468.1 2003.4 2060.9 3368.6 3147.1 2533.0 740.8 1645.0 2221.2 1921.0 2149.1 8653.7 903.9 919.3 894.2 1279.0 880.3 907.3 907.4 899.1 910.7 935.9 927.2 928.1 711.6 262.8 501.5 27.7 1274.1 1505.2 1217.7 1648.8 900.3 184.0 1219.6 1850.4 598.0 684.9 778.6 566.4 102.2 899.8 862.2 593.0 1412.6 561.2 902.9 629.9 703.6 734.7 659.9 587.9 25.3 961.0 973.4 708.4 362.9 440.2 655.9 647.4 782.8 584.8 1830.1 72.3 25.0 892.0 734.5 1977.7 2549.4 3559.9 948.7 1235.9 1538.5 15.9 1663.4 619.2 905.3 21.6 27.6 705.6 990.6 655.2 582.9 971.9 1053.0 2024.3 862.7 321.5 552.2 713.6 902.4 469.7 234.3 762.4 1526.5 876.0 1147.0 658.2 849.4 1114.8 PGD ENSG00000142657 "Phosphogluconate dehydrogenase" P52209 1 10398592-10420511 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Gluconate utilization, Pentose shunt" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 400.2;esophagus: 572.4" "Cell type enhanced" "Detected in all" "monocytes: 214.9;Squamous epithelial cells: 496.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 1060.2;classical monocyte: 321.0;eosinophil: 1074.7;neutrophil: 332.6" "Group enriched" "Detected in all" 5 "granulocytes: 1074.7;monocytes: 321.0" "Cell line enhanced" "Detected in all" "A549: 1445.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031314, HPA031315" Enhanced Supported Approved "Intermediate filaments,Cytosol" No No 41000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments, Cytosol" "HPA031314: AB_10610278, HPA031315: AB_2673825" "unprognostic (4.65e-2)" "unprognostic (2.58e-1)" "unprognostic (8.65e-2)" "unprognostic (9.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.90e-2)" "unprognostic (2.83e-1)" "unprognostic (1.40e-2)" "unprognostic (4.92e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" 115.8 51.0 49.5 59.8 49.2 400.2 89.0 52.9 49.3 75.9 52.5 52.9 91.6 23.1 41.9 572.4 30.0 94.2 34.3 47.4 54.3 53.2 81.3 88.5 38.1 57.0 54.6 35.7 32.0 52.7 43.8 47.4 55.4 30.4 46.3 49.1 133.7 22.9 34.7 50.0 70.7 35.0 49.7 110.4 61.4 68.3 59.2 53.6 71.8 28.2 73.8 61.8 126.9 52.0 191.5 1445.2 319.3 340.6 445.4 274.0 71.8 124.8 185.9 144.4 195.3 219.2 190.4 163.5 151.0 109.2 202.4 148.0 225.6 192.1 96.4 127.5 199.9 227.8 264.3 452.1 136.3 390.9 249.7 196.5 92.2 229.4 55.5 186.9 344.0 223.0 305.3 145.7 183.5 202.5 321.4 179.4 194.7 221.0 109.1 252.7 298.1 312.2 199.6 105.5 178.0 154.1 99.1 153.5 137.5 196.7 173.3 308.5 369.3 81.1 149.6 98.3 134.5 111.6 256.0 323.5 175.1 393.9 73.6 1060.2 321.0 1074.7 23.2 137.7 26.5 33.1 21.4 20.8 144.6 23.3 21.1 22.3 332.6 19.7 105.6 98.7 23.1 225.0 49.5 49.2 52.9 49.3 47.4 54.3 57.0 54.6 55.4 49.7 59.2 52.0 7.4 19.2 35.0 11.8 24.9 13.0 30.8 78.0 70.6 7.8 30.4 18.5 11.0 50.1 73.2 20.2 18.8 134.6 29.8 24.3 52.8 52.1 10.9 17.8 18.6 22.6 23.4 55.7 8.6 40.3 40.7 37.5 41.8 24.5 25.9 53.9 16.1 66.2 134.6 1.7 12.6 30.2 59.0 163.8 30.9 13.4 17.1 150.9 17.8 4.7 214.9 16.5 10.3 13.6 9.0 38.7 26.7 10.5 41.9 43.5 66.6 55.1 46.2 20.2 19.7 23.4 21.5 41.5 38.4 496.0 16.6 81.3 19.4 27.3 51.7 76.1 PGM2 FLJ10983 ENSG00000169299 "Phosphoglucomutase 2" Q96G03 4 37826660-37862937 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 334.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040676 Uncertain Approved "Intermediate filaments" NA NA 1700000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 5: Muller glia cells - Visual perception" "Intermediate filaments" "HPA040676: AB_2677076" "unprognostic (3.11e-2)" "unprognostic (1.01e-2)" "prognostic favorable (2.14e-5)" "unprognostic (2.29e-1)" "unprognostic (3.94e-1)" "unprognostic (5.44e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-3)" "unprognostic (5.32e-2)" "unprognostic (7.02e-2)" "unprognostic (5.37e-2)" "unprognostic (2.22e-2)" "unprognostic (6.72e-3)" "unprognostic (3.21e-2)" "unprognostic (1.88e-1)" "unprognostic (9.97e-2)" "unprognostic (1.02e-1)" 8.2 11.2 3.2 9.5 3.2 10.1 8.8 4.6 4.5 10.9 4.5 9.8 7.6 10.1 4.9 36.6 7.9 11.3 5.6 4.9 3.1 8.0 14.8 6.9 10.0 3.4 3.0 6.9 4.4 8.4 3.0 11.7 3.6 7.8 9.0 18.2 7.7 5.2 1.2 17.5 7.8 13.7 3.5 8.3 6.1 5.3 3.1 10.2 9.7 1.9 22.7 18.9 16.4 3.7 27.4 9.5 14.6 16.6 10.2 12.4 19.8 32.6 18.9 27.8 26.4 18.0 19.2 38.0 15.5 17.8 34.9 13.8 36.0 32.0 65.1 23.0 21.0 40.1 15.2 12.3 23.2 44.2 26.5 17.0 36.0 22.0 18.6 16.2 41.6 31.2 53.6 6.2 24.3 15.6 49.8 49.6 17.3 19.2 15.5 35.8 23.1 14.8 15.7 52.3 31.8 10.8 17.5 23.3 12.0 19.5 21.5 45.4 37.0 19.7 24.9 27.3 67.1 14.0 38.4 40.3 10.9 56.2 32.9 19.8 27.5 67.2 9.8 22.4 11.5 9.4 8.0 11.1 31.9 5.5 7.7 9.8 33.6 28.1 18.2 7.1 14.9 17.0 3.2 3.2 4.6 4.5 4.9 3.1 3.4 3.0 3.6 3.5 3.1 3.7 16.9 0.0 8.2 5.2 13.8 14.7 14.3 32.9 17.6 7.8 12.6 6.9 4.5 14.3 23.1 3.7 0.0 31.9 11.9 10.6 5.9 16.0 0.9 9.0 12.7 22.9 7.2 8.0 8.3 11.8 37.8 10.3 5.6 14.7 12.7 56.4 42.5 9.7 37.9 6.7 5.6 9.2 4.1 24.4 15.2 2.0 8.4 24.5 5.4 4.7 46.1 334.1 13.4 8.0 0.9 14.5 6.7 9.8 10.5 17.7 6.9 10.4 9.8 16.0 13.1 5.8 23.8 0.6 2.1 42.5 32.1 79.8 14.7 19.8 12.9 20.4 PHACTR4 "FLJ13171, PPP1R124" ENSG00000204138 "Phosphatase and actin regulator 4" Q8IZ21 1 28369582-28500364 "Predicted intracellular proteins" Neurogenesis "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 212.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028985 Approved Approved "Plasma membrane,Intermediate filaments,Cytosol" NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 44: Endometrium - Transcription" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA028985: AB_10602142" "unprognostic (1.55e-1)" "unprognostic (2.61e-2)" "unprognostic (4.50e-3)" "unprognostic (1.73e-1)" "unprognostic (5.27e-1)" "prognostic favorable (1.05e-4)" "unprognostic (9.65e-3)" "unprognostic (8.77e-2)" "unprognostic (2.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (2.94e-2)" "unprognostic (3.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.03e-2)" "unprognostic (2.26e-2)" 7.2 6.5 6.3 8.6 8.1 11.8 10.1 8.2 6.8 13.6 10.2 12.9 9.1 13.7 7.1 33.0 13.2 8.9 8.9 5.8 8.5 14.1 16.3 12.4 7.8 9.1 6.8 13.1 11.7 15.1 4.0 10.4 7.2 11.8 14.1 5.1 11.3 8.2 11.9 16.2 10.3 13.8 5.5 12.0 10.7 8.6 8.0 11.9 12.4 18.3 12.2 9.4 14.8 9.3 26.0 17.2 37.8 27.5 9.6 10.2 5.8 18.1 18.3 38.5 40.0 16.4 28.1 24.5 15.9 21.6 24.3 17.7 26.3 17.4 33.9 18.1 14.9 51.6 28.2 26.5 14.3 31.2 56.7 9.9 16.4 24.7 42.7 14.0 52.0 19.5 26.0 16.9 24.5 8.0 22.3 7.8 28.3 14.0 11.8 23.2 35.7 18.5 20.2 22.8 20.1 26.0 41.0 16.9 20.9 14.9 22.5 11.1 33.3 18.8 34.6 13.4 35.8 12.4 19.7 20.1 18.4 26.2 20.3 1.9 2.0 2.0 3.3 2.0 2.9 1.4 2.6 3.3 2.2 2.2 1.8 2.6 1.4 2.4 3.3 2.6 1.2 1.5 6.3 8.1 8.2 6.8 5.8 8.5 9.1 6.8 7.2 5.5 8.0 9.3 65.9 70.5 49.8 60.7 38.9 38.6 23.6 24.1 46.7 34.6 37.0 35.8 38.5 40.0 53.7 23.9 20.9 17.6 36.7 59.9 17.6 32.4 6.1 125.6 58.6 56.2 49.3 32.2 65.8 36.5 17.3 29.1 35.2 212.6 48.0 38.8 42.5 63.3 22.8 23.5 82.6 57.0 24.4 33.6 32.3 8.5 19.3 40.3 17.8 92.8 33.7 19.8 51.5 117.1 148.1 48.2 33.5 29.7 30.8 24.4 40.0 45.5 63.3 39.8 39.5 45.6 31.0 47.1 39.4 62.1 54.1 15.2 35.7 15.3 50.6 30.9 PJA2 "KIAA0438, Neurodap1, RNF131" ENSG00000198961 "Praja ring finger ubiquitin ligase 2" O43164 5 109334713-109409974 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040347, HPA057636" Supported Enhanced "Intermediate filaments" No No "Cluster 14: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 43: Cardiomyocytes - Nuclear processes" "Intermediate filaments" "HPA040347: AB_10795631, HPA057636: AB_2683485" "unprognostic (5.78e-2)" "unprognostic (1.25e-1)" "unprognostic (5.48e-3)" "unprognostic (1.17e-1)" "unprognostic (2.99e-1)" "unprognostic (7.83e-2)" "unprognostic (2.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.84e-2)" "prognostic unfavorable (8.02e-4)" "unprognostic (4.46e-2)" "unprognostic (6.03e-2)" "unprognostic (5.64e-3)" "unprognostic (1.47e-3)" "unprognostic (5.94e-2)" "unprognostic (7.59e-2)" "unprognostic (1.00e-2)" 59.3 67.9 63.3 44.4 72.9 87.9 57.0 44.9 89.8 68.9 22.1 56.1 33.4 74.5 62.2 50.8 46.2 48.3 65.8 78.6 77.0 61.1 77.3 51.4 41.4 52.6 52.1 87.8 38.8 88.1 36.8 58.2 56.2 78.4 52.5 64.2 49.2 91.9 39.0 30.6 40.6 77.1 58.9 54.7 33.1 47.0 58.6 53.8 92.1 54.2 44.6 53.7 36.9 68.9 36.0 24.6 96.2 74.6 93.4 101.3 52.4 57.9 86.5 44.6 72.6 22.9 47.6 46.0 78.1 111.8 71.8 20.5 57.0 71.3 81.1 39.5 21.7 53.5 47.4 31.1 66.2 40.2 75.8 70.4 58.1 59.7 85.1 80.0 72.4 40.8 37.2 84.0 73.0 21.9 48.8 36.9 19.2 21.9 16.3 31.1 84.6 77.5 69.5 31.9 18.4 47.1 59.8 21.5 70.5 64.2 48.6 58.7 84.6 63.4 30.7 58.8 27.5 56.4 51.6 53.5 66.8 54.8 42.6 32.9 19.2 29.3 14.4 19.7 14.4 16.5 14.1 13.4 19.3 11.7 18.0 13.4 49.0 17.8 27.7 8.0 20.5 18.5 63.3 72.9 44.9 89.8 78.6 77.0 52.6 52.1 56.2 58.9 58.6 68.9 85.2 67.3 58.4 71.2 76.9 63.5 56.2 59.8 58.1 102.1 53.0 58.5 127.5 51.5 51.7 57.0 62.6 24.1 78.2 85.9 49.0 40.8 22.5 42.8 97.5 70.3 67.6 32.1 159.0 33.3 31.0 86.7 32.1 68.2 47.5 99.3 70.6 94.8 54.5 77.4 126.0 53.1 36.7 91.5 78.5 20.7 85.1 77.1 60.5 66.5 73.4 93.0 68.0 60.8 111.6 30.9 30.4 92.6 72.0 59.2 46.8 58.7 48.4 91.3 78.9 105.0 110.1 73.4 42.9 43.7 58.2 26.3 68.7 61.6 39.3 44.0 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 80.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 80.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 19.3 16.5 9.3 17.6 14.2 48.7 24.1 20.7 10.9 16.4 17.0 23.9 30.5 23.6 25.0 24.7 18.1 17.1 14.1 9.5 9.7 16.9 20.5 20.4 18.2 12.3 10.4 31.2 15.5 22.3 10.1 24.7 12.7 20.3 30.0 26.7 16.3 15.4 9.8 20.3 30.8 18.5 10.1 19.0 20.9 10.5 12.6 17.8 26.1 13.4 17.4 21.3 15.4 17.6 61.1 23.8 45.2 27.3 29.8 33.6 29.6 35.3 32.2 38.5 39.8 25.3 42.5 23.9 41.0 33.6 47.3 46.7 44.7 26.6 52.4 8.6 33.0 17.7 49.3 21.4 26.2 17.6 5.1 27.7 27.1 30.2 36.3 30.6 44.7 18.6 29.9 16.8 42.2 12.2 20.5 15.2 22.8 23.1 27.1 19.3 68.8 9.8 34.3 117.9 22.0 14.5 52.7 29.8 45.7 33.9 22.5 15.7 42.2 32.5 29.2 42.1 37.2 9.2 8.6 16.6 13.6 17.1 12.6 15.3 9.9 16.6 5.7 5.9 5.1 8.0 5.1 5.3 5.0 9.3 6.6 5.6 80.5 3.5 8.0 8.6 4.6 2.7 9.3 14.2 20.7 10.9 9.5 9.7 12.3 10.4 12.7 10.1 12.6 17.6 104.7 41.7 57.8 102.5 52.5 48.4 44.3 33.3 75.1 85.4 60.2 67.9 50.8 38.6 47.9 69.9 89.6 42.9 48.1 101.5 11.7 61.2 2.6 63.7 68.7 59.5 44.3 57.7 134.2 60.7 33.1 53.1 85.6 84.6 15.8 107.0 47.5 39.4 24.2 65.6 130.8 64.3 32.6 35.8 27.9 6.6 54.3 44.9 32.0 178.0 57.3 50.5 22.6 117.1 146.4 77.6 98.1 48.2 54.8 64.7 84.0 26.7 49.1 150.5 39.5 62.8 55.5 43.6 34.6 83.0 52.4 37.4 44.8 90.2 65.0 124.2 PLEC "EBS1, PCN, PLEC1, PLTN" ENSG00000178209 Plectin Q15149 8 143915153-143976734 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 256.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 257.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "PC-3: 384.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003847, HPA025967, HPA029906" Enhanced Supported "Intermediate filaments,Focal adhesion sites,Cytosol" NA NA 7400000 "Cluster 39: Non-specific - mRNA processing" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Intermediate filaments, Cytosol" "Focal adhesion sites" "CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279" "unprognostic (1.02e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.29e-4)" "unprognostic (2.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.72e-3)" "unprognostic (1.13e-2)" "unprognostic (2.85e-3)" "unprognostic (5.48e-2)" "prognostic unfavorable (7.98e-6)" "unprognostic (2.30e-1)" "unprognostic (4.04e-2)" "unprognostic (6.58e-2)" "unprognostic (5.58e-3)" 41.8 30.9 44.2 22.6 25.4 43.2 37.9 20.4 39.7 57.4 6.7 58.0 21.1 55.2 8.5 59.7 47.9 22.8 78.9 42.2 31.0 30.0 31.3 49.2 22.1 48.5 28.6 47.1 27.6 8.1 33.0 18.3 30.8 49.5 13.0 3.9 42.9 19.8 256.5 83.1 53.8 27.7 28.8 46.1 49.1 15.3 43.2 14.4 25.7 74.7 15.8 56.5 55.7 25.9 92.6 247.3 15.1 20.3 31.6 66.9 62.8 125.9 49.3 32.3 18.7 39.2 88.5 8.9 82.9 179.7 54.6 98.9 10.3 162.6 13.3 58.7 10.0 24.9 268.0 34.0 54.0 9.6 26.1 71.8 40.7 84.6 164.2 28.3 43.0 7.6 16.2 25.9 39.7 175.3 5.1 19.8 12.2 29.4 384.8 1.8 46.2 24.6 67.7 147.7 16.6 16.8 217.4 50.0 21.1 21.7 55.7 12.4 125.7 117.8 217.3 110.6 155.1 4.7 3.7 6.3 106.9 15.2 176.2 0.0 2.0 0.1 0.6 1.7 1.3 0.6 1.2 0.9 1.6 0.6 0.8 0.5 0.4 0.3 1.2 1.3 1.4 2.0 44.2 25.4 20.4 39.7 42.2 31.0 48.5 28.6 30.8 28.8 43.2 25.9 83.8 28.9 15.6 78.0 27.0 108.0 53.1 62.9 50.7 15.8 29.4 27.9 39.3 31.5 42.9 40.5 25.0 34.4 27.1 257.8 0.0 39.3 1.4 39.4 52.6 68.2 32.2 11.8 47.3 20.2 32.1 45.7 170.2 57.3 8.2 14.4 63.1 69.0 35.2 30.3 36.5 79.9 10.2 67.5 100.4 5.0 44.4 61.2 33.8 27.2 54.9 11.2 15.5 14.6 3.4 157.8 194.1 74.9 39.3 144.9 124.9 4.6 50.3 10.8 6.6 42.1 61.5 1.2 7.1 72.2 76.7 69.0 35.0 18.8 61.6 121.0 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" No No "Cluster 7: Monocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (7.20e-2)" 5.4 5.7 3.7 5.8 4.0 4.9 4.5 3.1 4.7 4.9 4.0 4.9 4.1 8.2 3.0 6.0 5.2 2.9 5.8 3.9 3.6 4.6 5.0 4.0 4.6 3.4 3.6 5.2 5.2 7.1 4.9 5.0 3.3 4.5 5.0 3.5 3.9 5.1 10.8 5.5 3.8 6.9 2.7 3.8 4.5 6.2 4.4 6.2 4.5 7.4 4.9 5.2 4.2 4.3 18.5 41.1 18.0 34.7 17.2 13.7 25.9 16.6 10.9 23.2 14.4 51.9 14.2 41.9 17.2 17.0 22.7 20.9 46.6 24.4 20.6 17.6 24.0 36.2 18.0 35.1 12.1 34.8 18.7 10.5 15.0 34.6 26.7 8.8 18.2 19.0 48.8 10.3 16.2 16.4 25.8 15.1 32.7 24.4 26.8 30.7 39.5 19.6 10.5 29.7 27.7 14.6 18.3 23.8 12.7 12.3 14.0 12.0 29.3 28.0 22.2 24.3 33.8 14.5 15.3 35.7 14.6 29.3 25.3 0.5 0.4 0.0 0.7 0.6 0.9 0.5 0.3 0.6 0.4 0.6 0.3 0.4 0.1 0.5 0.5 0.7 0.1 0.4 3.7 4.0 3.1 4.7 3.9 3.6 3.4 3.6 3.3 2.7 4.4 4.3 4.9 3.2 9.1 13.4 8.8 4.2 4.9 5.3 12.0 12.4 6.2 5.5 11.1 8.6 4.7 9.2 16.7 6.3 7.2 5.1 3.9 6.0 3.0 5.4 13.8 6.5 9.6 10.9 19.7 4.9 5.4 7.7 8.2 6.9 6.3 11.0 4.2 8.3 12.5 11.8 18.1 6.7 2.0 3.1 3.5 1.7 6.2 5.5 5.4 6.5 3.3 4.2 6.2 20.1 18.2 6.6 3.0 5.3 10.1 9.1 3.5 3.4 5.2 9.7 0.0 14.3 6.2 5.0 7.2 13.4 2.7 3.8 7.5 12.4 10.4 4.0 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "bone marrow: 2.0;testis: 7.4" "Group enriched" "Detected in some" 106 "Early spermatids: 420.0;Late spermatids: 301.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: AB_2685611" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.0 0.1 0.0 2.0 0.1 0.5 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.1 7.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.1 0.4 0.0 0.6 0.3 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.4 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 420.0 0.2 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 301.8 2.5 0.2 0.0 0.0 0.0 0.1 0.0 2.0 0.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.1 3.4 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PRKCE ENSG00000171132 "Protein kinase C epsilon" Q02156 2 45651345-46187990 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell type enhanced" "Detected in many" "Early spermatids: 206.5;Excitatory neurons: 394.4;Inhibitory neurons: 531.9;Late spermatids: 456.4;Oligodendrocyte precursor cells: 147.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 18.5;basal ganglia: 20.0;cerebral cortex: 34.5;hippocampal formation: 33.1;white matter: 17.1" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "REH: 27.0;TIME: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001948, HPA008236, HPA044496" Enhanced Supported Supported "Vesicles,Plasma membrane,Intermediate filaments,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 58: Brain - Synaptic function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Intermediate filaments, Cytosol" "Vesicles, Plasma membrane" "CAB001948: , HPA008236: , HPA044496: AB_2678959" "unprognostic (1.10e-1)" "unprognostic (1.78e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (9.61e-2)" "unprognostic (5.70e-2)" "unprognostic (1.51e-1)" "prognostic favorable (9.62e-4)" "unprognostic (3.05e-1)" "unprognostic (6.72e-2)" "unprognostic (7.49e-3)" "unprognostic (9.99e-2)" "prognostic favorable (2.63e-7)" "unprognostic (1.21e-1)" "unprognostic (7.11e-2)" "unprognostic (6.43e-3)" "unprognostic (2.23e-2)" 4.4 5.6 18.5 3.7 20.0 8.0 4.2 5.5 34.5 4.6 0.0 5.7 2.6 4.4 2.3 4.1 5.7 3.0 6.2 33.1 0.0 10.0 12.5 20.1 5.7 6.0 0.2 2.8 3.3 9.4 5.2 8.3 4.4 2.9 3.3 15.4 2.7 3.0 7.6 2.7 3.5 4.1 0.0 3.9 4.1 7.6 1.1 3.1 4.9 5.3 4.2 4.9 3.4 17.1 7.7 2.7 3.8 3.8 5.8 6.7 3.1 4.9 9.5 4.3 4.5 0.7 7.0 11.3 4.8 5.5 6.1 1.8 2.5 2.8 6.1 6.9 4.4 0.1 1.8 1.5 6.5 0.9 3.8 5.8 3.0 6.5 4.7 3.6 16.0 2.4 1.6 2.6 5.0 3.8 3.8 0.5 1.3 4.2 1.4 27.0 18.3 12.4 3.9 5.1 2.6 5.7 2.4 7.6 17.1 1.4 6.1 2.6 26.8 8.2 8.5 6.1 5.1 0.0 0.0 9.3 6.7 6.3 8.4 0.0 0.5 0.7 0.3 0.1 0.4 1.5 0.2 0.2 0.8 1.8 0.5 0.1 0.1 0.4 0.6 0.3 0.0 0.3 18.5 20.0 5.5 34.5 33.1 0.0 6.0 0.2 4.4 0.0 1.1 17.1 12.6 6.4 9.2 90.4 20.7 5.0 8.4 5.0 9.1 55.3 6.4 5.7 11.9 8.6 17.2 11.0 14.6 0.5 9.3 6.1 3.9 3.7 206.5 6.8 7.0 13.8 7.7 0.4 394.4 3.8 7.2 8.7 11.2 6.9 7.0 2.9 13.2 12.5 2.8 11.8 531.9 5.8 0.0 19.0 10.7 456.4 5.3 11.5 14.2 70.3 9.4 6.5 1.0 147.8 96.0 3.6 2.9 6.0 4.2 5.3 4.1 30.2 19.3 7.6 13.1 2.9 6.4 2.8 2.3 9.0 4.8 2.9 6.8 1.2 6.2 8.8 PSMD10 p28 ENSG00000101843 "Proteasome 26S subunit, non-ATPase 10" O75832 X 108084207-108091549 "Predicted intracellular proteins" Apoptosis Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002920, CAB010434" Approved Supported "Intermediate filaments,Cytosol" NA NA 250000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" Cytosol "Intermediate filaments" "CAB010434: AB_640866, HPA002920: AB_1079708" "unprognostic (1.59e-3)" "unprognostic (4.12e-3)" "unprognostic (3.83e-1)" "unprognostic (3.00e-1)" "unprognostic (4.65e-2)" "unprognostic (1.50e-2)" "unprognostic (3.85e-3)" "unprognostic (2.35e-1)" "unprognostic (1.44e-1)" "unprognostic (2.06e-2)" "unprognostic (4.95e-2)" "unprognostic (7.37e-3)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (2.09e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 28.2 38.6 49.4 26.2 52.3 28.7 35.1 54.5 68.3 34.3 47.4 32.7 25.3 36.4 48.3 34.5 44.9 25.8 26.0 49.9 58.9 34.6 33.4 28.6 34.8 55.4 58.6 31.7 18.6 41.4 33.1 40.4 61.4 31.6 33.2 44.6 26.2 30.4 24.8 26.8 27.0 36.2 56.4 27.1 27.8 27.5 57.5 41.9 38.1 23.9 39.1 33.4 27.7 59.4 101.3 100.5 68.9 62.6 102.6 77.3 61.8 81.6 69.2 73.9 64.0 60.7 64.4 86.0 119.7 80.2 107.6 54.0 109.8 80.3 113.4 91.3 94.8 50.5 91.0 78.2 51.8 79.2 54.8 58.2 85.9 67.2 82.2 73.2 186.4 83.2 99.9 114.3 94.0 133.0 75.3 70.9 124.1 96.9 138.3 74.2 97.5 92.7 80.7 64.8 44.2 42.1 124.8 52.4 86.0 87.4 56.5 66.9 130.5 58.1 33.1 98.3 61.4 88.5 128.5 90.5 80.4 109.2 69.7 83.6 46.8 72.3 45.9 58.1 49.0 47.9 45.8 49.2 52.2 48.0 45.6 51.4 22.0 58.3 71.4 53.0 57.8 69.9 49.4 52.3 54.5 68.3 49.9 58.9 55.4 58.6 61.4 56.4 57.5 59.4 14.2 19.2 19.8 3.3 23.4 22.6 25.9 31.8 23.9 15.1 20.4 20.6 11.2 8.6 35.4 11.0 2.1 28.3 12.8 16.5 31.3 19.9 4.1 38.3 26.9 22.8 14.4 35.7 3.4 18.7 35.3 22.6 11.7 21.6 34.1 17.9 22.1 25.6 31.3 13.5 4.5 16.8 16.2 29.5 19.0 4.4 25.7 20.2 17.8 0.0 26.1 18.3 20.6 5.5 9.6 24.5 14.1 21.1 34.7 26.6 14.9 34.8 69.9 7.7 0.0 13.8 32.1 46.2 40.3 32.4 29.1 25.0 20.2 24.6 19.2 33.7 PTPN18 BDP1 ENSG00000072135 "Protein tyrosine phosphatase non-receptor type 18" Q99952 2 130356045-130375405 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 143.4;NK-cells: 148.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 63.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012174, HPA053367" Uncertain Approved "Intermediate filaments" NA NA 270000 "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" "Intermediate filaments" "CAB012174: AB_2173224, HPA053367: AB_2732579" "unprognostic (3.11e-3)" "unprognostic (2.89e-3)" "unprognostic (1.67e-3)" "unprognostic (1.73e-3)" "unprognostic (5.81e-3)" "unprognostic (3.08e-3)" "unprognostic (2.49e-2)" "unprognostic (1.28e-2)" "unprognostic (4.65e-1)" "unprognostic (2.10e-2)" "unprognostic (7.33e-2)" "unprognostic (5.65e-2)" "unprognostic (4.52e-2)" "unprognostic (1.00e-2)" "unprognostic (3.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.85e-3)" 22.3 12.3 19.6 23.2 19.4 28.2 21.5 21.7 21.4 21.2 18.4 35.3 21.7 15.7 6.1 17.8 19.6 14.8 15.3 18.8 19.1 25.4 37.8 22.0 42.7 21.0 19.6 12.5 34.6 9.5 19.0 12.2 20.1 33.3 24.7 6.4 31.9 13.2 7.5 12.7 39.4 13.3 18.7 63.8 27.0 4.6 20.0 11.1 20.0 7.5 48.6 18.8 18.9 19.6 12.4 8.3 3.2 16.2 19.7 13.5 32.9 6.2 5.6 7.9 8.8 16.4 18.5 46.4 6.2 15.2 3.7 13.8 14.3 14.1 7.6 21.1 8.0 16.9 9.8 19.5 10.2 16.6 44.5 16.0 11.4 8.7 12.0 1.7 15.2 10.1 16.1 34.2 15.4 24.3 3.1 28.4 3.3 26.6 8.6 28.4 9.5 63.0 15.9 7.5 20.6 5.4 10.9 38.6 18.7 3.1 13.2 24.1 14.4 11.2 12.6 6.2 5.9 5.6 1.6 44.5 17.1 14.9 12.4 8.4 7.8 6.7 6.4 11.2 4.0 7.3 4.2 6.1 6.9 5.1 2.6 5.1 4.8 3.1 19.4 7.5 6.0 10.7 19.6 19.4 21.7 21.4 18.8 19.1 21.0 19.6 20.1 18.7 20.0 19.6 37.2 28.9 23.9 12.1 43.6 6.5 28.8 15.9 12.0 13.4 52.0 53.5 9.0 18.6 17.5 36.8 4.2 15.6 85.6 75.9 54.8 19.0 0.9 20.6 14.0 30.7 48.6 32.4 18.2 45.4 30.5 16.3 65.2 24.0 35.5 12.2 25.7 21.1 92.4 10.1 18.6 52.5 30.5 113.6 35.9 1.6 19.0 143.4 33.8 35.6 65.2 18.4 148.3 5.5 6.1 29.0 66.9 11.3 23.5 37.9 41.3 37.3 20.5 11.6 19.7 15.1 21.5 2.6 6.0 19.4 5.8 11.5 39.3 16.2 47.5 28.9 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase receptor type E" P23469 10 127907103-128085855 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 46.9" "Cell type enhanced" "Detected in many" "dendritic cells: 256.6;Inhibitory neurons: 191.6;Langerhans cells: 307.9;Macrophages: 276.3;Oligodendrocyte precursor cells: 247.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 634.6;plasmacytoid DC: 475.9" "Group enriched" "Detected in all" 12 "dendritic cells: 475.9;granulocytes: 634.6;monocytes: 175.4" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 38.6;HUVEC TERT2: 41.6;NB-4: 32.5;TIME: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 13.6 16.7 13.9 25.3 8.9 46.9 6.7 5.7 13.9 3.9 7.7 9.2 9.5 3.5 2.6 7.9 4.9 10.3 10.6 14.2 11.1 4.3 4.4 16.0 16.4 11.6 9.0 1.6 2.7 2.7 5.0 7.8 10.7 3.4 9.3 1.0 5.8 2.4 1.3 4.7 12.9 7.4 10.8 20.6 7.4 2.6 10.7 8.6 5.5 3.1 9.8 12.7 4.4 14.2 4.3 0.9 0.5 0.0 2.5 0.4 7.5 0.1 0.0 1.6 3.6 1.7 25.1 3.3 2.6 2.1 5.2 2.3 2.1 12.2 0.7 4.0 1.9 0.4 1.4 0.0 4.1 16.2 11.6 0.8 6.9 6.1 12.1 38.6 41.6 10.3 0.0 1.9 2.6 4.0 4.9 32.5 0.2 4.6 1.5 19.1 2.6 6.4 6.8 18.0 0.0 2.5 7.4 1.3 0.3 1.8 0.6 20.1 79.5 1.7 1.8 7.8 8.9 0.9 1.3 4.6 11.3 12.5 0.0 174.3 175.4 147.2 36.6 64.5 22.3 7.7 16.5 25.1 97.9 8.3 11.5 19.6 634.6 31.6 54.9 475.9 26.7 43.3 13.9 8.9 5.7 13.9 14.2 11.1 11.6 9.0 10.7 10.8 10.7 14.2 25.0 83.3 57.2 22.5 26.2 59.5 54.3 42.4 15.9 5.2 14.2 23.6 20.3 8.6 23.7 3.7 0.0 43.2 256.6 15.7 0.0 3.7 2.1 3.6 10.6 78.0 6.7 10.3 112.7 4.4 67.4 17.5 10.7 7.7 31.6 3.7 47.5 2.3 57.5 0.0 191.6 15.8 18.3 166.7 307.9 2.5 0.6 276.3 24.9 165.8 139.5 0.0 150.4 247.3 93.4 49.2 13.3 0.4 38.5 21.3 13.9 2.2 7.8 0.9 0.0 86.0 12.8 0.5 1.9 20.4 64.6 17.0 59.3 9.2 11.7 40.3 QTRT2 "FLJ12960, QTRTD1" ENSG00000151576 "Queuine tRNA-ribosyltransferase accessory subunit 2" Q9H974 3 114005833-114088422 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 20.3;Endometrial stromal cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036827, HPA036828" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Intermediate filaments" "HPA036827: AB_2675336, HPA036828: AB_10696788" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (6.71e-3)" "unprognostic (1.01e-3)" "unprognostic (8.57e-2)" "unprognostic (4.41e-1)" "unprognostic (5.82e-3)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" "unprognostic (6.94e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.95e-4)" "unprognostic (1.44e-1)" "unprognostic (8.74e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-3)" 6.9 6.5 3.6 9.4 3.9 11.2 10.1 3.2 4.0 7.4 9.0 8.4 7.7 8.4 6.4 7.0 7.5 5.3 3.4 4.3 3.6 7.5 7.2 8.6 12.0 3.8 3.6 8.1 6.7 7.3 4.4 8.5 3.8 6.9 8.9 11.3 5.9 5.9 3.8 8.2 7.6 7.4 3.4 11.8 6.9 7.1 3.7 7.7 8.9 3.9 11.6 9.6 5.2 4.4 26.8 27.1 22.2 24.6 9.6 11.7 20.9 13.7 8.6 22.9 20.9 26.0 18.8 49.4 19.5 12.7 27.3 25.9 43.5 20.6 29.9 9.4 19.6 22.2 15.9 18.6 13.7 40.8 20.0 9.3 18.2 20.8 29.4 9.3 24.0 22.5 23.7 17.1 13.1 21.4 34.3 15.9 42.6 37.6 29.3 30.6 15.6 26.6 18.0 18.2 30.1 14.2 19.9 19.4 25.1 18.4 21.6 20.4 15.9 19.9 21.6 7.9 26.9 12.0 18.7 68.1 17.4 29.6 40.9 0.6 15.3 3.8 6.4 15.8 6.0 16.8 5.4 6.3 19.4 11.0 7.4 6.0 6.5 8.6 11.4 8.1 7.6 6.5 3.6 3.9 3.2 4.0 4.3 3.6 3.8 3.6 3.8 3.4 3.7 4.4 14.0 19.2 20.3 0.0 8.4 0.0 0.0 0.0 0.0 0.0 13.8 12.4 0.0 0.0 10.5 3.7 0.0 10.9 10.0 0.0 1.9 15.7 0.0 16.3 19.7 9.9 0.0 0.0 0.0 12.4 10.9 6.2 0.0 15.1 15.2 15.7 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 8.3 0.0 0.0 0.0 0.0 16.7 0.0 0.0 3.3 0.0 0.0 8.9 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 4.9 4.3 17.4 0.0 0.0 RAB3IP "FLJ22548, RABIN3, RABIN8" ENSG00000127328 "RAB3A interacting protein" Q96QF0 12 69738860-69823204 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 210.4;Early spermatids: 287.3;Late spermatids: 453.9;Oligodendrocyte precursor cells: 261.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 156.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039794 Uncertain Approved "Intermediate filaments" No No "Cluster 35: T-regs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Intermediate filaments" "HPA039794: AB_10960557" "unprognostic (4.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.66e-2)" "unprognostic (8.57e-2)" "unprognostic (3.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.75e-2)" "unprognostic (7.10e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-1)" "prognostic favorable (5.68e-13)" "unprognostic (6.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.15e-1)" "unprognostic (3.37e-1)" 3.7 15.9 17.7 6.4 22.0 25.6 19.9 79.7 16.9 8.4 51.6 21.7 19.2 5.5 44.3 8.6 15.2 15.1 18.3 18.7 18.9 48.5 16.6 14.9 13.6 25.7 21.7 3.1 22.8 26.9 20.2 12.0 26.2 20.8 22.6 88.6 12.8 9.7 9.7 11.8 22.4 4.9 12.1 6.8 18.4 74.7 19.7 12.7 16.2 14.3 15.3 11.8 4.8 25.6 44.1 23.5 14.3 22.9 6.9 3.1 41.0 4.3 9.9 16.9 22.6 67.3 19.1 34.1 13.9 2.3 21.9 33.0 14.7 22.9 29.0 51.7 25.6 25.3 8.4 32.9 6.4 29.9 15.4 7.4 23.3 15.6 52.4 17.5 24.8 44.4 12.1 30.3 9.6 46.8 30.3 12.8 35.7 46.1 25.7 35.3 22.2 35.9 55.1 53.5 56.7 10.2 16.7 28.0 6.4 57.0 47.6 11.1 7.4 7.2 18.3 3.0 20.3 14.2 63.4 156.9 17.5 18.3 11.2 1.8 5.2 7.2 4.2 1.9 8.5 9.2 7.5 6.8 5.6 8.6 9.3 9.1 6.9 7.8 2.3 5.1 12.6 4.4 17.7 22.0 79.7 16.9 18.7 18.9 25.7 21.7 26.2 12.1 19.7 25.6 4.0 60.9 51.1 19.6 17.7 23.6 55.6 28.8 19.4 210.4 44.6 13.0 50.2 85.8 48.8 51.5 110.5 21.7 6.4 33.1 37.2 64.6 287.3 79.7 5.2 8.7 40.8 14.1 22.6 31.8 8.2 6.4 39.3 119.7 2.5 19.3 7.1 16.5 3.5 28.6 186.1 39.3 46.8 1.9 7.5 453.9 4.4 8.0 5.4 9.4 16.6 96.6 4.1 261.9 104.1 51.1 38.6 3.8 25.9 77.9 46.1 82.1 54.4 95.8 6.6 31.8 12.3 48.9 37.7 24.2 29.8 8.5 15.1 3.5 45.8 76.7 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893204-22919182 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favorable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 31.8 37.9 35.8 34.1 38.5 53.2 40.7 55.0 42.0 46.0 48.4 38.3 30.7 53.4 39.3 39.6 59.4 39.1 33.6 35.8 42.9 44.2 40.7 42.0 44.8 38.6 38.5 57.9 39.2 83.2 40.6 46.7 37.0 39.0 41.7 52.2 38.0 40.1 29.1 36.3 37.3 45.9 37.7 45.4 39.2 31.3 43.4 57.9 54.5 40.7 50.6 43.5 37.7 45.0 55.9 86.3 86.6 45.4 46.5 39.6 36.1 59.9 81.3 114.0 88.8 39.6 66.6 93.0 45.8 55.8 54.8 77.3 98.3 50.3 92.2 73.1 81.2 43.7 65.8 2.8 72.9 84.6 68.9 51.0 68.3 65.8 43.4 63.4 64.4 45.5 56.5 58.3 56.6 71.1 93.8 38.0 38.7 84.8 80.3 80.1 71.8 56.6 44.0 78.0 59.5 66.3 89.8 68.8 38.6 56.6 50.8 49.6 59.8 19.3 33.3 47.5 56.1 55.1 77.0 87.6 32.4 48.2 71.7 40.1 47.7 50.7 37.1 37.0 25.1 29.3 26.3 32.2 49.5 34.7 31.5 28.2 136.6 59.7 49.7 24.6 30.0 32.0 35.8 38.5 55.0 42.0 35.8 42.9 38.6 38.5 37.0 37.7 43.4 45.0 36.8 44.8 48.3 12.1 82.3 18.4 44.7 28.4 27.9 66.4 38.7 35.9 24.3 68.6 42.7 33.1 116.7 53.0 53.8 48.8 45.0 36.3 9.5 55.1 36.8 39.5 65.4 54.1 13.5 33.5 48.0 32.0 36.7 41.4 70.9 27.2 53.2 37.2 31.5 50.5 16.1 39.3 20.3 54.9 33.6 11.9 35.4 40.4 16.0 19.7 70.8 52.4 102.0 18.6 15.3 39.7 55.1 28.2 42.2 29.1 57.3 33.1 64.0 164.2 32.9 47.8 32.1 52.0 64.3 22.0 21.0 101.4 64.0 28.1 42.3 27.8 RESF1 "C12orf35, FLJ10652, FLJ20696, GET, KIAA1551, UTA2-1" ENSG00000174718 "Retroelement silencing factor 1" Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 73.9" "Cell type enhanced" "Detected in some" "Adipocytes: 35.8;B-cells: 43.7;dendritic cells: 88.1;Hofbauer cells: 34.1;Plasma cells: 66.6;T-cells: 21.5" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 212.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 212.8" "Cell line enhanced" "Detected in all" "SuSa: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Nucleoli rim" "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 14.3 7.1 2.5 50.7 3.1 21.8 13.9 7.5 10.9 28.9 2.2 14.0 23.8 23.2 9.1 10.6 38.1 19.3 8.1 1.8 3.3 9.1 24.9 17.1 70.2 4.1 2.8 73.9 6.7 9.8 4.0 37.9 5.0 9.2 13.8 7.0 8.2 11.2 4.1 9.1 27.3 16.0 2.0 45.3 20.5 13.2 3.6 60.7 12.6 11.9 62.5 17.7 8.6 5.1 7.6 13.3 22.5 8.6 10.1 12.0 33.6 9.1 9.0 6.0 6.9 50.6 48.9 36.4 21.9 7.6 21.5 9.6 31.3 6.0 8.4 27.1 4.4 51.1 6.7 6.7 19.7 37.0 79.2 6.5 9.0 7.1 11.6 25.4 50.3 24.0 29.5 56.1 6.8 3.7 52.6 15.6 48.3 28.4 5.5 24.1 21.4 16.0 6.3 14.0 9.0 8.1 11.7 6.0 6.0 112.9 20.8 40.5 32.0 6.7 10.4 11.5 9.6 33.9 38.1 44.8 3.6 20.6 7.4 55.5 14.7 15.4 42.2 16.1 40.3 33.6 38.0 40.7 12.3 26.8 44.1 43.8 212.8 30.6 18.1 7.7 38.9 20.4 2.5 3.1 7.5 10.9 1.8 3.3 4.1 2.8 5.0 2.0 3.6 5.1 35.8 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 15.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 2.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 5.1 21.5 0.0 0.0 0.0 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357924-177372596 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 72.8;Proximal tubular cells: 113.7;Squamous epithelial cells: 95.8;Suprabasal keratinocytes: 115.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 110.4;cerebral cortex: 67.9;hippocampal formation: 56.4" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 112.5;HMC-1: 95.4;NB-4: 44.8;RPMI-8226: 57.9" "Group enriched" "Detected in many" 10 "amygdala: 66.0;basal ganglia: 57.9;cerebral cortex: 46.8;hippocampal formation: 93.6;white matter: 23.8" "Region enhanced" "Detected in many" "basal ganglia: 102.1" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: AB_2679836, HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 3.5 2.8 16.0 13.9 110.4 22.4 2.9 0.0 67.9 3.1 1.8 3.7 6.3 2.3 0.4 10.0 7.7 4.3 1.3 56.4 4.5 8.5 28.7 5.5 18.1 0.0 0.4 1.1 3.7 1.5 2.4 1.4 0.1 3.5 0.9 0.0 6.2 2.1 2.6 6.1 11.0 1.8 0.1 27.7 4.9 1.9 15.2 16.3 6.1 0.9 6.6 4.1 5.0 3.2 5.4 1.1 2.3 1.4 0.1 0.0 3.7 0.2 0.0 0.5 0.6 3.7 10.4 13.3 7.3 0.4 1.3 10.6 0.2 3.8 0.0 112.5 0.5 20.7 1.0 4.7 0.9 16.3 95.4 1.8 1.1 0.6 0.7 1.4 0.6 14.9 3.5 26.5 0.2 0.4 21.7 44.8 1.7 5.4 2.8 10.2 0.3 57.9 1.5 1.6 0.4 1.9 0.4 0.4 8.8 0.0 3.5 25.2 1.1 0.2 1.9 0.0 9.7 13.9 7.1 5.8 1.6 30.3 2.4 70.6 39.9 148.8 62.4 37.9 63.0 27.7 57.9 57.8 39.8 26.6 47.4 43.1 140.0 23.6 41.2 17.6 60.9 43.9 16.0 110.4 0.0 67.9 56.4 4.5 0.0 0.4 0.1 0.1 15.2 3.2 5.3 6.4 4.4 2.6 27.3 68.8 23.9 15.4 72.8 0.7 8.9 11.8 2.3 37.1 5.6 11.0 2.1 3.9 41.4 4.2 31.3 11.4 0.6 19.5 2.0 6.5 4.8 7.4 4.6 16.7 10.4 5.4 12.2 8.1 24.7 2.8 8.2 64.0 26.1 0.0 1.5 10.0 10.2 17.0 23.3 1.5 2.8 18.2 21.4 6.5 18.1 9.9 48.4 0.5 0.3 12.8 17.2 2.2 18.0 14.1 16.8 113.7 11.7 2.0 0.0 1.6 4.6 0.1 20.3 95.8 115.1 3.3 51.2 1.1 4.4 20.0 RWDD4 "FAM28A, MGC10198, RWDD4A" ENSG00000182552 "RWD domain containing 4" Q6NW29 4 183639635-183659203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036501, HPA036502" Approved Approved "Intermediate filaments" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Intermediate filaments" "HPA036501: AB_2675159, HPA036502: AB_10670800" "unprognostic (1.30e-1)" "unprognostic (4.15e-1)" "unprognostic (7.50e-2)" "unprognostic (2.30e-1)" "unprognostic (7.80e-2)" "unprognostic (1.72e-1)" "unprognostic (1.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.27e-2)" "unprognostic (2.21e-2)" "unprognostic (4.68e-2)" "unprognostic (2.98e-1)" "prognostic favorable (1.01e-6)" "unprognostic (6.77e-2)" "unprognostic (1.14e-1)" "unprognostic (3.51e-2)" "unprognostic (4.65e-2)" 11.9 52.1 9.2 8.9 9.6 14.7 19.1 10.9 12.5 12.3 14.5 12.0 11.0 12.1 14.3 14.5 13.7 12.7 16.2 9.2 11.7 23.7 15.9 9.6 10.7 9.8 10.2 40.4 26.2 11.8 19.0 11.6 9.5 15.2 12.1 6.2 20.6 11.0 44.9 11.2 10.0 10.7 9.5 9.8 13.7 10.0 10.9 15.9 22.2 32.2 12.5 14.0 10.4 10.1 25.6 14.6 22.0 27.2 35.1 36.5 16.7 31.8 25.4 38.9 24.7 9.5 32.8 38.6 7.1 26.6 18.8 11.8 31.1 29.7 40.8 25.5 14.0 27.7 16.4 24.4 24.7 42.5 20.3 24.2 30.0 21.6 24.0 30.2 29.8 29.7 27.0 48.5 42.0 10.8 44.7 36.7 14.7 9.8 19.2 30.7 17.0 24.8 38.5 12.1 21.0 29.6 29.9 34.4 29.0 16.9 17.3 25.8 20.9 16.3 8.0 17.6 24.9 16.2 13.1 13.1 30.6 31.8 23.7 3.2 3.4 6.8 4.4 4.5 4.4 3.8 4.0 4.2 4.4 2.5 3.7 3.9 2.9 6.5 5.5 4.7 5.7 3.5 9.2 9.6 10.9 12.5 9.2 11.7 9.8 10.2 9.5 9.5 10.9 10.1 29.4 22.4 19.5 7.2 25.6 33.6 35.4 32.0 27.3 17.9 39.2 40.8 11.5 37.1 25.3 18.4 6.2 25.9 32.9 19.7 74.3 38.8 10.6 38.4 28.6 27.3 21.7 30.3 10.3 77.5 42.4 33.4 28.1 28.2 35.5 35.9 26.4 35.6 36.1 10.1 9.5 21.6 38.7 30.1 21.9 9.9 74.0 23.8 56.9 6.5 34.7 30.9 32.0 6.6 7.7 55.8 17.1 70.7 32.5 90.3 19.6 116.1 32.0 22.1 19.7 44.5 27.4 47.7 59.7 46.0 35.5 27.1 26.7 70.2 25.4 59.1 S100A8 "60B8AG, CAGA, CFAG, CGLA, MRP8, P8" ENSG00000143546 "S100 calcium binding protein A8" P05109 1 153390032-153391073 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" Antimicrobial "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35382.0;esophagus: 24565.6;vagina: 11166.4" "Group enriched" "Detected in many" 7 "Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1" "Cancer enhanced" "Detected in all" "cervical cancer: 2290.9;head and neck cancer: 2382.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 9 "classical monocyte: 26833.7;neutrophil: 52973.6" "Group enriched" "Detected in all" 9 "granulocytes: 52973.6;monocytes: 26833.7" "Group enriched" "Detected in some" 24 "hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002791, HPA024372" Enhanced Supported "Intermediate filaments,Cytosol" "Secreted to blood" NA NA 10900000 370000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Intermediate filaments" Cytosol "CAB002791: , HPA024372: AB_1856536" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-2)" "unprognostic (8.60e-3)" "unprognostic (9.26e-3)" "unprognostic (4.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (8.94e-7)" "unprognostic (1.17e-1)" "unprognostic (8.90e-2)" "unprognostic (8.27e-2)" "unprognostic (8.94e-3)" 582.3 54.3 41.7 1245.8 45.6 35382.0 70.0 43.4 88.0 5650.6 45.5 55.2 15.4 23.1 5.5 24565.6 236.1 99.0 121.1 40.9 42.7 103.0 176.7 1061.7 29.5 47.7 44.8 25.8 52.0 9.6 41.7 205.8 50.7 43.1 14.7 5.6 3988.2 5.0 48.5 267.3 47.7 430.2 44.2 3239.5 93.8 16.2 45.5 281.3 48.8 174.8 8952.6 561.9 11166.4 46.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 1.3 0.0 0.3 12.4 0.0 18.7 0.0 0.1 0.0 3.5 0.0 0.0 0.0 5.6 0.1 0.0 241.8 0.0 7.5 0.0 0.0 0.0 9.6 1.2 0.0 0.9 0.4 1.5 0.3 0.0 0.0 0.4 5.8 1.0 0.0 0.0 0.4 0.5 3.6 719.0 0.0 0.0 4.7 400.6 10.6 0.0 0.2 0.9 0.1 0.2 1.3 2.7 0.3 13.9 0.0 848.0 26833.7 3023.7 33.4 1999.2 49.2 57.2 21.8 18.2 4686.1 23.5 21.6 23.3 52973.6 27.1 493.1 188.1 37.1 24979.9 41.7 45.6 43.4 88.0 40.9 42.7 47.7 44.8 50.7 44.2 45.5 46.2 1.1 224.4 489.8 0.0 77.2 19.6 3.5 4126.5 50.7 0.0 13.2 3.9 10.0 70.1 817.0 14.7 0.0 5.8 67.1 0.3 0.0 1.0 210.7 0.5 0.6 33.1 0.0 143.5 0.0 0.9 8.5 61.3 1.1 0.5 227.1 0.1 76.1 54.6 417.5 0.0 0.0 0.2 207.5 6348.0 5.1 172.4 4.1 3758.3 0.0 0.0 6932.6 0.0 289.4 0.0 0.0 1.4 0.0 1.5 26.1 0.9 0.0 25.0 162.8 0.0 0.0 7.7 32.3 2.1 1.0 8480.1 113.2 6.7 91.4 0.0 0.0 31.3 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294219 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 224.6;Excitatory neurons: 244.9;Inhibitory neurons: 367.4;Microglial cells: 273.6;Oligodendrocyte precursor cells: 290.5;Oligodendrocytes: 228.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 105.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: AB_2681280" "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favorable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 13.3 7.6 8.6 6.2 9.2 4.0 9.2 6.4 7.7 15.2 5.1 9.3 6.8 11.3 9.1 11.6 10.2 10.4 8.9 6.7 7.7 13.8 9.5 7.4 3.9 6.9 8.1 18.0 5.1 17.1 4.6 14.2 7.2 10.6 10.5 14.9 9.3 11.4 4.7 7.4 6.6 10.9 7.1 7.8 9.5 10.8 7.1 6.1 16.7 8.9 4.2 11.2 8.2 8.2 15.1 12.1 20.8 15.0 27.1 35.4 105.4 11.6 20.9 13.1 18.2 9.1 18.1 5.8 6.2 20.6 19.1 9.8 12.5 9.8 22.9 6.2 8.6 2.5 9.1 11.9 10.6 5.6 8.0 17.5 12.3 6.6 25.8 20.2 21.8 12.1 5.1 5.2 15.8 4.3 8.1 1.5 9.1 13.5 13.3 7.5 14.5 7.6 11.9 13.4 6.9 15.4 15.7 22.4 10.0 10.6 6.7 4.0 24.4 23.1 11.5 24.3 9.5 1.7 4.6 8.0 17.4 2.7 17.0 0.0 0.7 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 1.1 0.3 1.6 0.1 0.1 0.2 8.6 9.2 6.4 7.7 6.7 7.7 6.9 8.1 7.2 7.1 7.1 8.2 50.2 44.8 83.9 224.6 16.4 25.5 43.4 24.1 27.3 35.1 16.4 14.5 31.4 22.8 30.8 16.5 75.0 13.8 14.6 20.3 3.9 13.9 18.3 17.8 31.1 40.9 43.8 11.4 244.9 8.8 12.9 40.0 40.8 30.1 21.5 41.7 49.6 16.6 18.6 37.0 367.4 16.2 24.4 55.0 34.1 9.2 51.0 44.8 30.2 273.6 37.6 12.0 29.9 290.5 228.4 13.5 21.2 27.1 9.5 56.5 14.5 13.1 38.3 71.6 26.3 44.0 34.8 24.5 17.4 30.6 30.7 13.8 20.6 25.9 20.1 47.4 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.2;pituitary gland: 28.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 31.6;Excitatory neurons: 58.8;Horizontal cells: 20.2;Inhibitory neurons: 35.7;Late spermatids: 31.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Group enriched" "Detected in many" 8 "amygdala: 34.3;basal ganglia: 40.6;cerebral cortex: 49.7;hippocampal formation: 54.2;white matter: 15.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;GAMG: 1.8;hTCEpi: 5.8;RH-30: 2.0;SCLC-21H: 5.5;SH-SY5Y: 4.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "hippocampal formation: 166.1" HPA041707 Approved "Intermediate filaments,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Intermediate filaments" Cytosol "HPA041707: AB_2732493" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 1.9 8.4 34.3 0.6 40.6 0.4 1.8 0.0 49.7 1.0 0.0 1.4 0.8 1.5 0.7 0.7 1.2 0.5 1.4 54.2 2.4 1.4 0.1 1.0 0.3 0.0 4.7 1.0 1.1 4.4 28.0 0.1 0.5 0.8 0.8 10.0 0.7 0.5 14.1 1.5 1.3 1.4 0.9 0.5 0.7 2.2 0.9 0.2 4.1 3.3 0.2 0.8 1.0 15.3 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.9 0.1 1.8 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 5.8 0.1 0.1 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.0 0.0 0.0 0.1 5.5 4.5 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 34.3 40.6 0.0 49.7 54.2 2.4 0.0 4.7 0.5 0.9 0.9 15.3 7.7 0.0 0.5 3.9 0.0 5.7 1.1 0.0 1.2 31.6 1.3 1.0 2.1 0.0 0.0 1.8 6.2 0.1 0.0 0.3 0.0 0.3 13.9 0.2 0.3 13.0 4.2 0.0 58.8 1.0 0.1 1.5 0.0 0.2 0.0 1.4 5.3 0.0 0.2 20.2 35.7 0.0 0.0 0.0 2.3 31.3 0.0 0.4 0.0 5.6 0.0 6.3 1.0 4.5 2.5 0.3 0.0 0.4 0.0 1.0 0.1 0.5 0.0 6.0 6.6 5.7 0.8 1.0 2.0 0.4 5.5 0.0 0.1 1.4 0.1 0.5 SEC62 "Dtrp1, HTP1, TLOC1" ENSG00000008952 "SEC62 homolog, preprotein translocation factor" Q99442 3 169966635-169998373 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014059, HPA061450" Approved Approved "Endoplasmic reticulum,Intermediate filaments" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" "Endoplasmic reticulum" "Intermediate filaments" "HPA014059: AB_1858029, HPA061450: AB_2684524" "unprognostic (8.15e-2)" "unprognostic (6.84e-2)" "unprognostic (2.72e-1)" "unprognostic (4.93e-3)" "unprognostic (5.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (4.04e-1)" "unprognostic (6.78e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-1)" 104.9 86.5 82.9 58.6 94.3 94.4 64.5 88.1 120.6 74.4 74.6 60.9 58.5 74.7 131.9 44.4 52.3 58.5 49.1 81.8 108.1 118.6 193.7 67.6 63.3 94.9 97.7 75.9 116.5 109.7 41.5 71.0 97.9 82.5 56.6 128.9 130.4 83.5 55.3 27.4 59.4 68.3 95.5 83.5 91.1 34.6 92.3 51.1 120.9 60.2 67.0 63.7 31.7 99.9 140.4 96.6 74.2 66.3 217.9 114.7 46.7 175.5 128.3 80.0 82.5 104.0 143.9 156.8 190.7 125.9 132.5 130.3 92.3 84.8 124.7 123.1 89.2 108.6 57.2 105.6 157.9 111.6 68.5 115.0 79.7 88.0 85.3 108.8 80.1 47.3 68.0 147.2 96.3 117.2 58.9 59.0 76.4 110.8 62.5 77.6 107.6 212.8 115.1 88.5 76.1 71.9 143.7 155.8 125.3 71.3 233.5 101.0 107.8 113.1 51.0 95.6 143.1 168.8 134.9 240.8 118.5 85.1 108.0 17.2 34.8 62.3 44.2 37.1 49.2 77.6 40.6 43.5 30.9 82.1 50.9 46.6 52.0 31.8 29.0 35.1 39.1 27.6 82.9 94.3 88.1 120.6 81.8 108.1 94.9 97.7 97.9 95.5 92.3 99.9 419.0 237.2 291.5 64.6 362.7 254.4 252.8 511.1 144.0 362.0 223.3 278.5 582.1 320.3 431.7 680.5 277.3 218.7 209.5 144.7 195.6 256.4 31.6 302.9 424.8 363.7 261.1 874.1 79.3 347.6 215.0 396.3 104.5 455.3 293.5 105.2 463.7 1081.6 214.7 452.6 86.8 285.4 364.2 237.2 268.0 43.4 560.1 208.4 279.3 48.7 280.0 486.8 183.4 47.3 103.1 283.4 217.4 435.6 469.8 223.5 233.7 416.9 385.8 418.4 295.9 358.9 423.4 206.5 142.2 90.2 172.3 434.1 205.5 175.9 182.2 176.8 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443555-116574823 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 60.1;brain: 75.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1" "Cancer enhanced" "Detected in all" "testis cancer: 20.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" NA NA 620000 "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 13.4 60.1 24.1 4.9 48.6 3.5 13.1 39.9 31.9 10.0 0.3 20.6 19.9 6.0 2.8 4.4 8.2 12.9 7.1 24.5 40.3 8.6 5.6 17.9 4.5 51.9 41.0 18.1 11.2 2.0 5.8 31.9 50.0 6.0 17.5 10.4 16.6 2.5 8.2 6.9 25.5 5.8 32.9 11.2 7.0 7.5 44.1 3.6 9.1 6.5 2.2 5.6 8.1 75.2 0.3 0.1 36.9 44.3 0.2 0.0 38.2 0.7 0.4 0.2 0.2 2.2 1.5 1.6 1.7 0.6 0.7 0.4 52.0 0.0 0.1 1.6 7.7 0.7 0.7 13.1 0.5 0.5 2.6 0.7 0.0 0.0 0.0 0.5 0.2 0.3 0.3 0.4 0.2 0.8 0.7 3.9 115.2 0.2 0.3 6.9 24.2 1.8 19.0 33.7 10.3 3.7 0.2 0.7 19.7 221.1 14.4 2.6 0.9 3.6 3.1 0.4 1.5 0.6 0.7 0.8 0.6 1.8 13.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.1 48.6 39.9 31.9 24.5 40.3 51.9 41.0 50.0 32.9 44.1 75.2 64.7 0.0 0.6 71.8 1.1 6.5 0.7 13.1 34.7 17.9 17.0 8.3 8.6 61.5 3.1 14.7 2.1 128.9 0.3 73.3 0.0 42.9 13.6 12.2 4.8 60.9 28.1 2.7 26.9 1.3 8.1 15.4 1.1 10.6 0.0 9.7 145.6 0.9 12.5 138.0 62.2 30.7 0.0 14.8 4.6 2.4 6.5 1.1 24.9 54.4 0.1 5.8 0.0 138.7 311.3 2.0 46.7 1.9 2.6 1.5 40.7 4.4 0.6 3.5 0.0 36.1 8.1 0.9 1.5 11.3 4.1 348.1 0.8 3.5 40.3 2.2 SESTD1 "DKFZp434O0515, Solo" ENSG00000187231 "SEC14 and spectrin domain containing 1" Q86VW0 2 179101678-179264832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 175.5;Horizontal cells: 301.2;Oligodendrocytes: 311.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058236, HPA077408" Approved Enhanced "Intermediate filaments" NA Yes "Cluster 21: B-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 44: Endometrium - Transcription" "Intermediate filaments" "HPA058236: AB_2732619, HPA077408: AB_2732344" "unprognostic (2.76e-1)" "unprognostic (3.55e-2)" "unprognostic (2.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (9.47e-2)" "unprognostic (1.64e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "unprognostic (9.21e-2)" "prognostic favorable (2.78e-11)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.25e-2)" "unprognostic (1.25e-1)" "unprognostic (2.57e-2)" 15.4 2.4 11.6 3.2 17.2 4.7 11.2 12.5 11.4 6.2 0.9 7.1 2.0 5.8 3.9 4.5 4.5 6.4 6.3 8.2 10.3 6.7 3.4 9.2 3.4 16.2 13.5 4.5 3.3 3.9 3.6 6.8 14.6 4.2 3.8 7.5 11.0 4.6 3.6 4.5 5.4 8.1 15.1 3.5 5.5 9.0 18.1 2.9 3.7 5.8 4.9 10.0 4.8 23.6 0.0 2.1 25.5 4.6 45.2 19.5 13.5 9.0 3.7 3.7 6.3 4.6 6.0 4.5 11.7 8.7 4.5 4.2 11.0 5.1 6.8 3.3 2.9 5.5 11.2 12.3 3.5 3.1 2.3 14.6 2.1 5.7 14.3 8.9 15.2 4.6 0.8 2.3 6.4 3.1 7.2 0.3 6.6 4.7 2.6 10.3 16.8 2.9 10.0 23.2 5.6 9.5 8.0 3.4 2.5 18.7 0.5 3.4 26.7 12.3 6.2 6.3 4.7 1.3 0.0 11.0 6.2 1.2 3.7 0.0 0.9 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.4 1.5 0.0 0.0 0.1 0.3 1.6 0.0 0.0 0.2 11.6 17.2 12.5 11.4 8.2 10.3 16.2 13.5 14.6 15.1 18.1 23.6 46.2 109.0 29.9 53.2 30.6 9.8 24.7 19.1 7.4 31.3 30.4 15.6 15.3 28.6 32.9 12.9 18.8 10.7 5.7 11.9 17.6 31.3 9.8 61.3 33.1 32.1 25.0 7.2 110.8 27.7 73.4 65.1 13.7 175.5 0.0 23.1 21.4 9.6 12.3 301.2 147.9 7.3 14.2 28.7 43.4 7.3 12.2 37.2 14.2 89.0 21.9 33.4 5.2 86.5 311.1 33.3 13.3 30.5 4.7 67.7 22.5 39.1 42.8 10.4 19.7 43.7 29.2 34.9 66.0 10.2 10.1 18.1 5.7 9.8 9.7 119.9 SFRP2 "FRP-2, SARP1, SDF-5" ENSG00000145423 "Secreted frizzled related protein 2" Q96HF1 4 153780591-153789083 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 318.8;urinary bladder: 306.7" "Cell type enriched" "Detected in many" 4 "Fibroblasts: 806.1" "Cancer enhanced" "Detected in all" "pancreatic cancer: 370.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "AF22: 229.1;ASC diff: 85.2;HSkMC: 140.2;NTERA-2: 318.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002652 Approved "Intermediate filaments" "Secreted in other tissues" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Intermediate filaments" "HPA002652: AB_2732394" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (7.21e-3)" "unprognostic (1.80e-2)" "unprognostic (2.73e-1)" "unprognostic (8.80e-3)" "unprognostic (5.71e-3)" "unprognostic (2.62e-2)" "unprognostic (2.79e-1)" "unprognostic (7.47e-3)" "unprognostic (1.44e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (8.56e-6)" "unprognostic (9.29e-3)" "unprognostic (4.72e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.39e-4)" 188.2 16.0 4.9 84.6 4.0 0.3 154.9 3.6 6.3 23.2 11.2 72.2 18.4 12.0 22.2 212.7 62.1 318.8 6.2 12.3 13.8 4.5 0.3 62.5 11.8 4.5 3.7 8.3 45.1 7.0 72.5 0.4 4.6 56.5 44.3 2.3 83.4 70.5 6.5 80.5 57.3 89.5 3.8 0.7 34.4 1.5 2.2 9.6 92.3 38.7 3.6 306.7 63.0 12.3 0.0 0.0 229.1 0.2 85.2 15.1 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 140.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 318.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.1 0.1 0.0 8.1 0.2 0.0 0.0 0.4 0.1 0.0 12.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.0 3.6 6.3 12.3 13.8 4.5 3.7 4.6 3.8 2.2 12.3 15.5 3.2 0.6 9.4 0.5 115.5 0.8 0.0 5.7 0.0 3.7 7.9 0.3 0.0 1.9 0.0 0.0 0.1 2.0 0.0 0.0 0.2 0.0 0.1 0.1 11.8 0.0 0.0 0.7 0.0 0.2 806.1 38.7 0.3 1.3 0.0 0.0 0.0 4.4 0.0 0.6 0.0 0.0 0.0 175.0 0.5 4.1 5.0 119.2 0.0 0.6 0.0 0.0 0.5 0.1 0.1 0.0 7.2 4.1 0.7 0.0 0.1 2.9 0.0 0.0 6.7 59.4 0.0 0.1 6.9 106.0 0.1 8.6 0.0 0.0 0.9 SH3RF1 "KIAA1494, POSH, RNF142, SH3MD2" ENSG00000154447 "SH3 domain containing ring finger 1" Q7Z6J0 4 169094259-169270956 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 146.3;Oligodendrocytes: 213.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.2;myeloid DC: 2.5;non-classical monocyte: 6.7" "Group enriched" "Detected in many" 15 "dendritic cells: 2.5;monocytes: 6.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074783 Approved Supported "Vesicles,Intermediate filaments" No No "Cluster 51: Monocytes - Innate immune response" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" Vesicles "Intermediate filaments" "HPA074783: AB_2732268" "unprognostic (4.14e-1)" "unprognostic (4.67e-2)" "unprognostic (1.23e-1)" "unprognostic (7.83e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (1.29e-1)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (9.58e-2)" "unprognostic (4.77e-3)" "unprognostic (7.88e-2)" "prognostic favorable (5.51e-8)" "unprognostic (4.43e-2)" "unprognostic (1.63e-1)" "unprognostic (5.99e-2)" "unprognostic (1.77e-1)" 9.8 3.7 8.7 4.4 10.0 3.4 8.2 7.6 13.1 5.7 5.9 15.1 13.8 4.3 5.7 5.9 5.6 11.9 5.7 18.2 8.6 12.2 8.0 9.4 3.3 8.8 9.7 8.5 10.4 3.7 3.7 7.4 9.4 14.3 13.6 2.4 15.8 8.4 9.4 5.1 13.1 4.0 8.2 3.9 24.7 6.1 9.5 2.0 19.9 10.0 3.2 9.3 4.4 13.0 15.2 12.2 11.0 31.9 11.5 14.3 14.1 40.5 19.7 30.0 13.8 12.5 17.8 0.0 1.9 43.1 8.1 9.8 8.9 16.2 32.4 0.1 5.2 8.7 27.4 6.5 26.0 3.1 0.3 8.5 8.6 25.7 19.9 37.3 18.7 3.3 0.1 0.0 27.8 6.0 3.1 2.9 5.6 19.2 10.5 4.5 3.6 0.6 13.6 11.8 8.3 9.9 10.4 15.7 4.2 4.7 5.2 1.3 17.1 14.2 11.0 23.6 14.7 1.1 0.0 0.1 16.0 3.0 17.3 0.0 1.0 0.0 0.0 4.2 0.0 0.3 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.2 6.7 0.2 0.0 0.6 8.7 10.0 7.6 13.1 18.2 8.6 8.8 9.7 9.4 8.2 9.5 13.0 28.0 64.1 37.7 146.3 3.4 34.3 48.3 11.9 13.6 3.5 21.1 15.6 11.2 44.3 34.4 27.6 0.0 12.7 0.4 69.3 11.7 42.2 5.5 28.5 14.2 13.0 31.3 2.1 54.9 63.7 22.1 16.5 65.7 46.5 10.2 5.6 11.4 12.4 7.4 0.0 54.9 27.1 12.2 9.3 5.3 3.5 12.2 11.1 3.6 52.5 3.9 11.3 0.0 89.5 213.0 68.4 37.2 12.0 2.4 63.2 28.9 18.4 31.7 1.2 65.7 24.1 36.9 5.4 10.7 9.4 12.6 13.1 1.7 6.5 34.4 72.0 SIK2 "DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2" ENSG00000170145 "Salt inducible kinase 2" Q9H0K1 11 111602449-111730855 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 113.3;Excitatory neurons: 217.6;Inhibitory neurons: 132.4;Oligodendrocytes: 191.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "ASC diff: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016026, HPA071049" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Vesicles" "Nuclear speckles, Intermediate filaments, Cytosol" "HPA016026: AB_1857321, HPA071049: " "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.59e-2)" "unprognostic (4.81e-2)" "prognostic favorable (4.93e-4)" "unprognostic (6.41e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.72e-3)" "unprognostic (9.27e-2)" "prognostic favorable (1.17e-9)" "unprognostic (1.23e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-3)" "unprognostic (2.13e-2)" 29.7 9.3 9.2 5.3 12.4 3.1 20.7 7.9 11.1 7.6 11.0 7.9 5.9 7.3 5.0 5.9 8.1 10.0 12.3 9.5 14.7 11.4 22.7 11.7 4.4 11.9 11.9 14.9 31.8 21.3 16.6 5.8 10.6 6.7 6.2 30.7 13.8 6.2 33.1 8.9 7.5 5.9 5.5 4.6 17.6 3.0 9.3 5.4 8.7 23.2 4.3 7.7 6.1 11.6 9.2 6.0 10.3 11.1 50.3 14.8 6.1 7.9 11.2 5.9 6.7 20.5 9.6 7.2 10.7 9.2 6.9 12.7 8.2 5.9 7.6 5.4 3.4 7.9 5.2 10.1 10.9 7.7 4.9 14.5 8.6 8.7 11.1 11.7 7.1 7.1 7.4 10.3 9.4 4.3 8.0 7.0 3.5 7.6 5.9 10.6 11.0 8.7 13.1 8.2 4.8 11.3 11.6 4.7 4.5 9.4 11.5 6.2 9.9 12.9 7.7 8.3 10.9 2.9 2.4 14.8 4.2 10.6 8.8 0.3 0.7 0.6 0.7 0.7 0.3 0.4 0.5 0.5 0.6 0.4 0.2 0.4 0.3 0.5 0.6 0.3 0.5 0.5 9.2 12.4 7.9 11.1 9.5 14.7 11.9 11.9 10.6 5.5 9.3 11.6 22.1 19.2 24.8 113.3 14.1 14.7 6.2 5.2 18.2 15.7 10.5 9.9 21.3 27.1 10.0 16.5 66.7 4.4 11.4 15.6 5.9 10.4 16.5 27.7 14.9 18.8 18.0 12.4 217.6 7.9 4.6 20.1 27.5 45.3 9.5 24.3 9.3 38.7 5.4 32.0 132.4 11.3 4.1 12.4 16.9 14.1 11.5 13.3 19.6 73.1 6.0 14.5 4.1 86.0 191.9 8.4 10.3 14.7 8.9 6.9 8.3 23.1 13.4 60.9 0.0 19.1 19.0 3.9 6.4 10.3 11.9 5.2 12.6 5.0 11.5 7.1 SLC10A3 "DXS253E, P3" ENSG00000126903 "Solute carrier family 10 member 3" P09131 X 154487306-154490690 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 63.6;Syncytiotrophoblasts: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 10 "basophil: 218.6" "Lineage enriched" "Detected in all" 17 "granulocytes: 218.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021656 Approved Approved "Intermediate filaments" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" "Intermediate filaments" "HPA021656: AB_1856955" "unprognostic (1.60e-1)" "prognostic favorable (4.53e-4)" "prognostic unfavorable (4.15e-5)" "unprognostic (8.00e-3)" "prognostic unfavorable (9.97e-4)" "unprognostic (5.47e-2)" "unprognostic (2.28e-3)" "unprognostic (9.76e-2)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.42e-1)" "unprognostic (2.52e-3)" "unprognostic (6.23e-2)" "unprognostic (2.99e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-2)" 23.3 22.9 6.1 13.1 6.2 34.0 21.0 6.8 7.9 27.1 5.8 22.5 13.9 29.6 18.4 31.2 22.8 21.3 23.2 5.9 6.1 20.6 10.3 22.7 15.1 7.4 6.8 40.8 22.8 9.6 18.8 21.1 7.4 22.9 8.3 2.0 17.4 15.7 18.3 42.9 18.7 13.5 6.9 19.3 18.9 8.9 8.1 9.8 20.6 9.4 11.2 31.8 26.0 7.7 66.4 27.0 7.3 38.3 25.2 27.6 48.9 49.2 29.2 32.5 32.3 25.0 31.8 51.0 91.1 46.8 41.3 55.9 24.4 24.7 8.6 32.7 11.8 15.9 36.0 20.3 47.0 19.0 24.9 34.8 28.1 29.9 15.8 28.5 22.6 8.7 17.6 48.6 21.6 90.0 10.2 17.0 5.9 32.4 54.9 16.8 19.9 38.8 24.7 24.2 6.8 12.0 29.8 55.4 13.0 8.5 17.9 15.0 29.5 38.0 23.9 89.6 63.2 34.3 35.6 52.8 40.9 39.6 20.2 218.6 4.5 21.1 12.9 6.5 9.6 5.3 8.5 9.2 3.9 5.2 6.0 5.9 6.1 8.8 5.6 9.5 6.4 6.3 6.1 6.2 6.8 7.9 5.9 6.1 7.4 6.8 7.4 6.9 8.1 7.7 13.3 3.2 7.0 2.3 21.1 22.6 27.1 15.2 50.7 2.8 13.7 11.8 4.0 15.7 7.3 18.4 6.2 49.5 17.4 22.1 7.9 17.8 3.6 13.0 14.8 15.8 10.2 11.1 1.6 19.4 63.6 21.2 13.7 21.0 12.7 15.8 16.8 2.3 19.4 3.3 1.4 15.5 4.1 8.4 19.6 1.2 27.1 22.7 3.6 1.0 13.2 3.0 23.7 1.5 1.6 20.9 16.0 13.2 19.8 14.1 17.2 10.4 6.9 1.9 6.6 12.1 14.3 1.9 2.9 45.5 27.8 103.0 24.5 5.4 11.7 23.5 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 9.1" "Cell type enhanced" "Detected in some" "Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075017 Approved Approved "Intermediate filaments,Focal adhesion sites" No NA "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Focal adhesion sites" "Intermediate filaments" "HPA075017: AB_2732276" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 0.5 0.3 1.1 0.0 3.3 0.2 0.6 0.2 6.0 0.7 0.0 0.3 0.1 0.4 0.0 0.3 0.9 0.1 0.6 0.8 1.1 0.4 0.2 0.3 0.0 4.0 1.4 0.3 0.4 0.0 1.6 0.0 3.6 1.7 0.0 0.1 1.2 0.0 0.5 0.7 0.2 0.0 0.3 0.3 0.4 0.8 2.8 0.0 0.7 0.0 0.0 0.4 0.7 9.1 0.3 0.0 0.1 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.4 0.1 2.1 0.0 0.2 0.1 1.3 0.0 0.0 0.0 1.2 0.0 0.0 4.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.3 0.2 6.0 0.8 1.1 4.0 1.4 3.6 0.3 2.8 9.1 0.6 0.0 0.0 0.7 0.0 1.3 0.5 0.6 0.6 0.1 0.6 0.8 0.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.3 0.1 0.9 0.2 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.4 0.0 1.7 0.7 0.1 1.0 0.0 0.4 0.2 0.0 0.8 1.4 2.5 4.4 0.7 5.4 0.0 0.0 1.4 0.0 0.5 4.0 0.3 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 1.5 2.4 2.1 7.7 0.5 0.9 0.0 0.3 0.6 0.1 0.7 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 88.2;testis: 28.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 17.1;Early spermatids: 35.3;Horizontal cells: 23.5;Late spermatids: 31.8;Syncytiotrophoblasts: 40.0" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in all" 6 "cerebellum: 88.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.4;NTERA-2: 6.1;U-698: 28.3" "Region enriched" "Detected in all" 6 "cerebellum: 136.3" "Region enhanced" "Detected in all" "cerebellum: 53.8" "HPA041505, HPA044066" Enhanced Supported Supported "Plasma membrane,Intermediate filaments" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane" "Intermediate filaments" "HPA041505: AB_2677520, HPA044066: AB_2678796" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (6.88e-6)" 0.1 0.2 9.1 0.2 10.8 0.9 0.4 88.2 14.4 0.1 0.5 0.2 0.3 0.4 1.7 0.1 0.2 0.2 0.2 14.5 5.0 0.1 0.2 0.2 0.3 3.7 7.5 0.3 0.6 0.9 0.3 0.7 8.1 0.5 0.3 2.3 0.4 0.5 0.3 8.6 0.3 0.2 3.2 0.4 0.2 28.0 6.6 0.2 0.3 0.1 0.3 0.1 0.1 5.1 0.1 0.1 0.3 0.4 0.2 0.2 0.9 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.4 7.4 0.2 0.1 0.2 0.1 0.2 0.4 0.3 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.1 0.6 0.0 0.5 6.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.5 0.2 0.2 2.8 0.0 1.1 0.3 0.1 0.0 0.3 1.1 0.3 0.1 0.5 0.1 28.3 0.1 0.3 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 9.1 10.8 88.2 14.4 14.5 5.0 3.7 7.5 8.1 3.2 6.6 5.1 0.0 0.0 0.0 0.7 0.0 3.2 0.7 0.0 0.0 17.1 0.0 0.1 2.1 0.0 0.0 1.8 0.0 1.9 0.0 0.0 0.0 0.0 35.3 0.0 0.1 0.1 0.0 0.0 8.2 0.4 9.9 0.4 0.0 0.0 0.0 5.8 0.0 0.0 0.5 23.5 8.6 0.0 0.0 0.0 0.7 31.8 0.6 0.0 0.0 1.0 0.0 0.7 0.0 4.5 0.9 0.0 0.0 0.7 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.0 0.4 2.2 6.3 0.0 6.8 40.0 0.0 0.0 0.0 0.1 SLC25A48 "FLJ44862, HDMCP" ENSG00000145832 "Solute carrier family 25 member 48" Q6ZT89 5 135579202-135889770 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 28.2;skeletal muscle: 8.8" "Cell type enhanced" "Detected in some" "Astrocytes: 31.0;Distal tubular cells: 9.8;Proximal enterocytes: 11.1;Proximal tubular cells: 45.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.7;HEK 293: 2.0;HEL: 1.7;RPMI-8226: 1.9;SCLC-21H: 1.9;U-2 OS: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014674 Uncertain Approved "Intermediate filaments,Actin filaments" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Intermediate filaments" "Actin filaments" "HPA014674: AB_1859512" "unprognostic (2.09e-1)" "unprognostic (2.24e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.96e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-7)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" 0.9 0.1 13.5 0.3 14.4 0.2 1.1 10.9 16.4 0.3 4.8 0.9 0.7 0.2 0.1 0.4 0.1 0.2 0.2 14.4 17.7 7.5 0.5 0.0 0.3 14.7 18.0 0.1 2.1 0.0 0.1 0.4 17.5 0.4 0.9 0.5 1.7 0.0 8.8 1.9 2.4 0.1 16.8 0.2 0.1 0.4 18.3 0.0 0.2 2.3 0.1 0.1 0.2 28.2 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.2 2.7 0.0 0.0 0.3 2.0 1.7 0.3 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 1.9 0.1 0.2 1.9 0.2 0.3 0.2 0.4 0.7 1.0 0.2 0.1 0.1 2.3 0.1 0.1 0.8 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 13.5 14.4 10.9 16.4 14.4 17.7 14.7 18.0 17.5 16.8 18.3 28.2 0.1 0.0 0.0 31.0 0.0 2.4 0.1 0.0 0.0 0.2 2.3 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.0 9.8 0.0 0.0 2.0 1.2 0.1 0.0 0.0 0.6 0.0 0.2 0.7 0.0 7.1 0.0 0.0 0.0 1.3 0.1 0.0 3.1 2.8 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.0 5.0 4.2 0.1 5.0 0.0 0.0 0.3 11.1 45.8 0.0 0.2 0.0 0.5 0.1 0.5 4.3 0.0 0.9 0.1 0.1 0.0 1.6 0.1 SLC31A2 "COPT2, CTR2, hCTR2" ENSG00000136867 "Solute carrier family 31 member 2" O15432 9 113150976-113164140 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 571.4;salivary gland: 409.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 96.4;Kupffer cells: 145.6;Macrophages: 101.3;monocytes: 84.1;Oligodendrocytes: 113.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 12 "classical monocyte: 226.0;intermediate monocyte: 331.9;myeloid DC: 134.6;neutrophil: 355.8;non-classical monocyte: 423.3" "Group enriched" "Detected in all" 47 "dendritic cells: 134.6;granulocytes: 355.8;monocytes: 423.3" "Cell line enhanced" "Detected in many" "ASC diff: 54.4;hTCEpi: 85.0;hTERT-HME1: 57.7;LHCN-M2: 68.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014861 Approved Approved "Nuclear speckles,Plasma membrane,Intermediate filaments" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" "Nuclear speckles" "Plasma membrane, Intermediate filaments" "HPA014861: AB_1857098" "unprognostic (2.26e-1)" "unprognostic (7.20e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (5.63e-2)" "unprognostic (3.31e-2)" "unprognostic (2.24e-1)" "unprognostic (3.44e-2)" "unprognostic (1.47e-1)" "unprognostic (1.86e-1)" "unprognostic (6.05e-3)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" "unprognostic (8.89e-2)" 48.2 16.7 45.0 18.4 72.6 20.1 24.4 68.2 77.8 7.3 34.2 11.3 10.8 4.4 16.7 9.3 6.9 8.6 10.3 45.1 54.0 27.8 33.4 27.4 16.1 76.6 65.8 5.1 19.2 571.4 2.5 23.6 71.4 4.4 12.1 0.8 409.1 42.6 16.7 48.2 17.2 10.8 61.5 32.7 11.8 13.8 61.7 12.1 6.3 14.6 17.6 13.3 10.7 108.2 7.8 3.1 1.3 1.7 54.4 22.3 6.5 4.0 13.9 12.8 12.3 2.4 1.5 0.3 0.5 9.1 7.9 37.7 5.1 31.0 12.0 2.2 1.3 0.1 1.2 3.3 20.7 1.9 0.8 25.3 85.0 30.0 57.7 1.8 6.9 3.0 1.4 2.6 68.9 6.5 1.6 0.7 0.4 1.8 2.6 0.2 39.3 0.0 4.5 4.2 0.9 2.5 6.9 36.4 1.4 0.8 8.6 2.5 2.4 2.0 1.9 13.7 3.2 2.1 5.0 0.1 12.5 3.2 2.0 5.1 226.0 24.0 4.3 331.9 6.5 1.2 4.9 5.2 134.6 1.0 3.8 3.9 355.8 1.0 423.3 2.1 3.0 104.9 45.0 72.6 68.2 77.8 45.1 54.0 76.6 65.8 71.4 61.5 61.7 108.2 13.8 9.6 9.2 2.3 7.0 37.1 6.4 37.7 13.6 7.0 15.3 10.8 0.6 4.3 10.9 1.8 35.5 96.4 3.6 12.8 3.9 13.5 4.1 23.5 4.9 6.4 3.5 0.4 2.1 7.7 9.0 14.4 3.6 8.4 0.0 2.7 12.8 18.1 57.2 6.7 1.8 4.5 10.2 145.6 65.6 4.6 15.8 101.3 0.0 4.7 84.1 6.9 3.1 0.5 113.7 18.5 11.0 9.4 9.1 10.2 51.3 18.2 14.8 9.1 19.7 8.7 7.8 31.0 5.2 3.3 38.4 43.1 7.9 4.6 5.7 7.6 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 32.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "RT4: 3.6;SCLC-21H: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2" "Group enriched" "Detected in many" 6 "basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 15: RT4 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.1 0.7 1.1 0.5 3.0 0.0 0.1 0.0 10.3 0.7 1.0 2.6 0.7 0.1 0.1 0.3 0.1 0.1 0.3 0.2 5.3 0.3 0.0 0.2 0.0 20.2 21.2 0.2 0.1 0.0 0.0 0.0 32.9 0.3 0.7 0.9 0.3 1.1 0.0 0.0 0.8 0.7 2.8 0.0 0.5 0.1 1.6 0.0 1.2 0.1 0.0 1.3 0.6 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.0 0.0 10.3 0.2 5.3 20.2 21.2 32.9 2.8 1.6 7.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 SMARCA2 "BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2" ENSG00000080503 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2" P51531 9 1980290-2193624 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Disease variant, Hypotrichosis, Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 246.5;Inhibitory neurons: 263.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "HDLM-2: 1486.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029981, CAB037276" Enhanced Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA 19000 "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB037276: AB_477083, HPA029981: AB_10602406" "unprognostic (5.34e-2)" "unprognostic (1.99e-2)" "unprognostic (6.27e-2)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (2.62e-1)" "unprognostic (3.97e-1)" "unprognostic (3.60e-3)" "unprognostic (9.64e-2)" "prognostic favorable (1.26e-6)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (8.32e-3)" "unprognostic (8.50e-2)" 51.9 55.9 68.9 36.1 73.9 95.7 62.0 87.4 81.7 42.1 40.2 31.0 20.2 53.2 57.3 41.7 57.4 46.0 43.8 60.3 53.7 45.9 58.3 40.3 50.9 43.2 54.4 166.0 36.8 170.3 32.7 48.2 50.6 42.5 31.7 63.6 50.7 53.2 97.7 48.2 27.7 44.2 40.3 52.3 32.0 56.3 55.7 42.2 55.7 60.1 47.8 31.8 28.8 52.9 45.7 32.9 23.7 33.8 47.2 56.6 71.7 59.4 44.6 24.9 19.5 0.5 17.7 76.2 22.0 50.7 13.5 18.8 12.9 46.5 17.6 1486.7 20.2 208.3 88.2 16.2 18.7 88.3 118.1 37.6 17.5 24.9 46.4 44.9 40.3 35.4 7.3 255.1 43.0 19.1 22.2 72.3 23.4 26.4 12.6 97.6 30.5 69.4 57.6 40.9 15.3 14.0 36.2 8.3 14.9 34.1 16.3 55.8 49.1 40.6 19.8 25.8 27.3 22.9 31.8 33.6 43.5 32.5 11.4 26.1 5.2 15.8 10.8 7.2 10.4 12.3 10.5 11.2 6.4 9.4 13.1 10.3 14.6 9.9 10.3 12.5 12.6 5.0 68.9 73.9 87.4 81.7 60.3 53.7 43.2 54.4 50.6 40.3 55.7 52.9 83.9 73.7 70.6 246.5 57.2 58.6 18.3 55.0 82.6 57.6 103.7 74.3 95.2 31.5 54.1 106.7 37.5 99.3 102.8 32.0 31.3 30.6 38.0 44.1 61.6 69.0 37.2 41.2 216.2 22.4 24.5 65.7 19.4 45.2 48.0 27.9 36.8 62.0 31.5 35.3 263.2 31.2 48.8 54.9 34.7 22.6 76.7 57.5 49.8 142.4 45.2 53.4 43.3 120.6 100.8 18.7 15.1 86.9 71.4 13.9 26.9 18.5 88.3 37.4 13.1 58.7 40.3 42.9 14.6 66.2 52.7 88.7 74.8 56.1 28.2 12.7 SMG7 "C1orf16, EST1C, KIAA0250, SGA56M, SMG-7" ENSG00000116698 "SMG7 nonsense mediated mRNA decay factor" Q92540 1 183472216-183598246 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029350 Supported Supported "Intermediate filaments,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Intermediate filaments, Cytosol" "HPA029350: AB_10603031" "unprognostic (6.06e-2)" "unprognostic (1.79e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-3)" "unprognostic (1.98e-2)" "unprognostic (1.36e-1)" "unprognostic (5.44e-2)" "unprognostic (6.15e-2)" "unprognostic (1.46e-1)" "unprognostic (9.01e-2)" "unprognostic (6.17e-2)" "unprognostic (2.69e-1)" "unprognostic (6.47e-3)" "unprognostic (7.82e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (4.40e-3)" 17.4 16.2 19.2 21.9 20.8 43.1 17.0 28.1 24.4 19.6 21.4 20.0 20.5 19.6 15.4 22.9 25.9 15.3 22.0 20.4 18.1 21.8 22.7 18.7 25.8 16.5 17.8 25.9 21.8 24.8 20.4 18.9 16.0 17.0 23.8 32.0 21.6 16.1 25.8 25.3 20.5 17.9 16.0 21.5 22.4 67.5 19.5 35.7 23.5 27.9 30.2 18.1 19.3 20.0 56.4 33.6 47.5 37.3 31.8 29.8 78.9 33.8 61.8 36.9 28.0 50.1 42.8 78.9 37.9 42.1 33.5 59.4 64.5 50.1 43.4 35.2 28.1 63.8 36.3 41.0 32.1 84.4 39.1 27.3 45.0 50.6 116.1 30.0 41.0 42.9 80.6 54.0 38.8 56.9 59.7 37.1 82.4 66.9 19.1 37.2 53.0 61.9 28.3 51.7 63.7 49.7 52.2 73.1 40.5 80.4 72.9 34.0 39.3 41.5 42.9 41.7 48.5 58.6 74.3 63.5 33.8 46.9 45.3 2.0 5.8 6.2 5.6 5.7 5.1 5.5 5.0 5.5 6.6 4.7 5.5 5.9 6.8 5.9 3.2 7.0 4.9 5.1 19.2 20.8 28.1 24.4 20.4 18.1 16.5 17.8 16.0 16.0 19.5 20.0 31.3 22.4 20.6 66.3 26.8 27.0 11.6 13.9 23.3 22.6 21.4 15.6 31.8 20.0 20.5 27.6 31.3 11.4 23.9 38.5 9.8 12.1 58.1 39.8 23.6 26.8 34.6 28.8 63.0 15.8 16.5 14.9 31.1 48.0 22.1 19.4 25.4 45.2 13.2 30.3 63.0 23.0 6.1 38.6 48.6 49.5 15.2 25.2 10.6 52.5 20.0 9.6 15.5 70.9 99.1 17.6 19.9 12.4 36.2 16.7 30.4 12.9 30.5 19.0 39.5 14.5 23.8 35.2 23.8 30.8 26.9 10.8 24.2 13.0 18.8 23.2 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292615 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 1371.3;Syncytiotrophoblasts: 1413.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 852.5;CAPAN-2: 1219.1;OE19: 1500.4;RPTEC TERT1: 896.7;SK-BR-3: 789.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" No NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favorable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 10.5 44.6 56.9 65.3 57.3 81.1 178.5 47.2 66.3 145.6 80.0 297.0 247.4 44.6 269.6 351.9 189.7 105.1 13.6 58.9 92.9 216.1 14.3 138.3 37.4 52.0 54.8 83.3 234.2 252.9 435.9 156.4 56.2 181.8 251.7 23.6 503.9 111.3 1.8 257.0 267.0 19.0 47.6 50.2 219.4 215.7 70.3 82.6 321.3 0.9 101.3 140.1 157.6 51.0 852.5 603.0 3.0 3.4 0.4 0.0 387.4 16.2 1.7 1.2 2.6 426.8 1219.1 6.7 65.8 4.6 1.2 274.6 42.7 587.0 1.4 7.9 51.7 159.4 15.3 0.9 0.9 1.5 0.8 0.1 662.5 0.7 278.6 71.5 2.0 144.2 4.0 0.4 1.0 652.8 25.6 2.8 60.4 1500.4 172.1 87.9 0.6 386.2 896.7 707.4 222.2 3.4 246.5 789.2 2.1 231.0 353.7 104.5 0.7 1.2 4.7 3.4 3.2 56.1 76.4 47.6 1.0 11.2 1.0 515.9 127.4 531.9 3.8 91.1 7.9 143.2 44.2 21.5 297.7 160.4 86.1 80.4 56.4 19.0 64.4 523.5 19.1 142.8 56.9 57.3 47.2 66.3 58.9 92.9 52.0 54.8 56.2 47.6 70.3 51.0 8.0 368.6 233.9 10.4 90.9 376.9 563.9 954.0 278.9 14.3 487.2 518.2 2.8 316.0 655.6 559.1 6.2 1371.3 79.5 1028.3 101.8 866.9 61.8 401.4 47.3 24.3 360.5 83.9 20.7 659.8 502.0 34.6 234.5 490.4 115.5 371.8 32.5 2.0 230.3 3.3 39.8 672.8 734.5 55.5 139.0 55.6 19.0 133.6 88.9 24.4 364.3 129.6 1.0 4.5 9.0 910.4 889.4 17.0 61.3 684.9 918.6 208.8 495.1 17.2 52.6 1.2 76.7 545.2 264.1 507.7 428.3 1413.2 42.6 3.4 582.2 989.6 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 21.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 54.9;Gastric mucus-secreting cells: 46.9;Intestinal goblet cells: 43.8;Paneth cells: 39.9;Syncytiotrophoblasts: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "OE19: 29.5;T-47d: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: AB_2677464, HPA049415: AB_2680755" "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.6 2.1 8.8 1.2 9.0 1.2 1.9 12.5 12.3 2.5 3.8 15.7 7.8 1.7 1.8 2.9 6.1 2.0 0.9 9.1 7.6 4.5 6.5 2.3 0.5 9.8 7.9 1.8 2.2 3.6 21.5 4.5 10.4 4.7 8.2 3.1 2.5 3.1 0.6 2.0 9.2 1.0 5.5 1.0 14.4 5.0 7.5 0.4 6.9 0.0 0.4 6.1 2.2 8.5 0.4 8.4 5.2 4.2 1.4 0.9 17.5 2.7 1.6 3.9 1.6 3.2 9.0 5.8 1.2 0.8 4.0 9.0 2.2 0.3 1.1 2.2 10.1 1.3 7.1 8.9 1.4 0.3 1.8 1.8 2.0 1.2 1.0 0.5 0.2 0.5 9.2 1.4 1.1 12.8 0.1 2.2 5.7 29.5 5.3 4.6 1.9 1.3 2.0 8.6 13.6 7.0 11.6 5.0 5.1 4.4 18.8 3.0 0.4 2.3 4.9 3.3 2.5 0.7 3.7 0.5 3.5 2.1 4.9 2.4 0.5 0.3 0.4 0.3 0.2 0.4 0.3 0.2 0.1 0.7 0.4 0.4 2.0 0.5 0.5 0.6 0.2 0.3 8.8 9.0 12.5 12.3 9.1 7.6 9.8 7.9 10.4 5.5 7.5 8.5 0.7 6.4 4.8 10.7 0.6 0.9 5.1 1.7 2.2 13.0 4.3 2.8 2.4 14.3 2.4 12.9 4.2 15.7 2.1 54.9 3.9 1.5 3.1 11.9 2.6 1.1 15.7 0.0 20.2 0.4 3.6 1.4 46.9 3.2 0.0 4.2 0.0 2.4 2.7 23.5 23.6 43.8 2.0 1.0 1.1 2.5 0.9 1.4 0.0 1.9 0.2 2.8 1.0 7.1 4.1 1.5 39.9 1.9 0.7 5.0 29.8 0.8 13.5 10.7 0.0 2.8 1.6 6.0 8.8 3.8 0.6 70.5 1.3 5.7 33.5 30.2 SRMS "C20orf148, dJ697K14.1, PTK70, SRM" ENSG00000125508 "Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites" Q9H3Y6 20 63540810-63547504 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "stomach 1: 1.6" "Cell type enriched" "Detected in single" 4 "Gastric mucus-secreting cells: 3.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.3;MCF7: 3.0;OE19: 4.4;RT4: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB044668, CAB044669, HPA073987" Uncertain Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" "Intermediate filaments" "Actin filaments, Cytosol" "CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650" "unprognostic (2.26e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.62e-1)" "unprognostic (5.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.28e-1)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (7.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.73e-3)" "unprognostic (2.58e-3)" "unprognostic (4.75e-2)" "unprognostic (4.97e-2)" "unprognostic (2.54e-3)" 0.0 0.0 0.1 0.2 0.1 0.1 0.4 0.6 0.2 0.0 0.0 0.7 0.2 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.8 0.0 0.0 0.4 0.2 0.0 0.1 0.9 1.6 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 1.3 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.1 0.0 4.4 0.4 0.0 0.1 0.0 0.0 6.0 0.4 0.5 0.1 1.2 0.2 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201896-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 56.0;retina: 27.2" "Group enriched" "Detected in many" 7 "Bipolar cells: 153.1;Cone photoreceptor cells: 479.6;Excitatory neurons: 139.1;Horizontal cells: 171.6;Inhibitory neurons: 144.4;Rod photoreceptor cells: 421.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SCLC-21H: 10.9;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.0 2.1 6.0 0.1 13.2 0.0 0.0 56.0 30.7 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.0 0.0 0.1 4.8 0.2 0.0 0.0 0.0 0.0 41.5 3.2 0.2 0.3 0.3 8.9 0.0 40.1 0.1 0.1 27.2 0.1 0.0 0.1 0.0 0.1 0.0 1.6 0.0 0.4 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.3 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 8.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 13.2 56.0 30.7 4.8 0.2 41.5 3.2 40.1 1.6 0.9 4.7 0.3 0.0 0.0 8.1 0.0 2.0 6.4 1.9 7.4 153.1 1.8 0.5 6.9 1.5 1.2 0.0 479.6 0.4 0.0 0.2 0.0 2.0 22.2 0.5 4.2 1.2 12.1 0.0 139.1 2.4 8.1 4.8 0.5 1.0 0.0 12.0 1.8 0.0 0.5 171.6 144.4 0.1 2.0 0.0 0.8 32.2 2.1 0.2 3.6 5.6 0.0 15.9 0.0 18.6 4.9 0.9 0.1 2.2 0.0 2.2 0.0 0.4 0.2 421.8 0.0 1.2 2.0 8.6 3.1 4.9 1.1 2.2 0.1 0.2 0.0 4.9 STK3 "KRS1, MST2" ENSG00000104375 "Serine/threonine kinase 3" Q13188 8 98371228-98942827 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 152.7;Oligodendrocytes: 189.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 7.9;granulocytes: 8.8;monocytes: 8.5" "Cell line enhanced" "Detected in many" "A-431: 85.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007120, CAB025316" Uncertain Approved "Intermediate filaments,Rods & Rings" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 64: Astrocytes - Nervous system maintenance" "Intermediate filaments, Rods & Rings" "CAB025316: , HPA007120: AB_10601664" "unprognostic (7.88e-3)" "unprognostic (1.96e-1)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.53e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-3)" "unprognostic (9.68e-3)" "prognostic unfavorable (4.25e-4)" "unprognostic (6.71e-2)" "unprognostic (9.83e-2)" "prognostic unfavorable (9.21e-5)" "unprognostic (9.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (9.72e-2)" 15.1 14.4 5.6 7.9 7.0 3.5 14.1 6.6 7.4 17.4 7.2 13.1 5.5 24.9 14.3 10.2 17.0 14.2 9.1 5.1 6.3 15.6 14.3 11.1 5.5 7.7 6.7 25.0 10.0 16.1 6.4 18.5 7.4 16.5 6.7 12.0 10.7 17.6 11.4 9.6 8.3 17.2 6.3 6.8 8.5 11.4 7.1 5.1 11.9 8.6 5.5 13.6 13.7 7.9 85.3 15.7 16.2 22.0 51.2 25.4 16.4 28.8 25.6 26.3 22.8 11.7 35.7 0.0 25.6 28.7 14.1 33.4 11.4 24.8 42.2 20.5 14.8 22.9 7.2 8.0 17.5 7.7 19.0 17.0 41.9 13.5 36.6 17.2 11.5 13.4 9.8 12.2 19.4 10.7 19.3 9.4 4.9 58.0 6.1 17.1 14.1 7.5 29.9 10.7 4.3 9.6 18.4 21.1 18.2 21.0 17.8 12.3 8.7 17.9 11.5 27.1 16.3 9.8 15.5 6.2 15.9 9.5 29.0 2.0 8.3 4.6 1.3 8.5 1.4 1.8 0.7 1.8 7.9 1.1 1.0 0.6 8.8 2.0 5.4 3.3 0.1 2.8 5.6 7.0 6.6 7.4 5.1 6.3 7.7 6.7 7.4 6.3 7.1 7.9 25.9 38.5 37.4 132.9 6.0 43.7 44.8 25.3 23.3 6.9 29.0 15.5 16.6 31.5 37.7 29.5 14.6 43.6 2.5 11.7 23.5 21.5 118.3 23.7 65.8 31.3 9.1 16.2 34.3 18.9 56.1 39.8 9.7 28.9 17.1 13.3 24.3 23.7 19.2 10.1 33.5 7.8 26.4 17.0 25.1 77.1 91.0 18.6 24.9 152.7 13.8 15.0 3.1 60.3 189.9 24.9 13.1 74.1 6.2 42.1 32.3 25.0 29.0 15.6 39.5 43.8 39.7 16.7 12.6 12.3 40.5 64.7 5.9 47.0 13.8 36.0 STX19 MGC21382 ENSG00000178750 "Syntaxin 19" Q8N4C7 3 94014365-94028597 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.3;intestine: 13.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 39.4;Glandular and luminal cells: 19.7;Intestinal goblet cells: 31.7;Paneth cells: 38.0;Proximal enterocytes: 19.2" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HaCaT: 1.3;hTCEpi: 4.0" "Not detected" "Not detected" HPA030604 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Intermediate filaments" Cytosol "HPA030604: AB_10601268" "unprognostic (7.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-1)" "unprognostic (5.17e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (9.04e-2)" "unprognostic (1.29e-2)" "unprognostic (4.32e-2)" "unprognostic (7.00e-3)" "unprognostic (1.19e-2)" "unprognostic (1.96e-1)" "unprognostic (2.12e-1)" "unprognostic (4.87e-3)" 0.1 0.0 0.3 1.7 0.5 0.0 5.4 0.4 0.6 2.8 3.7 13.0 7.6 0.8 16.3 6.0 1.4 1.8 0.1 0.3 0.2 0.4 0.1 4.0 0.0 0.3 0.6 0.1 6.7 4.6 0.1 0.1 0.2 3.9 13.4 1.2 8.8 0.1 0.1 9.1 8.1 0.3 0.1 0.4 7.3 0.2 0.2 0.2 0.1 0.0 1.2 0.2 2.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 4.0 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.6 0.3 0.2 0.3 0.6 0.2 0.1 0.2 0.3 0.4 16.0 15.9 1.0 0.2 1.7 2.2 6.4 2.8 3.0 5.6 3.7 0.1 0.0 9.9 0.0 12.5 0.2 0.1 39.4 1.9 4.4 1.9 15.9 2.1 0.2 0.0 0.0 3.9 8.2 0.0 0.1 10.2 19.7 0.0 0.1 0.0 0.0 0.2 0.0 2.4 31.7 10.2 0.0 0.0 0.6 0.0 0.1 0.0 1.0 0.0 0.5 0.0 1.0 1.6 7.1 38.0 0.7 0.0 1.5 19.2 0.1 16.1 14.8 0.0 1.0 0.5 0.2 0.1 2.7 1.8 0.3 0.3 0.0 15.7 1.6 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715144 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favorable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 25.3 19.3 12.0 32.9 12.4 67.2 22.2 26.7 11.6 16.2 13.1 20.9 25.4 13.0 43.1 31.8 21.0 27.5 15.6 13.5 12.8 22.2 12.2 37.1 30.4 24.5 14.5 13.5 22.1 16.6 14.4 17.0 15.3 17.8 19.0 15.6 29.7 16.7 12.3 27.3 32.8 19.7 18.2 33.6 20.9 10.7 14.2 21.7 22.4 11.5 36.2 21.7 18.1 15.5 19.4 4.9 7.0 6.4 14.0 10.2 12.8 10.7 22.6 6.0 5.8 5.9 16.7 22.6 11.8 13.5 4.8 26.4 4.0 22.1 5.6 38.9 3.0 18.4 4.1 9.8 22.6 3.0 45.6 16.6 21.5 10.1 18.7 6.5 12.4 6.9 5.7 19.6 8.4 9.5 4.5 8.1 1.4 11.3 5.0 7.7 6.2 9.1 11.5 9.8 3.0 4.7 8.8 25.4 4.0 5.1 10.4 8.3 19.4 13.8 8.1 8.8 4.4 13.5 3.2 15.7 8.9 10.3 7.4 16.3 11.6 12.3 5.5 10.2 5.5 5.3 4.8 3.4 7.6 5.0 4.6 3.4 33.0 4.1 13.7 4.3 4.6 8.8 12.0 12.4 26.7 11.6 13.5 12.8 24.5 14.5 15.3 18.2 14.2 15.5 45.6 12.8 30.0 22.2 24.6 0.0 36.0 0.0 23.3 16.7 44.2 21.5 14.0 21.5 11.2 18.4 20.9 4.3 32.9 44.3 7.9 26.7 1.0 34.7 13.3 32.8 7.3 13.9 34.6 24.6 1.7 13.1 18.8 28.4 8.8 9.7 17.9 15.9 23.5 15.2 21.1 21.9 0.0 67.4 0.0 5.1 5.3 44.3 0.0 107.7 31.6 4.3 16.5 22.1 28.4 38.7 20.4 6.8 15.1 43.0 74.1 15.2 10.9 23.7 26.3 18.3 19.0 8.4 15.4 19.7 0.0 9.2 21.2 7.6 8.5 54.6 SYCE1L MRP2 ENSG00000205078 "Synaptonemal complex central element protein 1 like" A8MT33 16 77199408-77213215 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 89.5;Breast myoepithelial cells: 125.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 11.1;U-698: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA062464, HPA066691" Enhanced "Intermediate filaments" No No "Cluster 35: T-regs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 35: Glandular cells - Unknown function" "Intermediate filaments" "HPA062464: , HPA066691: AB_2685702" "unprognostic (5.54e-3)" "unprognostic (2.15e-1)" "unprognostic (1.65e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (2.00e-3)" "unprognostic (6.28e-3)" "unprognostic (1.02e-1)" "unprognostic (7.48e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (9.27e-2)" "unprognostic (4.27e-1)" "unprognostic (2.68e-2)" "unprognostic (1.73e-2)" 2.7 1.5 1.7 0.4 1.3 1.2 3.6 7.9 2.3 5.5 1.6 1.7 0.8 3.0 1.5 1.5 3.2 0.4 1.4 1.2 3.0 3.2 1.4 1.4 1.0 2.0 2.7 5.2 2.0 0.7 2.1 0.5 1.7 7.0 0.5 2.8 5.1 0.6 0.8 2.9 2.1 0.5 2.0 2.0 1.1 23.5 1.6 0.4 3.4 0.0 0.6 2.4 4.1 1.1 2.4 0.9 2.3 0.9 0.2 0.0 0.3 0.6 0.2 0.3 0.6 0.4 4.6 1.3 2.6 0.4 0.1 3.4 0.2 0.0 0.2 1.4 11.1 0.3 0.8 0.0 1.5 0.8 0.8 0.0 0.3 0.1 0.2 0.3 1.6 2.0 0.6 0.1 0.2 3.6 0.5 0.9 1.4 0.3 3.8 5.7 0.6 0.4 2.3 0.5 2.3 2.2 0.3 0.2 0.0 0.1 0.0 0.8 5.1 0.3 5.1 0.6 0.1 4.1 1.9 8.0 1.9 0.4 0.1 4.5 1.3 13.9 6.8 2.6 7.8 4.0 8.2 9.0 1.8 2.6 8.9 8.4 1.4 3.6 2.1 13.8 12.6 3.4 1.7 1.3 7.9 2.3 1.2 3.0 2.0 2.7 1.7 2.0 1.6 1.1 19.5 3.2 3.7 6.5 7.6 17.3 10.9 15.2 15.9 3.7 89.5 125.7 1.7 32.9 7.4 27.6 10.4 6.8 8.9 22.4 15.6 24.8 24.7 7.1 4.5 15.9 22.4 1.3 5.9 27.9 4.0 13.8 2.6 15.2 1.3 5.0 18.2 13.2 2.3 1.7 9.2 52.0 12.2 15.8 9.7 55.5 13.7 3.6 19.6 5.6 2.9 35.1 3.1 7.5 10.6 13.9 27.2 6.8 6.9 16.7 22.3 31.9 2.6 44.5 6.6 19.9 5.4 30.4 9.9 6.7 17.0 2.9 9.4 0.5 52.5 7.1 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63761899-64226433 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 198.5" "Cell type enhanced" "Detected in all" "Granulosa cells: 454.6;Rod photoreceptor cells: 568.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 73.8" "Group enriched" "Detected in many" 11 "granulocytes: 73.8;T-cells: 38.5" "Cell line enhanced" "Detected in many" "Daudi: 48.8;SiHa: 29.8;U-698: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Approved "Nuclear membrane,Intermediate filaments" No Yes "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favorable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.1 6.0 8.8 3.4 9.2 7.9 28.0 21.1 8.7 15.4 89.5 13.3 4.5 18.1 9.9 24.3 14.3 5.5 58.3 9.6 7.6 29.0 19.5 18.4 8.5 7.7 9.6 35.9 37.7 66.6 16.7 9.9 7.5 11.5 4.4 24.8 16.1 3.7 198.5 39.7 11.4 4.6 7.0 10.0 12.4 13.1 11.4 5.5 24.4 96.7 6.1 13.6 19.0 6.9 23.2 8.7 11.0 3.5 11.3 3.2 12.3 1.3 1.6 2.7 4.2 2.8 3.3 48.8 2.3 1.7 2.6 11.0 6.2 3.5 3.2 8.9 3.5 0.4 7.9 0.7 3.0 1.0 0.3 4.4 15.1 3.4 2.2 2.6 7.0 7.5 0.4 4.8 1.8 11.2 6.2 0.3 3.4 5.4 3.3 6.9 14.5 1.8 20.0 13.6 9.9 8.2 29.8 3.8 7.0 5.5 5.0 0.3 7.3 4.2 7.5 1.5 4.5 4.9 3.5 27.5 1.8 0.0 5.7 0.5 0.1 73.8 38.5 0.3 27.6 5.2 24.3 28.0 0.0 5.3 11.8 18.5 30.1 3.9 0.3 1.2 30.1 3.4 8.8 9.2 21.1 8.7 9.6 7.6 7.7 9.6 7.5 7.0 11.4 6.9 414.4 307.7 140.1 8.5 44.9 111.3 138.9 46.4 174.2 27.4 70.3 59.1 261.4 105.8 184.5 202.3 183.5 168.8 226.8 51.0 19.6 108.2 9.4 249.9 71.2 238.8 46.2 10.5 9.5 55.4 65.7 59.6 126.9 365.2 25.9 454.6 73.5 33.3 17.7 6.7 13.9 60.9 59.0 5.7 13.2 14.3 100.9 12.8 48.0 128.4 8.9 107.2 300.7 33.2 6.6 71.7 27.9 53.4 180.3 65.0 35.9 72.2 196.1 568.7 111.7 73.5 167.0 13.0 17.0 104.6 87.5 224.0 222.1 69.5 80.6 80.6 SYNM "DMN, KIAA0353, SYN" ENSG00000182253 Synemin O15061 15 99098217-99135593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 594.1;skeletal muscle: 624.7;urinary bladder: 406.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 103.5;Cardiomyocytes: 502.5;Muller glia cells: 127.8;Smooth muscle cells: 98.5" "Cancer enhanced" "Detected in all" "prostate cancer: 28.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 36.8;HeLa: 58.0;WM-115: 124.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017192, HPA040066, HPA044200, HPA077856" Enhanced Supported "Intermediate filaments" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 17: WM-115 - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (3.52e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.34e-2)" "unprognostic (6.75e-2)" "unprognostic (3.54e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-2)" "unprognostic (5.92e-3)" "unprognostic (3.26e-3)" 37.2 20.3 51.4 26.5 66.0 0.4 56.7 70.1 58.2 11.8 52.5 594.1 27.1 50.8 12.7 169.6 36.5 19.2 144.2 44.4 75.4 6.9 4.8 23.1 4.2 81.7 66.6 14.1 6.3 8.2 23.2 14.0 81.6 150.6 52.0 40.3 25.6 291.3 624.7 17.0 105.7 160.9 71.6 2.9 158.4 5.2 69.3 3.7 11.2 277.1 4.0 406.3 41.0 79.8 6.6 36.8 8.1 21.9 15.9 0.9 0.5 3.7 5.3 2.1 1.3 5.4 4.9 0.0 5.3 5.3 17.7 4.2 5.5 0.1 1.6 0.5 9.0 0.1 58.0 5.4 9.0 0.0 1.0 0.9 0.3 3.7 0.8 6.0 4.3 0.0 0.2 7.4 5.5 3.7 0.7 0.8 7.2 0.7 11.4 0.0 7.5 5.5 2.1 3.6 3.6 4.2 21.9 3.4 13.5 12.7 0.2 3.6 4.8 4.1 0.4 2.9 8.9 0.1 1.0 0.0 0.4 0.0 124.5 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 51.4 66.0 70.1 58.2 44.4 75.4 81.7 66.6 81.6 71.6 69.3 79.8 14.8 0.0 1.7 15.3 0.9 2.3 0.7 0.9 2.8 12.6 32.7 103.5 502.5 0.0 1.2 0.0 16.7 1.5 6.6 2.1 0.0 0.5 9.5 1.3 1.0 24.2 3.0 0.0 15.6 1.3 0.7 20.3 5.1 4.2 0.0 1.1 3.6 1.3 0.3 42.1 9.8 0.9 0.0 0.0 5.1 4.5 1.2 2.0 5.4 12.2 0.6 127.8 1.0 2.5 14.0 0.2 2.3 4.1 5.4 2.0 0.6 0.3 3.1 10.2 32.9 19.6 98.5 7.9 11.5 2.1 3.7 0.4 5.9 0.2 0.7 0.9 TBC1D16 "FLJ20748, MGC25062" ENSG00000167291 "TBC1 domain family member 16" Q8TBP0 17 79932343-80035872 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 307.9" "Cancer enhanced" "Detected in all" "melanoma: 35.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 2.3" "Lineage enhanced" "Detected in single" "monocytes: 2.3" "Cell line enhanced" "Detected in many" "ASC diff: 179.1;SK-MEL-30: 192.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024482, HPA065839" Approved Approved "Intermediate filaments" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 62: Horizontal cells - Visual perception" "Intermediate filaments" "HPA024482: AB_1857790, HPA065839: AB_2685566" "unprognostic (4.53e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" "unprognostic (4.92e-2)" "unprognostic (7.21e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (5.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.52e-3)" "unprognostic (3.02e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-3)" "unprognostic (3.99e-3)" 37.3 8.1 17.6 8.7 24.8 0.9 18.4 24.4 14.6 10.4 5.3 8.0 7.9 12.4 11.5 10.1 12.9 9.5 10.7 10.6 15.2 27.7 7.4 9.0 7.8 18.0 22.7 11.7 15.7 12.9 7.0 7.5 16.0 17.7 5.9 7.6 29.4 10.8 5.1 17.3 9.0 10.5 13.0 7.3 8.4 4.1 38.9 4.0 10.1 6.7 3.5 8.6 6.2 17.4 30.3 28.2 43.1 50.8 179.1 93.7 8.2 17.3 17.1 10.7 12.0 53.6 10.3 0.1 11.9 29.2 20.3 9.4 45.8 16.2 8.2 1.5 21.5 0.0 13.3 25.1 30.5 0.6 4.1 106.1 28.1 23.2 16.7 17.1 45.9 19.8 7.2 19.6 20.2 18.4 8.1 2.7 51.8 39.3 15.4 25.4 27.2 17.5 12.6 36.5 43.8 56.8 15.4 42.5 192.4 26.7 27.9 13.6 31.3 37.1 26.1 29.5 15.3 59.9 11.4 3.3 15.9 11.2 47.8 0.0 0.1 0.0 0.0 1.9 0.2 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.2 17.6 24.8 24.4 14.6 10.6 15.2 18.0 22.7 16.0 13.0 38.9 17.4 5.7 0.0 7.9 15.7 1.7 5.5 5.2 4.3 2.8 8.5 12.3 7.5 8.1 17.2 5.5 7.3 10.4 6.1 0.3 3.1 9.8 15.1 0.9 15.3 22.7 10.4 31.8 3.6 7.3 22.1 1.5 17.5 9.7 26.0 7.6 23.8 14.6 17.9 3.2 307.9 8.9 6.3 14.2 58.4 3.1 2.2 5.9 6.4 76.5 37.5 0.9 23.1 2.1 14.6 4.9 17.4 4.8 7.9 0.4 12.5 3.5 13.5 8.2 7.0 6.6 19.3 10.3 0.3 4.3 5.8 4.5 1.9 2.7 7.6 7.0 5.9 TEKT4 MGC27019 ENSG00000163060 "Tektin 4" Q8WW24 2 94871430-94876823 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.4" "Group enriched" "Detected in many" 7 "Early spermatids: 137.1;Endometrial ciliated cells: 49.0;Late spermatids: 129.3;Respiratory ciliated cells: 51.6" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 2.7" "Region enhanced" "Detected in single" "midbrain: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "midbrain: 2.9" "HPA048600, HPA053929, HPA069872" Enhanced Uncertain "Intermediate filaments" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "Intermediate filaments" "HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: " "unprognostic (1.49e-2)" "unprognostic (4.00e-1)" "prognostic favorable (1.29e-4)" "unprognostic (9.95e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (2.82e-3)" "unprognostic (2.15e-1)" "unprognostic (5.25e-2)" "unprognostic (5.00e-2)" "unprognostic (9.01e-2)" "unprognostic (5.25e-3)" "unprognostic (5.45e-3)" "unprognostic (2.33e-1)" "unprognostic (3.27e-2)" "unprognostic (7.56e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.7 1.6 0.5 0.3 0.1 0.2 3.6 0.0 1.5 2.9 0.4 1.5 0.1 1.9 0.0 0.0 0.7 0.6 0.5 7.2 4.7 1.8 0.0 0.5 0.1 0.3 1.9 1.9 137.1 49.0 1.3 1.3 0.0 0.0 1.3 0.4 0.5 1.1 0.0 0.9 1.3 0.1 1.8 1.5 0.2 0.0 0.9 0.2 0.0 1.6 0.5 129.3 2.8 0.8 0.0 1.0 2.6 0.0 0.0 2.0 2.3 0.8 0.0 1.2 0.0 0.4 0.0 8.3 51.6 0.0 6.6 0.6 0.9 12.4 2.4 0.0 1.3 0.5 0.5 0.0 0.2 0.4 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995948 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 44: Endometrium - Transcription" "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 12.1 12.2 7.2 20.7 7.5 17.5 10.6 7.2 7.6 18.8 9.3 25.8 18.5 16.3 8.5 14.3 15.3 15.8 13.0 7.4 5.5 12.1 13.5 12.4 25.4 6.1 7.5 16.3 19.0 27.5 11.1 18.3 6.1 16.6 23.2 11.4 13.4 11.5 24.4 24.1 19.4 16.5 6.6 18.4 26.2 14.7 10.3 18.4 12.8 22.3 23.1 14.1 10.4 8.6 26.1 15.7 28.8 21.0 29.6 35.8 31.4 37.8 36.5 18.9 22.7 20.3 36.8 41.3 20.4 39.3 32.2 18.4 30.5 50.5 28.0 29.4 19.8 30.0 10.6 29.3 33.4 28.2 38.6 34.4 20.2 33.7 34.7 32.0 23.5 19.8 18.1 42.8 58.2 15.7 20.6 17.9 15.8 20.2 33.4 29.7 18.3 18.3 19.3 30.7 32.3 15.7 24.4 16.7 23.2 30.7 14.0 25.8 28.1 49.1 22.4 23.9 14.7 18.1 26.8 20.6 38.5 24.3 33.9 3.7 1.3 3.6 1.7 1.6 1.9 2.1 1.5 1.7 1.7 1.9 1.7 2.3 0.9 2.5 1.6 2.4 1.0 1.0 7.2 7.5 7.2 7.6 7.4 5.5 6.1 7.5 6.1 6.6 10.3 8.6 29.4 16.0 27.9 90.1 41.2 19.8 17.7 16.3 24.5 28.3 17.3 16.0 34.7 15.7 23.4 20.2 22.9 15.4 33.1 62.2 3.9 9.7 14.4 88.9 33.9 19.3 30.1 23.5 113.1 24.0 12.7 23.5 60.1 86.8 23.5 21.3 22.9 26.0 24.5 25.2 99.7 45.6 10.2 29.2 18.5 20.1 20.8 35.8 12.4 87.1 47.0 14.1 9.2 92.5 129.8 18.1 40.1 19.2 36.3 17.9 27.4 7.0 38.2 19.3 13.1 31.9 24.9 21.2 26.0 25.0 25.6 13.5 22.4 28.0 36.6 16.0 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA052515 Approved "Intermediate filaments" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Intermediate filaments" "HPA052515: AB_2681858" "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.67e-4)" 2.3 3.7 8.8 1.1 9.1 1.5 1.8 11.5 12.4 4.0 8.1 2.7 0.9 2.4 2.0 2.8 2.7 0.8 4.1 9.1 8.8 4.4 6.0 2.9 1.7 8.7 8.7 4.0 2.5 1.5 3.9 1.3 8.7 3.7 1.1 4.3 2.1 1.3 6.6 3.7 2.6 1.1 8.5 5.4 2.6 5.8 9.4 3.2 2.8 2.4 1.7 2.7 3.3 9.6 1.8 2.8 4.6 6.0 6.6 2.6 2.3 3.4 2.0 1.7 1.0 5.0 1.2 3.4 2.4 1.9 2.5 1.6 7.5 2.8 3.0 3.0 2.9 2.9 3.8 2.5 4.5 1.5 1.5 2.6 5.1 2.7 1.3 4.5 3.4 4.0 6.5 1.4 2.2 3.6 3.4 6.3 3.5 2.3 4.0 2.3 5.3 3.6 4.0 1.8 2.9 4.5 2.1 2.5 5.6 7.1 1.9 6.2 1.6 3.2 1.6 4.1 3.7 3.2 4.2 2.7 4.5 2.2 5.5 1.7 0.4 0.0 1.8 0.6 0.0 0.6 0.8 0.4 0.6 0.5 0.8 1.4 1.0 0.0 0.6 0.6 1.1 0.4 8.8 9.1 11.5 12.4 9.1 8.8 8.7 8.7 8.7 8.5 9.4 9.6 0.5 0.0 0.0 2.0 0.7 2.3 0.5 0.6 0.0 0.8 1.6 1.4 2.0 1.5 0.4 3.7 0.0 0.2 1.6 0.8 0.0 0.7 15.6 1.1 0.6 0.9 0.0 0.0 2.0 0.6 0.5 0.6 0.0 1.3 0.0 2.3 0.4 1.0 0.6 1.7 1.5 0.5 2.0 0.3 2.1 3.1 0.0 0.9 1.8 1.0 0.4 1.4 3.1 1.0 1.3 0.8 0.1 0.4 1.3 1.2 0.4 1.3 0.5 1.1 0.0 1.0 0.6 0.9 1.1 0.5 2.6 0.1 0.9 0.4 0.6 1.0 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838981-1841680 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 25 "skeletal muscle: 7969.8;tongue: 2622.3" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 449.4;Skeletal myocytes: 598.7" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 86.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 35.7;hTCEpi: 101.2" "Region enriched" "Detected in single" 6 "olfactory bulb: 5.1" "Not detected" "Not detected" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" NA NA 110000 "Cluster 52: Eosinophils - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: AB_2682976" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 3.0 1.8 0.3 1.1 0.3 6.1 7.9 0.3 0.6 1.0 0.4 1.2 0.3 0.8 0.3 66.9 0.9 5.6 1.7 0.3 0.4 0.7 1.6 7.8 1.6 0.4 0.4 0.7 8.8 0.0 0.9 3.0 0.4 14.0 0.2 0.0 216.1 3.2 7969.8 55.2 2.7 0.2 0.4 5.8 1.1 0.7 0.5 1.9 2.8 2622.3 1.0 27.4 3.2 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 35.7 1.0 0.2 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 8.1 101.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 3.1 0.0 0.1 1.2 2.4 0.0 1.0 0.0 1.0 0.0 0.7 0.0 0.0 12.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 13.8 5.8 53.3 0.1 12.5 0.1 3.8 0.0 0.0 8.0 4.8 0.0 0.0 39.7 0.4 17.6 86.4 0.0 2.5 0.3 0.3 0.3 0.6 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.6 1.2 3.2 4.4 0.0 9.1 25.1 2.6 1.8 15.4 0.0 0.5 23.7 5.6 21.5 3.0 0.0 0.0 33.8 15.7 0.1 0.0 1.4 0.0 1.4 0.2 2.0 0.0 0.0 0.0 0.6 449.4 2.4 1.1 0.1 10.8 0.4 0.4 0.3 39.6 0.0 0.0 0.0 2.0 18.8 10.7 0.0 0.3 25.9 0.0 0.0 16.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 4.2 0.1 0.0 0.2 13.2 0.0 0.0 598.7 2.4 0.0 0.6 2.7 6.5 87.2 1.9 4.3 0.0 0.9 TOM1L2 ENSG00000175662 "Target of myb1 like 2 membrane trafficking protein" Q6ZVM7 17 17843511-17972422 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 180.5;Cone photoreceptor cells: 158.4;Oligodendrocytes: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 104.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022541, HPA023304" Enhanced Approved "Golgi apparatus,Intermediate filaments" NA NA 73000 "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" "Intermediate filaments" "Golgi apparatus" "HPA022541: AB_1858182, HPA023304: AB_1858183" "unprognostic (2.32e-1)" "unprognostic (7.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.25e-2)" "prognostic favorable (1.24e-4)" "unprognostic (2.22e-1)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "prognostic unfavorable (2.58e-4)" "prognostic favorable (1.92e-4)" "unprognostic (3.19e-2)" "prognostic favorable (6.21e-9)" "unprognostic (7.11e-2)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (4.51e-2)" 20.7 30.5 64.0 9.5 62.7 6.1 20.3 52.7 70.0 31.9 21.3 44.2 14.0 33.2 11.0 64.4 26.6 13.0 141.0 66.0 56.4 31.3 13.9 23.2 7.7 91.5 80.3 32.9 19.7 40.3 42.2 9.0 95.3 37.3 13.8 50.2 21.3 28.7 67.1 59.7 20.9 23.3 49.7 16.6 34.9 39.4 74.6 8.8 48.5 55.4 12.9 31.4 35.1 72.7 27.1 29.0 8.2 6.2 19.1 19.3 14.2 43.3 20.1 22.9 19.3 28.2 17.6 5.0 52.9 40.8 13.3 104.3 6.8 24.1 14.0 7.2 12.7 8.0 28.0 6.0 12.2 2.0 5.2 22.9 16.6 20.5 15.2 19.6 23.3 7.3 3.0 6.9 30.3 27.1 3.6 4.6 1.5 34.4 19.5 4.7 20.7 12.0 32.4 48.1 8.7 8.4 19.5 25.2 15.3 55.9 13.4 3.6 31.8 21.9 6.5 46.0 16.8 6.1 5.1 2.3 26.4 2.7 55.2 10.0 3.3 4.8 2.8 1.0 2.0 1.6 2.6 2.4 1.6 2.2 4.3 3.2 12.8 1.4 3.3 1.9 1.3 1.7 64.0 62.7 52.7 70.0 66.0 56.4 91.5 80.3 95.3 49.7 74.6 72.7 10.1 32.1 17.0 180.5 9.5 10.8 14.6 13.9 7.4 74.5 20.9 14.1 73.7 15.7 16.6 11.0 158.4 8.5 10.2 43.3 5.9 12.2 30.8 14.1 9.4 12.4 20.4 4.8 63.2 8.7 17.4 12.7 13.3 15.7 2.5 28.1 16.4 13.4 9.2 95.9 74.2 19.2 18.3 8.5 7.6 64.2 26.4 6.4 12.4 35.6 11.8 28.1 10.3 66.9 123.2 16.1 41.0 25.6 8.4 39.1 22.4 11.1 22.9 78.3 19.7 18.0 13.0 16.7 12.1 37.2 17.2 32.2 10.0 30.8 15.4 64.5 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111286-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 600.1;skin 1: 551.2;vagina: 269.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "spinal cord: 4.0" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 2.5 1.0 0.1 0.4 0.2 0.4 41.7 0.0 0.4 133.8 1.6 3.0 1.7 2.6 4.8 600.1 17.4 3.5 0.4 0.3 0.0 1.7 1.8 3.7 0.0 1.8 0.6 0.4 1.0 0.0 8.1 30.7 1.8 31.4 2.6 0.3 131.5 23.7 2.2 551.2 1.0 1.5 2.6 0.3 1.4 2.7 0.0 19.9 0.4 0.2 107.2 55.8 269.1 0.6 34.4 2.5 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.2 0.1 0.8 25.6 0.2 3.9 0.2 0.5 399.9 0.0 107.5 0.0 0.1 0.0 0.2 25.4 0.4 0.0 0.2 0.5 0.0 476.0 0.0 2.6 0.0 0.0 0.0 0.2 0.7 0.0 4.4 0.0 0.0 0.1 11.4 0.1 0.0 0.3 0.0 0.3 190.5 1.3 5.9 268.3 35.2 0.1 0.2 1.9 0.0 0.4 0.1 2.1 0.2 0.1 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.3 0.0 1.8 0.6 1.8 2.6 0.0 0.6 0.5 0.0 1.5 3.3 0.2 272.0 106.1 76.4 250.4 0.0 9.5 58.8 1.2 1.5 39.2 0.0 0.0 41.0 0.2 11.3 0.0 5.0 28.1 8.7 0.8 3.4 2.4 0.0 0.5 4.3 7.1 5.6 1.1 3.6 1.3 0.0 0.0 0.4 5.0 0.0 0.1 2.1 12.2 0.0 30.3 150.3 0.6 1.4 23.2 1.0 0.0 0.0 0.0 0.0 0.1 57.1 11.3 0.0 0.0 66.0 0.2 0.6 64.6 0.0 0.0 0.1 4.9 0.8 2.6 552.9 460.6 24.8 2.4 0.1 3.7 159.3 TRIM32 "BBS11, HT2A, LGMD2H, TATIP" ENSG00000119401 "Tripartite motif containing 32" Q13049 9 116687305-116701300 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Limb-girdle muscular dystrophy, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050060 Approved Approved "Intermediate filaments" No No "Cluster 35: T-regs - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" "HPA050060: AB_2681000" "unprognostic (2.47e-2)" "unprognostic (7.06e-3)" "unprognostic (5.50e-2)" "unprognostic (3.63e-1)" "unprognostic (5.08e-2)" "prognostic unfavorable (4.53e-4)" "prognostic unfavorable (4.72e-4)" "unprognostic (2.41e-3)" "unprognostic (2.92e-1)" "unprognostic (5.01e-2)" "unprognostic (1.79e-2)" "unprognostic (5.63e-2)" "unprognostic (6.03e-2)" "unprognostic (7.06e-2)" "unprognostic (2.73e-1)" "unprognostic (6.64e-3)" "unprognostic (9.77e-2)" 6.7 7.2 4.6 5.4 4.5 1.0 6.8 16.4 5.4 10.1 15.2 6.0 5.9 10.6 6.5 7.4 13.1 6.4 7.9 4.7 6.1 5.2 3.8 5.5 8.1 3.6 2.8 10.1 6.2 8.6 3.5 6.1 3.9 6.9 6.2 7.2 5.2 7.3 18.6 4.6 7.2 10.7 2.1 6.2 5.4 5.2 4.5 7.5 6.3 12.5 7.4 7.6 5.7 3.4 10.9 24.5 14.3 15.7 28.3 20.1 10.8 19.9 21.7 22.1 18.4 16.4 11.7 11.3 8.6 30.7 16.5 22.8 17.5 22.4 20.0 9.9 8.5 6.1 15.4 10.2 14.7 4.1 19.1 17.4 19.7 21.0 12.3 24.4 14.6 12.4 8.6 9.3 26.3 13.9 11.0 0.1 13.0 26.2 14.6 12.7 38.2 7.4 9.0 25.1 14.2 7.2 15.7 10.8 11.4 14.3 29.8 4.0 18.2 20.4 16.2 15.3 15.2 15.1 4.3 17.7 17.0 2.7 20.5 0.0 1.7 0.0 10.9 3.3 8.4 7.3 9.5 8.7 2.3 5.1 9.6 9.8 0.3 7.0 3.0 4.3 20.9 6.0 4.6 4.5 16.4 5.4 4.7 6.1 3.6 2.8 3.9 2.1 4.5 3.4 2.5 6.4 0.6 5.5 4.3 4.2 6.3 9.3 5.7 11.7 3.1 3.7 7.6 7.2 7.3 9.2 0.0 6.7 2.1 1.7 1.9 8.5 3.5 7.1 10.7 3.6 4.2 0.4 7.6 8.0 3.6 6.1 3.6 2.3 2.5 4.5 2.9 4.1 7.2 1.7 10.1 4.0 8.2 2.4 4.7 2.1 5.3 2.2 1.8 1.9 0.8 4.0 3.1 6.6 5.1 5.0 2.6 12.0 3.1 2.8 10.6 3.1 10.8 4.8 0.0 6.0 6.6 17.7 13.1 5.6 3.7 7.4 4.7 5.0 5.3 4.8 TRIM52 RNF102 ENSG00000183718 "Tripartite motif containing 52" Q96A61 5 181254417-181261139 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA054565, HPA056819" Approved Approved "Nucleoli,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoli "Intermediate filaments" "HPA054565: AB_2682525, HPA056819: AB_2683245" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-2)" "unprognostic (5.23e-1)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.98e-2)" "unprognostic (7.37e-2)" "unprognostic (2.71e-1)" "unprognostic (2.24e-3)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (2.96e-1)" "unprognostic (6.41e-2)" "unprognostic (1.33e-2)" "prognostic favorable (4.07e-4)" 9.3 10.0 10.8 8.6 10.9 8.7 9.0 14.0 14.4 14.2 11.0 12.2 8.1 10.1 9.1 7.0 12.3 5.5 11.0 10.9 10.8 13.7 11.6 12.1 14.2 11.4 10.5 16.0 15.6 9.2 18.9 5.9 11.6 15.2 6.6 21.5 11.5 7.0 6.7 10.0 13.1 5.3 9.6 18.7 11.0 11.6 11.4 10.8 17.3 3.9 9.7 12.0 10.8 11.7 4.3 4.9 7.8 10.0 13.8 8.7 6.9 4.6 4.1 4.4 3.8 7.1 7.7 9.3 4.9 5.0 12.0 7.8 4.2 6.2 5.1 16.0 8.9 3.6 21.4 6.0 3.3 11.0 7.9 8.7 5.1 4.7 2.7 7.2 5.3 13.5 3.8 21.3 4.6 8.1 6.1 10.0 2.7 4.8 6.3 7.1 4.2 6.4 3.7 5.6 8.8 7.1 6.6 4.7 4.4 6.8 8.8 7.4 6.5 8.8 4.6 4.2 4.4 15.5 8.1 6.3 10.0 9.5 3.5 5.8 2.2 5.2 7.1 1.9 7.9 4.9 7.5 7.8 1.8 3.5 9.2 7.5 2.3 5.1 1.9 2.4 5.5 3.3 10.8 10.9 14.0 14.4 10.9 10.8 11.4 10.5 11.6 9.6 11.4 11.7 11.9 19.2 23.6 6.5 20.5 8.8 6.5 3.1 8.0 27.8 6.7 6.7 9.4 8.6 15.0 7.3 39.6 3.7 28.1 7.2 3.9 3.5 27.2 10.3 14.4 14.0 9.0 8.6 9.5 2.5 1.1 12.6 6.6 11.8 17.7 21.2 7.9 3.5 4.2 28.6 10.5 8.3 2.0 6.0 9.7 5.4 12.8 10.3 5.4 9.4 12.5 17.3 35.0 6.6 8.1 2.3 8.1 9.4 24.9 4.5 8.1 3.4 11.6 42.9 0.0 20.3 13.3 25.2 11.0 5.5 6.1 4.2 25.9 19.0 7.8 4.1 TTBK2 "KIAA0847, SCA11" ENSG00000128881 "Tau tubulin kinase 2" Q6IQ55 15 42738730-42920809 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.8;Inhibitory neurons: 185.1;Late spermatids: 146.2;Oligodendrocytes: 125.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018113, HPA049866" Approved Uncertain "Intermediate filaments" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Intermediate filaments" "HPA018113: AB_1858421, HPA049866: AB_2680923" "unprognostic (2.15e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (7.73e-2)" "unprognostic (4.26e-1)" "unprognostic (6.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.78e-2)" "unprognostic (8.62e-2)" "unprognostic (3.46e-2)" "unprognostic (7.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" 5.3 4.2 7.7 3.0 9.9 5.2 4.4 11.3 20.0 6.0 2.1 6.7 1.6 5.3 3.9 2.6 5.5 3.7 7.2 6.9 13.9 3.4 3.1 4.8 3.4 17.4 9.1 6.4 2.5 4.6 5.6 4.0 18.9 4.7 3.0 17.7 3.2 3.8 10.4 3.1 3.9 5.0 6.3 4.3 3.4 33.4 16.9 5.2 3.8 6.3 3.1 5.3 4.7 13.8 5.7 3.8 8.4 4.2 6.5 6.6 1.8 4.6 7.4 4.5 6.9 4.3 1.3 3.3 6.1 4.7 9.2 3.9 8.1 6.7 6.8 13.0 3.6 4.8 6.9 1.6 5.0 6.7 7.8 4.7 6.5 3.9 21.1 9.9 5.2 5.1 7.0 4.9 4.5 0.9 4.1 4.3 2.3 1.7 3.8 7.2 9.1 1.7 5.8 4.0 6.6 6.5 12.6 0.9 2.5 5.8 2.6 8.7 5.8 5.1 4.7 5.7 6.0 7.1 11.3 5.5 3.9 5.8 3.0 0.1 0.5 0.2 0.2 0.3 0.5 0.3 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.4 0.2 0.2 0.1 0.1 7.7 9.9 11.3 20.0 6.9 13.9 17.4 9.1 18.9 6.3 16.9 13.8 16.2 6.4 11.8 75.7 11.5 10.7 12.1 11.8 26.2 36.3 9.6 7.6 17.6 12.8 10.0 9.2 37.5 4.1 9.1 3.9 0.0 5.7 80.5 24.9 11.7 17.0 14.3 17.4 153.8 4.3 3.2 15.5 4.6 4.6 19.0 16.2 17.5 9.8 7.4 45.4 185.1 5.1 2.0 16.0 25.9 146.2 16.8 16.4 12.4 69.3 16.9 16.5 6.2 97.5 125.6 7.5 2.6 20.3 6.6 12.4 5.5 5.5 40.5 39.4 13.1 24.6 16.3 34.5 10.1 12.5 9.2 3.1 13.4 11.3 5.3 7.4 TTC4 "CNS1, FLJ41930, MGC5097" ENSG00000243725 "Tetratricopeptide repeat domain 4" O95801 1 54715861-54742657 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041608, HPA042459" Approved Enhanced "Intermediate filaments,Cytoplasmic bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Intermediate filaments" "Cytoplasmic bodies" "HPA041608: AB_10794485, HPA042459: AB_10797496" "unprognostic (4.89e-2)" "unprognostic (1.81e-1)" "unprognostic (2.05e-2)" "unprognostic (8.62e-4)" "unprognostic (8.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.21e-5)" "unprognostic (1.39e-4)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (2.42e-3)" "unprognostic (7.12e-2)" "unprognostic (2.85e-1)" "unprognostic (7.79e-2)" "unprognostic (5.86e-2)" "unprognostic (1.76e-3)" 8.9 8.8 21.2 5.3 21.8 2.0 10.4 22.0 24.7 10.4 20.4 9.7 5.6 8.5 8.1 10.6 9.1 3.9 16.5 21.7 22.2 11.0 10.2 5.6 7.2 22.2 22.2 12.5 11.7 11.7 12.8 7.7 22.3 8.8 6.3 9.0 9.1 8.3 33.7 10.3 8.0 7.6 22.5 6.6 10.8 8.6 22.0 12.8 8.0 22.2 8.9 11.0 10.1 23.9 24.3 18.2 20.1 10.9 29.2 16.6 17.9 32.6 16.0 39.8 26.6 20.5 6.9 40.1 17.4 22.4 42.2 13.1 43.7 31.1 41.6 38.2 31.7 38.4 7.7 11.9 27.4 32.4 10.6 16.1 30.4 58.2 34.9 17.8 17.3 31.3 45.5 6.3 22.7 11.3 30.0 18.3 41.0 29.1 30.9 27.1 43.0 22.5 19.9 6.5 13.5 9.7 28.4 13.8 27.2 33.0 13.2 16.5 17.4 19.5 21.2 20.5 44.9 16.1 29.9 34.0 25.9 36.5 20.8 7.3 12.3 10.3 13.9 14.0 14.8 12.6 11.1 13.3 13.5 12.6 15.9 14.3 0.2 18.9 15.1 11.2 11.8 13.0 21.2 21.8 22.0 24.7 21.7 22.2 22.2 22.2 22.3 22.5 22.0 23.9 3.7 9.6 2.6 0.0 6.2 1.1 3.4 2.1 7.4 4.5 3.1 3.3 3.2 1.5 5.2 0.0 0.0 3.9 2.4 1.5 0.0 3.5 0.5 4.7 8.8 3.4 1.2 3.0 0.0 4.2 2.4 5.4 3.6 4.5 7.0 3.0 3.9 2.4 1.4 5.0 0.0 1.3 0.0 0.6 1.5 0.7 4.1 2.7 1.8 0.0 5.9 2.3 6.2 0.0 0.0 3.9 1.7 2.6 6.1 3.0 2.0 6.4 2.6 3.8 0.0 3.8 3.5 9.2 8.2 5.7 1.6 1.4 4.6 1.9 2.5 1.8 UAP1L1 ENSG00000197355 "UDP-N-acetylglucosamine pyrophosphorylase 1 like 1" Q3KQV9 9 137077517-137084539 "Metabolic proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 21.7;Horizontal cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 58.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044356 Approved Approved "Intermediate filaments,Cytosol" No No "Cluster 7: Monocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Intermediate filaments" Cytosol "HPA044356: AB_10959902" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.25e-3)" "unprognostic (2.49e-2)" "unprognostic (3.80e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (3.01e-2)" "unprognostic (2.33e-1)" "unprognostic (5.65e-2)" "prognostic favorable (5.23e-4)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (1.67e-2)" "unprognostic (6.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.64e-3)" 11.6 14.1 13.5 5.5 18.7 3.1 9.5 14.3 16.4 15.0 15.8 8.1 5.7 6.7 5.1 6.0 7.6 5.3 11.0 14.4 14.0 14.0 2.8 12.5 7.9 16.6 15.8 3.8 9.6 7.9 15.4 6.3 15.8 13.0 3.6 2.9 11.0 5.6 2.7 10.1 10.8 3.5 12.6 22.0 10.2 3.2 19.0 2.4 14.1 2.7 5.9 10.0 9.1 24.1 0.8 5.8 0.0 15.7 26.4 12.1 4.5 8.1 21.1 22.4 15.4 11.7 2.6 3.7 4.7 8.3 40.6 12.1 29.6 2.0 4.6 10.0 2.7 7.9 9.5 11.3 58.5 0.1 31.5 8.9 2.1 12.7 10.4 10.4 17.7 7.3 2.4 18.0 15.2 13.5 0.8 8.1 2.6 28.3 8.3 12.8 0.2 11.3 8.9 1.1 9.3 5.8 2.0 44.3 18.7 3.7 23.9 21.8 14.1 40.2 8.6 28.3 3.9 19.6 30.1 7.9 34.9 8.6 11.7 0.1 1.0 0.0 0.2 0.5 0.8 0.5 0.1 0.3 0.5 0.2 0.2 0.3 0.1 0.0 0.0 0.3 0.5 0.4 13.5 18.7 14.3 16.4 14.4 14.0 16.6 15.8 15.8 12.6 19.0 24.1 2.4 0.0 8.4 16.0 6.9 6.1 0.6 2.0 4.0 6.8 4.8 3.9 4.0 5.7 1.5 0.0 2.1 0.4 7.1 2.1 11.7 1.4 0.2 2.2 4.9 3.1 1.8 0.4 3.3 0.9 5.0 4.0 1.1 3.4 4.5 0.8 7.1 0.7 21.7 20.2 5.1 1.8 6.1 10.9 9.9 0.2 2.5 11.2 8.8 6.5 9.1 4.7 3.1 6.6 18.4 0.8 1.9 3.8 5.6 2.0 0.5 3.4 1.1 5.1 0.0 3.0 16.5 0.6 1.5 3.5 4.4 1.4 4.5 1.0 3.1 0.2 UNC13B "hmunc13, Munc13-2, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Alveolar cells type 2: 80.7;Cone photoreceptor cells: 95.9;Excitatory neurons: 60.4;Microglial cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Yes No "Cluster 77: Retina - Visual perception" "Cluster 21: OE19 - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: AB_2684742" "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favorable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favorable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favorable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favorable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 12.6 12.8 10.5 5.6 13.3 1.0 10.3 6.6 14.5 12.5 15.7 22.2 11.6 10.1 7.7 17.5 10.4 11.5 13.6 11.4 7.2 21.8 12.8 38.9 1.8 8.3 9.5 7.3 21.3 15.0 11.5 6.0 7.8 22.6 25.0 41.2 17.8 23.3 24.2 12.3 13.4 11.9 7.3 4.7 17.9 15.6 10.6 3.0 12.2 10.4 5.0 10.2 12.7 9.0 9.8 12.8 13.9 22.6 26.3 14.6 11.8 15.7 7.1 11.4 15.3 10.7 4.5 0.0 7.0 20.6 20.1 4.7 35.4 18.2 14.5 0.0 11.3 5.9 36.6 13.9 12.7 2.2 6.4 11.6 14.0 18.0 18.5 18.2 37.3 15.8 13.5 8.1 13.5 7.5 2.1 0.2 12.6 30.2 13.3 0.1 8.6 3.4 15.5 12.6 14.9 15.7 11.0 6.8 11.4 23.0 11.6 7.5 34.5 7.8 7.2 12.3 12.2 12.7 16.2 0.0 8.5 18.4 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 13.3 6.6 14.5 11.4 7.2 8.3 9.5 7.8 7.3 10.6 9.0 6.7 57.7 80.7 28.7 0.8 3.1 1.1 2.1 3.4 42.3 7.3 4.4 11.4 18.6 16.7 9.2 95.9 3.7 0.1 24.4 3.9 6.0 6.9 8.2 5.1 8.5 24.6 1.7 60.4 12.2 2.1 4.8 16.3 13.9 2.5 8.7 5.7 12.5 4.9 6.7 17.7 31.9 0.0 2.4 3.0 12.3 2.1 3.7 7.2 73.1 0.1 5.7 0.0 42.3 36.7 7.8 11.9 3.0 4.2 11.7 10.5 7.8 10.0 40.8 6.6 8.4 6.5 8.7 7.5 14.3 7.4 2.9 1.0 5.7 19.5 5.7 USP47 ENSG00000170242 "Ubiquitin specific peptidase 47" Q96K76 11 11841423-11961887 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029286, HPA029289" Supported Approved "Vesicles,Intermediate filaments" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" Vesicles "HPA029286: AB_10599852, HPA029289: AB_10601675" "unprognostic (2.02e-1)" "unprognostic (2.72e-1)" "unprognostic (3.05e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (2.65e-2)" "unprognostic (2.27e-2)" "unprognostic (7.39e-2)" "unprognostic (1.54e-2)" "unprognostic (7.05e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-1)" "unprognostic (1.51e-1)" "unprognostic (9.96e-3)" "unprognostic (1.90e-1)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" 15.7 14.3 11.9 11.4 15.8 19.0 15.1 17.3 12.8 14.3 10.2 19.8 10.3 17.2 15.6 16.1 13.5 12.3 23.5 12.5 14.1 13.2 23.3 16.2 13.3 14.1 12.8 15.9 16.9 22.2 13.8 16.7 15.0 16.6 12.3 25.7 14.1 15.4 59.8 18.0 14.1 17.8 14.1 11.8 16.6 15.0 12.7 19.1 14.9 33.6 13.8 16.7 14.2 20.6 26.8 15.7 30.3 13.1 21.8 23.2 12.6 31.6 22.3 20.1 22.1 16.5 22.2 29.6 13.3 28.0 23.7 17.8 23.7 15.3 30.3 27.5 20.4 18.6 30.3 12.6 21.5 25.0 23.9 22.3 22.5 12.3 29.0 26.1 21.8 21.7 35.8 23.7 25.4 10.6 21.7 14.3 7.9 28.1 12.7 21.4 30.3 9.4 24.6 29.1 9.8 21.0 25.8 19.6 19.3 18.4 14.4 20.6 24.9 27.8 16.2 22.3 19.6 7.9 18.1 25.9 19.9 15.2 20.3 14.7 5.9 11.9 11.0 7.4 14.5 7.4 10.3 11.4 7.9 6.7 13.1 11.4 2.8 18.5 11.5 4.8 8.3 7.9 11.9 15.8 17.3 12.8 12.5 14.1 14.1 12.8 15.0 14.1 12.7 20.6 41.1 70.5 63.1 116.5 46.9 71.0 68.8 28.8 45.5 67.5 41.1 30.9 222.5 40.0 56.0 23.9 47.9 69.6 57.2 30.4 25.4 39.5 40.1 49.8 63.0 44.8 59.3 34.3 122.7 38.9 33.2 69.7 44.4 134.5 54.3 52.6 32.5 53.9 28.0 63.9 136.5 32.9 24.4 27.7 39.7 30.0 44.1 41.8 24.9 96.5 40.5 79.7 68.0 171.4 315.9 44.8 31.5 50.0 55.2 65.5 29.7 21.9 48.2 52.4 52.6 85.0 68.2 92.8 55.1 46.6 87.9 125.7 65.0 41.8 35.0 58.9 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "parathyroid gland: 235.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 141.7;Proximal enterocytes: 88.7;Undifferentiated cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.5;non-classical monocyte: 6.7" "Group enriched" "Detected in many" 8 "dendritic cells: 5.1;granulocytes: 6.5;monocytes: 6.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 55.5;HDLM-2: 80.0;U-937: 85.3" "Region enhanced" "Detected in single" "olfactory bulb: 2.1" "Region enhanced" "Detected in some" "spinal cord: 4.3" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favorable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.6 13.7 0.2 13.3 0.2 8.2 11.3 0.2 0.4 5.0 0.9 40.4 56.0 1.6 0.4 13.6 1.8 8.5 1.2 0.2 0.7 21.0 1.1 7.7 5.3 0.7 0.4 0.5 2.1 235.9 11.1 2.9 0.6 1.9 35.3 0.2 6.1 1.8 2.8 22.1 55.0 3.8 0.1 2.6 7.4 1.0 1.4 1.5 2.2 0.6 7.2 10.4 7.6 0.3 15.0 2.6 0.1 0.1 12.0 16.4 0.2 17.7 8.6 15.0 12.9 10.6 12.1 3.5 17.4 13.6 10.7 27.1 0.5 55.5 6.4 80.0 4.0 6.3 3.1 0.9 8.1 12.2 20.3 23.6 30.5 16.4 26.0 22.3 1.2 1.3 1.8 3.9 7.0 9.2 0.3 6.0 0.2 34.8 19.1 0.3 0.0 9.9 13.3 13.5 6.2 0.2 14.7 42.6 5.9 0.1 47.6 6.7 1.0 28.8 7.3 8.2 10.2 2.2 0.1 3.0 8.6 85.3 7.7 0.1 3.5 1.9 0.0 6.5 0.1 0.5 0.3 0.0 5.1 0.0 0.1 0.0 6.5 0.2 6.7 0.4 0.7 1.5 0.2 0.2 0.2 0.4 0.2 0.7 0.7 0.4 0.6 0.1 1.4 0.3 0.4 12.8 20.1 0.3 1.4 36.1 9.0 8.5 24.5 0.5 21.2 13.7 1.7 0.0 9.2 7.3 0.0 0.2 0.9 141.7 7.9 3.5 0.2 11.9 0.5 1.3 21.7 0.0 0.4 10.9 0.1 5.3 14.3 4.7 7.0 0.2 0.0 0.3 3.4 0.0 0.3 32.8 2.0 7.3 43.4 0.0 0.0 21.2 8.8 1.0 10.4 0.2 0.0 0.5 0.1 22.4 43.3 0.4 10.9 8.3 88.7 32.0 9.0 0.2 0.0 1.1 2.2 0.7 0.3 23.4 40.6 0.3 2.8 0.0 72.4 11.6 VIM ENSG00000026025 Vimentin P08670 10 17228241-17237593 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 18287.8;fHDF/TERT166: 10084.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000080, HPA001762, CAB058687" Enhanced Supported "Intermediate filaments" NA NA 35000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 41: Macrophages - Immune response" "Intermediate filaments" "CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568" "unprognostic (1.02e-1)" "unprognostic (2.58e-1)" "unprognostic (2.87e-2)" "prognostic favorable (9.75e-6)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.05e-1)" "unprognostic (9.29e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.87e-3)" "unprognostic (7.32e-2)" "unprognostic (1.82e-1)" "unprognostic (9.47e-3)" 3467.6 423.1 349.3 610.6 369.5 1455.5 2362.8 289.1 527.4 1816.3 568.1 923.2 218.4 1226.5 400.0 451.5 1458.7 960.2 1364.3 337.5 404.6 473.6 192.8 1133.2 806.2 667.4 328.2 3690.8 370.0 224.8 574.5 1030.0 443.7 570.0 400.8 731.0 628.5 551.8 363.7 1126.8 674.7 1109.3 414.6 819.9 522.8 251.7 472.7 412.2 1391.1 555.8 744.7 983.5 1366.6 425.5 21.2 1119.0 1981.0 3180.7 6407.4 18287.8 3.0 5238.5 3458.9 3859.2 3421.5 8.5 70.4 2.9 273.2 10084.4 1804.7 8.4 283.8 147.0 3734.1 3567.5 387.2 563.2 523.5 0.3 1967.3 301.1 222.8 6746.8 6.5 5712.0 3213.4 9020.8 6366.3 372.4 889.3 1575.4 6939.5 4.5 736.6 911.2 632.4 1.4 1394.0 564.8 2745.9 95.7 3925.3 0.8 8.1 946.6 1.4 6.9 5447.5 1133.1 8.6 341.8 5459.0 3819.8 1644.5 3244.7 6311.5 1754.4 953.7 130.4 5775.4 28.9 3726.3 667.8 751.8 215.2 219.5 469.3 278.7 176.3 357.0 285.0 866.0 117.5 217.1 217.2 409.3 99.2 471.2 342.3 481.5 615.4 349.3 369.5 289.1 527.4 337.5 404.6 667.4 328.2 443.7 414.6 472.7 425.5 3211.7 157.0 349.4 53.5 605.8 725.8 21.6 361.2 58.1 74.2 108.8 539.1 109.5 94.4 157.3 108.5 50.1 22.1 1110.1 9.1 5.9 198.8 58.1 922.9 2314.1 2923.2 309.1 236.5 0.4 569.0 45.8 3443.0 101.4 693.7 2776.4 4879.0 2195.6 19.2 3541.4 33.7 0.3 1.8 16.2 2841.2 4893.1 131.6 5013.2 3177.8 3082.5 85.3 3893.1 8977.0 259.5 1.0 0.4 525.9 1.5 2336.6 2097.2 79.5 3.1 181.6 90.7 284.1 1420.0 3171.9 3714.2 55.1 27.5 39.4 473.0 52.7 1566.3 1791.1 6.2 28.9 VPS4B "SKD1, SKD1B, VPS4-2" ENSG00000119541 "Vacuolar protein sorting 4 homolog B" O75351 18 63389190-63422483 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040393, CAB046445, HPA057649" Approved Approved "Vesicles,Intermediate filaments" No No 32000 "Cluster 1: Neutrophils - Mixed function" "Cluster 37: Intestine - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Vesicles "Intermediate filaments" "CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489" "unprognostic (8.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.10e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.23e-4)" "unprognostic (4.59e-1)" "unprognostic (1.40e-1)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" 24.2 18.3 10.5 25.5 13.1 52.6 28.8 13.2 17.8 26.8 9.3 42.3 35.1 22.7 19.5 75.4 18.6 23.7 16.2 10.3 14.6 23.8 28.4 23.8 31.2 13.5 15.9 19.3 17.3 27.8 11.5 28.7 14.0 23.4 37.0 7.0 24.7 19.5 11.0 32.3 36.4 21.0 12.6 28.8 32.5 12.1 12.5 31.4 28.5 13.0 39.1 30.2 31.1 15.6 57.1 21.9 22.4 24.5 33.5 47.1 38.9 48.6 45.5 36.4 39.2 15.7 39.4 54.1 31.2 35.7 30.9 119.6 26.8 53.1 47.5 40.6 22.3 27.6 27.8 23.7 48.6 94.5 56.8 43.1 80.3 32.3 56.2 36.5 33.9 31.0 14.3 49.4 52.1 20.2 59.9 29.2 23.2 22.7 32.3 48.8 47.2 52.4 45.6 66.2 38.2 33.6 36.9 35.4 55.3 28.3 34.2 50.5 52.8 55.4 27.3 21.6 32.7 163.6 86.5 69.3 31.9 44.0 42.3 163.6 54.6 125.0 52.2 56.5 49.0 64.8 54.3 54.2 46.2 73.4 48.2 51.1 185.9 68.4 76.5 45.6 66.7 56.6 10.5 13.1 13.2 17.8 10.3 14.6 13.5 15.9 14.0 12.6 12.5 15.6 52.0 115.4 57.4 21.5 62.4 68.8 47.2 66.5 44.9 37.0 54.4 46.0 39.5 47.1 72.4 33.1 22.9 70.0 92.2 142.0 45.0 48.0 113.3 92.2 74.0 44.6 45.5 27.8 27.3 42.1 56.7 51.0 47.4 145.5 59.3 37.7 36.8 55.8 46.4 43.7 29.6 76.8 67.1 58.8 33.0 15.5 49.0 58.0 32.0 18.7 53.4 39.2 76.2 18.6 49.5 91.3 120.7 36.5 42.1 43.1 61.8 57.9 85.1 31.5 59.2 45.6 54.7 30.1 29.4 87.5 83.4 140.4 67.4 56.5 72.6 79.5 WDR37 KIAA0982 ENSG00000047056 "WD repeat domain 37" Q9Y2I8 10 1049538-1132384 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 184.8;Late spermatids: 92.9;NK-cells: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037376, HPA037565" Enhanced Approved "Intermediate filaments" No No "Cluster 48: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 34: Spermatids - Unknown function" "Intermediate filaments" "HPA037376: AB_10672789, HPA037565: AB_10696937" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (9.08e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.75e-5)" "unprognostic (2.59e-3)" "unprognostic (3.56e-2)" "unprognostic (1.80e-1)" "unprognostic (1.62e-2)" "prognostic favorable (1.46e-6)" "unprognostic (3.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (5.98e-2)" 8.4 16.5 10.4 9.3 10.5 22.2 7.8 0.4 18.7 8.1 2.0 8.9 7.3 7.9 8.9 9.1 7.8 6.1 17.6 13.1 2.5 8.7 10.3 10.3 12.5 1.5 1.9 9.7 10.1 9.8 14.6 6.3 2.9 8.1 6.7 14.9 7.6 5.1 18.3 11.5 11.2 6.6 0.0 21.0 10.3 21.2 3.1 10.3 9.5 15.7 9.8 7.0 7.9 9.7 12.4 9.0 11.6 9.4 10.9 15.8 8.2 15.5 8.4 9.5 9.4 11.3 10.4 6.1 9.2 20.3 2.0 11.2 6.1 18.1 8.1 7.4 10.0 14.8 9.6 7.7 7.7 8.8 16.0 19.8 13.6 13.6 4.8 11.3 21.0 12.1 9.1 7.3 15.2 10.9 9.8 6.9 6.4 9.6 4.8 14.9 6.5 10.5 13.2 13.8 5.2 10.1 7.2 13.3 11.9 8.8 12.8 17.9 27.7 7.5 2.5 24.8 12.5 13.4 13.3 8.2 17.4 9.9 5.4 6.0 4.8 3.5 10.0 6.2 8.7 5.5 5.6 7.4 5.2 4.4 6.3 7.3 3.8 11.2 7.1 4.8 5.3 5.2 10.4 10.5 0.4 18.7 13.1 2.5 1.5 1.9 2.9 0.0 3.1 9.7 10.5 3.2 8.1 33.6 14.5 13.4 13.0 7.5 10.2 16.3 8.4 7.2 23.3 5.7 7.9 11.0 12.5 6.2 27.4 8.6 0.0 4.8 184.8 5.7 8.6 13.6 10.7 6.5 65.3 6.1 4.2 9.0 13.3 11.1 12.0 7.3 30.7 7.0 9.0 8.4 59.7 8.1 8.2 18.8 13.7 92.9 12.5 14.8 16.0 43.1 23.7 5.3 86.5 36.7 47.3 9.5 8.3 18.0 9.6 13.6 7.2 4.8 4.9 14.7 6.6 13.0 8.5 11.6 14.3 11.9 12.4 11.4 19.1 10.1 5.9 19.7 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 58: T-cells - T-cell receptor" "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favorable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 4.9 5.8 4.4 7.6 4.9 3.0 8.1 7.0 5.9 6.8 3.3 6.1 5.1 6.9 6.8 5.3 6.4 4.8 4.4 4.5 4.6 8.8 8.8 5.4 11.2 4.5 4.4 8.2 5.9 7.4 3.0 6.6 4.2 5.8 6.8 11.4 4.1 4.5 5.8 6.1 4.0 5.3 3.9 8.6 5.4 5.3 5.1 10.1 9.2 7.3 10.3 6.6 4.4 5.7 35.4 16.2 18.2 10.2 10.7 11.2 27.2 14.0 7.6 14.4 16.2 11.6 17.0 33.7 11.4 4.2 9.7 16.7 22.8 13.2 24.3 21.8 13.1 22.7 10.5 14.4 13.8 29.9 15.5 10.1 17.1 16.0 22.7 8.1 12.8 24.0 19.7 17.8 10.5 19.5 24.0 17.3 17.5 23.9 29.2 18.2 18.3 19.2 15.5 14.6 16.5 12.4 15.0 16.8 11.1 18.1 19.2 16.0 9.2 16.8 16.4 11.0 16.6 10.4 8.8 20.9 7.2 20.9 11.9 0.1 2.8 0.5 8.4 2.7 10.5 8.0 8.8 7.8 4.8 7.3 14.3 12.4 0.6 9.4 4.6 3.1 10.1 5.3 4.4 4.9 7.0 5.9 4.5 4.6 4.5 4.4 4.2 3.9 5.1 5.7 5.6 9.6 6.7 4.9 14.5 9.7 13.9 4.6 8.0 6.7 6.3 5.3 4.8 8.6 7.0 5.5 4.2 9.9 7.0 3.8 13.7 6.8 2.8 3.4 7.7 7.0 3.6 11.6 11.3 5.5 13.6 6.5 2.6 4.1 1.3 7.5 5.3 8.0 6.3 1.7 13.2 5.1 4.1 6.3 4.2 4.6 4.4 5.1 3.6 6.5 5.6 7.0 8.2 8.5 14.5 3.6 2.4 6.4 6.1 11.2 2.7 7.9 3.1 9.3 13.1 6.9 4.9 6.1 11.6 6.3 10.9 7.0 11.2 8.7 5.5 7.3 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type palmitoyltransferase 12" Q96GR4 9 128720870-128724127 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 18.8 23.9 7.8 15.5 7.7 41.3 19.3 7.5 9.9 16.8 8.4 40.5 26.3 12.9 7.1 67.8 12.0 14.1 13.7 7.4 8.8 30.6 52.3 23.3 20.0 9.6 7.8 7.4 67.1 9.8 11.3 16.3 8.4 26.6 13.7 0.5 43.2 12.5 15.6 42.4 36.8 6.3 8.4 31.7 49.2 24.7 10.5 12.4 16.2 4.1 13.7 18.7 30.5 9.7 53.5 127.6 6.0 31.3 17.6 12.1 59.4 32.8 28.8 34.5 22.9 109.6 61.5 37.3 29.6 25.5 62.9 139.8 13.0 65.0 3.8 65.0 31.7 20.1 92.7 49.1 34.7 33.1 87.1 19.9 44.7 29.6 11.0 17.7 25.6 65.6 18.8 93.6 7.1 187.3 45.9 66.2 26.8 118.8 107.6 21.0 21.0 108.4 28.7 43.4 42.1 30.4 46.2 64.1 18.3 9.6 98.9 35.6 27.5 0.1 36.9 25.9 45.8 58.1 106.8 17.3 61.3 38.4 41.4 231.1 122.3 385.6 105.1 123.9 91.2 94.6 95.9 101.5 100.1 111.0 99.2 91.4 269.5 90.5 150.0 244.7 130.9 101.0 7.8 7.7 7.5 9.9 7.4 8.8 9.6 7.8 8.4 8.4 10.5 9.7 10.0 16.0 12.0 1.3 31.8 16.2 43.3 94.0 10.8 1.2 55.5 30.4 14.8 77.2 59.0 46.0 0.0 183.9 39.1 171.0 13.7 106.8 73.2 20.7 11.5 21.1 51.2 51.1 0.6 200.0 224.0 14.2 38.7 52.5 18.4 13.7 35.7 55.3 137.0 0.0 0.5 108.5 67.1 62.2 20.9 30.0 9.6 46.5 42.7 6.5 115.3 18.4 81.4 0.5 2.0 133.8 167.7 7.2 43.3 56.5 186.0 48.5 20.1 2.0 6.6 5.4 16.3 36.0 18.6 55.2 28.1 134.1 34.1 22.0 110.0 77.5 ZFC3H1 "CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2" ENSG00000133858 "Zinc finger C3H1-type containing" O60293 12 71609599-71667725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007072, HPA007151" Enhanced Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Intermediate filaments" "HPA007072: AB_1846134, HPA007151: AB_1846133" "unprognostic (3.90e-3)" "unprognostic (3.69e-1)" "unprognostic (2.78e-1)" "unprognostic (2.15e-2)" "unprognostic (9.44e-2)" "unprognostic (6.14e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (6.56e-2)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" 9.6 12.3 4.1 10.1 5.1 18.5 8.1 8.1 6.2 9.5 5.3 10.6 6.2 8.7 10.5 10.4 9.2 7.3 7.8 4.2 6.0 7.9 5.5 12.1 14.5 4.5 4.2 11.0 8.0 7.6 8.0 8.0 4.5 8.3 8.9 13.4 8.1 8.2 7.7 9.1 11.1 6.3 2.9 10.9 10.1 12.4 5.0 13.2 9.0 5.6 12.0 9.8 9.5 6.2 16.1 15.7 12.6 8.6 14.4 26.5 7.6 12.9 18.6 17.8 17.7 15.1 9.2 21.2 7.3 15.0 7.9 19.2 15.3 7.4 23.8 20.8 13.0 21.6 27.6 7.3 8.6 22.0 10.5 15.2 14.6 13.1 6.1 25.4 18.2 17.1 19.6 9.8 17.0 5.0 15.5 8.2 11.5 7.2 9.6 14.0 13.7 15.9 13.5 12.4 8.3 8.3 13.4 8.1 8.0 12.0 21.0 14.4 16.7 12.2 7.4 6.9 6.9 17.3 10.5 15.2 12.6 15.8 7.7 60.5 20.9 27.1 15.0 10.7 12.1 21.7 13.3 10.4 9.3 29.9 13.1 11.2 60.7 11.7 20.3 27.1 11.9 3.5 4.1 5.1 8.1 6.2 4.2 6.0 4.5 4.2 4.5 2.9 5.0 6.2 33.5 35.3 25.5 37.2 50.1 47.9 85.8 20.6 46.7 32.8 28.4 17.1 18.4 7.2 30.5 14.7 22.9 14.6 60.2 35.7 1.9 20.5 97.6 33.2 46.0 35.8 20.9 24.8 56.9 16.9 14.5 40.2 52.0 66.5 48.8 32.7 23.9 12.0 17.5 58.9 58.1 32.1 18.3 17.8 47.0 65.2 32.0 49.7 10.6 55.3 39.3 14.7 37.0 62.4 68.6 28.5 36.4 23.0 54.0 45.1 32.1 8.4 22.9 33.0 26.3 39.9 37.5 51.7 30.8 79.3 40.9 11.5 44.9 29.2 28.7 93.4 ZFP36 "G0S24, NUP475, RNF162A, TIS11, TTP" ENSG00000128016 "ZFP36 ring finger protein" P26651 19 39406847-39409412 "Predicted intracellular proteins" "Host-virus interaction, mRNA transport, RNA-mediated gene silencing, Transport" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 2759.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 313.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 154.7;hTCEpi: 179.0;Karpas-707: 167.0;U-266/84: 149.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "spinal cord: 151.4" HPA006009 Approved Approved "Intermediate filaments" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "Intermediate filaments" "HPA006009: AB_1859030" "unprognostic (2.30e-2)" "unprognostic (2.27e-1)" "unprognostic (8.26e-2)" "unprognostic (6.76e-2)" "unprognostic (4.74e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (4.59e-2)" "unprognostic (5.20e-1)" "unprognostic (3.61e-3)" "unprognostic (9.44e-2)" "unprognostic (3.11e-1)" "unprognostic (4.20e-3)" "unprognostic (5.22e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (6.92e-3)" 1520.5 341.7 46.9 258.1 49.9 745.3 716.3 55.6 74.0 517.1 71.2 582.4 168.3 316.1 17.0 645.5 1276.8 520.0 575.4 42.8 84.3 288.1 462.0 1135.1 175.1 130.5 63.1 480.5 160.6 124.5 311.5 120.9 68.5 342.3 175.6 39.2 329.7 143.6 322.8 828.9 322.5 426.0 78.8 282.1 554.4 49.4 86.3 269.6 510.2 281.6 73.1 523.2 712.5 79.6 27.5 16.5 4.3 1.5 108.8 154.7 7.7 20.8 26.7 11.2 8.7 12.8 28.3 16.8 6.2 32.7 12.1 13.2 1.0 35.0 3.5 21.1 1.6 7.2 12.1 8.0 70.2 7.4 41.6 56.7 179.0 8.0 66.3 14.6 6.6 18.7 10.2 167.0 19.4 21.5 13.2 17.7 1.6 83.4 2.6 18.9 2.3 35.9 14.9 43.6 1.2 4.2 10.1 23.6 6.1 6.3 16.8 39.8 11.4 15.3 6.1 28.2 6.3 116.5 149.7 19.5 15.4 15.1 6.4 121.8 72.2 68.8 38.8 69.9 32.8 47.8 33.4 39.5 69.0 45.5 38.0 37.0 313.6 17.4 95.5 50.9 41.9 44.3 46.9 49.9 55.6 74.0 42.8 84.3 130.5 63.1 68.5 78.8 86.3 79.6 2759.0 419.9 864.0 7.5 686.2 1160.4 1543.0 789.3 2108.6 0.4 819.5 566.2 514.9 351.8 426.9 80.9 4.2 70.3 962.4 628.2 31.3 234.2 6.1 528.1 797.5 1208.6 631.9 109.2 0.4 105.6 95.5 2072.6 881.3 1055.0 690.7 45.7 668.6 206.4 703.1 1.7 0.2 608.3 250.3 669.9 2332.1 17.4 557.7 1189.0 631.5 24.4 125.6 55.0 94.7 0.0 1.6 156.4 907.8 139.5 1540.1 823.3 1060.8 60.2 298.5 7.1 769.2 878.2 1346.7 2.9 5.4 1641.6 1585.6 154.2 1193.0 87.1 366.5 639.9 ZIK1 ZNF762 ENSG00000171649 "Zinc finger protein interacting with K protein 1" Q3SY52 19 57578456-57593890 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 5.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 28.8;NTERA-2: 34.3;REH: 25.6;U-266/84: 34.8" "Low region specificity" "Detected in all" HPA059975 Uncertain Approved "Intermediate filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" "HPA059975: AB_2684184" "unprognostic (2.14e-2)" "unprognostic (9.03e-3)" "unprognostic (9.42e-2)" "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (1.34e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (1.02e-1)" "unprognostic (4.18e-6)" "unprognostic (6.21e-2)" "unprognostic (5.15e-1)" "unprognostic (5.21e-2)" "unprognostic (3.50e-1)" 1.9 1.9 2.0 2.6 2.5 4.6 3.2 5.6 2.1 2.9 2.1 2.1 0.6 2.4 4.3 1.3 4.9 1.9 3.1 1.9 2.3 2.2 0.7 2.5 5.9 1.5 1.7 6.0 1.1 6.7 2.6 3.3 1.4 3.2 1.4 6.9 1.7 4.0 1.8 2.1 2.2 2.7 1.7 4.6 1.6 5.2 2.6 7.1 5.6 2.4 6.4 2.0 1.1 2.3 0.1 0.0 22.5 0.1 0.9 0.9 0.0 7.9 7.4 11.3 10.2 0.1 0.2 0.0 5.6 4.0 8.9 0.6 0.0 12.6 16.0 0.0 28.8 4.6 0.1 2.5 2.6 0.1 8.5 4.6 0.0 8.7 0.0 1.0 0.8 1.8 0.2 0.0 3.7 0.0 17.8 2.4 34.3 0.0 2.8 25.6 0.1 5.6 3.2 0.0 16.4 16.5 0.1 0.0 0.7 17.4 0.1 0.3 0.1 10.2 5.2 0.0 9.3 0.2 34.8 8.8 0.1 0.0 10.1 1.8 1.6 8.1 1.8 1.9 3.5 6.8 3.5 2.2 2.6 9.4 6.5 3.2 0.3 4.1 1.7 2.8 4.4 2.6 2.0 2.5 5.6 2.1 1.9 2.3 1.5 1.7 1.4 1.7 2.6 2.3 1.4 0.0 0.0 3.3 4.5 1.0 1.4 1.8 1.2 3.7 1.7 1.4 3.0 5.7 1.9 5.5 0.0 2.0 1.1 0.0 3.9 3.0 2.9 0.3 1.5 1.8 0.0 4.2 2.3 0.2 1.0 1.7 2.0 0.3 3.8 5.4 2.9 0.3 1.9 3.3 1.9 0.1 4.1 0.8 1.8 3.4 2.1 1.2 0.0 1.0 1.0 4.8 0.0 4.0 0.7 0.2 0.1 2.2 2.6 0.7 0.0 0.5 0.9 5.0 6.6 1.5 1.9 1.0 5.6 0.7 0.9 1.2 2.3 1.7 0.1 1.1 ZKSCAN5 "ZFP95, ZNF914, ZSCAN37" ENSG00000196652 "Zinc finger with KRAB and SCAN domains 5" Q9Y2L8 7 99504662-99534700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003201 Uncertain Approved "Intermediate filaments" No No "Cluster 22: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Intermediate filaments" "HPA003201: AB_10610701" "unprognostic (2.47e-1)" "unprognostic (2.34e-2)" "unprognostic (2.99e-2)" "unprognostic (2.18e-1)" "unprognostic (4.42e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.59e-6)" "unprognostic (1.12e-1)" "unprognostic (2.15e-2)" "unprognostic (2.62e-1)" "unprognostic (5.35e-2)" "unprognostic (8.07e-2)" "unprognostic (1.18e-2)" "unprognostic (6.82e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (3.42e-1)" 2.7 3.2 4.8 2.9 5.1 3.1 3.4 6.0 5.7 3.1 4.1 3.0 1.6 3.3 3.5 2.3 3.0 2.6 3.2 4.8 4.8 3.2 3.1 2.9 3.4 4.5 4.8 3.6 1.5 3.8 2.9 3.3 5.0 3.3 2.7 5.4 2.0 3.5 4.7 2.4 2.4 4.1 4.3 3.1 2.5 8.4 4.9 6.0 3.7 6.8 3.8 3.1 2.6 5.2 6.6 10.6 12.4 16.5 8.5 6.4 5.3 11.1 10.6 12.7 12.4 7.6 5.9 11.3 9.9 8.3 15.5 5.2 11.1 7.2 12.7 6.5 6.6 7.2 6.9 7.1 8.9 10.8 11.4 5.7 10.2 10.9 16.7 8.1 9.1 9.9 14.8 15.0 13.7 8.5 15.0 11.8 10.9 5.9 8.6 9.4 10.6 9.4 8.1 6.5 8.8 14.0 10.0 9.4 7.4 9.8 5.7 7.5 8.7 16.2 11.7 13.1 9.5 9.6 14.6 16.9 7.5 7.5 14.6 0.8 0.8 2.4 2.0 1.2 1.6 0.7 0.7 1.0 1.6 0.6 1.6 1.6 0.7 1.7 0.8 1.1 1.4 1.0 4.8 5.1 6.0 5.7 4.8 4.8 4.5 4.8 5.0 4.3 4.9 5.2 6.9 6.4 3.2 7.8 5.8 2.7 1.9 2.3 4.6 5.8 4.7 4.4 6.1 0.0 4.8 3.7 14.6 3.8 5.6 4.3 0.0 3.3 6.2 3.8 5.8 6.4 6.0 6.5 8.5 3.5 3.4 3.7 5.6 4.4 5.7 7.5 4.6 4.2 3.4 10.1 8.6 3.0 8.2 3.9 4.0 2.9 4.1 4.9 0.0 9.4 3.5 8.7 2.1 6.0 8.4 4.3 0.8 5.7 4.4 2.4 4.1 2.5 3.0 6.3 6.6 6.5 4.1 18.0 6.6 5.9 2.8 2.6 4.4 5.9 3.3 1.8 ZNF131 "pHZ-10, ZBTB35" ENSG00000172262 "Zinc finger protein 131" P52739 5 43065176-43192021 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007023, HPA027748, HPA074630" Approved Enhanced "Nucleoplasm,Intermediate filaments" No No "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Intermediate filaments" "HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705" "unprognostic (1.23e-1)" "unprognostic (8.24e-2)" "unprognostic (4.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.84e-2)" "unprognostic (7.18e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (2.52e-1)" "unprognostic (2.98e-3)" "unprognostic (1.94e-2)" "unprognostic (5.83e-2)" "unprognostic (8.07e-2)" "unprognostic (2.09e-2)" "unprognostic (1.47e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-3)" "unprognostic (1.46e-2)" 13.2 13.5 12.5 13.9 12.8 28.4 19.5 17.3 21.7 13.8 10.0 13.2 10.0 17.6 9.6 14.4 12.6 12.9 9.6 12.8 12.4 12.0 14.3 11.4 20.3 11.4 11.9 15.9 12.2 11.7 10.7 16.9 11.9 12.6 13.2 14.7 10.4 9.0 15.8 18.2 12.0 15.9 11.3 15.9 11.6 32.6 12.3 26.7 11.8 17.1 17.5 15.0 13.3 14.2 25.4 15.2 32.4 43.2 30.1 20.6 27.3 32.8 26.6 31.9 26.9 24.0 22.2 50.8 25.9 22.1 29.7 17.7 38.9 20.8 44.9 24.8 34.1 31.4 92.2 18.0 27.7 55.0 24.7 18.8 38.2 23.5 38.3 22.8 24.7 39.0 40.7 52.7 36.8 24.5 53.9 68.8 21.5 23.4 24.9 35.3 49.4 39.9 27.1 24.4 20.0 29.4 83.5 39.8 43.2 21.7 22.3 51.6 18.5 39.8 37.3 20.5 31.1 21.1 32.5 58.4 21.0 71.2 27.1 10.4 8.2 5.8 19.1 9.5 19.2 13.1 18.5 18.5 11.9 16.8 22.3 18.3 3.9 17.2 6.6 11.3 14.9 10.0 12.5 12.8 17.3 21.7 12.8 12.4 11.4 11.9 11.9 11.3 12.3 14.2 42.5 22.4 21.9 28.7 44.7 49.6 51.4 24.1 53.5 52.1 32.3 29.7 17.5 22.8 19.4 9.2 52.1 27.0 53.3 28.0 31.3 15.3 52.9 30.0 47.7 32.8 31.2 39.1 31.2 11.8 25.0 32.4 23.0 49.7 24.1 39.4 24.7 13.3 16.4 38.7 33.6 29.7 20.3 25.8 35.4 19.5 20.5 30.9 21.4 14.0 27.5 29.0 49.4 38.7 24.2 17.9 24.7 21.1 27.8 38.5 34.9 13.1 15.7 70.0 26.3 57.0 43.2 109.6 80.3 45.9 65.5 25.4 59.3 37.3 38.7 35.6 ZNF132 pHZ-12 ENSG00000131849 "Zinc finger protein 132" P52740 19 58432814-58440153 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 4.0;Cone photoreceptor cells: 4.2;Early spermatids: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA008726 Uncertain Approved "Vesicles,Intermediate filaments" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Vesicles "Intermediate filaments" "HPA008726: AB_1080664" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (6.79e-3)" "unprognostic (3.06e-2)" "unprognostic (8.16e-2)" "unprognostic (4.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.32e-3)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.92e-4)" "unprognostic (4.51e-1)" "prognostic favorable (7.26e-13)" "unprognostic (2.70e-1)" "unprognostic (7.65e-2)" "unprognostic (6.09e-2)" "unprognostic (3.72e-1)" 1.4 2.3 1.8 1.3 1.9 0.3 2.6 4.7 2.7 2.7 4.6 1.7 1.2 1.8 3.5 1.6 3.8 1.3 3.0 1.8 1.9 3.0 0.8 1.8 1.8 1.5 2.3 3.7 1.6 8.9 3.4 1.8 1.6 2.9 1.1 5.0 3.0 3.1 1.9 2.3 1.1 2.1 1.4 2.3 1.5 3.1 1.7 1.6 5.4 1.7 2.2 1.9 1.5 2.7 1.2 1.3 3.4 1.2 3.9 3.3 0.1 2.6 3.2 2.1 2.0 0.1 1.0 3.3 0.2 3.2 2.1 1.3 0.0 3.9 1.5 0.5 5.9 0.6 1.1 0.7 3.4 1.3 2.1 3.5 1.3 3.6 2.3 2.5 2.0 0.5 0.4 0.3 4.1 0.5 0.7 0.1 3.5 0.4 1.2 0.4 0.7 0.9 1.3 1.4 3.0 3.1 1.0 0.9 1.1 3.6 0.2 3.2 2.4 2.1 0.2 0.5 0.5 4.1 0.8 0.0 1.0 0.1 1.4 0.0 0.8 0.8 0.9 1.0 2.2 1.1 1.1 0.5 1.2 1.4 1.7 1.4 0.0 1.2 1.2 1.0 1.1 0.8 1.8 1.9 4.7 2.7 1.8 1.9 1.5 2.3 1.6 1.4 1.7 2.7 0.4 0.0 0.5 1.6 0.6 0.0 0.6 0.5 0.0 1.2 0.4 0.4 4.0 1.5 0.2 0.0 4.2 0.5 0.2 0.1 0.0 0.6 3.7 1.2 1.0 0.8 0.0 1.7 2.0 0.4 0.2 0.7 2.0 0.4 1.3 1.6 0.4 0.9 0.5 3.3 2.3 0.8 0.0 0.3 0.0 0.7 0.6 0.7 0.0 0.0 0.2 1.4 0.0 1.0 2.5 0.1 0.0 0.7 0.5 0.9 0.3 1.5 0.7 1.7 0.0 0.7 0.8 2.5 0.8 0.8 0.3 0.4 0.5 0.8 0.2 0.3 ZNF189 ENSG00000136870 "Zinc finger protein 189" O75820 9 101398873-101410660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 86.0" "Cell type enriched" "Detected in all" 4 "Oligodendrocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034814 Uncertain Approved "Intermediate filaments" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Intermediate filaments" "HPA034814: AB_10601030" "unprognostic (3.87e-2)" "unprognostic (3.47e-1)" "unprognostic (5.30e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.26e-2)" "unprognostic (3.59e-3)" "unprognostic (1.70e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "prognostic favorable (5.32e-4)" "unprognostic (3.31e-1)" "unprognostic (4.58e-1)" "unprognostic (1.86e-2)" "unprognostic (6.57e-2)" 24.2 21.6 15.7 9.4 20.3 4.0 16.2 16.8 24.0 12.5 13.8 10.8 12.3 13.8 86.0 7.4 10.5 23.3 15.4 27.8 15.8 14.6 18.6 9.5 10.7 17.9 15.7 16.0 31.3 14.2 19.7 8.8 17.0 13.9 10.2 12.7 9.8 11.6 16.4 5.9 12.3 13.3 16.4 12.6 12.7 13.7 15.0 11.2 13.3 16.8 15.2 8.4 7.0 27.2 7.4 6.0 19.1 14.0 16.7 11.6 9.1 10.3 15.8 11.9 10.2 12.7 5.7 9.9 6.8 12.5 12.4 14.1 9.6 9.8 10.5 13.1 6.6 10.8 9.6 27.3 12.4 11.5 9.1 14.2 13.3 10.6 16.3 16.3 15.0 11.9 13.0 13.9 17.7 4.1 13.8 4.9 13.8 16.2 6.7 9.7 27.3 7.6 11.4 8.4 19.7 12.4 11.2 7.6 11.4 12.5 6.3 14.3 12.6 11.6 8.4 9.6 8.1 13.1 21.7 4.7 10.0 4.4 12.0 0.5 0.8 1.4 0.7 1.0 0.7 0.9 1.2 1.5 0.7 1.0 1.4 1.2 0.4 1.3 0.8 0.5 0.6 0.6 15.7 20.3 16.8 24.0 27.8 15.8 17.9 15.7 17.0 16.4 15.0 27.2 7.5 9.6 6.4 11.1 9.7 9.8 8.2 4.9 8.0 7.4 8.9 6.5 22.2 25.8 11.9 1.8 4.2 4.6 6.4 6.2 9.8 7.2 3.1 5.2 8.7 9.4 5.4 6.5 29.1 18.0 2.1 9.0 6.1 5.4 9.5 9.8 8.9 9.0 5.5 8.4 17.4 6.3 8.2 14.4 7.6 3.1 11.1 9.6 7.2 11.2 3.9 6.8 6.2 17.1 124.9 7.2 6.7 10.9 4.9 6.2 7.2 14.5 8.2 3.9 13.1 10.6 8.9 7.0 3.6 9.1 6.5 1.9 6.2 7.8 5.9 5.2 ZNF404 ENSG00000176222 "Zinc finger protein 404" Q494X3 19 43872365-43901385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 21.5;Oligodendrocytes: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2 OS: 43.7" "Low region specificity" "Detected in all" "HPA032014, HPA063607" Uncertain Supported "Nucleoli,Nucleoli rim,Intermediate filaments" NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 9: U-2 OS - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Nucleoli rim" "Intermediate filaments" "HPA032014: AB_10602591, HPA063607: AB_2732705" "unprognostic (3.76e-3)" "unprognostic (3.41e-1)" "unprognostic (1.11e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-2)" "unprognostic (2.82e-1)" "unprognostic (1.64e-2)" "unprognostic (2.68e-2)" "unprognostic (7.47e-2)" "unprognostic (1.26e-1)" "unprognostic (2.03e-5)" "unprognostic (1.46e-2)" "unprognostic (3.79e-3)" "unprognostic (2.89e-2)" "unprognostic (1.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.80e-3)" 2.4 3.2 9.2 1.1 10.3 0.6 2.7 9.7 11.3 3.8 8.3 5.8 0.6 2.4 9.6 2.0 6.4 2.4 9.1 8.8 9.3 3.9 2.3 2.1 3.6 9.9 9.7 6.8 2.4 2.5 14.3 2.9 9.9 6.1 1.8 18.0 2.8 2.3 2.6 3.1 2.7 2.0 9.7 5.4 3.2 4.6 10.3 2.3 4.2 1.9 1.6 4.6 2.9 12.0 3.4 0.5 3.4 0.4 8.4 11.8 2.0 4.6 2.2 2.9 4.0 0.3 1.2 0.0 4.7 2.2 0.1 0.4 0.6 2.3 3.9 0.5 3.3 1.2 0.1 1.3 3.0 0.3 0.9 7.1 5.5 2.1 2.0 9.8 2.5 0.0 0.1 0.0 2.7 0.3 0.0 0.1 2.8 0.1 0.7 0.0 1.8 0.7 2.8 2.2 1.8 1.4 1.9 0.8 2.4 6.1 0.1 1.3 1.1 4.1 43.7 3.7 2.7 5.8 8.1 0.0 5.8 0.0 2.4 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.3 0.3 0.0 0.5 0.0 0.2 0.3 0.1 9.2 10.3 9.7 11.3 8.8 9.3 9.9 9.7 9.9 9.7 10.3 12.0 1.3 0.0 3.2 21.5 1.5 0.0 0.7 1.1 0.6 3.6 1.3 1.9 7.0 0.0 0.9 0.0 0.0 1.5 0.3 0.2 0.0 0.7 1.5 1.6 3.2 1.5 2.4 0.4 6.9 0.2 1.1 1.6 0.5 1.1 7.0 2.9 1.1 0.5 0.7 5.0 6.9 0.6 4.1 0.3 0.3 0.3 0.9 0.7 0.0 1.9 0.4 3.8 2.1 3.0 19.4 0.2 0.5 3.4 0.1 0.8 0.7 0.4 1.9 3.3 0.0 0.4 1.3 1.7 3.2 0.4 0.0 1.0 1.5 0.5 0.9 0.5 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069703-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments" No No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Intermediate filaments" "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favorable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favorable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favorable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 1.5 1.9 1.2 1.8 1.5 3.9 1.9 3.1 1.7 1.6 1.5 1.5 1.1 1.7 1.6 1.7 1.9 1.3 1.2 1.3 1.0 1.8 2.2 1.4 2.6 1.4 1.1 2.4 1.8 1.7 1.5 1.5 1.5 1.5 1.4 1.9 1.4 1.4 1.4 2.0 1.7 1.6 0.9 2.3 1.8 2.1 1.4 2.4 2.1 1.0 2.5 1.6 1.5 3.1 2.1 2.2 2.3 5.0 3.1 2.1 1.9 2.1 2.2 2.3 2.8 2.8 1.3 4.4 3.6 2.3 1.8 2.9 4.0 2.3 2.3 4.0 2.6 5.6 4.7 1.5 2.1 6.0 5.9 3.0 2.3 2.4 3.7 2.3 2.0 3.8 2.2 6.7 3.1 3.0 5.0 2.1 2.2 2.0 3.0 3.6 3.6 2.4 1.7 4.9 2.7 3.2 3.1 2.4 2.3 2.0 1.9 3.1 3.9 2.2 1.7 5.0 2.3 6.8 5.8 3.9 2.4 3.1 2.0 5.6 3.1 3.8 4.6 2.9 4.7 4.1 5.0 4.0 3.1 5.4 5.8 4.9 3.5 5.9 2.7 5.7 4.3 1.7 1.2 1.5 3.1 1.7 1.3 1.0 1.4 1.1 1.5 0.9 1.4 3.1 5.5 3.2 4.4 5.2 8.3 1.5 6.9 2.7 2.2 9.4 6.1 5.8 5.4 7.2 6.1 7.3 0.0 5.9 5.8 5.4 15.6 6.2 0.9 3.4 8.9 6.9 5.4 6.1 9.2 6.2 4.2 5.6 4.6 4.6 8.2 9.4 8.6 3.8 6.1 16.8 8.9 5.8 2.0 9.8 2.9 0.5 4.4 6.0 0.0 5.6 9.0 6.1 14.4 3.5 8.8 6.1 6.2 5.7 5.9 6.8 6.1 8.1 4.3 6.8 0.0 7.8 6.7 23.2 19.9 3.6 1.3 5.7 7.7 6.7 5.5 6.9 ZNF573 FLJ30921 ENSG00000189144 "Zinc finger protein 573" Q86YE8 19 37735833-37817300 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 37.9;Inhibitory neurons: 28.1;Oligodendrocytes: 22.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042776 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" Cytosol "HPA042776: AB_10961399" "unprognostic (3.79e-2)" "unprognostic (2.57e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (3.72e-2)" "unprognostic (3.29e-2)" "unprognostic (8.26e-2)" "unprognostic (1.10e-1)" "unprognostic (3.62e-2)" "unprognostic (3.69e-1)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "unprognostic (9.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (3.11e-2)" "unprognostic (2.60e-2)" 1.6 1.7 0.5 1.1 1.2 2.1 2.0 4.0 1.4 1.0 0.2 0.9 1.3 1.9 2.7 0.7 1.2 1.7 0.9 0.6 2.6 1.3 0.7 1.4 1.2 0.7 0.6 2.1 1.3 1.4 0.8 1.5 0.9 1.3 1.2 2.7 0.8 0.9 0.9 2.1 1.0 0.9 0.2 1.7 2.0 1.3 0.6 1.1 2.5 0.7 1.6 0.7 0.8 2.4 0.5 1.8 1.4 1.3 0.7 1.5 0.6 1.2 1.3 0.4 1.0 1.8 1.2 1.8 1.1 1.0 0.5 1.1 1.4 1.9 1.7 0.4 1.2 2.0 2.8 0.9 0.6 1.7 1.6 1.4 0.6 2.5 1.0 0.9 1.3 1.0 0.8 0.8 0.3 0.7 1.4 1.0 2.0 0.5 0.2 1.4 2.8 0.6 0.0 1.3 1.8 1.6 2.2 0.6 0.2 0.9 1.7 1.5 0.5 1.6 1.5 1.4 1.9 2.1 2.8 2.6 0.3 0.2 1.3 2.1 0.4 1.6 1.9 0.6 1.5 1.5 1.6 2.1 0.9 2.8 2.6 2.0 0.2 1.7 1.3 1.5 1.0 0.5 0.5 1.2 4.0 1.4 0.6 2.6 0.7 0.6 0.9 0.2 0.6 2.4 3.1 0.0 3.9 7.2 7.4 1.8 2.6 2.1 1.8 15.7 2.1 2.4 11.8 2.8 1.9 3.7 12.5 4.0 7.1 0.8 1.9 2.5 37.9 1.4 3.8 4.7 1.2 3.4 22.2 0.7 3.2 4.0 1.1 1.3 0.0 7.6 5.0 1.4 4.0 16.8 28.1 1.3 0.0 1.3 2.5 16.8 8.7 2.2 3.6 12.2 3.2 7.3 7.2 21.1 22.9 1.3 1.6 6.4 1.8 1.9 2.6 2.9 2.4 12.0 0.0 5.2 3.8 7.7 7.6 2.8 2.6 1.6 5.7 3.6 2.1 1.2 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40491053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 1.7 1.6 2.3 2.0 3.5 3.1 2.9 3.0 2.8 2.0 2.5 2.0 2.3 2.0 2.1 1.4 2.5 1.3 1.8 2.2 2.6 2.2 2.4 2.0 2.4 3.0 3.0 2.6 2.5 3.1 1.2 2.0 3.0 2.1 2.6 4.1 2.7 2.2 2.5 2.4 2.0 2.3 2.2 2.9 2.4 1.1 3.0 1.5 3.0 2.2 2.9 1.7 1.5 4.6 1.9 2.5 2.9 2.8 4.5 4.3 1.3 2.7 3.1 4.5 3.9 0.9 2.6 0.2 1.4 2.2 2.2 2.1 3.2 5.0 4.8 3.6 1.1 6.1 2.2 1.4 4.6 4.2 5.0 3.4 3.9 4.7 6.6 3.9 3.8 0.2 3.9 2.9 2.9 2.3 0.1 2.1 1.6 2.2 2.8 1.2 3.0 3.3 2.1 4.2 2.1 2.2 2.4 4.1 2.0 2.9 3.4 2.7 3.6 3.3 2.7 2.0 2.8 1.6 2.2 0.2 2.1 2.6 3.7 0.8 0.7 1.1 0.7 0.9 0.7 0.7 0.6 0.8 1.0 0.8 0.6 0.9 0.8 1.3 1.0 0.6 1.2 0.7 2.3 3.5 3.0 2.8 2.2 2.6 3.0 3.0 3.0 2.2 3.0 4.6 1.5 0.0 1.1 1.0 2.3 0.3 0.8 0.6 1.2 3.6 1.0 1.0 1.3 0.0 0.3 3.7 2.1 1.4 1.0 0.7 0.0 1.4 0.1 1.4 1.6 1.6 0.0 2.1 0.5 1.5 0.9 1.2 1.5 1.1 0.0 2.4 1.8 0.9 1.1 0.0 1.0 1.3 0.0 1.6 0.4 0.0 1.2 1.2 0.0 2.8 1.6 2.5 2.1 1.0 2.3 0.6 0.2 0.4 1.7 0.5 1.6 1.3 1.0 3.6 0.0 2.0 1.1 1.2 1.4 1.7 0.1 0.4 1.5 2.5 0.8 0.6 ZNF774 MGC75360 ENSG00000196391 "Zinc finger protein 774" Q6NX45 15 90352284-90369146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.0" "HPA030839, HPA030840" Uncertain Supported "Intermediate filaments,Cytosol" No No "Cluster 11: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "Intermediate filaments" Cytosol "HPA030839: AB_2673630, HPA030840: AB_10602691" "unprognostic (1.11e-1)" "unprognostic (2.14e-1)" "unprognostic (1.38e-1)" "unprognostic (5.82e-3)" "unprognostic (3.29e-2)" "unprognostic (1.35e-1)" "unprognostic (6.89e-2)" "unprognostic (9.22e-3)" "unprognostic (7.82e-2)" "unprognostic (1.94e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (2.71e-1)" "unprognostic (5.62e-2)" "unprognostic (1.27e-1)" "unprognostic (4.48e-2)" "unprognostic (4.82e-2)" 0.7 2.7 2.3 1.2 4.2 1.0 3.4 4.3 3.6 2.6 0.0 4.6 2.2 2.8 4.1 1.4 3.0 2.9 2.8 1.9 2.6 1.4 1.1 1.1 0.7 0.7 1.0 1.1 3.9 3.1 3.0 0.7 0.8 2.4 7.1 4.0 3.9 5.7 6.2 3.1 2.0 1.8 0.0 0.6 2.6 2.2 2.7 1.5 2.7 7.2 0.9 1.9 1.6 3.3 1.7 0.7 2.1 2.4 0.9 0.5 5.0 1.0 1.7 1.3 1.6 2.7 2.0 0.6 2.0 1.3 3.7 2.5 2.2 3.7 1.3 1.2 4.2 1.8 9.0 1.3 1.6 1.0 1.3 0.5 4.4 1.9 1.8 3.6 2.3 3.4 2.0 0.8 2.1 1.6 1.4 0.9 0.6 4.5 2.5 1.3 1.8 0.5 2.6 4.6 4.8 2.0 2.0 3.1 0.8 2.4 2.1 0.2 1.1 1.4 1.3 1.1 2.2 5.2 3.8 0.4 2.3 2.8 0.7 1.4 0.3 0.7 0.2 0.1 0.1 0.2 0.2 0.3 0.6 0.4 0.2 0.2 1.2 0.7 0.2 0.3 0.1 0.1 2.3 4.2 4.3 3.6 1.9 2.6 0.7 1.0 0.8 0.0 2.7 3.3 0.6 6.4 3.2 0.3 0.7 0.8 2.5 1.0 2.2 6.4 2.4 2.4 4.9 0.0 1.1 0.0 0.0 1.7 0.2 6.8 1.9 2.8 15.4 1.7 2.3 1.0 2.4 0.0 2.5 2.0 1.1 0.9 4.1 3.2 0.0 45.3 0.0 1.5 0.8 8.4 2.3 3.3 0.0 0.3 0.7 11.0 0.3 0.8 0.0 0.0 0.2 2.0 0.0 1.5 1.1 1.7 5.5 2.2 0.7 1.4 1.9 1.1 0.7 5.3 0.0 1.7 1.9 11.8 4.5 1.3 0.3 1.4 0.5 0.3 5.5 2.0 ZNF880 ENSG00000221923 "Zinc finger protein 880" Q6PDB4 19 52369917-52385795 "Predicted intracellular proteins, Transcription factors" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 38.9" HPA077316 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "HPA077316: AB_2686833" "unprognostic (2.66e-3)" "unprognostic (2.19e-2)" "unprognostic (2.55e-1)" "unprognostic (3.99e-2)" "unprognostic (7.72e-2)" "unprognostic (1.54e-2)" "unprognostic (7.61e-2)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (2.52e-1)" "prognostic favorable (4.33e-8)" "unprognostic (4.14e-2)" "unprognostic (4.99e-1)" "unprognostic (1.77e-1)" "unprognostic (5.60e-3)" 12.5 11.0 8.6 10.9 10.4 17.7 13.5 23.7 10.6 11.9 7.0 11.6 5.7 13.1 11.2 6.3 12.1 10.7 17.5 8.7 9.2 15.1 3.6 11.2 14.7 11.2 11.2 18.4 7.2 5.3 10.4 10.0 12.0 17.1 8.8 16.0 10.8 13.0 7.1 11.2 10.0 11.9 9.4 14.4 9.5 9.9 11.4 15.3 18.1 7.9 14.3 13.5 8.8 12.7 0.3 1.6 19.1 16.0 10.8 29.1 21.9 13.5 13.9 9.2 17.7 0.4 9.1 0.3 4.8 22.2 19.1 3.2 0.1 12.5 14.5 0.3 24.2 0.6 1.0 0.0 12.7 0.5 16.7 23.1 15.6 16.7 0.0 1.1 14.7 1.7 1.7 0.7 18.4 1.3 2.0 1.2 27.6 0.0 3.3 1.4 38.9 1.4 25.8 20.8 14.9 18.8 0.1 4.0 5.9 35.2 0.7 4.3 11.8 0.6 0.4 4.2 12.7 0.8 8.0 0.6 0.4 0.4 26.8 80.3 12.9 31.9 25.1 12.9 32.4 50.3 31.8 27.2 20.9 53.4 37.9 33.0 5.2 26.2 15.2 41.2 37.2 17.5 8.6 10.4 23.7 10.6 8.7 9.2 11.2 11.2 12.0 9.4 11.4 12.7 13.3 12.8 3.9 4.2 15.2 5.9 22.6 22.6 10.8 15.9 7.2 9.7 13.1 4.3 20.4 20.2 12.5 9.9 12.4 2.2 29.4 18.8 12.8 19.2 10.6 10.8 0.0 5.9 3.5 14.8 14.8 11.9 5.6 13.5 10.1 6.0 9.3 1.5 7.0 23.5 4.2 6.2 18.3 4.9 9.8 5.3 13.7 8.2 8.8 1.9 13.9 12.1 32.0 4.5 5.8 20.8 7.9 6.4 2.8 23.3 2.3 8.4 11.3 16.7 19.7 12.3 14.0 4.6 10.1 4.3 7.1 14.4 13.5 5.2 4.0 23.5 ZYG11B "FLJ13456, ZYG11" ENSG00000162378 "Zyg-11 family member B, cell cycle regulator" Q9C0D3 1 52726453-52827336 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 78.9;tongue: 62.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 107.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028156 Uncertain Approved "Golgi apparatus,Intermediate filaments" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus, Intermediate filaments" "HPA028156: AB_10602360" "unprognostic (2.54e-1)" "unprognostic (2.02e-1)" "prognostic favorable (5.42e-6)" "unprognostic (1.58e-2)" "unprognostic (4.44e-2)" "unprognostic (3.04e-3)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (4.84e-3)" "unprognostic (5.06e-2)" "unprognostic (2.76e-1)" "unprognostic (6.08e-2)" "prognostic favorable (9.80e-7)" "unprognostic (2.22e-1)" "unprognostic (3.37e-1)" "unprognostic (1.13e-1)" "unprognostic (9.57e-2)" 9.4 8.4 13.5 5.5 14.5 7.6 7.2 15.9 14.0 9.1 3.5 9.9 4.3 10.8 5.9 9.5 6.8 6.6 17.1 13.7 16.0 12.9 18.6 7.6 5.1 8.5 9.7 10.8 5.1 10.0 4.6 7.1 11.1 9.4 7.5 13.4 6.3 8.6 78.9 6.3 4.6 12.5 8.0 5.6 5.0 8.6 16.3 6.9 12.8 62.0 5.4 7.7 5.7 10.3 10.8 9.9 12.1 15.1 21.7 18.5 10.0 11.7 15.3 9.4 8.7 8.4 3.5 10.2 11.1 23.6 12.6 5.5 14.1 10.6 14.9 7.9 8.6 13.1 10.4 5.3 11.5 9.9 7.7 13.5 11.2 13.4 9.4 13.1 16.6 2.3 12.0 2.1 17.2 4.4 3.9 6.4 12.3 5.4 10.0 6.7 22.4 9.3 9.6 17.2 5.5 10.9 20.6 12.8 10.6 15.2 7.7 7.8 19.1 14.4 8.2 14.3 7.4 8.6 10.8 7.4 9.8 6.6 9.5 0.3 0.7 0.9 0.5 0.3 0.6 0.6 0.7 0.4 0.7 0.5 1.1 0.8 1.7 0.6 0.6 0.4 1.0 0.3 13.5 14.5 15.9 14.0 13.7 16.0 8.5 9.7 11.1 8.0 16.3 10.3 26.8 25.6 28.8 29.0 13.4 11.3 10.5 12.1 10.2 49.5 13.6 11.9 88.3 20.0 14.0 14.7 20.9 24.6 6.9 37.2 7.9 12.2 5.7 13.2 40.9 22.1 10.2 9.0 72.4 11.1 12.0 26.3 12.2 18.6 8.2 32.0 32.5 107.7 20.6 97.6 82.6 11.4 14.2 37.5 11.8 7.9 24.5 21.5 21.4 36.5 21.9 21.6 4.1 46.3 52.0 16.3 17.9 30.9 11.6 26.0 14.0 30.0 11.1 24.4 26.3 35.7 25.9 11.4 23.7 17.3 14.6 34.8 9.7 19.5 15.5 19.0